AU2018200117B2 - Isolated Polynucleotides and Polypeptides and Methods of Using Same for Increasing Plant Utility - Google Patents
Isolated Polynucleotides and Polypeptides and Methods of Using Same for Increasing Plant Utility Download PDFInfo
- Publication number
- AU2018200117B2 AU2018200117B2 AU2018200117A AU2018200117A AU2018200117B2 AU 2018200117 B2 AU2018200117 B2 AU 2018200117B2 AU 2018200117 A AU2018200117 A AU 2018200117A AU 2018200117 A AU2018200117 A AU 2018200117A AU 2018200117 B2 AU2018200117 B2 AU 2018200117B2
- Authority
- AU
- Australia
- Prior art keywords
- plant
- acid sequence
- seq
- blastp
- nucleic acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
- 102000040430 polynucleotide Human genes 0.000 title claims abstract description 256
- 108091033319 polynucleotide Proteins 0.000 title claims abstract description 256
- 239000002157 polynucleotide Substances 0.000 title claims abstract description 256
- 238000000034 method Methods 0.000 title claims abstract description 144
- 108090000765 processed proteins & peptides Proteins 0.000 title claims abstract description 101
- 102000004196 processed proteins & peptides Human genes 0.000 title claims abstract description 101
- 229920001184 polypeptide Polymers 0.000 title claims abstract description 100
- 230000001965 increasing effect Effects 0.000 title claims abstract description 99
- 150000007523 nucleic acids Chemical group 0.000 claims abstract description 172
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims abstract description 157
- 230000012010 growth Effects 0.000 claims abstract description 139
- 108091028043 Nucleic acid sequence Proteins 0.000 claims abstract description 117
- 239000002028 Biomass Substances 0.000 claims abstract description 98
- 230000036579 abiotic stress Effects 0.000 claims abstract description 85
- 229910052757 nitrogen Inorganic materials 0.000 claims abstract description 79
- 125000003275 alpha amino acid group Chemical group 0.000 claims abstract 16
- 230000009261 transgenic effect Effects 0.000 claims description 61
- 102000039446 nucleic acids Human genes 0.000 claims description 56
- 108020004707 nucleic acids Proteins 0.000 claims description 56
- 238000013518 transcription Methods 0.000 claims description 21
- 230000035897 transcription Effects 0.000 claims description 21
- 230000008723 osmotic stress Effects 0.000 claims description 18
- 241000894007 species Species 0.000 claims description 18
- 230000008641 drought stress Effects 0.000 claims description 8
- 244000038559 crop plants Species 0.000 claims description 7
- 230000001131 transforming effect Effects 0.000 claims description 7
- 230000002829 reductive effect Effects 0.000 claims description 3
- 241000196324 Embryophyta Species 0.000 description 549
- 108090000623 proteins and genes Proteins 0.000 description 340
- 241000219194 Arabidopsis Species 0.000 description 181
- 239000003921 oil Substances 0.000 description 138
- 235000019198 oils Nutrition 0.000 description 138
- 230000014509 gene expression Effects 0.000 description 106
- 235000004977 Brassica sinapistrum Nutrition 0.000 description 91
- 235000006008 Brassica napus var napus Nutrition 0.000 description 89
- 235000014698 Brassica juncea var multisecta Nutrition 0.000 description 88
- 240000000385 Brassica napus var. napus Species 0.000 description 88
- 235000006618 Brassica rapa subsp oleifera Nutrition 0.000 description 88
- 210000001519 tissue Anatomy 0.000 description 69
- 150000001413 amino acids Chemical group 0.000 description 62
- 210000004027 cell Anatomy 0.000 description 61
- 108020004999 messenger RNA Proteins 0.000 description 58
- 241000220259 Raphanus Species 0.000 description 52
- 235000006140 Raphanus sativus var sativus Nutrition 0.000 description 52
- 238000012546 transfer Methods 0.000 description 46
- 125000003729 nucleotide group Chemical group 0.000 description 42
- 241001506137 Rapa Species 0.000 description 40
- 239000002773 nucleotide Substances 0.000 description 40
- 102000004169 proteins and genes Human genes 0.000 description 40
- 239000013598 vector Substances 0.000 description 40
- 239000000047 product Substances 0.000 description 39
- 235000018102 proteins Nutrition 0.000 description 38
- 235000010469 Glycine max Nutrition 0.000 description 37
- 244000068988 Glycine max Species 0.000 description 37
- 108020004414 DNA Proteins 0.000 description 36
- 238000010367 cloning Methods 0.000 description 33
- 230000001105 regulatory effect Effects 0.000 description 33
- 240000008042 Zea mays Species 0.000 description 31
- 230000000694 effects Effects 0.000 description 31
- 238000004458 analytical method Methods 0.000 description 30
- 241000700605 Viruses Species 0.000 description 29
- 235000016383 Zea mays subsp huehuetenangensis Nutrition 0.000 description 29
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 29
- 235000009973 maize Nutrition 0.000 description 29
- 229920002477 rna polymer Polymers 0.000 description 28
- 230000009466 transformation Effects 0.000 description 27
- 108020004705 Codon Proteins 0.000 description 26
- 240000007594 Oryza sativa Species 0.000 description 24
- 235000007164 Oryza sativa Nutrition 0.000 description 24
- 241000219146 Gossypium Species 0.000 description 22
- 108091008146 restriction endonucleases Proteins 0.000 description 22
- 235000009566 rice Nutrition 0.000 description 22
- 229920000742 Cotton Polymers 0.000 description 21
- 230000000692 anti-sense effect Effects 0.000 description 20
- 244000062793 Sorghum vulgare Species 0.000 description 19
- 230000002222 downregulating effect Effects 0.000 description 18
- 235000003222 Helianthus annuus Nutrition 0.000 description 17
- 235000007688 Lycopersicon esculentum Nutrition 0.000 description 17
- 241000219000 Populus Species 0.000 description 17
- 240000003768 Solanum lycopersicum Species 0.000 description 17
- 240000006365 Vitis vinifera Species 0.000 description 17
- 235000014787 Vitis vinifera Nutrition 0.000 description 17
- 238000003556 assay Methods 0.000 description 17
- 230000003612 virological effect Effects 0.000 description 17
- 241000208818 Helianthus Species 0.000 description 16
- 241000208822 Lactuca Species 0.000 description 16
- 235000003228 Lactuca sativa Nutrition 0.000 description 16
- 241001520808 Panicum virgatum Species 0.000 description 16
- 238000002474 experimental method Methods 0.000 description 16
- 238000003306 harvesting Methods 0.000 description 16
- 108700010070 Codon Usage Proteins 0.000 description 15
- 239000002299 complementary DNA Substances 0.000 description 15
- 230000009368 gene silencing by RNA Effects 0.000 description 15
- 108091026890 Coding region Proteins 0.000 description 14
- 240000000111 Saccharum officinarum Species 0.000 description 14
- 235000007201 Saccharum officinarum Nutrition 0.000 description 14
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 14
- 235000011684 Sorghum saccharatum Nutrition 0.000 description 14
- 108091027544 Subgenomic mRNA Proteins 0.000 description 14
- 241000209140 Triticum Species 0.000 description 14
- 235000021307 Triticum Nutrition 0.000 description 14
- 235000009754 Vitis X bourquina Nutrition 0.000 description 14
- 235000012333 Vitis X labruscana Nutrition 0.000 description 14
- 210000000056 organ Anatomy 0.000 description 14
- 239000013612 plasmid Substances 0.000 description 14
- 241000220225 Malus Species 0.000 description 13
- 238000012228 RNA interference-mediated gene silencing Methods 0.000 description 13
- 108700008625 Reporter Genes Proteins 0.000 description 13
- 235000002595 Solanum tuberosum Nutrition 0.000 description 13
- 244000061456 Solanum tuberosum Species 0.000 description 13
- 238000004422 calculation algorithm Methods 0.000 description 13
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 13
- 101710132601 Capsid protein Proteins 0.000 description 12
- 241000207199 Citrus Species 0.000 description 12
- 101710094648 Coat protein Proteins 0.000 description 12
- 101710125418 Major capsid protein Proteins 0.000 description 12
- 101710141454 Nucleoprotein Proteins 0.000 description 12
- 101710083689 Probable capsid protein Proteins 0.000 description 12
- 235000020971 citrus fruits Nutrition 0.000 description 12
- 230000000295 complement effect Effects 0.000 description 12
- 230000008635 plant growth Effects 0.000 description 12
- 229920001817 Agar Polymers 0.000 description 11
- 108091060211 Expressed sequence tag Proteins 0.000 description 11
- 240000005979 Hordeum vulgare Species 0.000 description 11
- 235000007340 Hordeum vulgare Nutrition 0.000 description 11
- 235000010627 Phaseolus vulgaris Nutrition 0.000 description 11
- 244000046052 Phaseolus vulgaris Species 0.000 description 11
- 239000008272 agar Substances 0.000 description 11
- 239000002609 medium Substances 0.000 description 11
- 239000013600 plasmid vector Substances 0.000 description 11
- 230000008569 process Effects 0.000 description 11
- 108091092562 ribozyme Proteins 0.000 description 11
- 230000035882 stress Effects 0.000 description 11
- 241000589158 Agrobacterium Species 0.000 description 10
- 102100021181 Golgi phosphoprotein 3 Human genes 0.000 description 10
- 241000219977 Vigna Species 0.000 description 9
- 235000010726 Vigna sinensis Nutrition 0.000 description 9
- 230000003321 amplification Effects 0.000 description 9
- 210000003763 chloroplast Anatomy 0.000 description 9
- 235000013305 food Nutrition 0.000 description 9
- 239000012634 fragment Substances 0.000 description 9
- 238000003199 nucleic acid amplification method Methods 0.000 description 9
- 101150093826 par1 gene Proteins 0.000 description 9
- 239000010773 plant oil Substances 0.000 description 9
- 150000003839 salts Chemical class 0.000 description 9
- 239000000523 sample Substances 0.000 description 9
- 238000013515 script Methods 0.000 description 9
- 230000001629 suppression Effects 0.000 description 9
- 238000012360 testing method Methods 0.000 description 9
- 230000014616 translation Effects 0.000 description 9
- 238000013519 translation Methods 0.000 description 9
- 238000011144 upstream manufacturing Methods 0.000 description 9
- 235000015112 vegetable and seed oil Nutrition 0.000 description 9
- 108090000994 Catalytic RNA Proteins 0.000 description 8
- 102000053642 Catalytic RNA Human genes 0.000 description 8
- 241000219112 Cucumis Species 0.000 description 8
- 241000208125 Nicotiana Species 0.000 description 8
- 235000002637 Nicotiana tabacum Nutrition 0.000 description 8
- 108091027967 Small hairpin RNA Proteins 0.000 description 8
- 238000010276 construction Methods 0.000 description 8
- 239000013604 expression vector Substances 0.000 description 8
- 238000004519 manufacturing process Methods 0.000 description 8
- 239000003550 marker Substances 0.000 description 8
- 238000002493 microarray Methods 0.000 description 8
- 239000000203 mixture Substances 0.000 description 8
- 230000017260 vegetative to reproductive phase transition of meristem Effects 0.000 description 8
- 244000105624 Arachis hypogaea Species 0.000 description 7
- 235000015510 Cucumis melo subsp melo Nutrition 0.000 description 7
- 102000004190 Enzymes Human genes 0.000 description 7
- 108090000790 Enzymes Proteins 0.000 description 7
- 241001518935 Eragrostis Species 0.000 description 7
- FJJCIZWZNKZHII-UHFFFAOYSA-N [4,6-bis(cyanoamino)-1,3,5-triazin-2-yl]cyanamide Chemical compound N#CNC1=NC(NC#N)=NC(NC#N)=N1 FJJCIZWZNKZHII-UHFFFAOYSA-N 0.000 description 7
- 238000013459 approach Methods 0.000 description 7
- 235000013339 cereals Nutrition 0.000 description 7
- 239000003795 chemical substances by application Substances 0.000 description 7
- 238000007821 culture assay Methods 0.000 description 7
- 230000035784 germination Effects 0.000 description 7
- 230000004060 metabolic process Effects 0.000 description 7
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 7
- 235000015097 nutrients Nutrition 0.000 description 7
- 238000012163 sequencing technique Methods 0.000 description 7
- 239000011780 sodium chloride Substances 0.000 description 7
- 241000219195 Arabidopsis thaliana Species 0.000 description 6
- 235000017060 Arachis glabrata Nutrition 0.000 description 6
- 235000010777 Arachis hypogaea Nutrition 0.000 description 6
- 235000018262 Arachis monticola Nutrition 0.000 description 6
- 240000002791 Brassica napus Species 0.000 description 6
- 235000009467 Carica papaya Nutrition 0.000 description 6
- 240000006432 Carica papaya Species 0.000 description 6
- 108010073032 Grain Proteins Proteins 0.000 description 6
- 101710202365 Napin Proteins 0.000 description 6
- 108700026244 Open Reading Frames Proteins 0.000 description 6
- 241000245665 Taraxacum Species 0.000 description 6
- 235000005187 Taraxacum officinale ssp. officinale Nutrition 0.000 description 6
- 244000299461 Theobroma cacao Species 0.000 description 6
- 235000005764 Theobroma cacao ssp. cacao Nutrition 0.000 description 6
- 235000005767 Theobroma cacao ssp. sphaerocarpum Nutrition 0.000 description 6
- 235000001046 cacaotero Nutrition 0.000 description 6
- 230000007423 decrease Effects 0.000 description 6
- 238000010252 digital analysis Methods 0.000 description 6
- 238000002955 isolation Methods 0.000 description 6
- 238000005259 measurement Methods 0.000 description 6
- 230000004048 modification Effects 0.000 description 6
- 238000012986 modification Methods 0.000 description 6
- 239000002245 particle Substances 0.000 description 6
- 235000020232 peanut Nutrition 0.000 description 6
- 229920001223 polyethylene glycol Polymers 0.000 description 6
- 230000033458 reproduction Effects 0.000 description 6
- 238000007619 statistical method Methods 0.000 description 6
- 230000001052 transient effect Effects 0.000 description 6
- 241000219739 Lens Species 0.000 description 5
- 240000003183 Manihot esculenta Species 0.000 description 5
- 241000219823 Medicago Species 0.000 description 5
- 240000000528 Ricinus communis Species 0.000 description 5
- 235000004443 Ricinus communis Nutrition 0.000 description 5
- 108700019146 Transgenes Proteins 0.000 description 5
- 230000015572 biosynthetic process Effects 0.000 description 5
- 230000002596 correlated effect Effects 0.000 description 5
- 238000012258 culturing Methods 0.000 description 5
- 230000007812 deficiency Effects 0.000 description 5
- 238000005516 engineering process Methods 0.000 description 5
- 238000011156 evaluation Methods 0.000 description 5
- 238000011534 incubation Methods 0.000 description 5
- 238000003780 insertion Methods 0.000 description 5
- 230000037431 insertion Effects 0.000 description 5
- 150000002632 lipids Chemical class 0.000 description 5
- 239000000463 material Substances 0.000 description 5
- 108091070501 miRNA Proteins 0.000 description 5
- 238000010369 molecular cloning Methods 0.000 description 5
- 238000005457 optimization Methods 0.000 description 5
- 230000010076 replication Effects 0.000 description 5
- 230000002786 root growth Effects 0.000 description 5
- 239000000243 solution Substances 0.000 description 5
- 238000009331 sowing Methods 0.000 description 5
- 238000006467 substitution reaction Methods 0.000 description 5
- 244000296825 Amygdalus nana Species 0.000 description 4
- 235000003840 Amygdalus nana Nutrition 0.000 description 4
- 241000207875 Antirrhinum Species 0.000 description 4
- 241000218156 Aquilegia Species 0.000 description 4
- 241000743774 Brachypodium Species 0.000 description 4
- 235000003255 Carthamus tinctorius Nutrition 0.000 description 4
- 244000020518 Carthamus tinctorius Species 0.000 description 4
- 244000067602 Chamaesyce hirta Species 0.000 description 4
- 241000208947 Cynara Species 0.000 description 4
- 235000003198 Cynara Nutrition 0.000 description 4
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 4
- 108020004684 Internal Ribosome Entry Sites Proteins 0.000 description 4
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 4
- 241000758791 Juglandaceae Species 0.000 description 4
- 235000016735 Manihot esculenta subsp esculenta Nutrition 0.000 description 4
- 241001465754 Metazoa Species 0.000 description 4
- 108020004485 Nonsense Codon Proteins 0.000 description 4
- 108010076504 Protein Sorting Signals Proteins 0.000 description 4
- 235000011432 Prunus Nutrition 0.000 description 4
- 241001523344 Pseudoroegneria Species 0.000 description 4
- 241001250564 Thellungiella Species 0.000 description 4
- 241000723873 Tobacco mosaic virus Species 0.000 description 4
- 108091023040 Transcription factor Proteins 0.000 description 4
- 102000040945 Transcription factor Human genes 0.000 description 4
- 241000906460 Triphysaria Species 0.000 description 4
- 230000000875 corresponding effect Effects 0.000 description 4
- 238000012217 deletion Methods 0.000 description 4
- 230000037430 deletion Effects 0.000 description 4
- 230000003828 downregulation Effects 0.000 description 4
- 238000001035 drying Methods 0.000 description 4
- 230000007613 environmental effect Effects 0.000 description 4
- 238000000605 extraction Methods 0.000 description 4
- 239000000835 fiber Substances 0.000 description 4
- 230000002068 genetic effect Effects 0.000 description 4
- 239000011521 glass Substances 0.000 description 4
- 238000003384 imaging method Methods 0.000 description 4
- 239000004615 ingredient Substances 0.000 description 4
- 229930027917 kanamycin Natural products 0.000 description 4
- 229960000318 kanamycin Drugs 0.000 description 4
- SBUJHOSQTJFQJX-NOAMYHISSA-N kanamycin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CN)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](N)[C@H](O)[C@@H](CO)O2)O)[C@H](N)C[C@@H]1N SBUJHOSQTJFQJX-NOAMYHISSA-N 0.000 description 4
- 229930182823 kanamycin A Natural products 0.000 description 4
- 231100000783 metal toxicity Toxicity 0.000 description 4
- 235000018343 nutrient deficiency Nutrition 0.000 description 4
- 244000052769 pathogen Species 0.000 description 4
- 230000037361 pathway Effects 0.000 description 4
- FGIUAXJPYTZDNR-UHFFFAOYSA-N potassium nitrate Chemical compound [K+].[O-][N+]([O-])=O FGIUAXJPYTZDNR-UHFFFAOYSA-N 0.000 description 4
- 235000014774 prunus Nutrition 0.000 description 4
- 230000002441 reversible effect Effects 0.000 description 4
- 239000002904 solvent Substances 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- 238000009281 ultraviolet germicidal irradiation Methods 0.000 description 4
- 230000035899 viability Effects 0.000 description 4
- 235000020234 walnut Nutrition 0.000 description 4
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 3
- 102000040650 (ribonucleotides)n+m Human genes 0.000 description 3
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 3
- 235000009091 Cordyline terminalis Nutrition 0.000 description 3
- 244000289527 Cordyline terminalis Species 0.000 description 3
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 3
- 102100031780 Endonuclease Human genes 0.000 description 3
- 101100437498 Escherichia coli (strain K12) uidA gene Proteins 0.000 description 3
- 244000004281 Eucalyptus maculata Species 0.000 description 3
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 3
- 238000005481 NMR spectroscopy Methods 0.000 description 3
- 235000006508 Nelumbo nucifera Nutrition 0.000 description 3
- 235000006510 Nelumbo pentapetala Nutrition 0.000 description 3
- 108091034117 Oligonucleotide Proteins 0.000 description 3
- 241000219843 Pisum Species 0.000 description 3
- 108700001094 Plant Genes Proteins 0.000 description 3
- 229920002594 Polyethylene Glycol 8000 Polymers 0.000 description 3
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 3
- 238000000692 Student's t-test Methods 0.000 description 3
- 241000219793 Trifolium Species 0.000 description 3
- 239000002253 acid Substances 0.000 description 3
- 239000012190 activator Substances 0.000 description 3
- 230000004075 alteration Effects 0.000 description 3
- 230000008901 benefit Effects 0.000 description 3
- 238000004364 calculation method Methods 0.000 description 3
- 229910052799 carbon Inorganic materials 0.000 description 3
- 238000004113 cell culture Methods 0.000 description 3
- 238000006243 chemical reaction Methods 0.000 description 3
- 239000002131 composite material Substances 0.000 description 3
- 150000001875 compounds Chemical class 0.000 description 3
- 238000010219 correlation analysis Methods 0.000 description 3
- 238000011161 development Methods 0.000 description 3
- 238000009826 distribution Methods 0.000 description 3
- 241001493065 dsRNA viruses Species 0.000 description 3
- 238000010195 expression analysis Methods 0.000 description 3
- 230000004720 fertilization Effects 0.000 description 3
- 239000003337 fertilizer Substances 0.000 description 3
- 239000000446 fuel Substances 0.000 description 3
- 239000001963 growth medium Substances 0.000 description 3
- 230000008642 heat stress Effects 0.000 description 3
- 229910001385 heavy metal Inorganic materials 0.000 description 3
- 208000015181 infectious disease Diseases 0.000 description 3
- 230000005764 inhibitory process Effects 0.000 description 3
- 238000011081 inoculation Methods 0.000 description 3
- 230000000670 limiting effect Effects 0.000 description 3
- 235000021073 macronutrients Nutrition 0.000 description 3
- 230000001404 mediated effect Effects 0.000 description 3
- 235000019713 millet Nutrition 0.000 description 3
- 230000000877 morphologic effect Effects 0.000 description 3
- 230000002018 overexpression Effects 0.000 description 3
- 230000001717 pathogenic effect Effects 0.000 description 3
- 230000008121 plant development Effects 0.000 description 3
- 239000004033 plastic Substances 0.000 description 3
- 229920003023 plastic Polymers 0.000 description 3
- 239000011591 potassium Substances 0.000 description 3
- 229910052700 potassium Inorganic materials 0.000 description 3
- 238000012175 pyrosequencing Methods 0.000 description 3
- 238000011084 recovery Methods 0.000 description 3
- 238000010839 reverse transcription Methods 0.000 description 3
- 239000002689 soil Substances 0.000 description 3
- 239000000600 sorbitol Substances 0.000 description 3
- 238000010186 staining Methods 0.000 description 3
- 230000003827 upregulation Effects 0.000 description 3
- 230000009105 vegetative growth Effects 0.000 description 3
- 239000013603 viral vector Substances 0.000 description 3
- 101150096316 5 gene Proteins 0.000 description 2
- 235000009434 Actinidia chinensis Nutrition 0.000 description 2
- 244000298697 Actinidia deliciosa Species 0.000 description 2
- 235000009436 Actinidia deliciosa Nutrition 0.000 description 2
- 241000722957 Amborella Species 0.000 description 2
- 108091093088 Amplicon Proteins 0.000 description 2
- 244000144730 Amygdalus persica Species 0.000 description 2
- 108020005544 Antisense RNA Proteins 0.000 description 2
- 241001184073 Basilicum Species 0.000 description 2
- 241000710076 Bean common mosaic virus Species 0.000 description 2
- 235000011293 Brassica napus Nutrition 0.000 description 2
- 240000007124 Brassica oleracea Species 0.000 description 2
- 235000003899 Brassica oleracea var acephala Nutrition 0.000 description 2
- 235000011299 Brassica oleracea var botrytis Nutrition 0.000 description 2
- 235000012905 Brassica oleracea var viridis Nutrition 0.000 description 2
- 240000003259 Brassica oleracea var. botrytis Species 0.000 description 2
- 241000724256 Brome mosaic virus Species 0.000 description 2
- 101100297347 Caenorhabditis elegans pgl-3 gene Proteins 0.000 description 2
- 235000002566 Capsicum Nutrition 0.000 description 2
- 241000209120 Cenchrus Species 0.000 description 2
- 241000132570 Centaurea Species 0.000 description 2
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- 241000723343 Cichorium Species 0.000 description 2
- 244000037364 Cinnamomum aromaticum Species 0.000 description 2
- 235000014489 Cinnamomum aromaticum Nutrition 0.000 description 2
- 108020004635 Complementary DNA Proteins 0.000 description 2
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 2
- 108010066133 D-octopine dehydrogenase Proteins 0.000 description 2
- 102000012410 DNA Ligases Human genes 0.000 description 2
- 108010061982 DNA Ligases Proteins 0.000 description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- 238000002965 ELISA Methods 0.000 description 2
- 108010042407 Endonucleases Proteins 0.000 description 2
- 241000234642 Festuca Species 0.000 description 2
- 235000016623 Fragaria vesca Nutrition 0.000 description 2
- 240000009088 Fragaria x ananassa Species 0.000 description 2
- 235000011363 Fragaria x ananassa Nutrition 0.000 description 2
- 108010068370 Glutens Proteins 0.000 description 2
- 206010053759 Growth retardation Diseases 0.000 description 2
- 206010020649 Hyperkeratosis Diseases 0.000 description 2
- 235000021506 Ipomoea Nutrition 0.000 description 2
- 241000207783 Ipomoea Species 0.000 description 2
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 2
- 108091026898 Leader sequence (mRNA) Proteins 0.000 description 2
- 235000014647 Lens culinaris subsp culinaris Nutrition 0.000 description 2
- 240000007472 Leucaena leucocephala Species 0.000 description 2
- 235000010643 Leucaena leucocephala Nutrition 0.000 description 2
- 241000511731 Leymus Species 0.000 description 2
- 241000208202 Linaceae Species 0.000 description 2
- 235000004431 Linum usitatissimum Nutrition 0.000 description 2
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 2
- 229930195725 Mannitol Natural products 0.000 description 2
- 235000017587 Medicago sativa ssp. sativa Nutrition 0.000 description 2
- 241000353097 Molva molva Species 0.000 description 2
- 240000008790 Musa x paradisiaca Species 0.000 description 2
- 235000018290 Musa x paradisiaca Nutrition 0.000 description 2
- 240000002853 Nelumbo nucifera Species 0.000 description 2
- 238000000636 Northern blotting Methods 0.000 description 2
- 235000010582 Pisum sativum Nutrition 0.000 description 2
- 235000009827 Prunus armeniaca Nutrition 0.000 description 2
- 244000018633 Prunus armeniaca Species 0.000 description 2
- 235000006040 Prunus persica var persica Nutrition 0.000 description 2
- 108091034057 RNA (poly(A)) Proteins 0.000 description 2
- 239000013614 RNA sample Substances 0.000 description 2
- 108010092799 RNA-directed DNA polymerase Proteins 0.000 description 2
- 108020004511 Recombinant DNA Proteins 0.000 description 2
- 235000007230 Sorghum bicolor Nutrition 0.000 description 2
- 108091081024 Start codon Proteins 0.000 description 2
- 229930006000 Sucrose Natural products 0.000 description 2
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 2
- 108700005078 Synthetic Genes Proteins 0.000 description 2
- 244000269722 Thea sinensis Species 0.000 description 2
- 108091036066 Three prime untranslated region Proteins 0.000 description 2
- 108020004566 Transfer RNA Proteins 0.000 description 2
- 241000863480 Vinca Species 0.000 description 2
- 108020005202 Viral DNA Proteins 0.000 description 2
- 241001464837 Viridiplantae Species 0.000 description 2
- 235000007244 Zea mays Nutrition 0.000 description 2
- 230000002745 absorbent Effects 0.000 description 2
- 239000002250 absorbent Substances 0.000 description 2
- 230000035508 accumulation Effects 0.000 description 2
- 238000009825 accumulation Methods 0.000 description 2
- 230000009418 agronomic effect Effects 0.000 description 2
- 230000001580 bacterial effect Effects 0.000 description 2
- 239000003225 biodiesel Substances 0.000 description 2
- 239000002551 biofuel Substances 0.000 description 2
- 230000004071 biological effect Effects 0.000 description 2
- 230000033228 biological regulation Effects 0.000 description 2
- 238000012512 characterization method Methods 0.000 description 2
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- 210000000349 chromosome Anatomy 0.000 description 2
- 230000008645 cold stress Effects 0.000 description 2
- 238000004040 coloring Methods 0.000 description 2
- 239000003184 complementary RNA Substances 0.000 description 2
- 230000006835 compression Effects 0.000 description 2
- 238000007906 compression Methods 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 238000013461 design Methods 0.000 description 2
- 230000018109 developmental process Effects 0.000 description 2
- 230000004069 differentiation Effects 0.000 description 2
- 230000029087 digestion Effects 0.000 description 2
- 230000024346 drought recovery Effects 0.000 description 2
- 235000013399 edible fruits Nutrition 0.000 description 2
- 210000002257 embryonic structure Anatomy 0.000 description 2
- 230000001747 exhibiting effect Effects 0.000 description 2
- 238000011049 filling Methods 0.000 description 2
- 239000004459 forage Substances 0.000 description 2
- 239000002803 fossil fuel Substances 0.000 description 2
- 238000007710 freezing Methods 0.000 description 2
- 230000008014 freezing Effects 0.000 description 2
- 230000005714 functional activity Effects 0.000 description 2
- 239000007789 gas Substances 0.000 description 2
- 238000011223 gene expression profiling Methods 0.000 description 2
- 230000030279 gene silencing Effects 0.000 description 2
- 231100000001 growth retardation Toxicity 0.000 description 2
- 101150054900 gus gene Proteins 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- 238000009396 hybridization Methods 0.000 description 2
- BHEPBYXIRTUNPN-UHFFFAOYSA-N hydridophosphorus(.) (triplet) Chemical compound [PH] BHEPBYXIRTUNPN-UHFFFAOYSA-N 0.000 description 2
- 238000010191 image analysis Methods 0.000 description 2
- 238000003018 immunoassay Methods 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- 238000000126 in silico method Methods 0.000 description 2
- 238000001727 in vivo Methods 0.000 description 2
- 230000002401 inhibitory effect Effects 0.000 description 2
- 230000000977 initiatory effect Effects 0.000 description 2
- 229910052742 iron Inorganic materials 0.000 description 2
- 238000005304 joining Methods 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 239000000314 lubricant Substances 0.000 description 2
- 239000000594 mannitol Substances 0.000 description 2
- 235000010355 mannitol Nutrition 0.000 description 2
- 230000000442 meristematic effect Effects 0.000 description 2
- 239000006870 ms-medium Substances 0.000 description 2
- 238000002703 mutagenesis Methods 0.000 description 2
- 231100000350 mutagenesis Toxicity 0.000 description 2
- 230000035772 mutation Effects 0.000 description 2
- 238000007857 nested PCR Methods 0.000 description 2
- QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 description 2
- 230000037434 nonsense mutation Effects 0.000 description 2
- 108010058731 nopaline synthase Proteins 0.000 description 2
- 235000016709 nutrition Nutrition 0.000 description 2
- 244000045947 parasite Species 0.000 description 2
- 230000001766 physiological effect Effects 0.000 description 2
- 230000008488 polyadenylation Effects 0.000 description 2
- 235000010333 potassium nitrate Nutrition 0.000 description 2
- 230000001737 promoting effect Effects 0.000 description 2
- 108020001580 protein domains Proteins 0.000 description 2
- 210000001938 protoplast Anatomy 0.000 description 2
- 238000000746 purification Methods 0.000 description 2
- 239000002994 raw material Substances 0.000 description 2
- 230000006798 recombination Effects 0.000 description 2
- 238000005215 recombination Methods 0.000 description 2
- 238000007670 refining Methods 0.000 description 2
- 230000011514 reflex Effects 0.000 description 2
- 230000001850 reproductive effect Effects 0.000 description 2
- 238000012216 screening Methods 0.000 description 2
- 238000002791 soaking Methods 0.000 description 2
- 238000013517 stratification Methods 0.000 description 2
- 239000005720 sucrose Substances 0.000 description 2
- 230000004083 survival effect Effects 0.000 description 2
- 230000009885 systemic effect Effects 0.000 description 2
- 238000012353 t test Methods 0.000 description 2
- 230000002103 transcriptional effect Effects 0.000 description 2
- 150000003626 triacylglycerols Chemical class 0.000 description 2
- JWZZKOKVBUJMES-UHFFFAOYSA-N (+-)-Isoprenaline Chemical compound CC(C)NCC(O)C1=CC=C(O)C(O)=C1 JWZZKOKVBUJMES-UHFFFAOYSA-N 0.000 description 1
- HZWWPUTXBJEENE-UHFFFAOYSA-N 5-amino-2-[[1-[5-amino-2-[[1-[2-amino-3-(4-hydroxyphenyl)propanoyl]pyrrolidine-2-carbonyl]amino]-5-oxopentanoyl]pyrrolidine-2-carbonyl]amino]-5-oxopentanoic acid Chemical compound C1CCC(C(=O)NC(CCC(N)=O)C(=O)N2C(CCC2)C(=O)NC(CCC(N)=O)C(O)=O)N1C(=O)C(N)CC1=CC=C(O)C=C1 HZWWPUTXBJEENE-UHFFFAOYSA-N 0.000 description 1
- 102100028220 ABI gene family member 3 Human genes 0.000 description 1
- 240000004507 Abelmoschus esculentus Species 0.000 description 1
- 241000208140 Acer Species 0.000 description 1
- RZVAJINKPMORJF-UHFFFAOYSA-N Acetaminophen Chemical compound CC(=O)NC1=CC=C(O)C=C1 RZVAJINKPMORJF-UHFFFAOYSA-N 0.000 description 1
- 108090000104 Actin-related protein 3 Proteins 0.000 description 1
- 241000219068 Actinidia Species 0.000 description 1
- 102000007469 Actins Human genes 0.000 description 1
- 108010085238 Actins Proteins 0.000 description 1
- 241000157282 Aesculus Species 0.000 description 1
- 241000592335 Agathis australis Species 0.000 description 1
- 241000524150 Albizia amara Species 0.000 description 1
- 102100027211 Albumin Human genes 0.000 description 1
- 108010088751 Albumins Proteins 0.000 description 1
- 244000291564 Allium cepa Species 0.000 description 1
- 235000002732 Allium cepa var. cepa Nutrition 0.000 description 1
- 241000962146 Alsophila tricolor Species 0.000 description 1
- 235000009328 Amaranthus caudatus Nutrition 0.000 description 1
- 240000001592 Amaranthus caudatus Species 0.000 description 1
- QGZKDVFQNNGYKY-UHFFFAOYSA-O Ammonium Chemical compound [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 description 1
- 241000744007 Andropogon Species 0.000 description 1
- 240000007087 Apium graveolens Species 0.000 description 1
- 235000015849 Apium graveolens Dulce Group Nutrition 0.000 description 1
- 235000010591 Appio Nutrition 0.000 description 1
- 108700025350 Arabidopsis Fae1 Proteins 0.000 description 1
- 108700009650 Arabidopsis JGB Proteins 0.000 description 1
- 235000003911 Arachis Nutrition 0.000 description 1
- 244000080767 Areca catechu Species 0.000 description 1
- 235000006226 Areca catechu Nutrition 0.000 description 1
- 244000003416 Asparagus officinalis Species 0.000 description 1
- 235000005340 Asparagus officinalis Nutrition 0.000 description 1
- 241000243239 Astelia fragrans Species 0.000 description 1
- 241001061305 Astragalus cicer Species 0.000 description 1
- 244000075850 Avena orientalis Species 0.000 description 1
- 235000007319 Avena orientalis Nutrition 0.000 description 1
- 235000007558 Avena sp Nutrition 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 241000012950 Baikiaea plurijuga Species 0.000 description 1
- 241000702286 Bean golden mosaic virus Species 0.000 description 1
- 235000012284 Bertholletia excelsa Nutrition 0.000 description 1
- 244000205479 Bertholletia excelsa Species 0.000 description 1
- 241000219310 Beta vulgaris subsp. vulgaris Species 0.000 description 1
- 235000003932 Betula Nutrition 0.000 description 1
- 241000219429 Betula Species 0.000 description 1
- 241000283690 Bos taurus Species 0.000 description 1
- 235000011331 Brassica Nutrition 0.000 description 1
- 241000219198 Brassica Species 0.000 description 1
- 235000011301 Brassica oleracea var capitata Nutrition 0.000 description 1
- 235000004221 Brassica oleracea var gemmifera Nutrition 0.000 description 1
- 235000017647 Brassica oleracea var italica Nutrition 0.000 description 1
- 235000001169 Brassica oleracea var oleracea Nutrition 0.000 description 1
- 244000064816 Brassica oleracea var. acephala Species 0.000 description 1
- 244000308368 Brassica oleracea var. gemmifera Species 0.000 description 1
- DPUOLQHDNGRHBS-UHFFFAOYSA-N Brassidinsaeure Natural products CCCCCCCCC=CCCCCCCCCCCCC(O)=O DPUOLQHDNGRHBS-UHFFFAOYSA-N 0.000 description 1
- 244000277360 Bruguiera gymnorhiza Species 0.000 description 1
- 241000195940 Bryophyta Species 0.000 description 1
- 241001424028 Burkea africana Species 0.000 description 1
- 241000565319 Butea monosperma Species 0.000 description 1
- 235000008635 Cadaba farinosa Nutrition 0.000 description 1
- 241000628166 Cadaba farinosa Species 0.000 description 1
- 101100411570 Caenorhabditis elegans rab-28 gene Proteins 0.000 description 1
- 241001343295 Calliandra Species 0.000 description 1
- 244000292211 Canna coccinea Species 0.000 description 1
- 235000005273 Canna coccinea Nutrition 0.000 description 1
- 240000008574 Capsicum frutescens Species 0.000 description 1
- 108090000565 Capsid Proteins Proteins 0.000 description 1
- 241000701489 Cauliflower mosaic virus Species 0.000 description 1
- 235000021511 Cinnamomum cassia Nutrition 0.000 description 1
- 235000007460 Coffea arabica Nutrition 0.000 description 1
- 240000007154 Coffea arabica Species 0.000 description 1
- 241000350000 Colophospermum mopane Species 0.000 description 1
- 241000218631 Coniferophyta Species 0.000 description 1
- 241001507946 Cotoneaster Species 0.000 description 1
- 235000014493 Crataegus Nutrition 0.000 description 1
- 241001092040 Crataegus Species 0.000 description 1
- 240000005109 Cryptomeria japonica Species 0.000 description 1
- 241000195493 Cryptophyta Species 0.000 description 1
- 235000010071 Cucumis prophetarum Nutrition 0.000 description 1
- 235000009854 Cucurbita moschata Nutrition 0.000 description 1
- 240000001980 Cucurbita pepo Species 0.000 description 1
- 235000009852 Cucurbita pepo Nutrition 0.000 description 1
- 244000304337 Cuminum cyminum Species 0.000 description 1
- 241000723198 Cupressus Species 0.000 description 1
- 241000132493 Cyathea dealbata Species 0.000 description 1
- 102000001493 Cyclophilins Human genes 0.000 description 1
- 108010068682 Cyclophilins Proteins 0.000 description 1
- 235000009807 Cydonia Nutrition 0.000 description 1
- 241001507921 Cydonia Species 0.000 description 1
- 235000017788 Cydonia oblonga Nutrition 0.000 description 1
- 244000236931 Cydonia oblonga Species 0.000 description 1
- 241000931332 Cymbopogon Species 0.000 description 1
- FEPOUSPSESUQPD-UHFFFAOYSA-N Cymbopogon Natural products C1CC2(C)C(C)C(=O)CCC2C2(C)C1C1(C)CCC3(C)CCC(C)C(C)C3C1(C)CC2 FEPOUSPSESUQPD-UHFFFAOYSA-N 0.000 description 1
- 244000019459 Cynara cardunculus Species 0.000 description 1
- 235000019106 Cynara scolymus Nutrition 0.000 description 1
- 230000008836 DNA modification Effects 0.000 description 1
- 108010014303 DNA-directed DNA polymerase Proteins 0.000 description 1
- 102000016928 DNA-directed DNA polymerase Human genes 0.000 description 1
- 102000004163 DNA-directed RNA polymerases Human genes 0.000 description 1
- 108090000626 DNA-directed RNA polymerases Proteins 0.000 description 1
- 241000746417 Dalbergia monetaria Species 0.000 description 1
- 235000002767 Daucus carota Nutrition 0.000 description 1
- 244000000626 Daucus carota Species 0.000 description 1
- 241000035389 Davallia divaricata Species 0.000 description 1
- 102000000541 Defensins Human genes 0.000 description 1
- 108010002069 Defensins Proteins 0.000 description 1
- 241000522190 Desmodium Species 0.000 description 1
- 241000196119 Dicksonia Species 0.000 description 1
- 241000219761 Dioclea Species 0.000 description 1
- 241000219764 Dolichos Species 0.000 description 1
- 241000249436 Dorycnium rectum Species 0.000 description 1
- 241000628129 Echinochloa pyramidalis Species 0.000 description 1
- 241000380130 Ehrharta erecta Species 0.000 description 1
- 235000007349 Eleusine coracana Nutrition 0.000 description 1
- 244000078127 Eleusine coracana Species 0.000 description 1
- 108010093099 Endoribonucleases Proteins 0.000 description 1
- 102000002494 Endoribonucleases Human genes 0.000 description 1
- URXZXNYJPAJJOQ-UHFFFAOYSA-N Erucic acid Natural products CCCCCCC=CCCCCCCCCCCCC(O)=O URXZXNYJPAJJOQ-UHFFFAOYSA-N 0.000 description 1
- 241000588724 Escherichia coli Species 0.000 description 1
- 241001175061 Euclea schimperi Species 0.000 description 1
- 108091029865 Exogenous DNA Proteins 0.000 description 1
- 241000220485 Fabaceae Species 0.000 description 1
- 102000009114 Fatty acid desaturases Human genes 0.000 description 1
- 108010087894 Fatty acid desaturases Proteins 0.000 description 1
- 244000233576 Feijoa sellowiana Species 0.000 description 1
- 235000012068 Feijoa sellowiana Nutrition 0.000 description 1
- 241001022083 Flemingia Species 0.000 description 1
- 241000220223 Fragaria Species 0.000 description 1
- 241000169596 Freycinetia Species 0.000 description 1
- 101150104463 GOS2 gene Proteins 0.000 description 1
- 108700039691 Genetic Promoter Regions Proteins 0.000 description 1
- 229930182566 Gentamicin Natural products 0.000 description 1
- CEAZRRDELHUEMR-URQXQFDESA-N Gentamicin Chemical compound O1[C@H](C(C)NC)CC[C@@H](N)[C@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](NC)[C@@](C)(O)CO2)O)[C@H](N)C[C@@H]1N CEAZRRDELHUEMR-URQXQFDESA-N 0.000 description 1
- 244000105059 Geranium thunbergii Species 0.000 description 1
- 235000005491 Geranium thunbergii Nutrition 0.000 description 1
- 108010061711 Gliadin Proteins 0.000 description 1
- 241000411998 Gliricidia Species 0.000 description 1
- 235000009438 Gossypium Nutrition 0.000 description 1
- 244000299507 Gossypium hirsutum Species 0.000 description 1
- 235000009432 Gossypium hirsutum Nutrition 0.000 description 1
- 241001648387 Grevillea Species 0.000 description 1
- 241000013479 Guibourtia coleosperma Species 0.000 description 1
- 108090001102 Hammerhead ribozyme Proteins 0.000 description 1
- 241000214032 Hedysarum Species 0.000 description 1
- 244000020551 Helianthus annuus Species 0.000 description 1
- 108010066161 Helianthus annuus oleosin Proteins 0.000 description 1
- 241001582739 Heteropogon <robber fly> Species 0.000 description 1
- 241000238631 Hexapoda Species 0.000 description 1
- 108010033040 Histones Proteins 0.000 description 1
- 101000724234 Homo sapiens ABI gene family member 3 Proteins 0.000 description 1
- 244000284937 Hyparrhenia rufa Species 0.000 description 1
- 241000782597 Hypericum erectum Species 0.000 description 1
- 235000000177 Indigofera tinctoria Nutrition 0.000 description 1
- 206010021929 Infertility male Diseases 0.000 description 1
- 108091092195 Intron Proteins 0.000 description 1
- 108010044467 Isoenzymes Proteins 0.000 description 1
- 108010025815 Kanamycin Kinase Proteins 0.000 description 1
- 101710094902 Legumin Proteins 0.000 description 1
- 241001092400 Leptarrhena pyrolifolia Species 0.000 description 1
- 241000209510 Liliopsida Species 0.000 description 1
- 241000218300 Liriodendron Species 0.000 description 1
- 241000219743 Lotus Species 0.000 description 1
- 241001329168 Loudetia simplex Species 0.000 description 1
- 108060001084 Luciferase Proteins 0.000 description 1
- 239000005089 Luciferase Substances 0.000 description 1
- 241000219745 Lupinus Species 0.000 description 1
- 241000219822 Macrotyloma axillare Species 0.000 description 1
- 241000218922 Magnoliophyta Species 0.000 description 1
- 208000007466 Male Infertility Diseases 0.000 description 1
- 235000004456 Manihot esculenta Nutrition 0.000 description 1
- 241000218666 Metasequoia Species 0.000 description 1
- 108091092878 Microsatellite Proteins 0.000 description 1
- 241000362816 Miscanthus sinensis var. purpurascens Species 0.000 description 1
- NWBJYWHLCVSVIJ-UHFFFAOYSA-N N-benzyladenine Chemical compound N=1C=NC=2NC=NC=2C=1NCC1=CC=CC=C1 NWBJYWHLCVSVIJ-UHFFFAOYSA-N 0.000 description 1
- 229910002651 NO3 Inorganic materials 0.000 description 1
- 240000002778 Neonotonia wightii Species 0.000 description 1
- NHNBFGGVMKEFGY-UHFFFAOYSA-N Nitrate Chemical compound [O-][N+]([O-])=O NHNBFGGVMKEFGY-UHFFFAOYSA-N 0.000 description 1
- 101710163270 Nuclease Proteins 0.000 description 1
- 240000007817 Olea europaea Species 0.000 description 1
- 235000002725 Olea europaea Nutrition 0.000 description 1
- 108010038807 Oligopeptides Proteins 0.000 description 1
- 102000015636 Oligopeptides Human genes 0.000 description 1
- 241000219830 Onobrychis Species 0.000 description 1
- 241000209094 Oryza Species 0.000 description 1
- 238000012408 PCR amplification Methods 0.000 description 1
- 235000019482 Palm oil Nutrition 0.000 description 1
- 241001618237 Peltophorum africanum Species 0.000 description 1
- 241000209046 Pennisetum Species 0.000 description 1
- 239000006002 Pepper Substances 0.000 description 1
- 244000025272 Persea americana Species 0.000 description 1
- 235000011236 Persea americana var americana Nutrition 0.000 description 1
- 240000007377 Petunia x hybrida Species 0.000 description 1
- 241000219833 Phaseolus Species 0.000 description 1
- 235000015867 Phoenix canariensis Nutrition 0.000 description 1
- 244000297511 Phoenix canariensis Species 0.000 description 1
- 240000008340 Phormium cookianum Species 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- 241001092035 Photinia Species 0.000 description 1
- 240000000020 Picea glauca Species 0.000 description 1
- 235000008127 Picea glauca Nutrition 0.000 description 1
- 235000016761 Piper aduncum Nutrition 0.000 description 1
- 240000003889 Piper guineense Species 0.000 description 1
- 235000017804 Piper guineense Nutrition 0.000 description 1
- 235000008184 Piper nigrum Nutrition 0.000 description 1
- 108020005089 Plant RNA Proteins 0.000 description 1
- 235000018794 Podocarpus totara Nutrition 0.000 description 1
- 240000003145 Podocarpus totara Species 0.000 description 1
- 241000133788 Pogonarthria Species 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- 241000218976 Populus trichocarpa Species 0.000 description 1
- 240000000037 Prosopis spicigera Species 0.000 description 1
- 235000006629 Prosopis spicigera Nutrition 0.000 description 1
- 235000008572 Pseudotsuga menziesii Nutrition 0.000 description 1
- 240000001416 Pseudotsuga menziesii Species 0.000 description 1
- 241001112090 Pseudovirus Species 0.000 description 1
- 241000350492 Pterolobium stellatum Species 0.000 description 1
- 235000014443 Pyrus communis Nutrition 0.000 description 1
- 240000001987 Pyrus communis Species 0.000 description 1
- 241000219492 Quercus Species 0.000 description 1
- 102000009572 RNA Polymerase II Human genes 0.000 description 1
- 108010009460 RNA Polymerase II Proteins 0.000 description 1
- 238000002123 RNA extraction Methods 0.000 description 1
- 238000011530 RNeasy Mini Kit Methods 0.000 description 1
- 238000010240 RT-PCR analysis Methods 0.000 description 1
- 241001632422 Radiola linoides Species 0.000 description 1
- 235000011129 Rhopalostylis sapida Nutrition 0.000 description 1
- 240000007586 Rhopalostylis sapida Species 0.000 description 1
- 235000011483 Ribes Nutrition 0.000 description 1
- 241000220483 Ribes Species 0.000 description 1
- 244000171263 Ribes grossularia Species 0.000 description 1
- 235000002357 Ribes grossularia Nutrition 0.000 description 1
- 108091028664 Ribonucleotide Proteins 0.000 description 1
- 241001493421 Robinia <trematode> Species 0.000 description 1
- 235000011449 Rosa Nutrition 0.000 description 1
- 241001092459 Rubus Species 0.000 description 1
- 241000282849 Ruminantia Species 0.000 description 1
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 1
- 241000124033 Salix Species 0.000 description 1
- 241001116461 Sciadopitys Species 0.000 description 1
- 241001639806 Searsia natalensis Species 0.000 description 1
- 235000007238 Secale cereale Nutrition 0.000 description 1
- 244000082988 Secale cereale Species 0.000 description 1
- 238000012300 Sequence Analysis Methods 0.000 description 1
- 241001138418 Sequoia sempervirens Species 0.000 description 1
- 241000422846 Sequoiadendron giganteum Species 0.000 description 1
- 235000003434 Sesamum indicum Nutrition 0.000 description 1
- 244000040738 Sesamum orientale Species 0.000 description 1
- 239000005708 Sodium hypochlorite Substances 0.000 description 1
- 235000002597 Solanum melongena Nutrition 0.000 description 1
- 244000061458 Solanum melongena Species 0.000 description 1
- 241000251131 Sphyrna Species 0.000 description 1
- 241000219315 Spinacia Species 0.000 description 1
- 241000847989 Sporobolus fimbriatus Species 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 235000021536 Sugar beet Nutrition 0.000 description 1
- 241000505911 Tadehagi Species 0.000 description 1
- 241001138405 Taxodium distichum Species 0.000 description 1
- WFWLQNSHRPWKFK-UHFFFAOYSA-N Tegafur Chemical group O=C1NC(=O)C(F)=CN1C1OCCC1 WFWLQNSHRPWKFK-UHFFFAOYSA-N 0.000 description 1
- 241000248384 Tetrahymena thermophila Species 0.000 description 1
- 235000006468 Thea sinensis Nutrition 0.000 description 1
- 244000152045 Themeda triandra Species 0.000 description 1
- 108700009124 Transcription Initiation Site Proteins 0.000 description 1
- 244000098338 Triticum aestivum Species 0.000 description 1
- 240000003021 Tsuga heterophylla Species 0.000 description 1
- 235000008554 Tsuga heterophylla Nutrition 0.000 description 1
- 108090000848 Ubiquitin Proteins 0.000 description 1
- 102000044159 Ubiquitin Human genes 0.000 description 1
- 108091023045 Untranslated Region Proteins 0.000 description 1
- 235000012511 Vaccinium Nutrition 0.000 description 1
- 241000736767 Vaccinium Species 0.000 description 1
- 241000219873 Vicia Species 0.000 description 1
- 108700005077 Viral Genes Proteins 0.000 description 1
- 108020000999 Viral RNA Proteins 0.000 description 1
- 208000036142 Viral infection Diseases 0.000 description 1
- 241000596981 Watsonia Species 0.000 description 1
- 240000001198 Zantedeschia aethiopica Species 0.000 description 1
- 108700041896 Zea mays Ubi-1 Proteins 0.000 description 1
- 229920002494 Zein Polymers 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
- 235000012735 amaranth Nutrition 0.000 description 1
- 239000004178 amaranth Substances 0.000 description 1
- 210000003484 anatomy Anatomy 0.000 description 1
- 210000004102 animal cell Anatomy 0.000 description 1
- 239000006053 animal diet Substances 0.000 description 1
- 238000009360 aquaculture Methods 0.000 description 1
- 244000144974 aquaculture Species 0.000 description 1
- 235000016520 artichoke thistle Nutrition 0.000 description 1
- 210000004507 artificial chromosome Anatomy 0.000 description 1
- 230000002238 attenuated effect Effects 0.000 description 1
- 239000011230 binding agent Substances 0.000 description 1
- 229920000704 biodegradable plastic Polymers 0.000 description 1
- 238000003766 bioinformatics method Methods 0.000 description 1
- 230000007321 biological mechanism Effects 0.000 description 1
- 230000031018 biological processes and functions Effects 0.000 description 1
- 230000001486 biosynthesis of amino acids Effects 0.000 description 1
- 238000005422 blasting Methods 0.000 description 1
- 235000008429 bread Nutrition 0.000 description 1
- 239000007853 buffer solution Substances 0.000 description 1
- 238000011088 calibration curve Methods 0.000 description 1
- 239000001390 capsicum minimum Substances 0.000 description 1
- 238000005266 casting Methods 0.000 description 1
- 230000030833 cell death Effects 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 238000007385 chemical modification Methods 0.000 description 1
- 231100000481 chemical toxicant Toxicity 0.000 description 1
- 238000003776 cleavage reaction Methods 0.000 description 1
- ZPUCINDJVBIVPJ-LJISPDSOSA-N cocaine Chemical compound O([C@H]1C[C@@H]2CC[C@@H](N2C)[C@H]1C(=O)OC)C(=O)C1=CC=CC=C1 ZPUCINDJVBIVPJ-LJISPDSOSA-N 0.000 description 1
- 238000004891 communication Methods 0.000 description 1
- 238000010205 computational analysis Methods 0.000 description 1
- 238000004590 computer program Methods 0.000 description 1
- 238000012790 confirmation Methods 0.000 description 1
- 230000001276 controlling effect Effects 0.000 description 1
- 239000008162 cooking oil Substances 0.000 description 1
- 239000002537 cosmetic Substances 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 244000195896 dadap Species 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 230000007123 defense Effects 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 229960004042 diazoxide Drugs 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 235000015872 dietary supplement Nutrition 0.000 description 1
- NEKNNCABDXGBEN-UHFFFAOYSA-L disodium;4-(4-chloro-2-methylphenoxy)butanoate;4-(2,4-dichlorophenoxy)butanoate Chemical compound [Na+].[Na+].CC1=CC(Cl)=CC=C1OCCCC([O-])=O.[O-]C(=O)CCCOC1=CC=C(Cl)C=C1Cl NEKNNCABDXGBEN-UHFFFAOYSA-L 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 239000012154 double-distilled water Substances 0.000 description 1
- 239000008157 edible vegetable oil Substances 0.000 description 1
- 230000000459 effect on growth Effects 0.000 description 1
- 230000001729 effect on metabolism Effects 0.000 description 1
- 230000001463 effect on reproduction Effects 0.000 description 1
- 230000005684 electric field Effects 0.000 description 1
- 238000004520 electroporation Methods 0.000 description 1
- 230000013020 embryo development Effects 0.000 description 1
- 210000002472 endoplasmic reticulum Anatomy 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- DPUOLQHDNGRHBS-KTKRTIGZSA-N erucic acid Chemical compound CCCCCCCC\C=C/CCCCCCCCCCCC(O)=O DPUOLQHDNGRHBS-KTKRTIGZSA-N 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 235000014089 extruded snacks Nutrition 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 230000004136 fatty acid synthesis Effects 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 238000000855 fermentation Methods 0.000 description 1
- 230000004151 fermentation Effects 0.000 description 1
- 244000037666 field crops Species 0.000 description 1
- 239000011888 foil Substances 0.000 description 1
- ZZUFCTLCJUWOSV-UHFFFAOYSA-N furosemide Chemical compound C1=C(Cl)C(S(=O)(=O)N)=CC(C(O)=O)=C1NCC1=CC=CO1 ZZUFCTLCJUWOSV-UHFFFAOYSA-N 0.000 description 1
- 230000004927 fusion Effects 0.000 description 1
- 108020001507 fusion proteins Proteins 0.000 description 1
- 102000037865 fusion proteins Human genes 0.000 description 1
- 238000012215 gene cloning Methods 0.000 description 1
- 108091008053 gene clusters Proteins 0.000 description 1
- 230000004545 gene duplication Effects 0.000 description 1
- 238000012226 gene silencing method Methods 0.000 description 1
- 239000003365 glass fiber Substances 0.000 description 1
- 235000002532 grape seed extract Nutrition 0.000 description 1
- 235000021384 green leafy vegetables Nutrition 0.000 description 1
- 238000000227 grinding Methods 0.000 description 1
- -1 growth rate Substances 0.000 description 1
- 230000009931 harmful effect Effects 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 230000006801 homologous recombination Effects 0.000 description 1
- 238000002744 homologous recombination Methods 0.000 description 1
- 229930195733 hydrocarbon Natural products 0.000 description 1
- 150000002430 hydrocarbons Chemical class 0.000 description 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 description 1
- 210000001822 immobilized cell Anatomy 0.000 description 1
- 238000003365 immunocytochemistry Methods 0.000 description 1
- 238000010166 immunofluorescence Methods 0.000 description 1
- 238000003364 immunohistochemistry Methods 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 229940097275 indigo Drugs 0.000 description 1
- COHYTHOBJLSHDF-UHFFFAOYSA-N indigo powder Natural products N1C2=CC=CC=C2C(=O)C1=C1C(=O)C2=CC=CC=C2N1 COHYTHOBJLSHDF-UHFFFAOYSA-N 0.000 description 1
- 230000006698 induction Effects 0.000 description 1
- 230000008595 infiltration Effects 0.000 description 1
- 238000001764 infiltration Methods 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 239000000976 ink Substances 0.000 description 1
- 230000010354 integration Effects 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 230000002262 irrigation Effects 0.000 description 1
- 238000003973 irrigation Methods 0.000 description 1
- 239000003621 irrigation water Substances 0.000 description 1
- 108091070127 jacalin lectin family Proteins 0.000 description 1
- 102000039909 jacalin lectin family Human genes 0.000 description 1
- 235000021374 legumes Nutrition 0.000 description 1
- 230000037356 lipid metabolism Effects 0.000 description 1
- 239000006166 lysate Substances 0.000 description 1
- 229920002521 macromolecule Polymers 0.000 description 1
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 1
- 235000019341 magnesium sulphate Nutrition 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 210000001161 mammalian embryo Anatomy 0.000 description 1
- 108010083942 mannopine synthase Proteins 0.000 description 1
- 238000013507 mapping Methods 0.000 description 1
- 230000035800 maturation Effects 0.000 description 1
- 235000012054 meals Nutrition 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 238000010208 microarray analysis Methods 0.000 description 1
- 230000002906 microbiologic effect Effects 0.000 description 1
- 238000000520 microinjection Methods 0.000 description 1
- 239000011785 micronutrient Substances 0.000 description 1
- 235000013369 micronutrients Nutrition 0.000 description 1
- 239000011859 microparticle Substances 0.000 description 1
- 238000012544 monitoring process Methods 0.000 description 1
- 239000004570 mortar (masonry) Substances 0.000 description 1
- 235000020772 multivitamin supplement Nutrition 0.000 description 1
- 239000000618 nitrogen fertilizer Substances 0.000 description 1
- 108091027963 non-coding RNA Proteins 0.000 description 1
- 102000042567 non-coding RNA Human genes 0.000 description 1
- 238000007899 nucleic acid hybridization Methods 0.000 description 1
- 230000031787 nutrient reservoir activity Effects 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 238000002515 oligonucleotide synthesis Methods 0.000 description 1
- 230000000065 osmolyte Effects 0.000 description 1
- 230000003204 osmotic effect Effects 0.000 description 1
- 238000004806 packaging method and process Methods 0.000 description 1
- 239000003973 paint Substances 0.000 description 1
- 239000002540 palm oil Substances 0.000 description 1
- 230000007170 pathology Effects 0.000 description 1
- 239000003415 peat Substances 0.000 description 1
- 239000008188 pellet Substances 0.000 description 1
- 239000003208 petroleum Substances 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 239000008055 phosphate buffer solution Substances 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 230000000704 physical effect Effects 0.000 description 1
- 230000004962 physiological condition Effects 0.000 description 1
- 230000035479 physiological effects, processes and functions Effects 0.000 description 1
- 239000001739 pinus spp. Substances 0.000 description 1
- 238000003976 plant breeding Methods 0.000 description 1
- 239000003375 plant hormone Substances 0.000 description 1
- 230000037039 plant physiology Effects 0.000 description 1
- 238000003752 polymerase chain reaction Methods 0.000 description 1
- 239000013641 positive control Substances 0.000 description 1
- 230000000270 postfertilization Effects 0.000 description 1
- 230000032361 posttranscriptional gene silencing Effects 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 238000004321 preservation Methods 0.000 description 1
- 238000012514 protein characterization Methods 0.000 description 1
- 238000001742 protein purification Methods 0.000 description 1
- 238000003753 real-time PCR Methods 0.000 description 1
- 230000008929 regeneration Effects 0.000 description 1
- 238000011069 regeneration method Methods 0.000 description 1
- 238000007634 remodeling Methods 0.000 description 1
- 230000003252 repetitive effect Effects 0.000 description 1
- 238000003757 reverse transcription PCR Methods 0.000 description 1
- 210000000614 rib Anatomy 0.000 description 1
- 239000002336 ribonucleotide Substances 0.000 description 1
- 125000002652 ribonucleotide group Chemical group 0.000 description 1
- 230000021749 root development Effects 0.000 description 1
- 210000003296 saliva Anatomy 0.000 description 1
- 238000005070 sampling Methods 0.000 description 1
- 230000007017 scission Effects 0.000 description 1
- 238000010845 search algorithm Methods 0.000 description 1
- 230000008117 seed development Effects 0.000 description 1
- 238000010187 selection method Methods 0.000 description 1
- 239000013605 shuttle vector Substances 0.000 description 1
- HBMJWWWQQXIZIP-UHFFFAOYSA-N silicon carbide Chemical compound [Si+]#[C-] HBMJWWWQQXIZIP-UHFFFAOYSA-N 0.000 description 1
- 229910010271 silicon carbide Inorganic materials 0.000 description 1
- 235000011888 snacks Nutrition 0.000 description 1
- SUKJFIGYRHOWBL-UHFFFAOYSA-N sodium hypochlorite Chemical compound [Na+].Cl[O-] SUKJFIGYRHOWBL-UHFFFAOYSA-N 0.000 description 1
- 238000000638 solvent extraction Methods 0.000 description 1
- 210000001082 somatic cell Anatomy 0.000 description 1
- 238000004611 spectroscopical analysis Methods 0.000 description 1
- 235000020354 squash Nutrition 0.000 description 1
- 238000010561 standard procedure Methods 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000010902 straw Substances 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 238000004114 suspension culture Methods 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 230000002195 synergetic effect Effects 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 230000002194 synthesizing effect Effects 0.000 description 1
- 235000013616 tea Nutrition 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- 230000005026 transcription initiation Effects 0.000 description 1
- 238000000844 transformation Methods 0.000 description 1
- 239000013638 trimer Substances 0.000 description 1
- GPRLSGONYQIRFK-MNYXATJNSA-N triton Chemical compound [3H+] GPRLSGONYQIRFK-MNYXATJNSA-N 0.000 description 1
- 230000005740 tumor formation Effects 0.000 description 1
- WFKWXMTUELFFGS-UHFFFAOYSA-N tungsten Chemical compound [W] WFKWXMTUELFFGS-UHFFFAOYSA-N 0.000 description 1
- 229910052721 tungsten Inorganic materials 0.000 description 1
- 239000010937 tungsten Substances 0.000 description 1
- 239000008158 vegetable oil Substances 0.000 description 1
- 230000009385 viral infection Effects 0.000 description 1
- 238000012800 visualization Methods 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 238000001262 western blot Methods 0.000 description 1
- 239000002023 wood Substances 0.000 description 1
- 238000004383 yellowing Methods 0.000 description 1
- 239000005019 zein Substances 0.000 description 1
- 229940093612 zein Drugs 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
Landscapes
- Breeding Of Plants And Reproduction By Means Of Culturing (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
Abstract
Provided are isolated polypeptides comprising the amino acid sequence at least 80% homologous to SEQ ID NO:68. 51-66. 69-100, 379-656, 707-715, 720-723, 742-754, 764-771 or 772 with the proviso that the amino acid sequence is not as set forth by SEQ ID NO:765 or 771, isolated polynucleotides comprising the nucleic acid sequence at least 80% identical to SEQ ID NOs:18, 1-16, 19-50, 101-378, 657-672, 674-706, 716-719, 724-741 and 755-763 with the proviso that the nucleic acid sequence is not as set forth by SEQ ID NO:756 or 762, and isolated polynucleotides selected from the group consisting of SEQ ID NOs:779-792 and methods of using same for increasing oil content, yield, growth rate, biomass, vigor, abiotic stress tolerance and/or nitrogen use efficiency of a plant.
Description
ISOLATED POLYNUCLEOTIDES AND POLYPEPTIDES AND METHODS OF USING
SAME FOR INCREASING PLANT UTILITY
CROSS-REFERENCE TO RELATED APPLICATIONS
This application is a divisional application of Australian Application No. 2015202781, filed on 22 May 2015, which is a divisional application of Australian Application No. 2009250806, filed on 21 May 2009, and is related to International Patent Application No. PCT/IL2009/000508, filed on 21 May 2009 and claims priority from U.S. Provisional Patent Application Nos. 61/071,885, filed on 22 May 2008 and 61/129,296, filed on 17 June 2008;
each of which is incorporated herein by reference in its entirety.
FIELD AND BACKGROUND OF THE INVENTION
The present invention, in some embodiments thereof, relates to polypeptides, polynucleotides encoding same, transgenic plants expressing same and methods of producing 15 and using same, and, more particularly, but not exclusively, to methods of increasing plant yield, oil yield, seed yield, biomass, growth rate, vigor, oil content, abiotic stress tolerance and/or nitrogen use efficiency.
Abiotic stress conditions such as salinity, drought, flood, suboptimal temperature and toxic chemical pollution, cause substantial damage to agricultural plants. Most plants have 10 evolved strategies to protect themselves against these conditions. However, if the severity and duration of the stress conditions are too great, the effects on plant development, growth and yield of most crop plants are profound. Furthermore, most of the crop plants are highly susceptible to abiotic stress (ABS) and thus necessitate optimal growth conditions for commercial crop yields. Continuous exposure to stress causes major alterations in the plant 25 metabolism which ultimately leads to cell death and consequently yield losses.
The global shortage of water supply is one of the most severe agricultural problems affecting plant growth and crop yield and efforts are made to mitigate the harmful effects of desertification and salinization of the world’s arable land. Thus, Agbiotech companies attempt to create new crop varieties which are tolerant to different abiotic stresses focusing mainly in 30 developing new varieties that can tolerate water shortage for longer periods.
Suboptimal nutrient (macro and micro nutrient) affect plant growth and development through the whole plant life cycle. One of the essential macronutrients for the plant is Nitrogen. Nitrogen is responsible for biosynthesis of amino acids and nucleic acids, prosthetic groups, plant hormones, plant chemical defenses, and the like. Nitrogen is often the rate-limiting element in plant growth and all field crops have a fundamental dependence on inorganic nitrogenous fertilizer. Since fertilizer is rapidly depleted from most soil types, it must be supplied to growing crops two or three times [TEXT CONTINUES ON PAGE 2] la
2018200117 05 Jan 2018
2018200117 05 Jan 2018 during the growing season. Additional important macronutrients are Phosphorous (P) and Potassium (K), which have a direct correlation to yield and general plant tolerance.
Vegetable or seed oils are the major source of energy and nutrition in human and animal diet. They are also used for the production of industrial products, such as paints, inks and lubricants. In addition, plant oils represent renewable sources of longchain hydrocarbons which can be used as fuel. Since the currently used fossil fuels are finite resources and are gradually being depleted, fast growing biomass crops may be used as alternative fuels or for energy feedstocks and may reduce the dependence on fossil energy supplies. However, the major bottleneck for increasing consumption of plant oils as bio-fuel is the oil price, which is still higher than fossil fuel [Hypertext Transfer Protocol://World Wide Web (dot) eia (dot) doe (dot) gov/oiaf/analysispaper/biodiesel/; Hypertext Transfer Protocol://World Wide Web (dot) njbiz (dot)com/weekly_article.asp?aID=19755147 (dot) 6122555 (dot) 957931 (dot) 7393254 (dot) 4337383 (dot) 561&aID2=73678]. In addition, the production rate of plant oil is limited by the availability of agricultural land and water. Thus, increasing plant oil yields from the same growing area can effectively overcome the shortage in production space and can decrease vegetable oil prices at the same time.
Studies aiming at increasing plant oil yields focus on the identification of genes involved in oil metabolism as well as in genes capable of increasing plant and seed yields in transgenic plants.
Genes known to be involved in increasing plant oil yields include those participating in fatty acid synthesis or sequestering such as desaturase [e.g., DELTA6, DELTA12 or acyl-ACP (Ssi2; Arabidopsis Information Resource (TAIR; Hypertext Transfer Protocol://World Wide Web (dot) arabidopsis (dot) org/), TAIR No. AT2G43710)], OleosinA (TAIR No. AT3G01570) or FAD3 (TAIR No. AT2G29980), and various transcription factors and activators such as Led [TAIR No. AT1G21970, Lotan et al. 1998. Cell. 26,93(7): 1195-205], Lec2 [TAIR No. AT1G28300, Santos Mendoza et al. 2005, FEBS Lett. 579(21):4666-70], Fus3 (TAIR No. AT3G26790), ABI3 [TAIR No. AT3G24650, Lara et al. 2003. J Biol Chem. 278(23): 21003-11] and Wril [TAIR No. AT3G54320, Cernac and Benning, 2004. Plant J. 40(4): 575-85].
WO 2009/141824
PCT/IL2009/000508
2018200117 05 Jan 2018
Zabrouskov V., et al., 2002 (Physiol Plant. 116:172-185) describe an increase in the total lipid fraction by upregulation of endoplasmic reticulum (FAD3) and plastidal (FAD7) fatty acid desaturases in potato.
Wang HW et al., 2007 (Plant J. 52:716-29. Epub 2007 Sep 18) describe an 5 increase in the content of total fatty acids and lipids in plant seeds by over-expressing the GmDof4 and GmDofll transcription factors.
Vigeolas H, et al. [Plant Biotechnol J. 2007, 5(3):431-41] and U.S. Pat. Appl. No. 20060168684 discloses an increase in seed oil content in oil-seed rape (Brassica napus L.) by over-expression of a yeast glycerol-3-phosphate dehydrogenase under the 10 control of a seed-specific promoter.
Katavic V, et al., 2000 (Biochem Soc Trans. 28:935-7) describe the use of the Arabidopsis FAE1 and yeast SLC1-1 genes for improvements in erucic acid and oil content in rapeseed.
U.S. Pat. Appl. No. 20080076179 discloses an isolated moss nucleic acid 15 encoding a lipid metabolism protein (LMP) and transgenic plants expressing same with increased lipid levels.
U.S. Pat. Appl. No. 20060206961 discloses a method of increasing oil content in plants (e.g., in plant seeds), by expressing in the plant the Yprl40w polypeptide.
U.S. Pat. Appl. No. 20060174373 discloses a method of increasing oil content 20 in plants by expressing a nucleic acid encoding a triacylglycerols (TAG) synthesis enhancing protein (TEP) in the plant.
U.S. Pat. Appl. Nos. 20070169219, 20070006345, 20070006346 and 20060195943, disclose transgenic plants with improved nitrogen use efficiency which can be used for the conversion into fuel or chemical feedstocks.
W02004/104162 teaches polynucleotide sequences and methods of utilizing same for increasing the tolerance of a plant to abiotic stresses and/or increasing the biomass of a plant.
W02007/020638 teaches polynucleotide sequences and methods of utilizing same for increasing the tolerance of a plant to abiotic stresses and/or increasing the 30 biomass, vigor and/or yield of a plant.
W02008/122890 teaches polynucleotide sequences and methods of utilizing same for increasing oil content, growth rate, biomass, yield and/or vigor of a plant.
WO 2009/141824
PCT/IL2009/000508
2018200117 05 Jan 2018
SUMMARY OF THE INVENTION
According to an aspect of some embodiments of the present invention there is provided a method of increasing oil content, yield, growth rate, biomass, vigor, abiotic 5 stress tolerance and/or nitrogen use efficiency of a plant, comprising expressing within the plant an exogenous polynucleotide comprising a nucleic acid sequence at least 80 % identical to SEQ ID NOs: 18,1-16,19-50, 101-378, 657-672, 674-706, 716-719, 724-741 and 755-763 with the proviso that the nucleic acid sequence is not as set forth by SEQ ID NO:756 or 762, thereby increasing the oil content, yield, growth rate, biomass, vigor, 10 abiotic stress tolerance and/or nitrogen use efficiency of the plant.
According to an aspect of some embodiments of the present invention there is provided a method of increasing oil content, yield, growth rate, biomass, vigor, abiotic stress tolerance and/or nitrogen use efficiency of a plant, comprising expressing within the plant an exogenous polynucleotide comprising the nucleic acid sequence selected 15 from the group consisting of SEQ ID NOs: 18, 1-16, 19-50, 101-378, 657-672, 674-706, 716-719, 724-741, 755, 757-761 and 763, thereby increasing the oil content, yield, growth rate, biomass, vigor, abiotic stress tolerance and/or nitrogen use efficiency of the plant.
According to an aspect of some embodiments of the present invention there is 20 provided a method of increasing oil content, yield, growth rate, biomass, vigor, abiotic stress tolerance and/or nitrogen use efficiency of a plant, comprising transforming the plant with an exogenous polynucleotide capable of downregulating the expression level of a nucleic acid sequence at least 80 % identical to SEQ ID NO: 17 or 673, thereby increasing the oil content, yield, growth rate, biomass, vigor, abiotic stress tolerance 25 and/or nitrogen use efficiency of the plant.
According to an aspect of some embodiments of the present invention there is provided a method of increasing oil content, yield, growth rate, biomass, vigor, abiotic stress tolerance and/or nitrogen use efficiency of a plant, comprising transforming the plant with an exogenous polynucleotide capable of downregulating the expression level 30 of the nucleic acid sequence set forth in SEQ ID NO: 17 or 673, thereby increasing the oil content, yield, growth rate, biomass, vigor, abiotic stress tolerance and/or nitrogen use efficiency of the plant .
WO 2009/141824
PCT/IL2009/000508
2018200117 05 Jan 2018
According to an aspect of some embodiments of the present invention there is provided a method of producing oil, comprising: (a) providing the plant according to the method of the invention; and (b) extracting the oil from the plant; thereby producing the oil.
According to an aspect of some embodiments of the present invention there is provided an isolated polynucleotide comprising a nucleic acid sequence at least 80 % identical to SEQ ID NOs:18, 1-16, 19-50, 101-378, 657-672, 674-706, 716-719, 724741 and 755-763 with the proviso that the nucleic acid sequence is not as set forth by SEQ ID NO:756 or 762.
According to an aspect of some embodiments of the present invention there is provided an isolated polynucleotide comprising the nucleic acid sequence selected from the group consisting of SEQ ID NOs: 18, 1-16, 19-50,101-378, 657-672, 674-706, 716719, 724-741, 755, 757-761 and 763.
According to an aspect of some embodiments of the present invention there is 15 provided an isolated polynucleotide comprising a nucleic acid sequence capable of downregulating the expression level of a nucleic acid sequence at least 80 % identical to SEQ ID NO: 17 or 673.
According to an aspect of some embodiments of the present invention there is provided an isolated polynucleotide comprising a nucleic acid sequence capable of 20 downregulating the expression level of the nucleic acid sequence set forth in SEQ ID NO:17or673.
According to an aspect of some embodiments of the present invention there is provided an isolated polynucleotide comprising a nucleic acid sequence encoding a polypeptide which comprises an amino acid sequence at least 80 % homologous to the 25 amino acid sequence set forth in SEQ ID NOs:68, 5.1-66, 69-100, 379-656, 707-715, 720-723, 742-754 and 764-772 with the proviso that the amino acid sequence is not as set forth by SEQ ID NO: 765 or 771.
According to an aspect of some embodiments of the present invention there is provided an isolated polynucleotide comprising a nucleic acid sequence encoding a 30 polypeptide which comprises the amino acid sequence selected from the group consisting of SEQ ID NOs: 68, 51-66, 69-100, 379-656, 707-715, 720-723, 742-754, 764, 766-770 and 772.
WO 2009/141824
PCT/IL2009/000508
2018200117 05 Jan 2018
According to an aspect of some embodiments of the present invention there is provided an isolated polynucleotide comprising a nucleic acid sequence capable of downregulating the expression level or activity of a polypeptide at least 80 % homologous to the polypeptide set forth by SEQ ID NO:67.
According to an aspect of some embodiments of the present invention there is provided an isolated polynucleotide comprising a nucleic acid sequence capable of downregulating the expression level or activity of the polypeptide set forth by SEQ ID NO:67.
According to an aspect of some embodiments of the present invention there is 10 provided a nucleic acid construct comprising the isolated polynucleotide of the invention, and a promoter for directing transcription of the nucleic acid sequence in a host cell.
According to an aspect of some embodiments of the present invention there is provided an isolated polypeptide comprising an amino acid sequence at least 80 % 15 homologous to SEQ ID NO:68, 51-66, 69-100, 379-656, 707-715, 720-723, 742-754, 764-771 or 772 with the proviso that the amino acid sequence is not as set forth by SEQ ID NO:765 or 771.
According to an aspect of some embodiments of the present invention there is provided an isolated polypeptide comprising the amino acid sequence selected from the 20 group consisting of SEQ ID NOs: 68, 51-66, 69-100, 379-656, 707-715, 720-723, 742754, 764, 766-770 and 772.
According to an aspect of some embodiments of the present invention there is provided a nucleic acid construct comprising a nucleic acid sequence selected from the group consisting of SEQ ID NOs:779-792 and a heterologous polynucleotide sequence, 25 wherein the nucleic acid sequence is capable of regulating expression of the heterologous polynucleotide in a host cell.
According to some embodiments of the invention, the heterologous polynucleotide is a reporter gene.
According to some embodiments of the invention, regulating the expression of 30 the heterologous polynucleotide is in a tissue specific manner.
According to some embodiments of the invention, regulating the expression of the heterologous polynucleotide is in a developmental stage - specific manner.
WO 2009/141824
PCT/IL2009/000508
2018200117 05 Jan 2018
According to some embodiments of the invention, the heterologous polynucleotide comprises a nucleic acid sequence at least 80 % identical to the nucleic acid sequence selected from the group consisting of SEQ ID NOs:18,1-16,19-50,101378, 657-672, 674-706, 716-719, 724-741 and 755-763 with the proviso that the nucleic 5 acid sequence is not as set forth by SEQ ID NO:756 or 762.
According to some embodiments of the invention, the heterologous polynucleotide encodes an amino acid sequence at least at least 80 % homologous to SEQ ID NOs:68, 51-66, 69-100, 379-656, 707-715, 720-723, 742-754 and 764-772 with the proviso that the amino acid sequence is not as set forth by SEQ ID NO: 765 or 771.
According to an aspect of some embodiments of the present invention there is provided a method of increasing oil content, yield, growth rate, biomass, vigor, abiotic stress tolerance and/or nitrogen use efficiency of a plant comprising expressing within the plant the nucleic acid construct of claim 17, wherein the heterologous polynucleotide comprises a nucleic acid sequence at least 80 % identical to SEQ ID 15 NOs: 18, 1-16, 19-50, 101-378, 657-672, 674-706, 716-719, 724-741 and 755-763 with the proviso that the nucleic acid sequence is not as set forth by SEQ ID NO:756 or 762, thereby increasing the oil content, yield, growth rate, biomass, vigor, abiotic stress tolerance and/or nitrogen use efficiency of the plant.
According to an aspect of some embodiments of the present invention there is 20 provided a method of increasing oil content, yield, growth rate, biomass, vigor, abiotic stress tolerance and/or nitrogen use efficiency of a plant comprising expressing within the plant the nucleic acid construct of claim 17, wherein the heterologous polynucleotide encodes an amino acid sequence at least at least 80 % homologous to SEQ ID NOs:68,51-66, 69-100, 379-656, 707-715, 720-723, 742-754 and 764-772 with 25 the proviso that the amino acid sequence is not as set forth by SEQ ID NO: 765 or 771, thereby increasing the oil content, yield, growth rate, biomass, vigor, abiotic stress tolerance and/or nitrogen use efficiency of the plant.
According to an aspect of some embodiments of the present invention there is provided a plant cell exogenously expressing the polynucleotide of the invention, or the 30 nucleic acid construct of the invention.
According to an aspect of some embodiments of the present invention there is provided a plant cell exogenously expressing the polypeptide of the invention.
2018200117 14 Feb 2019
According to some embodiments of the invention, the nucleic acid sequence is as set forth in SEQ ID NO:18, 1-16, 19-50, 101-378, 657-672, 674-706, 716-719, 724-741, 755, 757761 or 763.
According to some embodiments of the invention, the polynucleotide consists of the 5 nucleic acid sequence selected from the group consisting of SEQ ID NOs:18, 1-16, 19-50, 101378, 657-672, 674-706, 716-719, 724-741, 755, 757-761 and 763.
According to some embodiments of the invention, the nucleic acid sequence encodes an amino acid sequence at least 80 % homologous to SEQ ID NO:68, 51-66, 69-100, 379-656, 707-715, 720-723, 742-754, 764-771 or 772 with the proviso that the amino acid sequence is 10 not as set forth by SEQ ID NO: 765 or 771.
According to some embodiments of the invention, the nucleic acid sequence encodes the amino acid sequence selected from the group consisting of SEQ ID NOs: 68, 51-66, 69-100, 379-656, 707-715, 720-723, 742-754, 764, 766-770 and 772.
According to some embodiments of the invention, the plant cell forms part of a plant.
According to an aspect of some embodiments of the present invention there is provided a transgenic plant exogenously expressing the polynucleotide of the invention.
According to some embodiments of the invention, the method further comprising growing the plant expressing the exogenous polynucleotide under the abiotic stress.
According to some embodiments of the invention, the abiotic stress is selected from the 10 group consisting of salinity, drought, water deprivation, low temperature, high temperature, heavy metal toxicity, anaerobiosis, nutrient deficiency, nutrient excess, atmospheric pollution and UV irradiation.
According to some embodiments of the invention, the polynucleotide is a cosuppression polynucleotide, an antisense polynucleotide, an RNA-interference polynucleotide 25 or a Ribozyme polynucleotide.
Definitions of the specific embodiments of the invention as claimed herein follow.
According to a first embodiment of the invention, there is provided a method of increasing yield, growth rate, biomass, vigor, abiotic stress tolerance and/or nitrogen use efficiency of a plant, comprising over-expressing within the plant a polypeptide comprising an 30 amino acid sequence at least 80 % identical to the amino acid sequence set forth in SEQ ID NO: 96, wherein said abiotic stress is drought and/or osmotic stress, thereby increasing the yield, growth rate, biomass, vigor, abiotic stress tolerance and/or nitrogen use efficiency of the plant.
8a
2018200117 14 Feb 2019
According to a second embodiment of the invention, there is provided a method of producing a crop, comprising:
(a) transforming parent plants with an exogenous polynucleotide comprising a nucleic acid sequence encoding a polypeptide at least 80 % identical to the amino acid sequence set forth in SEQ ID NO: 96;
(b) obtaining a population of transformed crop plants from step (a); and (c) selecting a transformed crop plant from step (b) which expresses said exogenous polynucleotide, and which exhibits an increased yield, increased growth rate, increased biomass, increased vigor, increased abiotic stress tolerance and/or increased nitrogen use efficiency as compared to a wild type plant of the same species which is grown under the same growth conditions, wherein said abiotic stress is drought and/or osmotic stress, thereby producing the crop.
According to a third embodiment of the invention, there is provided a method of selecting plants having increased yield, growth rate, biomass, vigor, abiotic stress tolerance 15 and/or nitrogen use efficiency, comprising:
(a) obtaining a population of transgenic plants over-expressing a polypeptide comprising an amino acid sequence at least 80 % identical to the amino acid sequence set forth in SEQ ID NO: 96, as compared to a wild type plant of the same species, and (b) selecting from said population of step (a) a plant which exhibits an >0 increased yield, increased growth rate, increased biomass, increased vigor, increased abiotic stress tolerance and/or increased nitrogen use efficiency as compared to a wild type plant of the same species which is grown under the same growth conditions, wherein said abiotic stress is drought and/or osmotic stress, thereby selecting the plants having the increased yield, growth rate, biomass, vigor, 25 abiotic stress tolerance and/or nitrogen use efficiency.
According to a fourth embodiment of the invention, there is provided a nucleic acid construct comprising an isolated polynucleotide comprising a nucleic acid sequence encoding a polypeptide which comprises an amino acid sequence at least 80 % identical to the amino acid sequence set forth in SEQ ID NO: 96, and a promoter for directing transcription of said nucleic 30 acid sequence in a host cell, wherein said promoter is heterologous to said isolated polynucleotide and wherein said promoter comprises a nucleic acid sequence selected from the group consisting of SEQ ID NOs:779-792.
8b
2018200117 14 Feb 2019
According to a fifth embodiment of the invention, there is provided a nucleic acid construct comprising an isolated polynucleotide comprising a nucleic acid sequence at least 80 % identical to SEQ ID NO: 702 or 46, and a promoter for directing transcription of said nucleic acid sequence in a host cell, wherein said promoter is heterologous to said isolated 5 polynucleotide and wherein said promoter comprises a nucleic acid sequence selected from the group consisting of SEQ ID NOs:779-792.
According to a sixth embodiment of the invention, there is provided a plant cell transformed with the nucleic acid construct of the fourth or fifth embodiments.
According to a seventh embodiment of the invention, there is provided a transgenic [0 plant transformed with the nucleic acid construct of the fourth or fifth embodiments.
BRIEF DESCRIPTION OF THE DRAWINGS
Some embodiments of the invention are herein described, by way of example only, with reference to the accompanying drawings. With specific reference now to the i5 drawings in detail, it is stressed that the particulars shown are by way of example and for purposes of illustrative discussion of embodiments of the invention. In this regard, [Text continues on page 9,]
WO 2009/141824
PCT/IL2009/000508
2018200117 05 Jan 2018 the description taken with the drawings makes apparent to those skilled in the art how embodiments of the invention may be practiced.
In the drawings:
FIGs. 1A-D are digital images of leaves depicting leaves parameters. Figure
1A - leaf length (the leaf length is represented by the arrow); Figure IB - laminar length (the laminar length is represented by the arrow); Figure IC - laminar area (the laminar area is represented by the white ellipse); Figure ID - laminar width (the laminar width is represented by the arrow). Blade circularity was calculated as laminar width divided by laminar length.
FIGs. 2A-B are images depicting visualization of root development of plants grown in transparent agar plates. The different transgenes were grown in transparent agar plates for 17 days and the plates were photographed every 2 days starting at day 7. Figure 2A - An image of a photograph of plants taken following 12 days on agar plates. Figure 2B - An image of root analysis in which the length of the root measured is represented by a red arrow.
FIG. 3 is a schematic illustration of the pGI binary plasmid used for expressing the isolated polynucleotide sequences of the invention. RB - T-DNA right border; LB T-DNA left border; H- HindlU restriction enzyme; X - Xbal restriction enzyme; B BamHI restriction enzyme; S - Sall restriction enzyme; Sm - Smal restriction enzyme;
R-I - EcoRI restriction enzyme; Sc - SacI/SsiI/£'c/136II; (numbers) - Length in basepairs; NOS pro = nopaline synthase promoter; NPT-II = neomycin phosphotransferase gene; NOS ter = nopaline synthase terminator; Poly-A signal (polyadenylation signal); GUSintron - the GUS reporter gene (coding sequence and intron). The isolated polynucleotide sequences of some embodiments of the invention were cloned into the vector while replacing the GUSintron reporter gene.
DESCRIPTION OF SPECIFIC EMBODIMENTS OF THE INVENTION
The present invention, in some embodiments thereof, relates to isolated polypeptides and polynucleotides encoding same, and more particularly, but not exclusively, to methods of using same for increasing oil content, growth rate, yield, biomass, vigor, abiotic stress tolerance and/or nitrogen use efficiency of a plant.
WO 2009/141824
PCT/IL2009/000508
2018200117 05 Jan 2018
Before explaining at least one embodiment of the invention in detail, it is to be understood that the invention is not necessarily limited in its application to the details set forth in the following description or exemplified by the Examples. The invention is capable of other embodiments or of being practiced or carried out in various ways.
While reducing the present invention to practice, the present inventors have identified novel polypeptides and polynucleotides which can be used to increase yield, growth rate, biomass, oil content, vigor, abiotic stress tolerance and/or nitrogen use efficiency of a plant.
Thus, as shown in the Examples section which follows, the present inventors have utilized bioinformatics tools to identify polynucleotides which enhance yield (e.g., seed yield, oil yield and oil content), growth rate, biomass, vigor, abiotic stress tolerance and/or nitrogen use efficiency of a plant. Genes which affect the trait-of-interest were identified based on expression profiles of genes of several Arabidopsis ecotypes and tissues, homology with genes known to affect the trait-of-interest and using digital expression profile in specific tissues and conditions (Tables 1, 3, 4, 5, 6, 7, 8, 9, 10 and 11, Examples 1 and 3). Homologous polypeptides and polynucleotides having the same function were also identified (Table 2, Example 2). Transgenic plants over-expressing the identified polynucleotides exhibit increased seed yield (e.g., weight of 1000 seeds), oil yield (e.g., oil percentage in seed), biomass (e.g., dry matter), harvest index, growth rate, rosette area, abiotic stress tolerance (e.g., to drought conditions) and nitrogen use efficiency (Tables 22, 23, 24, 25, 26 and 27; Examples 5 and 7; Tables 28-30, Example 8). In addition, the present inventors have uncovered that polynucleotides which reduce the expression level and/or activity of certain gene products (e.g., the BDL127 gene; SEQ ID NO: 17 or 673) can increase yield (e.g., seed yield), biomass and/or growth rate in plants (Tables 31-36; Example 9). As is further shown in the Examples section which follows, the present inventors have uncovered novel promoter sequences which can be used to express the gene-of-interest in a tissue specific and/or developmental stagespecific manner (Tables 16, 17, 18, 19, 20 and 21, Example 6). , Altogether, these results suggest the use of the polynucleotides or polypeptides of the invention for increasing yield, growth rate, biomass, vigor, abiotic stress tolerance and/or nitrogen use efficiency of a plant
WO 2009/141824
PCT/IL2009/000508
2018200117 05 Jan 2018
Thus, according to an aspect of some embodiments of the invention, there is provided method of increasing oil content, yield, growth rate, biomass, vigor, abiotic stress tolerance and/or nitrogen use efficiency of a plant, comprising expressing within the plant an exogenous polynucleotide comprising a nucleic acid sequence at least 80 % 5 identical to SEQ ID NOs:18, 1-16, 19-50, 101-378, 657-672, 674-706, 716-719, 724741 and 755-763 with the proviso that the nucleic acid sequence is not as set forth by SEQ ID NO:756 or 762, thereby increasing the oil content, yield, growth rate, biomass, vigor, abiotic stress tolerance and/or nitrogen use efficiency of the plant.
The phrase “oil content” as used herein refers to the amount of lipids in a given plant organ, either the seeds (seed oil content) or the vegetative portion of the plant (vegetative oil content) and is typically expressed as percentage of dry weight (10 % humidity of seeds) or wet weight (for vegetative portion).
It should be noted that oil content is affected by intrinsic oil production of a tissue (e.g., seed, vegetative portion), as well as the mass or size of the oil-producing 15 tissue per plant or per growth period.
In one embodiment, increase in oil content of the plant can be achieved by increasing the size/mass of a plant's tissue(s) which comprise oil per growth period. Thus, increased oil content of a plant can be achieved by increasing the yield, growth rate, biomass and vigor of the plant.
As used herein the phrase plant yield refers to the amount (as determined by weight or size) or quantity (numbers) of tissue produced per plant or per growing season. Hence increased yield could affect the economic benefit one can obtain from the plant in a certain growing area and/or growing time.
It should be noted that a plant yield can be affected by various parameters including, but not limited to, plant biomass; plant vigor; growth rate; seed yield; oil yield; content of oil, starch and/or protein in harvested organs (e.g., seeds or vegetative parts of the plant); number of flowers (florets) per panicle (expressed as a ratio of number of filled seeds over number of primary panicles); harvest index; number of plants grown per area; number and size of harvested organs per plant and per area;
number of plants per growing area (density); number of harvested organs in field; total leaf area; carbon assimilation and carbon partitioning (the distribution/allocation of carbon within the plant); resistance to shade; number of harvestable organs (e.g. seeds),
WO 2009/141824
PCT/IL2009/000508
2018200117 05 Jan 2018 seeds per pod, weight per seed; and modified architecture [such as increase stalk diameter, thickness or improvement of physical properties (e.g. elasticity)].
As used herein the phrase plant biomass refers to the amount (measured in grams of air-dry tissue) of a tissue produced from the plant in a growing season, which 5 could also determine or affect the plant yield or the yield per growing area. An increase in plant biomass can be in the whole plant or in parts thereof such as aboveground (harvestable) parts, vegetative biomass, roots and seeds.
As used herein the phrase “growth rate” refers to the increase in plant organ size per time (can be measured in cm2 per day).
As used herein the phrase plant vigor refers to the amount (measured by weight) of tissue produced by the plant in a given time. Hence increased vigor could determine or affect the plant yield or the yield per growing time or growing area. In addition, early vigor (seed and/or seedling) result with improved field stand.
As used herein the phrase “seed yield” refers to the number or weight of the seeds per plant, seeds per pod, or per growing area or to the weight of a single seed, or to the oil extracted per seed. Hence seed yield can be affected by seed dimensions (e.g., length, width, perimeter, area and/or volume), number of (filled) seeds and seed filling rate and by seed oil content. Hence increase seed yield per plant could affect the economic benefit one can obtain from the plant in a certain growing area and/or growing time; and increase seed yield per growing area could be achieved by increasing seed yield per plant, and/or by increasing number of plants grown on the same given area.
The term seed (also referred to as grain or kernel) as used herein refers to a small embryonic plant enclosed in a covering called the seed coat (usually with 25 some stored food), the product of the ripened ovule of gymnosperm and angiosperm plants which occurs after fertilization and some growth within the mother plant.
It should be noted that a plant yield can be determined under stress (e.g., abiotic stress, nitrogen-limiting conditions) or non-stress (normal) conditions.
As used herein, the phrase “non-stress conditions” refers to the growth conditions (e.g., water, temperature, light-dark cycles, humidity, salt concentration, fertilizer concentration in soil, nutrient supply such as nitrogen, phosphorous and/or potassium), which enable normal metabolism, growth, reproduction and/or viability of a
WO 2009/141824
PCT/IL2009/000508
2018200117 05 Jan 2018 plant at any stage in its life cycle (from seed to mature plant and back to seed again). It should be noted that while the non-stress conditions may include some mild variations from the optimal conditions (which vary from one type/species of a plant to another), such variations do not cause the plant to cease growing without the capacity to resume 5 growth.
The phrase abiotic stress as used herein refers to any adverse effect on metabolism, growth, reproduction and/or viability of a plant. Accordingly, abiotic stress can be induced by suboptimal environmental growth conditions such as, for example, salinity, water deprivation, flooding, freezing, low or high temperature, heavy 10 metal toxicity, anaerobiosis, nutrient deficiency, atmospheric pollution or UV irradiation. The implications of abiotic stress are discussed in the Background section.
The phrase “abiotic stress tolerance” as used herein refers to the ability of a plant to endure an abiotic stress without suffering a substantial alteration in metabolism, growth, productivity and/or viability.
As used herein the phrase “nitrogen use efficiency (NUE)” refers to the metabolic process(es) which lead to an increase in the plant’s yield, biomass, vigor, growth rate and abiotic stress tolerance per nitrogen unit applied. The metabolic process can be the uptake, spread, absorbent, accumulation, relocation (within the plant) and use of nitrogen absorbed by the plant.
As used herein the phrase “nitrogen-limiting conditions” refers to growth conditions which include a level (e.g., concentration) of nitrogen (e.g., ammonium or nitrate) applied which is below the level needed for normal plant metabolism, growth, reproduction and/or viability.
As used herein the term increasing refers to at least about 2 %, at least about 25 3 %, at least about 4 %, at least about 5 %, at least about 10 %, at least about 15 %, at least about 20 %, at least about 30 %, at least about 40 %, at least about 50 %, at least about 60 %, at least about 70 %, at least about 80 %, increase in oil content, yield, growth rate, biomass, vigor, abiotic stress tolerance and/or nitrogen use efficiency of a plant as compared to a native plant [i.e., a plant not modified with the biomolecules 30 (polynucleotide or polypeptides) of the invention, e.g., a non-transformed plant of the same species which is grown under the same growth conditions).
WO 2009/141824
PCT/IL2009/000508
2018200117 05 Jan 2018
As used herein, the phrase exogenous polynucleotide refers to a heterologous nucleic acid sequence which may not be naturally expressed within the plant or which overexpression in the plant is desired. The exogenous polynucleotide may be introduced into the plant in a stable or transient manner, so as to produce a 5 ribonucleic acid (RNA) molecule and/or a polypeptide molecule. It should be noted that the exogenous polynucleotide may comprise a nucleic acid sequence which is identical or partially homologous to an endogenous nucleic acid sequence of the plant.
According to some embodiments of the invention the exogenous polynucleotide comprises a nucleic acid sequence which is at least about 80 %, at least 10 about 81 %, at least about 82 %, at least about 83 %, at least about 84 %, at least about 85 %, at least about 86 %, at least about 87 %, at least about 88 %, at least about 89 %, at least about 90 %, at least about 91 %, at least about 92 %, at least about 93 %, at least about 93 %, at least about 94 %, at least about 95 %, at least about 96 %, at least about 97 %, at least about 98 %, at least about 99 %, e.g., 100 % identical to the nucleic acid 15 sequence selected from the group consisting of SEQ ID NOs: 18, 1-16, 19-50, 101-378, 657-672, 674-706, 716-719, 724-741 and 755-763 with the proviso that the nucleic acid sequence is not as set forth by SEQ ID NO:756 or 762.
Identity (e.g., percent homology) can be determined using any homology comparison software, including for example, the BlastN software of the National Center 20 of Biotechnology Information (NCBI) such as by using default parameters.
According to some embodiments of the invention the exogenous polynucleotide is at least about 80 %, at least about 81 %, at least about 82 %, at least about 83 %, at least about 84 %, at least about 85 %, at least about 86 %, at least about 87 %, at least about 88 %, at least about 89 %, at least about 90 %, at least about 91 %, 25 at least about 92 %, at least about 93 %, at least about 93 %, at least about 94 %, at least about 95 %, at least about 96 %, at least about 97 %, at least about 98 %, at least about 99 %, e.g., 100 % identical to the polynucleotide selected from the group consisting of SEQ ID NOs: 18, 1-16, 19-50, 101-378, 657-672, 674-706, 716-719, 724-741 and 755763 with the proviso that the exogenous polynucleotide is not as set forth by SEQ ID 30 NO:756 or 762.
WO 2009/141824
PCT/IL2009/000508
2018200117 05 Jan 2018
According to some embodiments of the invention the exogenous polynucleotide is set forth by SEQ ID NO:18, 1-16, 19-50, 101-378, 657-672, 674-706, 716-719, 724-741, 755, 757-761 or 763.
In exemplary embodiments the exogenous polynucleotide is not the 5 polynucleotide set forth by SEQ ID NO:807 or 808.
As used herein the term “polynucleotide” refers to a single or double stranded nucleic acid sequence which is isolated and provided in the form of an RNA sequence, a complementary polynucleotide sequence (cDNA), a genomic polynucleotide sequence and/or a composite polynucleotide sequences (e.g., a combination of the above).
The term “isolated” refers to at least partially separated from the natural environment e.g., from a plant cell.
As used herein the phrase complementary polynucleotide sequence refers to a sequence, which results from reverse transcription of messenger RNA using a reverse transcriptase or any other RNA dependent DNA polymerase. Such a sequence can be 15 subsequently amplified in vivo or in vitro using a DNA dependent DNA polymerase.
As used herein the phrase genomic polynucleotide sequence refers to a sequence derived (isolated) from a chromosome and thus it represents a contiguous portion of a chromosome.
As used herein the phrase composite polynucleotide sequence refers to a 20 sequence, which is at least partially complementary and at least partially genomic. A composite sequence can include some exonal sequences required to encode the polypeptide of the present invention, as well as some intronic sequences interposing therebetween. The intronic sequences can be of any source, including of other genes, and typically will include conserved splicing signal sequences. Such intronic sequences 25 may further include cis acting expression regulatory elements.
According to some embodiments of the invention, the exogenous polynucleotide of the invention encodes a polypeptide having an amino acid sequence at least about 80 %, at least about 81 %, at least about 82 %, at least about 83 %, at least about 84 %, at least about 85 %, at least about 86 %, at least about 87 %, at least about 30 88 %, at least about 89 %, at least about 90 %, at least about 91 %, at least about 92 %, at least about 93 %, at least about 94 %, at least about 95 %, at least about 96 %, at least about 97 %, at least about 98 %, at least about 99 %, or more say 100 % homologous to
WO 2009/141824
PCT/IL2009/000508
2018200117 05 Jan 2018 the amino acid sequence selected from the group consisting of SEQ ID NOs:68, 51-66, 69-100, 379-656, 707-715, 720-723, 742-754 and 764-772 with the proviso that the amino acid sequence is not as set forth by SEQ ID NO: 765 or 771.
Homology (e.g., percent homology) can be determined using any homology comparison software, including for example, the BlastP or TBLASTN software of the National Center of Biotechnology Information (NCBI) such as by using default parameters, when starting from a polypeptide sequence; or the tBLASTX algorithm (available via the NCBI) such as by using default parameters, which compares the sixframe conceptual translation products of a nucleotide query sequence (both strands) 10 against a protein sequence database.
Homologous sequences include both orthologous and paralogous sequences. The term “paralogous” relates to gene-duplications within the genome of a species leading to paralogous genes. The term “orthologous” relates to homologous genes in different organisms due to ancestral relationship.
One option to identify orthologues in monocot plant species is by performing a reciprocal blast search. This may be done by a first blast involving blasting the sequence-of-interest against any sequence database, such as the publicly available NCBI database which may be found at: Hypertext Transfer Protocol://World Wide Web (dot) ncbi (dot) nlm (dot) nih (dot) gov. If orthologues in rice were sought, the sequence-of20 interest would be blasted against, for example, the 28,469 full-length cDNA clones from Oryza sativa Nipponbare available at NCBI. The blast results may be filtered. The fulllength sequences of either the filtered results or the non-filtered results are then blasted back (second blast) against the sequences of the organism from which the sequence-ofinterest is derived. The results of the first and second blasts are then compared. An 25 orthologue is identified when the sequence resulting in the highest score (best hit) in the first blast identifies in the second blast the query sequence (the original sequence-ofinterest) as the best hit. Using the same rational a paralogue (homolog to a gene in the same organism) is found. In case of large sequence families, the ClustalW program may be used [Hypertext Transfer Protocol ://World Wide Web (dot) ebi (dot) ac (dot) 30 uk/Tools/clustalw2/index (dot) html], followed by a neighbor-joining tree (Hypertext Transfer Protocol://en (dot) wikipedia (dot) org/wiki/Neighbor-joining) which helps visualizing the clustering.
WO 2009/141824
PCT/IL2009/000508
2018200117 05 Jan 2018
In an exemplary embodiment the exogenous polynucleotide does not encode a polypeptide having the amino acid sequence selected from the group consisting of SEQ ID NOs: 809-852.
According to some embodiments of the invention, the exogenous polynucleotide encodes a polypeptide consisting of the amino acid sequence set forth by SEQ ID NO: 68, 51-66, 69-100, 379-656, 707-715, 720-723, 742-754, 764, 766-770 or 772.
Nucleic acid sequences encoding the polypeptides of the present invention may be optimized for expression. Non-limiting examples of optimized nucleic acid 10 sequences are provided in SEQ ID NOs:663 (BDL-113), 675 (BDL-129), 676 (BDL130), 680 (BDL-134), 683 (BDL-137), 684 (BDL-139) and 685 (BDL-141) which encode optimized polypeptide comprising the amino acid sequences set forth by SEQ ID NOs:57, 69, 712, 74, 77, 78 and 79. Examples of such sequence modifications include, but are not limited to, an altered G/C content to more closely approach that 15 typically found in the plant species of interest, and the removal of codons atypically found in the plant species commonly referred to as codon optimization.
The phrase codon optimization refers to the selection of appropriate DNA nucleotides for use within a structural gene or fragment thereof that approaches codon usage within the plant of interest. Therefore, an optimized gene or nucleic acid 20 sequence refers to a gene in which the nucleotide sequence of a native or naturally occurring gene has been modified in order to utilize statistically-preferred or statistically-favored codons within the plant. The nucleotide sequence typically is examined at the DNA level and the coding region optimized for expression in the plant species determined using any suitable procedure, for example as described in Sardana et 25 al. (1996, Plant Cell Reports 15:677-681). In this method, the standard deviation of codon usage, a measure of codon usage bias, may be calculated by first finding the squared proportional deviation of usage of each codon of the native gene relative to that of highly expressed plant genes, followed by a calculation of the average squared deviation. The formula used is: 1 SDCU = n= lN[(Xn-Yn)/Yn]2/N, where Xn 30 refers to the frequency of usage of codon n in highly expressed plant genes, where Yn to the frequency of usage of codon n in the gene of interest and N refers to the total number of codons in the gene of interest. A Table of codon usage from highly
WO 2009/141824
PCT/IL2009/000508
2018200117 05 Jan 2018 expressed genes of dicotyledonous plants is compiled using the data of Murray et al. (1989, Nuc Acids Res. 17:477-498).
One method of optimizing the nucleic acid sequence in accordance with the preferred codon usage for a particular plant cell type is based on the direct use, without 5 performing any extra statistical calculations, of codon optimization Tables such as those provided on-line at the Codon Usage Database through the NIAS (National Institute of Agrobiological Sciences) DNA bank in Japan (Hypertext Transfer Protocol://World Wide Web (dot) kazusa (dot) or (dot) jp/codon/). The Codon Usage Database contains codon usage tables for a number of different species, with each codon usage Table 10 having been statistically determined based on the data present in Genbank.
By using the above Tables to determine the most preferred or most favored codons for each amino acid in a particular species (for example, rice), a naturallyoccurring nucleotide sequence encoding a protein of interest can be codon optimized for that particular plant species. This is effected by replacing codons that may have a low 15 statistical incidence in the particular species genome with corresponding codons, in regard to an amino acid, that are statistically more favored. However, one or more lessfavored codons may be selected to delete existing restriction sites, to create new ones at potentially useful junctions (5' and 3' ends to add signal peptide or termination cassettes, internal sites that might be used to cut and splice segments together to produce a correct 20 full-length sequence), or to eliminate nucleotide sequences that may negatively effect mRNA stability or expression.
The naturally-occurring encoding nucleotide sequence may already, in advance of any modification, contain a number of codons that correspond to a statistically-favored codon in a particular plant species. Therefore, codon optimization 25 of the native nucleotide sequence may comprise determining which codons, within the native nucleotide sequence, are not statistically-favored with regards to a particular plant, and modifying these codons in accordance with a codon usage table of the particular plant to produce a codon optimized derivative. A modified nucleotide sequence may be fully or partially optimized for plant codon usage provided that the 30 protein encoded by the modified nucleotide sequence is produced at a level higher than the protein encoded by the corresponding naturally occurring or native gene.
WO 2009/141824
PCT/IL2009/000508
2018200117 05 Jan 2018
Construction of synthetic genes by altering the codon usage is described in for example PCT Patent Application 93/07278.
Thus, the invention encompasses nucleic acid sequences described hereinabove; fragments thereof, sequences hybridizable therewith, sequences homologous thereto, sequences encoding similar polypeptides with different codon usage, altered sequences characterized by mutations, such as deletion, insertion or substitution of one or more nucleotides, either naturally occurring or man induced, either randomly or in a targeted fashion.
The invention provides an isolated polynucleotide comprising a nucleic acid sequence at least about 80 %, at least about 81 %, at least about 82 %, at least about 83 %, at least about 84 %, at least about 85 %, at least about 86 %, at least about 87 %, at least about 88 %, at least about 89 %, at least about 90 %, at least about 91 %, at least about 92 %, at least about 93 %, at least about 93 %, at least about 94 %, at least about %, at least about 96 %, at least about 97 %, at least about 98 %, at least about 99 %, 15 e.g., 100 % identical to the polynucleotide selected from the group consisting of SEQ ID
NOs: 18, 1-16, 19-50, 101-378, 657-672, 674-706, 716-719, 724-741 and 755-763 with the proviso that the nucleic acid sequence is not as set forth by SEQ ID NO:756 or 762.
According to some embodiments of the invention the isolated polynucleotide comprising the nucleic acid sequence selected from the group consisting of SEQ ID
NOs: 18, 1-16, 19-50, 101-378, 657-672, 674-706, 716-719, 724-741, 755, 757-761 and 763.
According to some embodiments of the invention the isolated polynucleotide is set forth by SEQ ID NO: 18, 1-16, 19-50, 101-378, 657-672, 674-706, 716-719, 724741, 755, 757-761 or 763.
In exemplary embodiments the isolated polynucleotide is not the polynucleotide set forth by SEQ ID NO:807 or 808.
The invention provides an isolated polynucleotide comprising a nucleic acid sequence encoding a polypeptide which comprises an amino acid sequence at least about 80 %, at least about 81 %, at least about 82 %, at least about 83 %, at least about 30 84 %, at least about 85 %, at least about 86 %, at least about 87 %, at least about 88 %, at least about 89 %, at least about 90 %, at least about 91 %, at least about 92 %, at least about 93 %, at least about 93 %, at least about 94 %, at least about 95 %, at least about
WO 2009/141824
PCT/IL2009/000508
2018200117 05 Jan 2018 %, at least about 97 %, at least about 98 %, at least about 99 %, or more say 100 % homologous to the amino acid sequence selected from the group consisting of SEQ ID NOs:68, 51-66, 69-100, 379-656, 707-715, 720-723, 742-754 and 764-772 with the proviso that the amino acid sequence is not as set forth by SEQ ID NO: 765 or 771.
The invention provides an isolated polynucleotide comprising a nucleic acid sequence encoding a polypeptide which comprises the amino acid sequence selected from the group consisting of SEQ ID NOs:68, 51-66, 69-100, 379-656, 707-715, 720723, 742-754, 764, 766-770 and 772.
The invention provides an isolated polypeptide comprising an amino acid sequence at least about 80 %, at least about 81 %, at least about 82 %, at least about 83 %, at least about 84 %, at least about 85 %, at least about 86 %, at least about 87 %, at least about 88 %, at least about 89 %, at least about 90 %, at least about 91 %, at least about 92 %, at least about 93 %, at least about 93 %, at least about 94 %, at least about %, at least about 96 %, at least about 97 %, at least about 98 %, at least about 99 %, or more say 100 % homologous to an amino acid sequence selected from the group consisting of SEQ ID NOs:68, 51-66, 69-100, 379-656, 707-715, 720-723, 742-754 and 764-772 with the proviso that the amino acid sequence is not as set forth by SEQ ID NO: 765 or 771.
In an exemplary embodiment the polypeptide is not the polypeptide set forth 20 by SEQ ID NO: 809-851 or 852.
According to some embodiments of the invention, the polypeptide comprising an amino acid sequence selected from the group consisting of SEQ ID SEQ ID NOs:68, 51-66, 69-100, 379-656, 707-715, 720-723, 742-754, 764, 766-770 and 772.
According to some embodiments of the invention, the polypeptide is set forth by SEQ ID NO: 68, 51-66, 69-100, 379-656, 707-715, 720-723, 742-754, 764, 766-770 or 772.
The invention also encompasses fragments of the above described polypeptides and polypeptides having mutations, such as deletions, insertions or substitutions of one or more amino acids, either naturally occurring or man induced, 30 either randomly or in a targeted fashion.
The term 'plant as used herein encompasses whole plants, ancestors and progeny of the plants and plant parts, including seeds, shoots, stems, roots (including
WO 2009/141824
PCT/IL2009/000508
2018200117 05 Jan 2018 tubers), and plant cells, tissues and organs. The plant may be in any form including suspension cultures, embryos, meristematic regions, callus tissue, leaves, gametophytes, sporophytes, pollen, and microspores. Plants that are particularly useful in the methods of the invention include all plants which belong to the superfamily Viridiplantae, in 5 particular monocotyledonous and dicotyledonous plants including a fodder or forage legume, ornamental plant, food crop, tree, or shrub selected from the list comprising Acacia spp., Acer spp., Actinidia spp., Aesculus spp., Agathis australis, Albizia amara, Alsophila tricolor, Andropogon spp., Arachis spp, Areca catechu, Astelia fragrans, Astragalus cicer, Baikiaea plurijuga, Betula spp., Brassica spp., Bruguiera gymnorrhiza, 10 Burkea africana, Butea frondosa, Cadaba farinosa, Calliandra spp, Camellia sinensis,
Canna indica, Capsicum spp., Cassia spp., Centroema pubescens, Chacoomeles spp., Cinnamomum cassia, Coffea arabica, Colophospermum mopane, Coronillia varia, Cotoneaster serotina, Crataegus spp., Cucumis spp., Cupressus spp., Cyathea dealbata, Cydonia oblonga, Cryptomeria japonica, Cymbopogon spp., Cynthea dealbata, Cydonia 15 oblonga, Dalbergia monetaria, Davallia divaricata, Desmodium spp., Dicksonia squarosa, Dibeteropogon amplectens, Dioclea spp, Dolichos spp., Dorycnium rectum, Echinochloa pyramidalis, Ehraffia spp., Eleusine coracana, Eragrestis spp., Erythrina spp., Eucalypfus spp., Euclea schimperi, Eulalia vi/losa, Pagopyrum spp., Feijoa sellowlana, Fragaria spp., Flemingia spp, Freycinetia banksli, Geranium thunbergii, 20 GinAgo biloba, Glycine javanica, Gliricidia spp, Gossypium hirsutum, Grevillea spp.,
Guibourtia coleosperma, Hedysarum spp., Hemaffhia altissima, Heteropogon contoffus, Hordeum vulgare, Hyparrhenia rufa, Hypericum erectum, Hypeffhelia dissolute, Indigo incamata, Iris spp., Leptarrhena pyrolifolia, Lespediza spp., Lettuca spp., Leucaena leucocephala, Loudetia simplex, Lotonus bainesli, Lotus spp., Macrotyloma axillare, 25 Malus spp., Manihot esculenta, Medicago saliva, Metasequoia glyptostroboides, Musa sapientum, Nicotianum spp., Onobrychis spp., Omithopus spp., Oryza spp., Peltophorum africanum, Pennisetum spp., Persea gratissima, Petunia spp., Phaseolus spp., Phoenix canariensis, Phormium cookianum, Photinia spp., Picea glauca, Pinus spp., Pisum sativam, Podocarpus totara, Pogonarthria fleckii, Pogonaffhria squarrosa, 30 Populus spp., Prosopis cineraria, Pseudotsuga menziesii, Pterolobium stellatum, Pyrus communis, Quercus spp., Rhaphiolepsis umbellata, Rhopalostylis sapida, Rhus natalensis, Ribes grossularia, Ribes spp., Robinia pseudoacacia, Rosa spp., Rubus spp.,
WO 2009/141824
PCT/IL2009/000508
2018200117 05 Jan 2018
Salix spp., Schyzachyrium sanguineum, Sciadopitys vefficillata, Sequoia sempervirens, Sequoiadendron giganteum, Sorghum bicolor, Spinacia spp., Sporobolus fimbriatus, Stiburus alopecuroides, Stylosanthos humilis, Tadehagi spp, Taxodium distichum, Themeda triandra, Trifolium spp., Triticum spp., Tsuga heterophylla, Vaccinium spp., 5 Vicia spp., Vitis vinifera, Watsonia pyramidata, Zantedeschia aethiopica, Zea mays, amaranth, artichoke, asparagus, broccoli, Brussels sprouts, cabbage, canola, carrot, cauliflower, celery, collard greens, flax, kale, lentil, oilseed rape, okra, onion, potato, rice, soybean, straw, sugar beet, sugar cane, sunflower, tomato, squash tea, maize, wheat, barely, rye, oat, peanut, pea, lentil and alfalfa, cotton, rapeseed, canola, pepper, 10 sunflower, tobacco, eggplant, eucalyptus, a tree, an ornamental plant, a perennial grass and a forage crop. Alternatively algae and other non-Viridiplantae can be used for the methods of the present invention.
According to some embodiments of the invention, the plant used by the method of the invention is a crop plant such as rice, maize, wheat, barley, peanut, 15 potato, sesame, olive tree, palm oil, banana, soybean, sunflower, canola, sugarcane, alfalfa, millet, leguminosae (bean, pea), flax, lupinus, rapeseed, tobacco, poplar and cotton.
Expressing the exogenous polynucleotide of the invention within the plant can be effected by transforming one or more cells of the plant with the exogenous 20 polynucleotide, followed by generating a mature plant from the transformed cells and cultivating the mature plant under conditions suitable for expressing the exogenous polynucleotide within the mature plant.
According to some embodiments of the invention, the transformation is effected by introducing to the plant cell a nucleic acid construct which includes the 25 exogenous polynucleotide of some embodiments of the invention and at least one promoter for directing transcription of the exogenous polynucleotide in a host cell (a plant cell). Further details of suitable transformation approaches are provided hereinbelow.
According to some embodiments of the invention, there is provided a nucleic 30 acid construct comprising the isolated polynucleotide of the invention, and a promoter for directing transcription of the nucleic acid sequence in a host cell.
WO 2009/141824
PCT/IL2009/000508
2018200117 05 Jan 2018
As used herein, the term “promoter” refers to a region of DNA which lies upstream of the transcriptional initiation site of a gene to which RNA polymerase binds to initiate transcription of RNA. The promoter controls where (e.g., which portion of a plant) and/or when (e.g., at which stage or condition in the lifetime of an organism) the 5 gene is expressed.
Any suitable promoter sequence can be used by the nucleic acid construct of the present invention. Preferably the promoter is a constitutive promoter, a tissuespecific, or an abiotic stress-inducible promoter.
Suitable constitutive promoters include, for example, CaMV 35S promoter 10 (SEQ ID NO:777; Odell et al., Nature 313:810-812, 1985); Arabidopsis At6669 promoter (SEQ ID NO:775; see PCT Publication No. W004081173A2); maize Ubi 1 (Christensen et al., Plant Sol. Biol. 18:675-689, 1992); rice actin (McElroy et al., Plant Cell 2:163-171, 1990); pEMU (Last et al., Theor. Appl. Genet. 81:581-588, 1991); CaMV 19S (Nilsson et al., Physiol. Plant 100:456-462, 1997); GOS2 (de Pater et al, 15 Plant J Nov;2(6):837-44, 1992); ubiquitin (Christensen et al, Plant Mol. Biol. 18: 675689,1992); Rice cyclophilin (Bucholz et al, Plant Mol Biol. 25(5):837-43,1994); Maize H3 histone (Lepetit et al, Mol. Gen. Genet. 231: 276-285,1992); Actin 2 (An et al, Plant J. 10(l);107-121, 1996) and Synthetic Super MAS (Ni et al., The Plant Journal 7: 66176, 1995). Other constitutive promoters include those in U.S. Pat. Nos. 5,659,026, 20 5,608,149; 5.608,144; 5,604,121; 5.569,597: 5.466,785; 5,399,680; 5,268,463; and
5,608,142.
Suitable tissue-specific promoters include, but not limited to, leaf-specific promoters [such as described, for example, by Yamamoto et al., Plant J. 12:255-265, 1997; Kwon et al., Plant Physiol. 105:357-67, 1994; Yamamoto et al., Plant Cell 25 Physiol. 35:773-778, 1994; Gotor et al., Plant J. 3:509-18, 1993; Orozco et al., Plant Mol. Biol. 23:1129-1138, 1993; and Matsuoka et al., Proc. Natl. Acad. Sci. USA 90:9586-9590, 1993], seed-preferred promoters [e.g., from seed specific genes (Simon, et al., Plant Mol. Biol. 5. 191, 1985; Scofield, et al., J. Biol. Chem. 262: 12202, 1987; Baszczynski, et al., Plant Mol. Biol. 14: 633,1990), Brazil Nut albumin (Pearson1 et al., 30 Plant Mol. Biol. 18: 235- 245,1992), legumin (Ellis, et al. Plant Mol. Biol. 10: 203-214, 1988), Glutelin (rice) (Takaiwa, et al., Mol. Gen. Genet. 208: 15-22, 1986; Takaiwa, et al., FEBS Letts. 221: 43-47, 1987), Zein (Matzke et al Plant Mol Biol, 143).323-32
WO 2009/141824
PCT/IL2009/000508
2018200117 05 Jan 2018
1990), napA (Stalberg, et al, Planta 199: 515-519, 1996), Wheat SPA (Albanietal, Plant Cell, 9: 171- 184, 1997), sunflower oleosin (Cummins, etal., Plant Mol. Biol. 19: 873876, 1992)], endosperm specific promoters [e.g., wheat LMW and HMW, glutenin-1 (Mol Gen Genet 216:81-90, 1989; NAR 17:461-2), wheat a, b and g gliadins (EMBO3:1409-15, 1984), Barley ltrl promoter, barley Bl, C, D hordein (Theor Appl
Gen 98:1253-62, 1999; Plant J 4:343-55, 1993; Mol Gen Genet 250:750- 60, 1996),
Barley DOF (Mena et al, The Plant Journal, 116(1): 53- 62, 1998), Biz2 (EP99106056.7), Synthetic promoter (Vicente-Carbajosa et al., Plant J. 13: 629-640, 1998), rice prolamin NRP33, rice -globulin Glb-1 (Wu et al, Plant Cell Physiology 10 39(8) 885- 889, 1998), rice alpha-globulin REB/OHP-1 (Nakase et al. Plant Mol. Biol.
33: 513-S22,1997), rice ADP-glucose PP (Trans Res 6:157-68,1997), maize ESR gene family (Plant J 12:235-46, 1997), sorgum gamma- kafirin (PMB 32:1029-35, 1996)], embryo specific promoters [e.g., rice OSHI (Sato et al, Proc. Nati. Acad. Sci. USA, 93: 8117-8122), KNOX (Postma-Haarsma et al, Plant Mol. Biol. 39:257-71, 1999), rice oleosin (Wu et at, J. Biochem., 123:386, 1998)], and flower-specific promoters [e.g., AtPRP4, chalene synthase (chsA) (Van der Meer, et al., Plant Mol. Biol. 15, 95109,1990), LAT52 (Twell et al Mol. Gen Genet. 217:240-245; 1989), apetala- 3].
Suitable abiotic stress-inducible promoters include, but not limited to, saltinducible promoters such as RD29A (Yamaguchi-Shinozalei et al., Mol. Gen. Genet.
236:331-340, 1993); drought-inducible promoters such as maize rabl7 gene promoter (Pla et. al., Plant Mol. Biol. 21:259-266, 1993), maize rab28 gene promoter (Busk et.
al., Plant J. 11:1285-1295, 1997) and maize Ivr2 gene promoter (Pelleschi et. al., Plant Mol. Biol. 39:373-380, 1999); heat-inducible promoters such as heat tomato hsp80promoter from tomato (U.S. Pat. No. 5,187,267).
As mentioned above, and further described in Example 6 of the Examples section which follows, the present inventors have uncovered novel promoter sequences (regulatory nucleic acid sequences) which can be used to express a polynucleotide-ofinterest in a plant.
Thus, according to an aspect of some embodiments of the invention, there is 30 provided a nucleic acid construct comprising a nucleic acid sequence selected from the group consisting of SEQ ID NOs:779-792 and a heterologous polynucleotide sequence,
WO 2009/141824
PCT/IL2009/000508
2018200117 05 Jan 2018 wherein the nucleic acid sequence is capable of regulating expression of the heterologous polynucleotide in a host cell.
According to some embodiments of the invention the heterologous polynucleotide is operably linked to the regulatory nucleic acid sequence selected from 5 the group consisting of SEQ ID NOs:779-792.
According to some embodiments of the invention, the regulatory nucleic acid sequence of the invention range in length from about 500 nucleotides to about 4000 nucleotides and include one or more sequence regions which are capable of recognizing and binding RNA polymerase II and other proteins (trans-acting transcription factors) 10 involved in transcription.
A coding nucleic acid sequence is “operably linked” to a regulatory sequence if the regulatory sequence is capable of exerting a regulatory effect on the coding sequence linked thereto. According to some embodiments of the invention, the regulatory sequence is positioned 1-500 bp upstream of the ATG codon of the coding 15 nucleic acid sequence, although it will be appreciated that regulatory sequences can also exert their effect when positioned elsewhere with respect to the coding nucleic acid sequence (e.g., within an intron).
As is clearly illustrated in the Examples section which follows, the novel regulatory nucleic acid sequences of the invention are capable of regulating expression 20 of a coding nucleic acid sequence (e.g., a reporter gene such as GUS, luciferase) operably linked thereto (see Example 6 of the Examples section which follows).
According to some embodiments of the invention, the regulatory nucleic acid sequences of the invention regulate the expression of the heterologous polynucleotide in a tissue specific manner.
According to some embodiments of the invention, the regulatory nucleic acid sequences of the invention regulate the expression of the heterologous polynucleotide in a developmental stage - specific manner.
According to some embodiments of the invention, the regulatory nucleic acid sequences of the invention are modified to create variations in the molecule sequences 30 such as to enhance their promoting activities, using methods known in the art, such as PCR-based DNA modification, or standard DNA mutagenesis techniques, or by chemically synthesizing the modified polynucleotides.
WO 2009/141824
PCT/IL2009/000508
2018200117 05 Jan 2018
Accordingly, the regulatory nucleic acid sequences set forth in SEQ ID NOs:779-792 may be truncated or deleted and still retain the capacity of directing the transcription of an operably linked heterologous DNA sequence. The minimal length of a promoter region can be determined by systematically removing sequences from the 5' 5 and 3'-ends of the isolated polynucleotide by standard techniques known in the art, including but not limited to removal of restriction enzyme fragments or digestion with nucleases. Consequently, any sequence fragments, portions, or regions of the disclosed promoter polynucleotide sequences of the invention can be used as regulatory sequences. It will be appreciated that modified sequences (mutated, truncated and the 10 like) can acquire different transcriptional properties such as the direction of different pattern of gene expression as compared to the unmodified element.
Optionally, the sequences set forth in SEQ ID NOs:779-792 may be modified, for example for expression in a range of plant systems. In another approach, novel hybrid promoters can be designed or engineered by a number of methods. Many 15 promoters contain upstream sequences which activate, enhance or define the strength and/or specificity of the promoter, such as described, for example, by Atchison [Ann. Rev. Cell Biol. 4:127 (1988)]. T-DNA genes, for example contain TATA boxes defining the site of transcription initiation and other upstream elements located upstream of the transcription initiation site modulate transcription levels [Gelvin In: 20 Transgenic Plants (Kung, S.-D. and Us, R., Eds, San Diego: Academic Press, pp.49-87, (1988)]. Another chimeric promoter combined a trimer of the octopine synthase (OCS) activator to the mannopine synthase (mas) activator plus promoter and reported an increase in expression of a reporter gene [Min Ni et al. The Plant Journal 7:661 (1995)]. The upstream regulatory sequences of the promoter polynucleotide sequences of the 25 invention can be used for the construction of such chimeric or hybrid promoters.
Methods for construction of variant promoters include, but are not limited to, combining control elements of different promoters or duplicating portions or regions of a promoter (see for example, U.S. Pat. Nos. 5,110,732 and 5,097,025). Those of skill in the art are familiar with the specific conditions and procedures for the construction, manipulation 30 and isolation of macromolecules (e.g., DNA molecules, plasmids, etc.), generation of recombinant organisms and the screening and isolation of genes, [see for example Sambrook et al., Molecular Cloning: A Laboratory Manual, Cold Spring Harbor Press,
WO 2009/141824
PCT/IL2009/000508
2018200117 05 Jan 2018 (1989); Mailga et al., Methods in Plant Molecular Biology, Cold Spring Harbor Press, (1995); Birren et al., Genome Analysis: volume 1, Analyzing DNA, (1997); volume 2, Detecting Genes, (1998); volume 3, Cloning Systems, (1999); and volume 4, Mapping Genomes, (1999), Cold Spring Harbor, N.Y].
According to some embodiments of the invention the heterologous polynucleotide which is regulated by the regulatory nucleic acid sequence of the invention (e.g., SEQ ID NO:779-791 or 792) comprises a nucleic acid sequence at least about 80 %, at least about 81 %, at least about 82 %, at least about 83 %, at least about 84 %, at least about 85 %, at least about 86 %, at least about 87 %, at least about 88 %, 10 at least about 89 %, at least about 90 %, at least about 91 %, at least about 92 %, at least about 93 %, at least about 93 %, at least about 94 %, at least about 95 %, at least about 96 %, at least about 97 %, at least about 98 %, at least about 99 %, e.g., 100 % identical to the nucleic acid sequence selected from the group consisting of SEQ ID NOs: 18, 116, 19-50, 101-378, 657-672, 674-706, 716-719, 724-741 and 755-763 with the proviso 15 that the nucleic acid sequence is not as set forth by SEQ ID NO:756 or 762.
According to some embodiments of the invention the heterologous polynucleotide encodes an amino acid sequence at least about 80 %, at least about 81 %, at least about 82 %, at least about 83 %, at least about 84 %, at least about 85 %, at least about 86 %, at least about 87 %, at least about 88 %, at least about 89 %, at least about 20 90 %, at least about 91 %, at least about 92 %, at least about 93 %, at least about 93 %, at least about 94 %, at least about 95 %, at least about 96 %, at least about 97 %, at least about 98 %, at least about 99 %, or more say 100 % homologous to SEQ ID NO:68,5166, 69-100, 379-656, 707-715, 720-723, 742-754, 764-771 or 772, with the proviso that the amino acid sequence is not as set forth by SEQ ID NO: 765 or 771.
According to some embodiments the heterologous polynucleotide does not encode the amino acid sequence set forth by SEQ ID NO: 809-851 or 852.
According to some embodiments the heterologous polynucleotide does not comprise the nucleic acid sequence set forth by SEQ ID NO:807 or 808.
Thus, according to some embodiments of the invention, the method of increasing oil content, yield, growth rate, biomass, vigor, abiotic stress tolerance and/or nitrogen use efficiency of a plant is effected by expressing within the plant a nucleic acid construct of the invention which comprises a nucleic acid sequence selected from
WO 2009/141824
PCT/IL2009/000508
2018200117 05 Jan 2018 the group consisting of SEQ ID NOs:779-792 and a heterologous polynucleotide sequence which comprises a nucleic acid sequence at least about 80 %, at least about 81 %, at least about 82 %, at least about 83 %, at least about 84 %, at least about 85 %, at least about 86 %, at least about 87 %, at least about 88 %, at least about 89 %, at least 5 about 90 %, at least about 91 %, at least about 92 %, at least about 93 %, at least about %, at least about 94 %, at least about 95 %, at least about 96 %, at least about 97 %, at least about 98 %, at least about 99 %, e.g., 100 % identical to SEQ ID NOs: 18,1-16, 19-50,101-378, 657-672, 674-706, 716-719, 724-741 and 755-763 with the proviso that the nucleic acid sequence is not as set forth by SEQ ID NO:756 or 762, wherein the 10 nucleic acid sequence is capable of regulating expression of the heterologous polynucleotide in a host cell.
According to some embodiments of the invention, the method of increasing oil content, yield, growth rate, biomass, vigor, abiotic stress tolerance and/or nitrogen use efficiency of a plant is effected by expressing within the plant a nucleic acid construct 15 which comprises a nucleic acid sequence selected from the group consisting of SEQ ID NOs:779-792 and a heterologous polynucleotide sequence which encodes an amino acid sequence at least about 80 %, at least about 81 %, at least about 82 %, at least about 83 %, at least about 84 %, at least about 85 %, at least about 86 %, at least about 87 %, at least about 88 %, at least about 89 %, at least about 90 %, at least about 91 %, at least 20 about 92 %, at least about 93 %, at least about 93 %, at least about 94 %, at least about 95 %, at least about 96 %, at least about 97 %, at least about 98 %, at least about 99 %, or more say 100 % homologous to SEQ ID NO:68, 51-66, 69-100, 379-656, 707-715, 720-723, 742-754, 764-771 or 772 with the proviso that the amino acid sequence is not as set forth by SEQ ID NO: 765 or 771, wherein the nucleic acid sequence is capable of 25 regulating expression of the heterologous polynucleotide in a host cell.
The nucleic acid construct of some embodiments of the invention can further include an appropriate selectable marker and/or an origin of replication. According to some embodiments of the invention, the nucleic acid construct utilized is a shuttle vector, which can propagate both in E. coli (wherein the construct comprises an 30 appropriate selectable marker and origin of replication) and be compatible with propagation in cells. The construct according to the present invention can be, for
WO 2009/141824
PCT/IL2009/000508
2018200117 05 Jan 2018 example, a plasmid, a bacemid, a phagemid, a cosmid, a phage, a virus or an artificial chromosome.
The nucleic acid construct of some embodiments of the invention can be utilized to stably or transiently transform plant cells. In stable transformation, the 5 exogenous polynucleotide is integrated into the plant genome and as such it represents a stable and inherited trait. In transient transformation, the exogenous polynucleotide is expressed by the cell transformed but it is not integrated into the genome and as such it represents a transient trait.
There are various methods of introducing foreign genes into both 10 monocotyledonous and dicotyledonous plants (Potrykus, I. Annu. Rev. Plant. Physiol., Plant. Mol. Biol. (1991) 42:205-225; Shimamoto et al., Nature (1989) 338:274-276).
The principle methods of causing stable integration of exogenous DNA into plant genomic DNA include two main approaches:
(i) Agrobacterium-mediated gene transfer: Klee et al. (1987) Annu. 15 Rev. Plant Physiol. 38:467-486; Klee and Rogers in Cell Culture and Somatic Cell Genetics of Plants, Vol. 6, Molecular Biology of Plant Nuclear Genes, eds. Schell, J., and Vasil, L. K., Academic Publishers, San Diego, Calif. (1989) p. 2-25; Gatenby, in Plant Biotechnology, eds. Kung, S. and Amtzen, C. J., Butterworth Publishers, Boston, Mass. (1989) p. 93-112.
(ii) Direct DNA uptake: Paszkowski et al., in Cell Culture and Somatic Cell
Genetics of Plants, Vol. 6, Molecular Biology of Plant Nuclear Genes eds. Schell, J., and Vasil, L. K., Academic Publishers, San Diego, Calif. (1989) p. 52-68; including methods for direct uptake of DNA into protoplasts, Toriyama, K. et al. (1988) Bio/Technology 6:1072-1074. DNA uptake induced by brief electric shock of plant cells: Zhang et al. Plant Cell Rep. (1988) 7:379-384. Fromm et al. Nature (1986) 319:791-793. DNA injection into plant cells or tissues by particle bombardment, Klein et al. Bio/Technology (1988) 6:559-563; McCabe et al. Bio/Technology (1988) 6:923926; Sanford, Physiol. Plant. (1990) 79:206-209; by the use of micropipette systems: Neuhaus et al., Theor. Appl. Genet. (1987) 75:30-36; Neuhaus and Spangenberg,
Physiol. Plant. (1990) 79:213-217; glass fibers or silicon carbide whisker transformation of cell cultures, embryos or callus tissue, U.S. Pat. No. 5,464,765 or by the direct incubation of DNA with germinating pollen, DeWet et al. in Experimental Manipulation
WO 2009/141824
PCT/IL2009/000508
2018200117 05 Jan 2018 of Ovule Tissue, eds. Chapman, G. P. and Mantell, S. H. and Daniels, W. Longman,
London, (1985) p. 197-209; and Ohta, Proc. Natl. Acad. Sci. USA (1986) 83:715719.
The Agrobacterium system includes the use of plasmid vectors that contain defined DNA segments that integrate into the plant genomic DNA. Methods of inoculation of the plant tissue vary depending upon the plant species and the Agrobacterium delivery system. A widely used approach is the leaf disc procedure which can be performed with any tissue explant that provides a good source for initiation of whole plant differentiation. See, e.g., Horsch et al. in Plant Molecular
Biology Manual A5, Kluwer Academic Publishers, Dordrecht (1988) p. 1-9. A supplementary approach employs the Agrobacterium delivery system in combination with vacuum infiltration. The Agrobacterium system is especially viable in the creation of transgenic dicotyledonous plants.
There are various methods of direct DNA transfer into plant cells. In electroporation, the protoplasts are briefly exposed to a strong electric field. In microinjection, the DNA is mechanically injected directly into the cells using very small micropipettes. In microparticle bombardment, the DNA is adsorbed on microprojectiles such as magnesium sulfate crystals or tungsten particles, and the microprojectiles are physically accelerated into cells or plant tissues.
Following stable transformation plant propagation is exercised. The most common method of plant propagation is by seed. Regeneration by seed propagation, however, has the deficiency that due to heterozygosity there is a lack of uniformity in the crop, since seeds are produced by plants according to the genetic variances governed by Mendelian rules. Basically, each seed is genetically different and each will grow with its own specific traits. Therefore, it is preferred that the transformed plant be produced such that the regenerated plant has the identical traits and characteristics of the parent transgenic plant. Therefore, it is preferred that the transformed plant be regenerated by micropropagation which provides a rapid, consistent reproduction of the transformed plants.
Micropropagation is a process of growing new generation plants from a single piece of tissue that has been excised from a selected parent plant or cultivar. This process permits the mass reproduction of plants having the preferred tissue expressing
WO 2009/141824
PCT/IL2009/000508
2018200117 05 Jan 2018 the fusion protein. The new generation plants which are produced are genetically identical to, and have all of the characteristics of, the original plant. Micropropagation allows mass production of quality plant material in a short period of time and offers a rapid multiplication of selected cultivars in the preservation of the characteristics of the 5 original transgenic or transformed plant. The advantages of cloning plants are the speed of plant multiplication and the quality and uniformity of plants produced.
Micropropagation is a multi-stage procedure that requires alteration of culture medium or growth conditions between stages. Thus, the micropropagation process involves four basic stages: Stage one, initial tissue culturing; stage two, tissue culture 10 multiplication; stage three, differentiation and plant formation; and stage four, greenhouse culturing and hardening. During stage one, initial tissue culturing, the tissue culture is established and certified contaminant-free. During stage two, the initial tissue culture is multiplied until a sufficient number of tissue samples are produced to meet production goals. During stage three, the tissue samples grown in stage two are divided 15 and grown into individual plantlets. At stage four, the transformed plantlets are transferred to a greenhouse for hardening where the plants' tolerance to light is gradually increased so that it can be grown in the natural environment.
According to some embodiments of the invention, the transgenic plants are generated by transient transformation of leaf cells, meristematic cells or the whole plant. 20 Transient transformation can be effected by any of the direct DNA transfer methods described above or by viral infection using modified plant viruses.
Viruses that have been shown to be useful for the transformation of plant hosts include CaMV, Tobacco mosaic virus (TMV), brome mosaic virus (BMV) and Bean Common Mosaic Virus (BV or BCMV). Transformation of plants using plant viruses is 25 described in U.S. Pat. No. 4,855,237 (bean golden mosaic virus; BGV), EP-A 67,553 (TMV), Japanese Published Application No. 63-14693 (TMV), EPA 194,809 (BV), EPA 278,667 (BV); and Gluzman, Y. et al., Communications in Molecular Biology: Viral Vectors, Cold Spring Harbor Laboratory, New York, pp. 172-189 (1988). Pseudovirus particles for use in expressing foreign DNA in many hosts, including plants 30 are described in WO 87/06261.
According to some embodiments of the invention, the virus used for transient transformations is avirulent and thus is incapable of causing severe symptoms such as
WO 2009/141824
PCT/IL2009/000508
2018200117 05 Jan 2018 reduced growth rate, mosaic, ring spots, leaf roll, yellowing, streaking, pox formation, tumor formation and pitting. A suitable avirulent virus may be a naturally occurring avirulent virus or an artificially attenuated virus. Virus attenuation may be effected by using methods well known in the art including, but not limited to, sub-lethal heating, 5 chemical treatment or by directed mutagenesis techniques such as described, for example, by Kurihara and Watanabe (Molecular Plant Pathology 4:259-269, 2003), Galon et al. (1992), Atreya et al. (1992) and Huet et al. (1994).
Suitable virus strains can be obtained from available sources such as, for example, the American Type culture Collection (ATCC) or by isolation from infected 10 plants. Isolation of viruses from infected plant tissues can be effected by techniques well known in the art such as described, for example by Foster and Tatlor, Eds. “Plant Virology Protocols: From Virus Isolation to Transgenic Resistance (Methods in Molecular Biology (Humana Pr), Vol 81)”, Humana Press, 1998. Briefly, tissues of an infected plant believed to contain a high concentration of a suitable virus, preferably 15 young leaves and flower petals, are ground in a buffer solution (e.g., phosphate buffer solution) to produce a virus infected sap which can be used in subsequent inoculations.
Construction of plant RNA viruses for the introduction and expression of nonviral exogenous polynucleotide sequences in plants is demonstrated by the above references as well as by Dawson, W. O. et al., Virology (1989) 172:285-292; Takamatsu 20 et al. EMBO J. (1987) 6:307-311; French et al. Science (1986) 231:1294-1297;
Takamatsu et al. FEBS Letters (1990) 269:73-76; and U.S. Pat. No. 5,316,931.
When the virus is a DNA virus, suitable modifications can be made to the virus itself. Alternatively, the virus can first be cloned into a bacterial plasmid for ease of constructing the desired viral vector with the foreign DNA. The virus can then be 25 excised from the plasmid. If the virus is a DNA virus, a bacterial origin of replication can be attached to the viral DNA, which is then replicated by the bacteria. Transcription and translation of this DNA will produce the coat protein which will encapsidate the viral DNA. If the virus is an RNA virus, the virus is generally cloned as a cDNA and inserted into a plasmid. The plasmid is then used to make all of the 30 constructions. The RNA virus is then produced by transcribing the viral sequence of the plasmid and translation of the viral genes to produce the coat protein(s) which encapsidate the viral RNA.
WO 2009/141824
PCT/IL2009/000508
2018200117 05 Jan 2018
In one embodiment, a plant viral polynucleotide is provided in which the native coat protein coding sequence has been deleted from a viral polynucleotide, a nonnative plant viral coat protein coding sequence and a non-native promoter, preferably the subgenomic promoter of the non-native coat protein coding sequence, capable of 5 expression in the plant host, packaging of the recombinant plant viral polynucleotide, and ensuring a systemic infection of the host by the recombinant plant viral polynucleotide, has been inserted. Alternatively, the coat protein gene may be inactivated by insertion of the non-native polynucleotide sequence within it, such that a protein is produced. The recombinant plant viral polynucleotide may contain one or 10 more additional non-native subgenomic promoters. Each non-native subgenomic promoter is capable of transcribing or expressing adjacent genes or polynucleotide sequences in the plant host and incapable of recombination with each other and with native subgenomic promoters. Non-native (foreign) polynucleotide sequences may be inserted adjacent the native plant viral subgenomic promoter or the native and a non15 native plant viral subgenomic promoters if more than one polynucleotide sequence is included. The non-native polynucleotide sequences are transcribed or expressed in the host plant under control of the subgenomic promoter to produce the desired products.
In a second embodiment, a recombinant plant viral polynucleotide is provided as in the first embodiment except that the native coat protein coding sequence is placed 20 adjacent one of the non-native coat protein subgenomic promoters instead of a nonnative coat protein coding sequence.
In a third embodiment, a recombinant plant viral polynucleotide is provided in which the native coat protein gene is adjacent its subgenomic promoter and one or more non-native subgenomic promoters have been inserted into the viral polynucleotide. The 25 inserted non-native subgenomic promoters are capable of transcribing or expressing adjacent genes in a plant host and are incapable of recombination with each other and with native subgenomic promoters. Non-native polynucleotide sequences may be inserted adjacent the non-native subgenomic plant viral promoters such that the sequences are transcribed or expressed in the host plant under control of the subgenomic 30 promoters to produce the desired product.
WO 2009/141824
PCT/IL2009/000508
2018200117 05 Jan 2018
In a fourth embodiment, a recombinant plant viral polynucleotide is provided as in the third embodiment except that the native coat protein coding sequence is replaced by a non-native coat protein coding sequence.
The viral vectors are encapsidated by the coat proteins encoded by the recombinant plant viral polynucleotide to produce a recombinant plant virus. The recombinant plant viral polynucleotide or recombinant plant virus is used to infect appropriate host plants. The recombinant plant viral polynucleotide is capable of replication in the host, systemic spread in the host, and transcription or expression of foreign gene(s) (exogenous polynucleotide) in the host to produce the desired protein.
Techniques for inoculation of viruses to plants may be found in Foster and
Taylor, eds. “Plant Virology Protocols: From Virus Isolation to Transgenic Resistance (Methods in Molecular Biology (Humana Pr), Vol 81)”, Humana Press, 1998; Maramorosh and Koprowski, eds. “Methods in Virology” 7 vols, Academic Press, New York 1967-1984; Hill, S.A. “Methods in Plant Virology”, Blackwell, Oxford, 1984;
Walkey, D.G.A. “Applied Plant Virology”, Wiley, New York, 1985; and Kado and Agrawa, eds. “Principles and Techniques in Plant Virology”, Van Nostrand-Reinhold, New York.
In addition to the above, the polynucleotide of the present invention can also be introduced into a chloroplast genome thereby enabling chloroplast expression.
A technique for introducing exogenous polynucleotide sequences to the genome of the chloroplasts is known. This technique involves the following procedures. First, plant cells are chemically treated so as to reduce the number of chloroplasts per cell to about one. Then, the exogenous polynucleotide is introduced via particle bombardment into the cells with the aim of introducing at least one exogenous polynucleotide molecule into the chloroplasts. The exogenous polynucleotides selected such that it is integratable into the chloroplast's genome via homologous recombination which is readily effected by enzymes inherent to the chloroplast. To this end, the exogenous polynucleotide includes, in addition to a gene of interest, at least one polynucleotide stretch which is derived from the chloroplast's genome. In addition, the exogenous polynucleotide includes a selectable marker, which serves by sequential selection procedures to ascertain that all or substantially all of the copies of the chloroplast genomes following such selection will include the exogenous
WO 2009/141824
PCT/IL2009/000508
2018200117 05 Jan 2018 polynucleotide. Further details relating to this technique are found in U.S. Pat. Nos. 4,945,050; and 5,693,507 which are incorporated herein by reference. A polypeptide can thus be produced by the protein expression system of the chloroplast and become integrated into the chloroplast's inner membrane.
Since processes which increase oil content, yield, growth rate, biomass, vigor, abiotic stress tolerance and/or nitrogen use efficiency of a plant can involve multiple genes acting additively or in synergy (see, for example, in Quesda et al., Plant Physiol. 130:951-063, 2002), the present invention also envisages expressing a plurality of exogenous polynucleotides in a single host plant to thereby achieve superior effect on 10 oil content, yield, growth rate, biomass, vigor, abiotic stress tolerance and/or nitrogen use efficiency.
Expressing a plurality of exogenous polynucleotides in a single host plant can be effected by co-introducing multiple nucleic acid constructs, each including a different exogenous polynucleotide, into a single plant cell. The transformed cell can 15 than be regenerated into a mature plant using the methods described hereinabove.
Alternatively, expressing a plurality of exogenous polynucleotides in a single host plant can be effected by co-introducing into a single plant-cell a single nucleic-acid construct including a plurality of different exogenous polynucleotides. Such a construct can be designed with a single promoter sequence which can transcribe a polycistronic 20 messenger RNA including all the different exogenous polynucleotide sequences. To enable co-translation of the different polypeptides encoded by the polycistronic messenger RNA, the polynucleotide sequences can be inter-linked via an internal ribosome entry site (IRES) sequence which facilitates translation of polynucleotide sequences positioned downstream of the IRES sequence. In this case, a transcribed 25 polycistronic RNA molecule encoding the different polypeptides described above will be translated from both the capped 5' end and the two internal IRES sequences of the polycistronic RNA molecule to thereby produce in the cell all different polypeptides. Alternatively, the construct can include several promoter sequences each linked to a different exogenous polynucleotide sequence.
The plant cell transformed with the construct including a plurality of different exogenous polynucleotides, can be regenerated into a mature plant, using the methods described hereinabove.
WO 2009/141824
PCT/IL2009/000508
2018200117 05 Jan 2018
Alternatively, expressing a plurality of exogenous polynucleotides in a single host plant can be effected by introducing different nucleic acid constructs, including different exogenous polynucleotides, into a plurality of plants. The regenerated transformed plants can then be cross-bred and resultant progeny selected for superior 5 abiotic stress tolerance, growth, biomass, yield, vigor and/or nitrogen use efficiency traits, using conventional plant breeding techniques.
As mentioned above, and further described in Example 9 of the Examples section which follows, the present inventors have uncovered that downregulating the expression level of the BDL127 gene product (e.g., the polynucleotides set forth by 10 SEQ ID NO:17 or 673; or the polypeptide set forth by SEQ ID NO:67) and/or of homologous thereof can be used to increase yield (e.g., seed yield), oil content, biomass, growth rate, vigor, ABST and/or NUE in a plant.
In some cases, overexpression of the exogenous polynucleotide within the plant can result in silencing of the endogenous polynucleotide (which is homologous of 15 the exogenous polynucleotide), probably through RNA interference or co-suppression mechanisms. To test the effect of downregulation of the polynucleotide(s) of the invention on the desired plant trait (e.g., plant yield, oil content, biomass, vigor, ABST or NUE), various downregulation methods and agents can be used.
Downregulation (gene silencing) of the transcription or translation product of an endogenous gene such as BDL127 can be achieved by methods which are well known in the art e.g., co-suppression, antisense suppression, RNA interference and ribozyme polynucleotide molecules, changing the promoter structure, removal or creation transcription factor binding sites or expression under different promoters. Guidelines for effecting same are provided infra.
Co-suppression (sense suppression) - Inhibition of the endogenous gene can be achieved by co-suppression, using an RNA molecule (or an expression vector encoding same) which is in the sense orientation with respect to the transcription direction of the endogenous gene. The polynucleotide used for co-suppression may correspond to all or part of the sequence encoding the endogenous polypeptide and/or to 30 all or part of the 5' and/or 3' untranslated region of the endogenous transcript; it may also be an unpolyadenylated RNA; an RNA which lacks a 5' cap structure; or an RNA which contains an unsplicable intron. In some embodiments, the polynucleotide used
WO 2009/141824
PCT/IL2009/000508
2018200117 05 Jan 2018 for co-suppression is designed to eliminate the start codon of the endogenous polynucleotide so that no protein product will be translated. However, as with antisense suppression, the suppressive efficiency is enhanced as specificity of hybridization is increased, e.g., as the introduced sequence is lengthened, and/or as the sequence similarity between the introduced sequence and the endogenous gene is increased. For further details see U.S. Pat. Appl. Nos. 20050172364 and No. 5,231,020 which are fully incorporated herein by reference.
According to some embodiments of the invention, the exogenous polynucleotide comprises an untranslatable nucleic acid sequence, e.g., a sequence 10 comprising one or more pre-mature stop codons, or nonsense mutations, such as described in U.S. Pat. No. 5,583,021.
According to some embodiments of the invention, downregulation of the endogenous gene is performed using an amplicon expression vector which comprises a plant virus-derived sequence that contains all or part of the target gene but generally not 15 all of the genes of the native virus. The viral sequences present in the transcription product of the expression vector allow the transcription product to direct its own replication. The transcripts produced by the amplicon may be either sense or antisense relative to the target sequence [see for example, Angell and Baulcombe, (1997) EMBO J. 16:3675-3684; Angell and Baulcombe, (1999) Plant J. 20:357-362, and U.S. Pat. No.
6,646,805, each of which is herein incorporated by reference].
According to some embodiments of the invention, the exogenous polynucleotide comprises an untranslatable nucleic acid sequence, e.g., a sequence comprising one or more pre-mature stop codons, or nonsense mutations, such as described in U.S. Pat. No. 5,583,021.
Antisense suppression - Antisense suppression can be performed using an antisense polynucleotide or an expression vector which is designed to express an RNA molecule complementary to all or part of the messenger RNA (mRNA) encoding the endogenous polypeptide and/or to all or part of the 5' and/or 3' untranslated region of the endogenous gene. Over expression of the antisense RNA molecule can result in 30 reduced expression of the native (endogenous) gene. The antisense polynucleotide may be fully complementary to the target sequence (i.e., 100 % identical to the complement of the target sequence) or partially complementary to the target sequence (i.e., less than
WO 2009/141824
PCT/IL2009/000508
2018200117 05 Jan 2018
100 % identical, e.g., less than 90 %, less than 80 % identical to the complement of the target sequence). Antisense suppression may be used to inhibit the expression of multiple proteins in the same plant (see e.g., U.S. Pat. No. 5,942,657). In addition, portions of the antisense nucleotides may be used to disrupt the expression of the target 5 gene. Generally, sequences of at least about 50 nucleotides, at least about 100 nucleotides, at least about 200 nucleotides, at least about 300, at least about 400, at least about 450, at least about 500, at least about 550, or greater may be used. Methods of using antisense suppression to inhibit the expression of endogenous genes in plants are described, for example, in Liu, et al., (2002) Plant Physiol. 129:1732-1743 and U.S. Pat. 10 Nos. 5,759,829 and 5,942,657, each of which is herein incorporated by reference.
Efficiency of antisense suppression may be increased by including a poly-dT region in the expression cassette at a position 3' to the antisense sequence and 5' of the polyadenylation signal [See, U.S. Patent Publication No. 20020048814, herein incorporated by reference].
RNA interference - RNA interference can be achieved using a polynucleotide, which can anneal to itself and form a double stranded RNA having a stem-loop structure (also called hairpin structure), or using two polynucleotides, which form a double stranded RNA.
For hairpin RNA (hpRNA) interference, the expression vector is designed to 20 express an RNA molecule that hybridizes to itself to form a hairpin structure that comprises a single-stranded loop region and a base-paired stem.
In some embodiments of the invention, the base-paired stem region of the hpRNA molecule determines the specificity of the RNA interference. In this configuration, the sense sequence of the base-paired stem region may correspond to all 25 or part of the endogenous mRNA to be downregulated, or to a portion of a promoter sequence controlling expression of the endogenous gene to be inhibited; and the antisense sequence of the base-paired stem region is fully or partially complementary to the sense sequence. Such hpRNA molecules are highly efficient at inhibiting the expression of endogenous genes, in a manner which is inherited by subsequent 30 generations of plants [See, e.g., Chuang and Meyerowitz, (2000) Proc. Natl. Acad. Sci.
USA 97:4985-4990; Stoutjesdijk, et al., (2002) Plant Physiol. 129:1723-1731; and Waterhouse and Helliwell, (2003) Nat. Rev. Genet. 4:29-38; Chuang and Meyerowitz,
WO 2009/141824
PCT/IL2009/000508
2018200117 05 Jan 2018 (2000) Proc. Natl. Acad. Sci. USA 97:4985-4990; Pandolfini et al., BMC Biotechnology 3:7; Panstruga, et al., (2003) Mol. Biol. Rep. 30:135-140; and U.S. Patent Publication No. 2003/0175965; each of which is incorporated by reference].
According to some embodiments of the invention, the sense sequence of the base-paired stem is from about 10 nucleotides to about 2,500 nucleotides in length, e.g., from about 10 nucleotides to about 500 nucleotides, e.g., from about 15 nucleotides to about 300 nucleotides, e.g., from about 20 nucleotides to about 100 nucleotides, e.g., or from about 25 nucleotides to about 100 nucleotides.
According to some embodiments of the invention, the antisense sequence of 10 the base-paired stem may have a length that is shorter, the same as, or longer than the length of the corresponding sense sequence.
According to some embodiments of the invention, the loop portion of the hpRNA can be from about 10 nucleotides to about 500 nucleotides in length, for example from about 15 nucleotides to about 100 nucleotides, from about 20 nucleotides 15 to about 300 nucleotides or from about 25 nucleotides to about 400 nucleotides in length.
According to some embodiments of the invention, the loop portion of the hpRNA can include an intron (ihpRNA), which is capable of being spliced in the host cell. The use of an intron minimizes the size of the loop in the hairpin RNA molecule 20 following splicing and thus increases efficiency of the interference [See, for example, Smith, et al., (2000) Nature 407:319-320; Wesley, et al., (2001) Plant J. 27:581-590; Wang and Waterhouse, (2001) Curr. Opin. Plant Biol. 5:146-150; Helliwell and Waterhouse, (2003) Methods 30:289-295; Brummell, et al. (2003) Plant J. 33:793-800; and U.S. Patent Publication No. 2003/0180945; WO 98/53083; WO 99/32619; WO 25 98/36083; WO 99/53050; US 20040214330; US 20030180945; U.S. Pat. No.
5,034,323; U.S. Pat. No. 6,452,067; U.S. Pat. No. 6,777,588; U.S. Pat. No. 6,573,099 and U.S. Pat. No. 6,326,527; each of which is herein incorporated by reference].
In some embodiments of the invention, the loop region of the hairpin RNA determines the specificity of the RNA interference to its target endogenous RNA. In 30 this configuration, the loop sequence corresponds to all or part of the endogenous messenger RNA of the target gene. See, for example, WO 02/00904; Mette, et al., (2000) EMBO J 19:5194-5201; Matzke, et al., (2001) Curr. Opin. Genet. Devel. 11:221WO 2009/141824
PCT/IL2009/000508
2018200117 05 Jan 2018
227; Scheid, et al., (2002) Proc. Natl. Acad. Sci., USA 99:13659-13662; Aufsaftz, et al., (2002) Proc. Natl. Acad. Sci. 99(4): 16499-16506; Sijen, et al., Curr. Biol. (2001) 11:436-440), each of which is incorporated herein by reference.
For double-stranded RNA (dsRNA) interference, the sense and antisense RNA 5 molecules can be expressed in the same cell from a single expression vector (which comprises sequences of both strands) or from two expression vectors (each comprising the sequence of one of the strands). Methods for using dsRNA interference to inhibit the expression of endogenous plant genes are described in Waterhouse, et al., (1998) Proc. Natl. Acad. Sci. USA 95:13959-13964; and WO 99/49029, WO 99/53050, WO 10 99/61631, and WO 00/49035; each of which is herein incorporated by reference.
According to some embodiments of the invention, RNA interference is effected using an expression vector designed to express an RNA molecule that is modeled on an endogenous micro RNAs (miRNA) gene. Micro RNAs (miRNAs) are regulatory agents consisting of about 22 ribonucleotides and highly efficient at 15 inhibiting the expression of endogenous genes [Javier, et al., (2003) Nature 425:257263). The miRNA gene encodes an RNA that forms a hairpin structure containing a 22nucleotide sequence that is complementary to the endogenous target gene.
Ribozyme - Catalytic RNA molecules, ribozymes, are designed to cleave particular mRNA transcripts, thus preventing expression of their encoded polypeptides. 20 Ribozymes cleave mRNA at site-specific recognition sequences. For example, “hammerhead ribozymes” (see, for example, U.S. Pat. No. 5,254,678) cleave mRNAs at locations dictated by flanking regions that form complementary base pairs with the target mRNA. The sole requirement is that the target RNA contains a 5-UG-3' nucleotide sequence. Hammerhead ribozyme sequences can be embedded in a stable 25 RNA such as a transfer RNA (tRNA) to increase cleavage efficiency in vivo [Perriman et al. (1995) Proc. Natl. Acad. Sci. USA, 92(13):6175-6179; de Feyter and Gaudron Methods in Molecular Biology, Vol. 74, Chapter 43, Expressing Ribozymes in Plants, Edited by Turner, P. C, Humana Press Inc., Totowa, N.J.; U.S. Pat. No. 6,423,885]. RNA endoribonucleases such as that found in Tetrahymena thermophila are also useful 30 ribozymes (U.S. Pat. No. 4,987,071).
Plant lines transformed with any of the downregulating molecules described hereinabove are screened to identify those that show the greatest inhibition of the
WO 2009/141824
PCT/IL2009/000508
2018200117 05 Jan 2018 endogenous polynucleotide or polypeptide-of-interest, and thereby the increase of the desired plant trait (e.g., yield, oil content, growth rate, biomass, vigor, NUE and/or
ABST).
Thus, the invention encompasses plants exogenously expressing the 5 polynucleotide(s), the nucleic acid constructs and/or polypeptide(s) of the invention. Once expressed within the plant cell or the entire plant, the level of the polypeptide encoded by the exogenous polynucleotide can be determined by methods well known in the art such as, activity assays, Western blots using antibodies capable of specifically binding the polypeptide, Enzyme-Linked ImmunoSorbent Assay (ELISA), radio10 immuno-assays (RIA), immunohistochemistry, immunocytochemistry, immunofluorescence and the like.
The level of an RNA molecule-of interest in the plant [e.g., the RNA transcribed from the exogenous polynucleotide of the invention or the endogenous RNA which is targeted by the downregulating molecule of the invention] can be determined 15 using methods well known in the art such as Northern blot analysis, reverse transcription polymerase chain reaction (RT-PCR) analysis (including quantitative, semi-quantitative or real-time RT-PCR) and RNA-m situ hybridization.
The endogenous homolog of the exogenous polynucleotide or polypeptide of the invention, or a fragment of the endogenous homolog (e.g. introns or untranslated 20 regions) in the plant can be used as a marker for marker assisted selection (MAS), in which a marker is used for indirect selection of a genetic determinant or determinants of a trait of interest (e.g., biomass, growth rate, oil content, yield, abiotic stress tolerance and/or nitrogen use efficiency). These genes (DNA or RNA sequence) may contain or be linked to polymorphic sites or genetic markers on the genome such as restriction 25 fragment length polymorphism (RFLP), microsatellites and single nucleotide polymorphism (SNP), DNA fingerprinting (DFP), amplified fragment length polymorphism (AFLP), expression level polymorphism, polymorphism of the encoded polypeptide and any other polymorphism at the DNA or RNA sequence.
Examples of marker assisted selections include, but are not limited to, 30 selection for a morphological trait (e.g., a gene that affects form, coloration, male sterility or resistance such as the presence or absence of awn, leaf sheath coloration, height, grain color, aroma of rice); selection for a biochemical trait (e.g., a gene that
WO 2009/141824
PCT/IL2009/000508
2018200117 05 Jan 2018 encodes a protein that can be extracted and observed; for example, isozymes and storage proteins); selection for a biological trait (e.g., pathogen races or insect biotypes based on host pathogen or host parasite interaction can be used as a marker since the genetic constitution of an organism can affect its susceptibility to pathogens or parasites).
The polynucleotides and polypeptides described hereinabove can be used in a wide range of economical plants, in a safe and cost effective manner.
Plant lines exogenously expressing the polynucleotide or the polypeptide of the invention are screened to identify those that show the greatest increase of the desired plant trait.
The effect of the transgene (the exogenous polynucleotide encoding the polypeptide of the invention) or the downregulating molecule (e.g., RNA-interference molecule) on abiotic stress tolerance can be determined using known methods.
Abiotic stress tolerance - Transformed (i.e., expressing the transgene) and non-transformed (wild type) plants are exposed to an abiotic stress condition, such as 15 water deprivation, suboptimal temperature (low temperature, high temperature), nutrient deficiency, nutrient excess, a salt stress condition, osmotic stress, heavy metal toxicity, anaerobiosis, atmospheric pollution and UV irradiation.
Salinity tolerance assay - Transgenic plants with tolerance to high salt concentrations are expected to exhibit better germination, seedling vigor or growth in 20 high salt. Salt stress can be effected in many ways such as, for example, by irrigating the plants with a hyperosmotic solution, by cultivating the plants hydroponically in a hyperosmotic growth solution (e.g., Hoagland solution), or by culturing the plants in a hyperosmotic growth medium [e.g., 50 % Murashige-Skoog medium (MS medium)]. Since different plants vary considerably in their tolerance to salinity, the salt 25 concentration in the irrigation water, growth solution, or growth medium can be adjusted according to the specific characteristics of the specific plant cultivar or variety, so as to inflict a mild or moderate effect on the physiology and/or morphology of the plants (for guidelines as to appropriate concentration see, Bernstein and Kafkafi, Root Growth Under Salinity Stress In: Plant Roots, The Hidden Half 3rd ed. Waisel Y, Eshel 30 A and Kafkafi U. (editors) Marcel Dekker Inc., New York, 2002, and reference therein).
For example, a salinity tolerance test can be performed by irrigating plants at different developmental stages with increasing concentrations of sodium chloride (for
WO 2009/141824
PCT/IL2009/000508
2018200117 05 Jan 2018 example 50 mM, 100 mM, 200 mM, 400 mM NaCl) applied from the bottom and from above to ensure even dispersal of salt. Following exposure to the stress condition the plants are frequently monitored until substantial physiological and/or morphological effects appear in wild type plants. Thus, the external phenotypic appearance, degree of 5 wilting and overall success to reach maturity and yield progeny are compared between control and transgenic plants. Quantitative parameters of tolerance measured include, but are not limited to, the average wet and dry weight, the weight of the seeds yielded, the average seed size and the number of seeds produced per plant. Transformed plants not exhibiting substantial physiological and/or morphological effects, or exhibiting 10 higher biomass than wild-type plants, are identified as abiotic stress tolerant plants.
Osmotic tolerance test - Osmotic stress assays (including sodium chloride and mannitol assays) are conducted to determine if an osmotic stress phenotype was sodium chloride-specific or if it was a general osmotic stress related phenotype. Plants which are tolerant to osmotic stress may have more tolerance to drought and/or freezing. For 15 salt and osmotic stress germination experiments, the medium is supplemented for example with 50 mM, 100 mM, 200 mM NaCl or 100 mM, 200 mM NaCl, 400 mM mannitol.
Drought tolerance assaylOsmoticum assay - Tolerance to drought is performed to identify the genes conferring better plant survival after acute water 20 deprivation. To analyze whether the transgenic plants are more tolerant to drought, an osmotic stress produced by the presence of sorbitol or polyethylene glycol (PEG 8000) in the medium is performed. Control and transgenic plants are germinated and grown in plant-agar plates for 10 days, after which they are transferred to plates containing 1.5% PEG8000 or 500 mM of sorbitol. Plants are grown for about additional 10 days. The 25 treatment causes growth retardation, then both control and transgenic plants are compared, by measuring plant weight (fresh and dry), yield, and by growth rates.
Conversely, soil-based drought screens are performed with plants overexpressing the polynucleotides detailed above. Seeds from control Arabidopsis plants, or other transgenic plants overexpressing the polypeptide of the invention are 30 germinated and transferred to pots. Drought stress is obtained after irrigation is ceased accompanied by placing the pots on absorbent paper to enhance the soil-drying rate. Transgenic and control plants are compared to each other when the majority of the
WO 2009/141824
PCT/IL2009/000508
2018200117 05 Jan 2018 control plants develop severe wilting. Plants are re-watered after obtaining a significant fraction of the control plants displaying a severe wilting. Plants are ranked comparing to controls for each of two criteria: tolerance to the drought conditions and recovery (survival) following re-watering.
Cold stress tolerance - To analyze cold stress, mature (25 day old) plants are transferred to 4 °C chambers for 1 or 2 weeks, with constitutive light. Later on plants are moved back to greenhouse. Two weeks later damages from chilling period, resulting in growth retardation and other phenotypes, are compared between both control and transgenic plants, by measuring plant weight (wet and dry), and by 10 comparing growth rates measured as time to flowering, plant size, yield, and the like.
Heat stress tolerance - Heat stress tolerance is achieved by exposing the plants to temperatures above 34 °C for a certain period. Plant tolerance is examined after transferring the plants back to 22 °C for recovery and evaluation after 5 days relative to internal controls (non-transgenic plants) or plants not exposed to neither cold 15 or heat stress.
Germination tests - Germination tests compare the percentage of seeds from transgenic plants that could complete the germination process to the percentage of seeds from control plants that are treated in the same manner. Normal conditions are considered for example, incubations at 22 °C under 22-hour light 2-hour dark daily 20 cycles. Evaluation of germination and seedling vigor is conducted between 4 and 14 days after planting. The basal media is 50 % MS medium (Murashige and Skoog, 1962 Plant Physiology 15, 473-497).
Germination is checked also at unfavorable conditions such as cold (incubating at temperatures lower than 10 °C instead of 22 °C) or using seed inhibition 25 solutions that contain high concentrations of an osmolyte such as sorbitol (at concentrations of 50 mM, 100 mM, 200 mM, 300 mM, 500 mM, and up to 1000 mM) or applying increasing concentrations of salt (of 50 mM, 100 mM, 200 mM, 300 mM, 500 mM NaCl).
The effect of the transgene (the exogenous polynucleotide encoding the 30 polypeptide of the invention) or the downregulating molecule (e.g., RNA-interference molecule) on nitrogen use efficiency can be determined using known methods.
WO 2009/141824
PCT/IL2009/000508
2018200117 05 Jan 2018
Nitrogen use efficiency assay using plantlets -Briefly, transgenic plants which are grown for 7-10 days in 0.5 x MS [Murashige-Skoog] supplemented with a selection agent are transferred to two nitrogen fertilization conditions: MS media in which the combined nitrogen concentration (NH4NO3 and KNO3) was 0.75 mM (nitrogen 5 deficiency). Usually, 20 randomly selected plants from each event of a gene are transferred to the media. Plants are allowed to grow for additional 10 days. At the end of the 10 days plants are removed from the plate and immediately weighed (fresh weight) and then dried for 24 and re-weight (dry weight for later statistical analysis). Transgenic plants are compared to control plants grown in parallel under the same 10 conditions. Mock- transgenic plants used as control can be those transgenic plants expressing the uidA reporter gene (GUS) under the same promoter or transgenic plants harboring only the same promoter but lacking any reporter gene.
Grain protein concentration - Grain protein content (g grain protein m 2)is estimated as the product of the mass of grain N (g grain N m'2) multiplied by the 15 N/protein conversion ratio of k-5.13 (Mosse 1990, supra). The grain protein concentration is estimated as the ratio of grain protein content per unit mass of the grain (g grain protein kg'1 grain).
The effect of the transgene (the exogenous polynucleotide encoding the polypeptide of the invention) or the downregulating molecule (e.g., RNA-interference 20 molecule) on plant’s vigor, growth rate, biomass, yield and/or oil content can be determined using known methods.
Plant vigor - The plant vigor can be calculated by the increase in growth parameters such as leaf area, fiber length, rosette diameter, plant fresh weight and the like per time.
Growth rate - The growth rate can be measured using digital analysis of growing plants. For example, images of plants growing in greenhouse on plot basis can be captured every 3 days and the rosette area can be calculated by digital analysis. Rosette area growth is calculated using the difference of rosette area between days of sampling divided by the difference in days between samples.
Evaluation of growth rate can be done by measuring plant biomass produced, rosette area, leaf size or root length per time (can be measured in cm2 per day of leaf area).
WO 2009/141824
PCT/IL2009/000508
2018200117 05 Jan 2018
Relative growth area can be calculated using Formula I.
Formula I:
Relative growth area rate = (Δ Area / At) * (1/ Area tO)
At is the current analyzed image day subtracted from the initial day (t-tO).
Thus, the relative growth area rate is in units of 1/day and length growth rate is in units of 1/day.
Seed yield - Evaluation of the seed yield per plant can be done by measuring the amount (weight or size) or quantity (z.e., number) of dry seeds produced and harvested from 8-16 plants and divided by the number of plants.
For example, the total seeds from 8-16 plants can be collected, weighted using
e.g., an analytical balance and the total weight can be divided by the number of plants. Seed yield per growing area can be calculated in the same manner while taking into account the growing area given to a single plant. Increase seed yield per growing area could be achieved by increasing seed yield per plant, and/or by increasing number of 15 plants capable of growing in a given area.
In addition, seed yield can be determined via the weight of 1000 seeds. The weight of 1000 seeds can be determined as follows: seeds are scattered on a glass tray and a picture is taken. Each sample is weighted and then using the digital analysis, the number of seeds in each sample is calculated.
The 1000 seeds weight can be calculated using formula II:
Formula II:
1000 Seed Weight = number of seed in sample/ sample weight X 1000
The Harvest Index can be calculated using Formula III
Formula III:
Harvest Index = Average seed yield per plant/ Average dry weight
Fiber length - Fiber length can be measured using fibrograph. The fibrograph system was used to compute length in terms of Upper Half Mean length. The upper half mean (UHM) is the average length of longer half of the fiber distribution. The fibrograph measures length in span lengths at a given percentage point (Hypertext 30 Transfer Protocol://World Wide Web (dot) cottoninc (dot) com/ClassificationofCotton/?Pg=4#Length).
WO 2009/141824
PCT/IL2009/000508
2018200117 05 Jan 2018
Oil content - The oil content of a plant can be determined by extraction of the oil from the seed or the vegetative portion of the plant. Briefly, lipids (oil) can be removed from the plant (e.g., seed) by grinding the plant tissue in the presence of specific solvents (e.g., hexane or petroleum ether) and extracting the oil in a continuous 5 extractor. Indirect oil content analysis can be carried out using various known methods such as Nuclear Magnetic Resonance (NMR) Spectroscopy, which measures the resonance energy absorbed by hydrogen atoms in the liquid state of the sample [See for example, Conway TF. and Earle FR., 1963, Journal of the American Oil Chemists' Society; Springer Berlin / Heidelberg, ISSN: 0003-021X (Print) 1558-9331 (Online)];
the Near Infrared (NI) Spectroscopy, which utilizes the absorption of near infrared energy (1100-2500 nm) by the sample; and a method described in WO/2001/023884, which is based on extracting oil a solvent, evaporating the solvent in a gas stream which forms oil particles, and directing a light into the gas stream and oil particles which forms a detectable reflected light.
Thus, the present invention is of high agricultural value for promoting the yield of commercially desired crops (e.g., biomass of vegetative organ such as poplar wood, or reproductive organ such as number of seeds or seed biomass).
Any of the transgenic plants described hereinabove or parts thereof may be processed to produce a feed, meal, protein or oil preparation, such as for ruminant 20 animals.
The transgenic plants described hereinabove, which exhibit increased oil content can be used to produce plant oil (by extracting the oil from the plant).
The plant oil (including the seed oil and/or the vegetative portion oil) produced according to the method of the invention may be combined with a variety of other 25 ingredients. The specific ingredients included in a product are determined according to the intended use. Exemplary products include animal feed, raw material for chemical modification, biodegradable plastic, blended food product, edible oil, biofuel, cooking oil, lubricant, biodiesel, snack food, cosmetics, and fermentation process raw material. Exemplary products to be incorporated to the plant oil include animal feeds, human 30 food products such as extruded snack foods, breads, as a food binding agent, aquaculture feeds, fermentable mixtures, food supplements, sport drinks, nutritional food bars, multi-vitamin supplements, diet drinks, and cereal foods.
WO 2009/141824
PCT/IL2009/000508
2018200117 05 Jan 2018
According to some embodiments of the invention, the oil comprises a seed oil.
According to some embodiments of the invention, the oil comprises a vegetative portion oil.
According to some embodiments of the invention, the plant cell forms a part 5 of a plant.
As used herein the term “about” refers to ± 10 %.
The terms comprises, comprising, includes, including, “having” and their conjugates mean including but not limited to.
The term “consisting of means “including and limited to”.
The term consisting essentially of means that the composition, method or structure may include additional ingredients, steps and/or parts, but only if the additional ingredients, steps and/or parts do not materially alter the basic and novel characteristics of the claimed composition, method or structure.
As used herein, the singular form a, an and the include plural references unless the context clearly dictates otherwise. For example, the term a compound or at least one compound may include a plurality of compounds, including mixtures thereof.
Throughout this application, various embodiments of this invention may be presented in a range format. It should be understood that the description in range format 20 is merely for convenience and brevity and should not be construed as an inflexible limitation on the scope of the invention. Accordingly, the description of a range should be considered to have specifically disclosed all the possible sub-ranges as well as individual numerical values within that range. For example, description of a range such as from 1 to 6 should be considered to have specifically disclosed sub-ranges such as 25 from 1 to 3, from 1 to 4, from 1 to 5, from 2 to 4, from 2 to 6, from 3 to 6 etc., as well as individual numbers within that range, for example, 1, 2, 3, 4, 5, and 6. This applies regardless of the breadth of the range.
Whenever a numerical range is indicated herein, it is meant to include any cited numeral (fractional or integral) within the indicated range. The phrases 30 “ranging/ranges between” a first indicate number and a second indicate number and “ranging/ranges from” a first indicate number “to” a second indicate number are used
2018200117 05 Jan 2018 herein interchangeably and are meant to include the first and second indicated numbers and all the fractional and integral numerals therebetween.
As used herein the term method refers to manners, means, techniques and procedures for accomplishing a given task including, but not limited to, those manners, means, techniques 5 and procedures either known to, or readily developed from known manners, means, techniques and procedures by practitioners of the chemical, pharmacological, biological, biochemical and medical arts.
It is appreciated that certain features of the invention, which are, for clarity, described in the context of separate embodiments, may also be provided in combination in a single 10 embodiment. Conversely, various features of the invention, which are, for brevity, described in the context of a single embodiment, may also be provided separately or in any suitable subcombination or as suitable in any other described embodiment of the invention. Certain features described in the context of various embodiments are not to be considered essential features of those embodiments, unless the embodiment is inoperative without those elements.
L5 Various embodiments and aspects of the present invention as delineated hereinabove and as claimed in the claims section below find experimental support in the following examples.
Unless otherwise defined, all technical and/or scientific terms used herein have the same meaning as commonly understood by one of ordinary skill in the art to which the invention 10 pertains. Although methods and materials similar or equivalent to those described herein can be used in the practice or testing of embodiments of the invention, exemplary methods and/or materials are described below. In case of conflict, the patent specification, including definitions, will control. In addition, the materials, methods, and examples are illustrative only and are not intended to be necessarily limiting.
Any reference to publications cited in this specification is not an admission that the disclosures constitute common general knowledge in Australia.
2018200117 05 Jan 2018
WO 2009/141824 PCT/IL2009/000508
EXAMPLES
Reference is now made to the following examples, which together with the above descriptions illustrate some embodiments of the invention in a non limiting fashion.
Generally, the nomenclature used herein and the laboratory procedures utilized in the present invention include molecular, biochemical, microbiological and recombinant DNA techniques. Such techniques are thoroughly explained in the literature. See, for example, Molecular Cloning: A laboratory Manual Sambrook et al., (1989); Current Protocols in Molecular Biology Volumes I-III Ausubel, R. M., ed. (1994); Ausubel et al., Current Protocols in Molecular Biology, John Wiley and Sons, Baltimore, Maryland (1989); Perbal, A Practical Guide to Molecular Cloning, John Wiley & Sons, New York (1988); Watson et al., Recombinant DNA, Scientific American Books, New York; Birren et al. (eds) Genome Analysis: A Laboratory Manual Series, Vols. 1-4, Cold Spring Harbor Laboratory Press, New York (1998); methodologies as set forth in U.S. Pat. Nos. 4,666,828; 4,683,202; 4,801,531; 5,192,659 and 5,272,057; Cell Biology: A Laboratory Handbook, Volumes I-III Cellis, J. E., ed. (1994); Current Protocols in Immunology Volumes I-III Coligan J. E., ed. (1994); Stites et al. (eds), Basic and Clinical Immunology (8th Edition), Appleton & Lange, Norwalk, CT (1994); Mishell and Shiigi (eds), Selected Methods in Cellular Immunology, W. H. Freeman and Co., New York (1980); available immunoassays are extensively described in the patent and scientific literature, see, for example, U.S. Pat. Nos. 3,791,932; 3,839,153; 3,850,752; 3,850,578; 3,853,987; 3,867,517; 3,879,262; 3,901,654; 3,935,074; 3,984,533; 3,996,345; 4,034,074; 4,098,876; 4,879,219; 5,011,771 and 5,281,521; Oligonucleotide Synthesis Gait, M. J., ed. (1984); “Nucleic Acid Hybridization Hames, B. D., and Higgins S. J., eds. (1985); Transcription and Translation Hames, B. D., and Higgins S. J., Eds. (1984); Animal Cell Culture Freshney, R. I., ed. (1986); Immobilized Cells and Enzymes IRL Press, (1986); A Practical Guide to Molecular Cloning Perbal, B., (1984) and Methods in Enzymology Vol. 1-317, Academic Press; PCR Protocols: A Guide To Methods And Applications, Academic Press, San Diego, CA (1990); Marshak et al., Strategies for Protein Purification and Characterization - A Laboratory Course Manual CSHL Press (1996); all of which are incorporated by reference as if fully set forth herein. Other
WO 2009/141824
PCT/IL2009/000508
2018200117 05 Jan 2018 general references are provided throughout this document. The procedures therein are believed to be well known in the art and are provided for the convenience of the reader.
All the information contained therein is incorporated herein by reference.
EXAMPLE 1
GENE IDENTIFICATION AND GENE ROLE PREDICTION USING BIOINFORMATICS TOOLS
The present inventors have identified polynucleotides which can increase plant 10 yield, seed yield, oil yield, oil content, biomass, growth rate, abiotic stress tolerance, nitrogen use efficiency and/or vigor of a plant, as follows.
The nucleotide sequence datasets used here were from publicly available databases or from sequences obtained using the Solexa technology (e.g. Barley and Sorghum). Sequence data from 100 different plant species was introduced into a single, 15 comprehensive database. Other information on gene expression, protein annotation, enzymes and pathways were also incorporated. Major databases used include:
Genomes
Arabidopsis genome [TAIR genome version 6 (Hypertext Transfer Protocol://World Wide Web (dot) arabidopsis (dot) org/)];
Rice genome [IRGSP build 4.0 (Hypertext Transfer Protocol://rgp (dot) dna (dot) affic (dot) go (dot) jp/IRGSP/)];
Poplar [Populus trichocarpa release 1.1 from JGI (assembly release vl.0) (Hypertext Transfer Protocol://World Wide Web (dot) genome (dot) jgi-psf (dot) org/)];
Brachypodium [JGI 4x assembly, Hypertext Transfer Protocol ://World Wide 25 Web (dot) brachpodium (dot) org)];
Soybean [DOE-JGI SCP, version GlymaO (Hypertext Transfer Protocol://World Wide Web (dot) phytozome (dot) net/)];
Grape [French-Italian Public Consortium for Grapevine Genome Characterization grapevine genome (Hypertext Transfer Protocol:// World Wide Web 30 (dot) genoscope (dot) cns (dot) fr /)];
Castobean [TIGR/J Craig Venter Institute 4x assembly [(Hypertext Transfer Protocol ://msc (dot) jcvi (dot) org/r_communis];
WO 2009/141824
PCT/IL2009/000508
2018200117 05 Jan 2018
Sorghum [DOE-JGI SCP, version Sbil [Hypertext Transfer Protocol://World Wide Web (dot) phytozome (dot) net/)];
Partially assembled genome of Maize [Hypertext Transfer Protocol://maizesequence (dot) org/];
Expressed EST and mRNA sequences were extracted from the following databases:
GenBank versions 154, 157, 160, 161, 164, 165, 166 and 168 (Hypertext Transfer Protocol://World Wide Web (dot) ncbi (dot) nlm (dot) nih (dot) gov/dbEST/);
RefSeq (Hypertext Transfer Protocol://World Wide Web (dot) ncbi (dot) nlm 10 (dot) nih (dot) gov/RefSeq/);
TAIR (Hypertext Transfer Protocol://World Wide Web (dot) arabidopsis (dot) org/);
Protein and pathway databases
Uniprot [Hypertext Transfer Protocol://World Wide Web (dot) uniprot (dot) 15 org/].
AraCyc [Hypertext Transfer Protocol ://World Wide Web (dot) arabidopsis (dot) org/biocyc/index (dot) jsp].
ENZYME [Hypertext Transfer Protocol://expasy (dot) org/enzyme/].
Microarray datasets were downloaded from:
GEO (Hypertext Transfer Protocol://World Wide Web.ncbi.nlm.nih.gov/geo/)
TAIR (Hypertext Transfer Protocol://World Wide Web.arabidopsis.org/).
Proprietary Evogene's microarray data (See W02008/122980 to Evogene and Example 3 below.
QTL and SNPs information
Gramene [Hypertext Transfer Protocol ://World Wide Web (dot) gramene (dot) org/qtl/].
Panzea [Hypertext Transfer Protocol://World Wide Web (dot) panzea (dot) org/index (dot) html].
Database Assembly - was performed to build a wide, rich, reliable annotated 30 and easy to analyze database comprised of publicly available genomic mRNA, ESTs DNA sequences, data from various crops as well as gene expression, protein annotation and pathway data QTLs, and other relevant information.
WO 2009/141824
PCT/IL2009/000508
2018200117 05 Jan 2018
Database assembly is comprised of a toolbox of gene refining, structuring, annotation and analysis tools enabling to construct a tailored database for each gene discovery project. Gene refining and structuring tools enable to reliably detect splice variants and antisense transcripts, generating understanding of various potential 5 phenotypic outcomes of a single gene. The capabilities of the LEADS platform of Compugen LTD for analyzing human genome have been confirmed and accepted by the scientific community [see e.g., Widespread Antisense Transcription, Yelin, et al. (2003) Nature Biotechnology 21, 379-85; Splicing of Alu Sequences, Lev-Maor, et al. (2003) Science 300 (5623), 1288-91; “Computational analysis of alternative splicing 10 using EST tissue information”, Xie H et al. Genomics 2002], and have been proven most efficient in plant genomics as well.
EST clustering and gene assembly - For gene clustering and assembly of organisms with available genome sequence data (arabidopsis, rice, castorbean, grape, brachypodium, poplar, soybean, sorghum) the genomic LEADS version (GANG) was 15 employed. This tool allows most accurate clustering of ESTs and mRNA sequences on genome, and predicts gene structure as well as alternative splicing events and anti-sense transcription.
For organisms with no available full genome sequence data, expressed LEADS clustering software was applied.
Gene annotation - Predicted genes and proteins were annotated as follows:
Blast search [Hypertext Transfer Protocol://blast (dot) ncbi (dot) nlm (dot) nih (dot) gov /Blast (dot) cgi] against all plant UniProt [Hypertext Transfer Protocol://World Wide Web (dot) uniprot (dot) org/] sequences was performed. Open reading frames of each putative transcript were analyzed and longest ORF with higher 25 number of homologues was selected as predicted protein of the transcript. The predicted proteins were analyzed by InterPro [Hypertext Transfer Protocol ://World Wide Web (dot) ebi (dot) ac (dot) uk/interpro/].
Blast against proteins from AraCyc and ENZYME databases was used to map the predicted transcripts to AraCyc pathways.
Predicted proteins from different species were compared using blast algorithm [Hypertext Transfer Protocol ://World Wide Web (dot) ncbi (dot) nlm (dot) nih (dot) gov
WO 2009/141824
PCT/IL2009/000508
2018200117 05 Jan 2018 .
/Blast (dot) cgi] to validate the accuracy of the predicted protein sequence, and for efficient detection of orthologs.
Gene expression profiling - Several data sources were exploited for gene expression profiling which combined microarray data and digital expression profile (see 5 below). According to gene expression profile, a correlation analysis was performed to identify genes which are co-regulated under different developmental stages and environmental conditions and which are associated with different phenotypes.
Publicly available microarray datasets were downloaded from TAIR and NCBI GEO sites, renormalized, and integrated into the database. Expression profiling 10 is one of the most important resource data for identifying genes important for yield.
A digital expression profile summary was compiled for each cluster according to all keywords included in the sequence records comprising the cluster. Digital expression, also known as electronic Northern Blot, is a tool that displays virtual expression profile based on the EST sequences forming the gene cluster. The tool 15 provides the expression profile of a cluster in terms of plant anatomy (e.g., the tissue/organ in which the gene is expressed), developmental stage (the developmental stages at which a gene can be found) and profile of treatment (provides the physiological conditions under which a gene is expressed such as drought, cold, pathogen infection, etc). Given a random distribution of ESTs in the different clusters, 20 the digital expression provides a probability value that describes the probability of a cluster having a total of N ESTs to contain X ESTs from a certain collection of libraries. For the probability calculations, the following is taken into consideration: a) the number of ESTs in the cluster, b) the number of ESTs of the implicated and related libraries, c) the overall number of ESTs available representing the species. Thereby clusters with 25 low probability values are highly enriched with ESTs from the group of libraries of interest indicating a specialized expression.
Recently, the accuracy of this system was demonstrated by Portnoy et al., 2009 (Analysis Of The Melon Fruit Transcriptome Based On 454 Pyrosequencing) in: Plant & Animal Genomes XVII Conference, San Diego, CA. Transcriptomic analysis, 30 based on relative EST abundance in data was performed by 454 pyrosequencing of cDNA representing mRNA of the melon fruit. Fourteen double strand cDNA samples obtained from two genotypes, two fruit tissues (flesh and rind) and four developmental
WO 2009/141824
PCT/IL2009/000508
2018200117 05 Jan 2018 stages were sequenced. GS FLX pyrosequencing (Roche/454 Life Sciences) of nonnormalized and purified cDNA samples yielded 1,150,657 expressed sequence tags that assembled into 67,477 unigenes (32,357 singletons and 35,120 contigs). Analysis of the data obtained against the Cucurbit Genomics Database [Hypertext Transfer 5 Protocol ://World Wide Web (dot) icugi (dot) org/] confirmed the accuracy of the sequencing and assembly. Expression patterns of selected genes fitted well their qRTPCR data.
The concepts of orthology and paralogy have recently been applied to functional characterizations and classifications on the scale of whole-genome 10 comparisons. Orthologs and paralogs constitute two major types of homologs: The first evolved from a common ancestor by specialization, and the latter are related by duplication events. It is assumed that paralogs arising from ancient duplication events are likely to have diverged in function while true orthologs are more likely to retain identical function over evolutionary time.
To identify putative orthologs of the genes affecting plant yield, oil yield, oil content, seed yield, growth rate, vigor, biomass, abiotic stress tolerance and/or nitrogen use efficiency, all sequences were aligned using the BLAST (Basic Local Alignment Search Toot). Sequences sufficiently similar were tentatively grouped. These putative orthologs were further organized under a Phylogram - a branching diagram (tree) 20 assumed to be a representation of the evolutionary relationships among the biological taxa. Putative ortholog groups were analyzed as to their agreement with the phylogram and in cases of disagreements these ortholog groups were broken accordingly. Expression data was analyzed and the EST libraries were classified using a fixed vocabulary of custom terms such as developmental stages (e.g., genes showing similar 25 expression profile through development with up regulation at specific stage, such as at the seed filling stage) and/or plant organ (e.g., genes showing similar expression profile across their organs with up regulation at specific organs such as seed). The annotations from all the ESTs clustered to a gene were analyzed statistically by comparing their frequency in the cluster versus their abundance in the database, allowing the 30 construction of a numeric and graphic expression profile of that gene, which is termed “digital expression”. The rationale of using these two complementary methods with methods of phenotypic association studies of QTLs, SNPs and phenotype expression
WO 2009/141824
PCT/IL2009/000508
2018200117 05 Jan 2018 correlation is based on the assumption that true orthologs are likely to retain identical function over evolutionary time. These methods provide different sets of indications on function similarities between two homologous genes, similarities in the sequence level identical amino acids in the protein domains and similarity in expression profiles.
Overall, 50 genes were identified to have a major impact on plant yield, seed yield, oil yield, oil content, biomass, growth rate, vigor, abiotic stress tolerance (ABST) and/or nitrogen use efficiency (NUE) when expressed in a plant. The identified genes, their curated polynucleotide and polypeptide sequences, as well as their updated sequences according to Genbank database are provided in Table 1, hereinbelow.
10
Table 1
Identified polynucleotides which affect plant yield, seed yield, oil yield, oil content, biomass, growth rate, vigor, abiotic stress tolerance and/or nitrogen use efficiency of a plant
Gene Name | Cluster Name | Organism | Polynucleotide SEQ ID NO: | Polypeptide SEQ ID NO : |
BDL100 | rice|gbl57.2|BI812936 | rice | 1 | 51 |
BDL100 | 1 | 723 | ||
BDL106 | canola|gbl61|DY020650 | canola | 2 | 52 |
BDL106 | 724 | 52 | ||
BDL108 | canola|gbl61|CD818601 | canola | 3 | 53 |
BDL108 | 725 | 742 | ||
BDL108 | 726 | 743 | ||
BDL110 | canola|gbl61|CD814521 | canola | 4 | 54 |
BDL110 | 727 | 744 | ||
BDL110 | 728 | 745 | ||
BDL111 | canola|gbl61|CN829852 | canola | 5 | 55 |
BDL111 | 729 | 746 | ||
BDL111 | 730 | 747 | ||
BDL112 | arabidopsis|gbl65|AT3G23510 | arabidopsis | 6 | 56 |
BDL113 | arabidopsis|gbl65|AT2G45310 | arabidopsis | 7 | 57 |
BDL114 | arabidopsis|gbl65|AT5G27820 | arabidopsis | 8 | 58 |
BDL115 | arabidopsis|gbl65|AT4Gl 1090 | arabidopsis | 9 | 59 |
BDL116 | arabidopsis|gbl65|AT4G24175 | arabidopsis | 10 | 60 |
BDL119 | arabidopsis|gbl65|AT3G47965 | arabidopsis | 11 | 61 |
BDL119 | 731 | 748 | ||
BDL120 | arabidopsis|gbl65|AT3G03230 | arabidopsis | 12 | 62 |
BDL120 | 732 | 749 | ||
BDL122 | arabidopsis|gbl65|AT3G49000 | arabidopsis | 13 | 63 |
BDL123 | arabidopsis|gbl65|AT2G21860 | arabidopsis | 14 | 64 |
BDL124 | arabidopsis|gbl65|AT5G51590 | arabidopsis | 15 | 65 |
BDL124 | 733 | 750 | ||
BDL125 | arabidopsis|gbl65|AT3G16180 | arabidopsis | 16 | 66 |
BDL125 | 734 | 751 | ||
BDL127 | arabidopsis|gb!65|AT3G44940 | arabidopsis | 17 | 67 |
WO 2009/141824
PCT/IL2009/000508
2018200117 05 Jan 2018
BDL128 | arabidopsis|gbl65|ATlG60770 | arabidopsis | 18 | 68 |
BDL129 | arabidopsis|gbl65|AT4G08690 | arabidopsis | 19 | 69 |
BDL129 | 735 | 69 | ||
BDL130 | arabidopsis|gbl65|AT3G03870 | arabidopsis | 20 | 70 |
BDL130 | 736 | 752 | ||
BDL131 | arabidopsis|gbl65|AT4G27450 | arabidopsis | 21 | 71 |
BDL131 | 737 | 71 | ||
BDL132 | arabidopsis|gbl65|AT4G23730 | arabidopsis | 22 | 72 |
BDL133 | arabidopsis|gbl65|AT3G06150 | arabidopsis | 23 | 73 |
BDL134 | arabidopsis|gbl65|AT3G28420 | arabidopsis | 24 | 74 |
BDL134 | 738 | 753 | ||
BDL135 | arabidopsis|gbl65|AT3G18600 | arabidopsis | . 25 | 75 |
BDL136 | arabidopsis|gbl65|AT3G22990 | arabidopsis | 26 | 76 |
BDL137 | arabidopsis|gbl65|AT5G14530 | arabidopsis | 27 | 77 |
BDL139 | arabidopsis|gbl65|ATlG29800 | arabidopsis | 28 | 78 |
BDL141 | arabidopsis|gbl65|ATlG29980 | arabidopsis | 29 | 79 |
BDL142 | arabidopsis|gbl65|AT2G39110 | arabidopsis | 30 | 80 |
BDL142 | 30 | 754 | ||
BDL143 | arabidopsis|gbl65|ATlG62810 | arabidopsis | 31 | 81 |
BDL143 | 739 | 81 | ||
BDL144 | arabidopsis|gb 1651AT3 G14890 | arabidopsis | 32 | 82 |
BDL145 | arabidopsis|gbl65|ATlG24470 | arabidopsis | 33 | 83 |
BDL145 | 740 | 83 | ||
BDL146 | arabidopsis|gbl65|AT3G09310 | arabidopsis | 34 | 84 |
BDL146 | 741 | 84 | ||
BDL148 | arabidopsis|gbl65|AT4G35785 | arabidopsis | 35 | 85 |
BDL42 | arabidopsis|gbl65|AT5G13170 | arabidopsis | 36 | 86 |
BDL46 | arabidopsisjgb 1651AT2G13690 | arabidopsis | 37 | 87 |
BDL46 | 719 | 87 | ||
BDL51 | arabidopsis|gb 165|AT5 G64260 | arabidopsis | 38 | 88 |
BDL52 | tomato|gbl64|BG127438 | tomato | 39 | 89 |
BDL52 | 716 | 89 | ||
BDL54 | arabidopsis|gb 1651AT2G41090 | arabidopsis | 40 | 90 |
BDL56 | arabidopsis|gbl65|AT2G32990 | arabidopsis | 41 | 91 |
BDL59 | arabidopsis|gbl65|AT5G07110 | arabidopsis | 42 | 92 |
BDL59 | 717 | 92 | ||
BDL60 | arabidopsis|gbl65|AT2G45200 | arabidopsis | 43 | 93 |
BDL65 | arabidopsis|gbl65|AT4G20360 | arabidopsis | 44 | 94 |
BDL67 | arabidopsis|gbl65|ATlG73600 | arabidopsis | 45 | 95 |
BDL68 | arabidopsisjgbl65|AT2G17280 | arabidopsis | 46 | 96 |
BDL78 | arabidopsis|gbl65|AT3G26520 | arabidopsis | 47 | 97 |
BDL78 | 718 | 720 | ||
BDL82 | arabidopsis|gbl65|ATlG21790 | arabidopsis | 48 | 98 |
BDL89 | rice|gbl57.2|AA749665 | rice | 49 | 99 |
BDL89 | 49 | 721 | ||
BDL95 | rice|gbl57.2|AU062876 | rice | 50 | 100 |
BDL95 | 50 | 722 |
Table 1: Provided are the identified genes, their annotation, organism and polynucleotide and polypeptide sequence identifiers. Note that SEQ ID NOs:716-719 and 724-741 are variants of the identified polynucleotides and SEQ ID NOs:720-723 and 742-754 are variants of the identified polypeptides.
WO 2009/141824
PCT/IL2009/000508
2018200117 05 Jan 2018
EXAMPLE 2
IDENTIFICATION OF HOMOLOGOUS SEQUENCES THAT INCREASE SEED
YIELD, OIL YIELD, GROWTH RATE, OIL CONTENT, BIOMASS, VIGOR, ABST
AND/OR NUE OF A PLANT
The search and identification of homologous genes involves the screening of sequence information available, for example, in public databases such as the DNA Database of Japan (DDBJ), Genbank, and the European Molecular Biology Laboratory Nucleic Acid Sequence Database (EMBL) or versions thereof or the MIPS database. A number of different search algorithms have been developed, including but not limited to 10 the suite of programs referred to as BLAST programs. There are five implementations of BLAST, three designed for nucleotide sequence queries (BLASTN, BLASTX, and TBLASTX) and two designed for protein sequence queries (BLASTP and TBLASTN) (Coulson, Trends in Biotechnology: 76-80, 1994; Birren et al., Genome Analysis, I: 543, 1997). Such methods involve alignment and comparison of sequences. The 15 BLAST algorithm calculates percent sequence identity and performs a statistical analysis of the similarity between the two sequences. The software for performing BLAST analysis is publicly available through the National Centre for Biotechnology Information. Other such software or algorithms are GAP, BESTFIT, FASTA and TFASTA. GAP uses the algorithm of Needleman and Wunsch (J. Mol. Biol. 48: 44320 453, 1970) to find the alignment of two complete sequences that maximizes the number of matches and minimizes the number of gaps.
The homologous genes may belong to the same gene family. The analysis of a gene family may be carried out using sequence similarity analysis. To perform this analysis one may use standard programs for multiple alignments e.g. Clustal W. A 25 neighbour-joining tree of the proteins homologous to the genes in this invention may be used to provide an overview of structural and ancestral relationships. Sequence identity may be calculated using an alignment program as described above. It is expected that other plants will carry a similar functional gene (ortholog) or a family of similar genes and those genes will provide the same preferred phenotype as the genes presented here. 30 Advantageously, these family members may be useful in the methods of the invention. Example of other plants are included here but not limited to, barley (Hordeum vulgare), Arabidopsis (Arabidopsis thaliana), maize (Zea mays), cotton (Gossypium), Oilseed
WO 2009/141824
PCT/IL2009/000508
2018200117 05 Jan 2018 rape (Brassica napus), Rice (Oryza sativa), Sugar cane (Saccharum officinarum), Sorghum (Sorghum bicolor), Soybean (Glycine max), Sunflower (Helianthus annuus), Tomato (Lycopersicon esculentum), Wheat (Triticum aestivum).
The above-mentioned analyses for sequence homology can be carried out on a full-length sequence, but may also be based on a comparison of certain regions such as conserved domains. The identification of such domains, would also be well within the realm of the person skilled in the art and would involve, for example, a computer readable format of the nucleic acids of the present invention, the use of alignment software programs and the use of publicly available information on protein domains, 10 conserved motifs and boxes. This information is available in the PRODOM (Hypertext Transfer Protocol ://World Wide Web (dot) biochem (dot) ucl (dot) ac (dot) uk/bsm/dbbrowser/protocol/prodomqry (dot) html), PIR (Hypertext Transfer Protocol ://pir (dot) Georgetown (dot) edu/) or Pfam (Hypertext Transfer Protocol://World Wide Web (dot) sanger (dot) ac (dot) uk/Software/Pfam/) database.
Sequence analysis programs designed for motif searching may be used for identification of fragments, regions and conserved domains as mentioned above. Preferred computer programs include, but are not limited to, MEME, SIGNALSCAN, and GENESCAN.
A person skilled in the art may use the homologous sequences provided herein to find similar sequences in other species and other organisms. Homologues of a protein 20 encompass, peptides, oligopeptides, polypeptides, proteins and enzymes having amino acid substitutions, deletions and/or insertions relative to the unmodified protein in question and having similar biological and functional activity as the unmodified protein from which they are derived. To produce such homologues, amino acids of the protein may be replaced by other amino acids having similar properties (conservative changes, 25 such as similar hydrophobicity, hydrophilicity, antigenicity, propensity to form or break a-helical structures or 3-sheet structures). Conservative substitution tables are well known in the art (see for example Creighton (1984) Proteins. W.H. Freeman and Company). Homologues of a nucleic acid encompass nucleic acids having nucleotide substitutions, deletions and/or insertions relative to the unmodified nucleic acid in 30 question and having similar biological and functional activity as the unmodified nucleic acid from which they are derived.
WO 2009/141824
PCT/IL2009/000508
2018200117 05 Jan 2018
Genes identified in publicly available sequence databases as sharing high sequence homology to the arabidopsis genes identified herein are summarized in Table 2 below. Those genes are expected to increase plant yield, seed yield, oil yield, oil content, growth rate, biomass, vigor, ABST and/or NUE of a plant have been identified 5 from the databases using BLAST software (BLASTP and TBLASTN) and are provided in Table 2, hereinbelow.
Table 2
Homologous polynucleotides and polypeptides
Polynuc. SEQ ID NO: | Cluster name | Organism | Polypept. SEQ ID NO: | Homology to SEQ ID NO: | % identity | Algorithm |
101 | brachypodium|gbl69|BE4156 18 | brachypodi urn | 379 | 51 | 88.81 | blastp |
102 | maize|gbl69.2|AI600710 | maize | 380 | 51 | 90.11 | blastp |
103 | maize|gbl69.2|AI615263 | maize | 381 | 51 | 91.09 | blastp |
104 | sorghum|gbl61.crp|AI987481 | sorghum | 382 | 51 | 81.43 | blastp |
105 | sugarcane|gbl57.3|CA081111 | sugarcane | 383 | 51 | 86.03 | blastp |
106 | switchgrass|gbl67|FE601953 | switchgrass | 384 | 51 | 90.99 | blastp |
107 | wheat|gbl64|BE490052 | wheat | 385 | 51 | 89.72 | blastp |
108 | b rapa|gbl62|EX108797 | b rapa | 386 | 52 | 80 | tblastn |
109 | b rapa|gbl62|EX138742 | b rapa | 387 | 52 | 92.86 | blastp |
110 | canola|gbl61|CD821478 | canola | 388 | 52 | 80 | tblastn |
111 | radish|gbl64|EV569061 | radish | 389 | 52 | 83.1 | tblastn |
112 | antirrhinum|gbl66|AJ558675 | antirrhinum | 390 | 53 | 80.77 | blastp |
113 | apple|gbl57.3|CN580529 | apple | 391 | 53 | 80.22 | blastp |
114 | arabidopsis|gbl65|AT5G1575 0 | arabidopsis | 392 | 53 | 88.46 | blastp |
115 | b rapa|gbl62|CX270798 | b rapa | 393 | 53 | 93.41 | blastp |
116 | b rapa|gbl62|DY009670 | b rapa | 394 | 53 | 99.45 | blastp |
117 | bean|gbl67|CA897445 | bean | 395 | 53 | 84.07 | blastp |
118 | cacao|gbl67|CU485233 | cacao | 396 | 53 | 84.07 | blastp |
119 | canola|gbl61|EE456125 | canola | 397 | 53 | 91.21 | blastp |
120 | centaurea|gbl66|EH737065 | centaurea | 398 | 53 | 80.22 | blastp |
121 | citrus|gbl66|CB304606 | citrus | 399 | 53 | 82.97 | blastp |
122 | cotton|gbl64|BQ409188 | cotton | 400 | 53 | 86.26 | blastp |
123 | cowpea|gbl66|FF400239 | cowpea | 401 | 53 | 82.97 | blastp |
124 | cynara|gbl67|GE592319 | cynara | 402 | 53 | 81.32 | blastp |
125 | dandelion|gbl61|DY824742 | dandelion | 403 | 53 | 81.87 | tblastn |
126 | grape|gbl60|CA813426 | grape | 404 | 53 | 84.07 | blastp |
127 | ipomoea|gbl57.2|CJ749317 | ipomoea | 405 | 53 | 83.06 | blastp |
128 | kiwi|gbl66|FG473358 | kiwi | 406 | 53 | 82.42 | blastp |
129 | lettuce|gbl57.2|DW152666 | lettuce | 407 | 53 | 80.77 | blastp |
130 | melon|gbl65|EB714755 | melon | 408 | 53 | 80.22 | tblastn |
131 | radish|gbl64|EV526240 | radish | 409 | 53 | 95.63 | blastp |
WO 2009/141824
PCT/IL2009/000508
2018200117 05 Jan 2018
Polynuc. SEQ ID NO: | Cluster name | Organism | Polypept. SEQ ID NO: | Homology to SEQ ID NO: | % identity | Algorithm |
132 | radish|gbl64|EV537766 | radish | 410 | 53 | 95.63 | blastp |
133 | soybean|gbl68|BE202985 | soybean | 411 | 53 | 83.52 | blastp |
134 | soybean|gbl68|BM139685 | soybean | 412 | 53 | 83.52 | blastp |
135 | sunflower|gbl62|CD851096 | sunflower | 413 | 53 | 82.97 | blastp |
136 | thellungiella|gbl67|BY81024 4 | thellungiell a | 414 | 53 | 91.21 | tblastn |
137 | triphysaria|gbl64|BM356672 | triphysaria | 415 | 53 | 81.87 | blastp |
138 | arabidopsis|gbl65|ATlG2176 0 | arabidopsis | 416 | 54 | 92.38 | blastp |
139 | b oleracea|gbl61|AM059122 | b oleracea | 417 | 54 | 99.39 | blastp |
140 | b rapa|gbl62|DN965363 | b rapa | 418 | 54 | 86.06 | blastp |
141 | cotton|gbl64|C0083170 | cotton | 419 | 54 | 80.06 | tblastn |
142 | peanut|gbl67|ES716655 | peanut | 420 | 54 | 80.06 | blastp |
143 | radish|gbl64|EV546747 | radish | 421 | 54 | 99.39 | blastp |
144 | soybean|gbl68|AI967832 | soybean | 422 | 54 | 80.66 | blastp |
145 | soybean|gbl68|AW395758 | soybean | 423 | 54 | 80.97 | blastp |
146 | arabidopsis|gbl65|AT3G2353 0 | arabidopsis | 424 | 56 | 96.89 | blastp |
147 | arabidopsis|gb 1651 ATI G0200 0 | arabidopsis | 425 | 57 | 82.31 | blastp |
148 | arabidopsis|gbl65|AT2G4531 5 | arabidopsis | 426 | 57 | 86.5 | tblastn |
149 | arabidopsis|gbl65|AT4G0011 0 | arabidopsis | 427 | 57 | 83.07 | blastp |
150 | b rapa|gbl62|CV544806 | b rapa | 428 | 57 | 82.42 | blastp |
151 | canola|gbl61|CD830303 | canola | 429 | 57 | 82.65 | blastp |
152 | citrus|gbl66|CK740093 | citrus | 430 | 57 | 83.98 | blastp |
153 | soybean|gbl68|AW704756 | soybean | 431 | 57 | 80.78 | blastp |
154 | soybean|gbl68|CB540306 | soybean | 432 | 57 | 81.69 | blastp |
155 | tomato|gbl64|BG126144 | tomato | 433 | 57 | 81.01 | tblastn |
156 | b rapa|gbl62|CV432750 | b rapa | 434 | 58 | 95.61 | blastp |
157 | b rapa|gbl62|ES933357 | b rapa | 435 | 58 | 93.86 | blastp |
158 | canola|gbl61|CN730767 | canola | 436 | 58 | 94.74 | blastp |
159 | canola|gbl61|CX193104 | canola | 437 | 58 | 92.98 | blastp |
160 | canola|gbl61|EE472289 | canola | 438 | 58 | 94.74 | blastp |
161 | canola|gbl61|EV217368 | canola | 439 | 58 | 94.74 | blastp |
162 | cassava|gbl64|DV446328 | cassava | 440 | 58 | 82.61 | blastp |
163 | citrus|gbl66|CX667844 | citrus | 441 | 58 | 81.58 | blastp |
164 | papaya|gbl65|EX265359 | papaya | 442 | 58 | 81.58 | blastp |
165 | radish|gbl64|EW733783 | radish | 443 | 58 | 95.61 | blastp |
166 | radish|gbl64|FD535333 | radish | 444 | 58 | 94.74 | blastp |
167 | canola|gbl61|CD820476 | canola | 445 | 59 | 83.1 | blastp |
168 | arabidopsis|gbl65|ATlG3125 8 | arabidopsis | 446 | 61 | 97.73 | blastp |
169 | arabidopsis|gbl65|AT3G0324 0 | arabidopsis | 447 | 62 | 81.44 | blastp |
170 | canola|gbl61|CD818131 | canola | 448 | 62 | 81.68 | blastp |
171 | radish|gbl64|EX894603 | radish | 449 | 66 | 89.23 | blastp |
172 | canola|gbl61|CD814119 | canola | 450 | 68 | 86.35 | blastp |
173 | canola|gbl61|CD816209 | canola | 451 | 68 | 85.19 | blastp |
174 | b rapa|gbl62|ES934568 | b rapa | 452 | 69 | 87.04 | tblastn |
175 | radish|gbl64|EV538975 | radish | 453 | 69 | 84.39 | blastp |
WO 2009/141824
PCT/IL2009/000508
2018200117 05 Jan 2018
Polynuc. SEQ ID NO: | Cluster name | Organism | Polypept. SEQ ID NO: | Homology to SEQ ID NO: | % identity | Algorithm |
176 | apple|gbl57.3|AU223507 | apple | 454 | 71 | 81.18 | blastp |
177 | apple|gbl57.3|CN579496 | apple | 455 | 71 | 82.35 | blastp |
178 | b oleracea|gbl61|AM385211 | b oleracea | 456 | 71 | 97.2 | blastp |
179 | b oleraceajgbl61|AM386119 | b oleracea | 457 | 71 | 83.6 | blastp |
180 | b rapa|gbl62|CX273145 | b rapa | 458 | 71 | 95.6 | blastp |
181 | b rapa|gbl62|EX022604 | b rapa | 459 | 71 | 96 | blastp |
182 | bean|gbl67|FE686571 | bean | 460 | 71 | 80.31 | blastp |
183 | cacao|gbl67|EH057755 | cacao | 461 | 71 | 83.07 | blastp |
184 | canola|gbl61|CD834729 | canola | 462 | 71 | 95.6 | blastp |
185 | canola|gbl61|CX192269 | canola | 463 | 71 | 97.2 | blastp |
186 | canola|gbl61|H74607 | canola | 464 | 71 | 95.6 | blastp |
187 | cassava|gb 164|D V443366 | cassava | 465 | 71 | 82.35 | blastp |
188 | citrus|gbl66|BQ625207 | citrus | 466 | 71 | 81.57 | blastp |
189 | cotton|gbl64|AI054775 | cotton | 467 | 71 | 82.75 | blastp |
190 | cowpea|gbl66|FC457888 | cowpea | 468 | 71 | 80.71 | blastp |
191 | cynara|gbl67|GE589236 | cynara | 469 | 71 | 80.4 | tblastn |
192 | dandelion|gbl61|DY816357 | dandelion | 470 | 71 | 81.64 | blastp |
193 | grape|gbl60|BM436371 | grape | 471 | 71 | 80.39 | blastp |
194 | lettuce|gbl57.2|DW046017 | lettuce | 472 | 71 | 81.57 | blastp |
195 | lettuce|gbl57.2|DW076019 | lettuce | 473 | 71 | 81.96 | blastp |
196 | lettuce|gbl57.2|DWl 10290 | lettuce | 474 | 71 | 81.57 | blastp |
197 | lettuce|gbl57.2|DW153964 | lettuce | 475 | 71 | 82.35 | blastp |
198 | lotus|gbl57.2|CN825209 | lotus | 476 | 71 | 81.89 | blastp |
199 | melon|gbl65|AM715906 | melon | 477 | 71 | 81.89 | blastp |
200 | papaya|gbl65|EX227683 | papaya | 478 | 71 | 83.46 | blastp |
201 | peach|gbl57.2|BU039450 | peach | 479 | 71 | 81.18 | blastp |
202 | peanut|gbl67|CX127963 | peanut | 480 | 71 | 80.48 | tblastn |
203 | poplar|gbl57.2|BI068247 | poplar | 481 | 71 | 80.78 | blastp |
204 | prunus|gbl67|BU039450 | prunus | 482 | 71 | 81.18 | blastp |
205 | radish|gbl64|EV567811 | radish | 483 | 71 | 92.8 | tblastn |
206 | radish|gbl64|EV568452 | radish | 484 | 71 | 96.8 | blastp |
207 | radish|gbl64|EV572670 | radish | 485 | 71 | 82.4 | blastp |
208 | safflower|gbl62|EL387585 | safflower | 486 | 71 | 80.31 | blastp |
209 | soybean|gbl68|AF272360 | soybean | 487 | 71 | 83.07 | blastp |
210 | soybean|gbl68|AL370910 | soybean | 488 | 71 | 82.68 | blastp |
211 | soybean|gbl68|BE661209 | soybean | 489 | 71 | 80 | tblastn |
212 | strawberry|gbl64|CO817556 | strawberry | 490 | 71 | 81.18 | blastp |
213 | sunflower|gbl62|DY915187 | sunflower | 491 | 71 | 82 | tblastn |
214 | sunflower|gbl62|DY939330 | sunflower | 492 | 71 | 82 | tblastn |
215 | walnuts|gbl66|CB303475 | walnuts | 493 | 71 | 82.28 | blastp |
216 | walnuts|gbl66|CB303477 | walnuts | 494 | 71 | 80.8 | tblastn |
217 | b rapa|gbl62|EX017049 | b rapa | 495 | 72 | 89.87 | blastp |
218 | canola|gbl61|CD831601 | canola | 496 | . 72 | 82.28 | tblastn |
219 | radish|gbl64|EV547036 | radish | 497 | 72 | 89.87 | blastp |
220 | canola|gbl61|CX189942 | canola | 498 | 76 | 89.59 | blastp |
221 | canola|gbl61|H74865 | canola | 499 | 77 | 87.26 | blastp |
222 | castorbean|gbl60|EG664225 | castorbean | 500 | 77 | 80.91 | tblastn |
223 | cotton|gbl64|BG442642 | cotton | 501 | 77 | 81.82 | tblastn |
224 | grape|gbl60|CB916567 | grape | 502 | 77 | 80.24 | blastp |
225 | poplar|gbl57.2|BU816880 | poplar | 503 | 77 | 80.61 | tblastn |
226 | radish|gbl64|EV537923 | radish | 504 | 77 | 86.61 | blastp |
227 | soybean|gbl68|AW776674 | soybean | 505 | 77 | 80.29 | blastp |
WO 2009/141824
PCT/IL2009/000508
2018200117 05 Jan 2018
Polynuc. SEQ ID NO: | Cluster name | Organism | Polypept. SEQ ID NO: | Homology to SEQ ID NO: | % identity | Algorithm |
228 | thellungiella|gbl67|DN77378 0 | thellungieli a | 506 | 77 | 94.26 | tblastn |
229 | bJuncea|gbl64|EVGN00166 916743135 | b_j uncea | 507 | 79 | 88.75 | blastp |
230 | b rapa|gbl62|CX268133 | b rapa | 508 | 79 | 90.95 | blastp |
231 | radish|gbl64|EV573167 | radish | 509 | 79 | 89.73 | tblastn |
232 | radish|gbl64|EW724071 | radish | 510 | 83 | 86.58 | blastp |
233 | b rapa|gbl62|EE517848 | b rapa | 511 | 85 | 80.4 | blastp |
234 | canola|gbl61|CD824985 | canola | 512 | 86 | 80.54 | blastp |
235 | b oleracea|gbl61|AM057266 | b oleracea | 513 | 88 | 90.82 | blastp |
236 | b rapa|gbl62|BG543561 | b rapa | 514 | 88 | 87.87 | blastp |
237 | canola|gbl61|CD820232 | canola | 515 | 88 | 88.2 | blastp |
238 | canola|gbl61|DW999252 | canola | 516 | 88 | 87.87 | blastp |
239 | potato|gbl57.2|BG351102 | potato | 517 | 89 | 89.86 | blastp |
240 | potato|gbl57.2|BI435634 | potato | 518 | 89 | 90.65 | blastp |
241 | radish|gbl64|EY917873 | radish | 519 | 92 | 87.1 | blastp |
242 | antirrhinum|gbl66|AJ797267 | antirrhinum | 520 | 93 | 80.08 | blastp |
243 | apple|gbl57.3|CN489681 | apple | 521 | 93 | 88.28 | blastp |
244 | apricot|gbl57.2|CV051536 | apricot | 522 | 93 | 88.33 | blastp |
245 | aquilegia|gbl57.3|DT735665 | aquilegia | 523 | 93 | 82.85 | blastp |
246 | b oleracea|gbl61|ES939061 | b oleracea | 524 | 93 | 82.85 | blastp |
247 | b rapa|gbl62|EX075010 | b rapa | 525 | 93 | 92.08 | blastp |
248 | basilicum|gbl57.3|DY334833 | basilicum | 526 | 93 | 86.67 | tblastn |
249 | bean|gbl67|CV530444 | bean | 527 | 93 | 84.94 | blastp |
250 | cacao|gbl67|CU490565 | cacao | 528 | 93 | 89.96 | blastp |
251 | canola|gbl61|CD813794 | canola | 529 | 93 | 92.92 | blastp |
252 | canola|gbl61|CD826913 | canola | 530 | 93 | 94.56 | blastp |
253 | canola|gbl61|CN737313 | canola | 531 | 93 | 92.92 | blastp |
254 | cichorium|gbl66|EH687081 | cichorium | 532 | 93 | 82.01 | tblastn |
255 | citrus|gbl66|CF506133 | citrus | 533 | 93 | 89.54 | blastp |
256 | cotton|gbl64|AI730510 | cotton | 534 | 93 | 85.77 | blastp |
257 | cotton|gbl64|BF268340 | cotton | 535 | 93 | 82.57 | blastp |
258 | cowpea|gb 166|FF384748 | cowpea | 536 | 93 | 85.77 | blastp |
259 | dandelion|gbl61|DY819170 | dandelion | 537 | 93 | 81.17 | tblastn |
260 | eucalyptus|gbl66|CT983920 | eucalyptus | 538 | 93 | 87.08 | blastp |
261 | grape|gbl60|CD798978 | grape | 539 | 93 | 88.28 | blastp |
262 | lettuce|gbl57.2|DW062039 | lettuce | 540 | 93 | 82.85 | blastp |
263 | melon|gbl65|AM742165 | melon | 541 | 93 | 83.68 | blastp |
264 | poplar|gbl57.2|CF234347 | poplar | 542 | 93 | 85.89 | blastp |
265 | poplar|gbl57.2|CV241881 | poplar | 543 | 93 | 87.65 | blastp |
266 | potato|gbl57.2|BG595485 | potato | 544 | 93 | 85.89 | blastp |
267 | prunus|gbl67|AJ631796 | prunus | 545 | 93 | 88.33 | blastp |
268 | radish|gbl64|EV567266 | radish | 546 | 93 | 92.92 | blastp |
269 | radish|gbl64|EY912132 | radish | 547 | 93 | 92.08 | blastp |
270 | safflower|gbl62|EL405854 | safflower | 548 | 93 | 82.01 | tblastn |
271 | soybean|gbl68|BQ157726 | soybean | 549 | 93 | 87.45 | blastp |
272 | soybean|gbl68|CD399194 | soybean | 550 | 93 | 86.72 | blastp |
273 | spurge|gbl61|DV128393 | spurge | 551 | 93 | 88.7 | blastp |
274 | sunflower|gbl62|DY918314 | sunflower | 552 | 93 | 80.83 | tblastn |
275 | thellungiella|gbl67|BY82093 5 | thellungieli a | 553 | 93 | 97.07 | tblastn |
276 | tobacco|gbl62|EB445856 | tobacco | 554 | 93 | 84.71 | blastp |
WO 2009/141824
PCT/IL2009/000508
2018200117 05 Jan 2018
Polynuc. SEQ ID NO: | Cluster name | Organism | Polypept. SEQ ID NO: | Homology to SEQ ID NO: | % identity | Algorithm |
277 | tomato|gbl64|BG128536 | tomato | 555 | 93 | 86.31 | blastp |
278 | triphysaria|gbl64|EY139231 | triphysaria | 556 | 93 | 83.4 | blastp |
279 | apple|gbl57.3|CN489235 | apple | 557 | 94 | 83.95 | blastp |
280 | apple|gbl57.3|CN490414 | apple | 558 | 94 | 83.78 | blastp |
281 | aquilegia|gbl57.3|DR925212 | aquilegia | 559 | 94 | 83.64 | blastp |
282 | bean|gbl67|CA905538 | bean | 560 | 94 | 83.06 | blastp |
283 | bean|gbl67|CB542107 | bean | 561 | 94 | 83.27 | blastp |
284 | canola|gbl61|CD816386 | canola | 562 | 94 | 87.18 | blastp |
285 | canola|gbl61|CX187647 | canola | 563 | 94 | 89.98 | blastp |
286 | citrus|gbl66|BE213456 | citrus | 564 | 94 | 83.44 | blastp |
287 | clover|gbl62|BB936594 | clover | 565 | 94 | 81.48 | blastp |
288 | cotton|gbl64|BG440364 | cotton | 566 | 94 | 80.82 | blastp |
289 | cowpea|gbl66|FC460131 | cowpea | 567 | 94 | 83.12 | blastp |
290 | co wpea|gb 166|FF541811 | cowpea | 568 | 94 | 83.74 | blastp |
291 | grape|gbl60|BG273758 | grape | 569 | 94 | 80.29 | blastp |
292 | grape|gbl60|BQ792941 | grape | 570 | 94 | 81.17 | blastp |
293 | lettuce|gbl57.2|DW051431 | lettuce | 571 | 94 | 81.82 | blastp |
294 | lettuce|gbl57.2|DWl 12484 | lettuce | 572 | 94 | 81.82 | blastp |
295 | medicago|gbl57.2|AW68858 1 | medicago | 573 | 94 | 81.54 | tblastn |
296 | poplar|gbl57.2|BI072710 | poplar | 574 | 94 | 82.51 | blastp |
297 | poplar|gbl57.2|BU824581 | poplar | 575 | 94 | 82.79 | tblastn |
298 | potato|gbl57.2|AW907286 | potato | 576 | 94 | 81.54 | tblastn |
299 | potato|gbl57.2|BE921734 | potato | 577 | 94 | 82.3 | blastp |
300 | radish|gbl64|EX747018 | radish | 578 | 94 | 80.88 | blastp |
301 | soybean|gbl68|AL387670 | soybean | 579 | 94 | 82.4 | blastp |
302 | soybean|gbl68|BG239139 | soybean | 580 | 94 | 82.3 | blastp |
303 | soybean|gbl68|BG839432 | soybean | 581 | 94 | 83.37 | blastp |
304 | sunflower|gbl62|CD847955 | sunflower | 582 | 94 | 82.1 | blastp |
305 | sunflower|gbl62|CX944572 | sunflower | 583 | 94 | 81.57 | blastp |
306 | tobacco|gbl62|GFXTOBTEF TUX1 | tobacco | 584 | 94 | 80.75 | blastp |
307 | tomato|gbl64|BG124614 | tomato | 585 | 94 | 80.53 | blastp |
308 | tomato|gbl64|BG125985 | tomato | 586 | 94 | 81.99 | blastp |
309 | canola|gbl61|CD827895 | canola | 587 | 95 | 92.49 | blastp |
310 | canola|gbl61|CX188753 | canola | 588 | 95 | 92.69 | blastp |
311 | b rapa|gbl62|L35822 | b rapa | 589 | 96 | 88.19 | blastp |
312 | canola|gbl61|CD813792 | canola | 590 | 96 | 88.93 | blastp |
313 | radish|gbl64|EV526073 | radish | 591 | 96 | 88.19 | blastp |
314 | radish|gbl64|EW729491 | radish | 592 | 96 | 88.19 | blastp |
315 | arabidopsis|gbl65|AT2G3683 0 | arabidopsis | 593 | 97 | 85.38 | blastp |
316 | b_juncea|gbl64|EVGN00082 509070705 | bjuncea | 594 | 97 | 90.51 | blastp |
317 | bJuncea|gbl64|EVGN00089 315240635 | bjuncea | 595 | 97 | 92.09 | blastp |
318 | b_juncea|gbl64|EVGN00116 217230337 | bjuncea | 596 | 97 | 90.51 | blastp |
319 | bJuncea|gbl64|EVGN00256 308610946 | bjuncea | 597 | 97 | 92.09 | tblastn |
320 | bJuncea|gbl64|EVGN00465 908341698 | bjuncea | 598 | 97 | 84.58 | blastp |
WO 2009/141824
PCT/IL2009/000508
2018200117 05 Jan 2018
Polynuc. SEQ ID NO: | Cluster name | Organism | Polypept. SEQ ID NO: | Homology to SEQ ID NO: | % identity | Algorithm |
321 | b_juncea|gbl64|EVGN01252 008670772 | b_j uncea | 599 | 97 | 83.79 | blastp |
322 | b oleracea|gbl61|AM385528 | b oleracea | 600 | 97 | 91.3 | blastp |
323 | b oleracea|gbl61|BOU92651 | b oleracea | 601 | 97 | 84.19 | blastp |
324 | b rapa|gbl62|BG545002 | b rapa | 602 | 97 | 84.58 | blastp |
325 | b rapa|gbl62|BQ791222 | b rapa | 603 | 97 | 86.17 | blastp |
326 | b rapa|gbl62|L37468 | b rapa | 604 | 97 | 91.3 | blastp |
327 | canola|gb 1611AF118381 | canola | 605 | 97 | 84.19 | blastp |
328 | canola|gbl61|CD815565 | canola | 606 | 97 | 91.3 | blastp |
329 | canola|gbl61|CD824493 | canola | 607 | 97 | 84.58 | blastp |
330 | canola|gbl61|CD841035 | canola | 608 | 97 | 91.3 | blastp |
331 | canola|gbl61|CN729037 | canola | 609 | 97 | 84.58 | blastp |
332 | canola|gbl61|CX187880 | canola | 610 | 97 | 90.91 | blastp |
333 | radish|gbl64|D84669 | radish | 611 | 97 | 90.91 | blastp |
334 | radish|gbl64|EV549107 | radish | 612 | 97 | 91.3 | blastp |
335 | radish|gbl64|EV569856 | radish | 613 | 97 | 84.58 | blastp |
336 | radish|gbl64|EX748154 | radish | 614 | 97 | 83.79 | blastp |
337 | thellungiella|gbl67|EE68344 7 | thellungiell a | 615 | 97 | 91.7 | blastp |
338 | canola|gbl61|H74506 | canola | 616 | 98 | 88.54 | blastp |
339 | radish|gbl64|EW716884 | radish | 617 | 98 | 88.19 | blastp |
340 | barley|gbl57.3|AL450752 | barley | 618 | 99 | 82.46 | blastp |
341 | brachypodium|gbl69|BE3990 53 | brachypodi um | 619 | 99 | 85.96 | blastp |
342 | cenchrus|gb 166|EB653861 | cenchrus | 620 | 99 | 86.84 | blastp |
343 | fescue|gbl61|DT683655 | fescue | 621 | 99 | 80.7 | blastp |
344 | leymus|gbl66|CD809085 | leymus | 622 | 99 | 84.21 | blastp |
345 | lovegrass|gbl67|DN480336 | lovegrass | 623 | 99 | 86.84 | blastp |
346 | lovegrass|gbl67|DN480721 | lovegrass | 624 | 99 | 83.33 | tblastn |
347 | lovegrass|gbl67|EH184046 | lovegrass | 625 | 99 | 85.96 | blastp |
348 | maize|gbl69.2|AI586696 | maize | 626 | 99 | 84.21 | blastp |
349 | maize|gbl69.2|AI619158 | maize | 627 | 99 | 85.22 | blastp |
350 | maize|gbl69.2|AI619355 | maize | 628 | 99 | 84.21 | blastp |
351 | maize|gbl69.2|AI783324 | maize | 629 | 99 | 85.96 | blastp |
352 | maize|gbl69.2|DQ244850 | maize | 630 | 99 | 84.21 | blastp |
353 | maize|gbl69.2|FK957562 | maize | 631 | 99 | 83.33 | tblastn |
354 | maize|gbl69.2|X86553 | maize | 632 | 99 | 85.96 | blastp |
355 | millet|gbl61|CD725537 | millet | 633 | 99 | 85.96 | blastp |
356 | pseudoroegneria|gbl67|FF35 9011 | pseudoroeg neria | 634 | 99 | 84.21 | blastp |
357 | rice|gbl57.3|C26798 | rice | 635 | 99 | 83.33 | blastp |
358 | sorghum|gbl61.crp|AI621929 | sorghum | 636 | 99 | 87.72 | blastp |
359 | sorghum|gbl61.crp|AI666179 | sorghum | 637 | 99 | 85.96 | blastp |
360 | sorghum|gbl61.crp|CD22229 3 | sorghum | 638 | 99 | 81.58 | blastp |
361 | sugarcane|gbl57.3|BQ478960 | sugarcane | 639 | 99 | 86.84 | blastp |
362 | sugarcane|gbl57.3|BQ537227 | sugarcane | 640 | 99 | 85.96 | blastp |
363 | sugarcane|gbl57.3|CA074008 | sugarcane | 641 | 99 | 85.96 | blastp |
364 | sugarcane|gbl57.3|CA112912 | sugarcane | 642 | 99 | 81.74 | blastp |
365 | switchgrass|gb 167|DN150202 | switchgrass | 643 | 99 | 86.84 | blastp |
366 | switchgrass|gbl67|FE615220 | switchgrass | 644 | 99 | 86.84 | blastp |
367 | switchgrass|gbl67|FL725679 | switchgrass | 645 | 99 | 85.96 | blastp |
WO 2009/141824
PCT/IL2009/000508
2018200117 05 Jan 2018
Polynuc. SEQ ID NO: | Cluster name | Organism | Polypept. SEQ ID NO: | Homology to SEQ ID NO: | % identity | Algorithm |
368 | switchgrass|gbl67|FL732781 | switchgrass | 646 | 99 | 86.84 | blastp |
369 | switchgrass|gbl67|FL846775 | switchgrass | 647 | 99 | 85.34 | blastp |
370 | switchgrass|gbl67|FL899116 | switchgrass | 648 | 99 | 85.96 | blastp |
371 | switchgrass|gbl67|FL979422 | switchgrass | 649 | 99 | 85.96 | blastp |
372 | wheat|gbl64|BE398366 | wheat | 650 | 99 | 84.21 | blastp |
373 | wheat|gbl64|BE399053 | wheat | 651 | 99 | 84.21 | blastp |
374 | barley|gbl57.3|BF623452 | barley | 652 | 100 | 85.25 | tblastn |
375 | maize|gbl69.2|AW267619 | maize | 653 | 100 | 80.58 | tblastn |
376 | pseudoroegneria|gbl67|FF35 2828 | pseudoroeg neria | 654 | 100 | 84.89 | blastp |
377 | sorghum|gb 161 .crp|AW43824 9 | sorghum | 655 | 100 | 86.43 | blastp |
378 | wheat|gbl64|BQ905354 | wheat | 656 | 100 | 85.97 | tblastn |
755 | amborella|gbl66|CD482678 | amborella | 764 | 97 | 81.03 | blastp |
756 | castorbean|gbl60|AJ605571 | castorbean | 765 | 97 | 80.24 | blastp |
757 | cotton|gbl64|AI055329 | cotton | 766 | 97 | 83.79 | blastp |
758 | cotton|gbl64|AI731742 | cotton | 767 | 97 | 83.79 | blastp |
759 | liriodendron|gbl66|CK74443 0 | liriodendro n | 768 | 97 | 81.42 | blastp |
760 | papaya|gbl65|EX246150 | papaya | 769 | 97 | 81.82 | blastp |
761 | periwinkle|gbl64|EG554262 | periwinkle | 770 | 97 | 80.24 | blastp |
762 | spurge|gbl61|AW990927 | spurge | 771 | 97 | 80.63 | blastp |
763 | tobacco|gbl62|CV018899 | tobacco | 772 | 97 | 80.24 | blastp |
773 | canola|gbl61|DW999739 | canola | 774 | 747 | 82.78 | blastp |
Table 2: Provided are polynucleotides and polypeptides which are homologous to the identified polynucleotides or polypeptides of Table 1. Note that the following polypeptide sequences are 100 % identical: SEQ ID NO:201 is identical to SEQ ID NO:204; SEQ ID NO:409 is identical to SEQ ID NO.-410; SEQ ID NO:411 is identical to SEQ ID NO:412; SEQ ID NO:456 is identical to SEQ ID
NO:463; SEQ ID NO:458 is identical to SEQ ID NO:462; SEQ ID NO:472 is identical to SEQID
NO:474; SEQ ID NO:479 is identical to SEQ ID NO:482; SEQ ID NO:514 is identical to SEQID
NO:516; SEQ ID NO:522 is identical to SEQ ID NO:545; SEQ ID NO:600 is identical to SEQID
NO:604, 606 and 608; SEQ ID NO:602 is identical to SEQ ID NO:607 and 609; SEQ ID NO:610 is identical to SEQ ID NO:611; SEQ ID NO:620 is identical to SEQ ID NO:643; SEQ ID NO:622 is 10 identical to SEQ ID NO:630, 634, 650 and 65; SEQ ID NO:629 is identical to SEQ ID NO:632; SEQ ID
NO:637 is identical to SEQ ID NO:640 and 641; SEQ ID NO:644 is identical to SEQ ID NO:646; SEQ ID NO:648 is identical to SEQ ID NO:649; SEQ ID NO:650 is identical to SEQ ID NO:651; SEQ ID NO:624 is identical to SEQ ID NO:625.
EXAMPLE 3
PRODUCTION OF ARABIDOPSIS TRANSCRIPTOM AND HIGH
THROUGHPUT CORRELATION ANALYSIS USING 44K ARABIDOPSIS FULL GENOME OLIGONUCLEOTIDE MICRO-ARRAY
To produce a high throughput correlation analysis, the present inventors utilized an Arabidopsis thaliana oligonucleotide micro-array, produced by Agilent Technologies [Hypertext Transfer Protocol://World Wide Web (dot) chem. (dot) agilent
WO 2009/141824
PCT/IL2009/000508
2018200117 05 Jan 2018 (dot) com/Scripts/PDS (dot) asp?lPage=50879]. The array oligonucleotide represents about 40,000 A. thaliana genes and transcripts designed based on data from the TIGR ΑΊΉ1 v.5 database and Arabidopsis MPSS (University of Delaware) databases. To define correlations between the levels of RNA expression and yield components or 5 vigor related parameters, various plant characteristics of 15 different Arabidopsis ecotypes were analyzed. Among them, nine ecotypes encompassing the observed variance were selected for RNA expression analysis. The correlation between the RNA levels and the characterized parameters was analyzed using Pearson correlation test [Hypertext Transfer Protocol ://World Wide Web (dot) davidmlane (dot) 10 com/hyperstat/A34739 (dot) html].
Experimental procedures
RNA extraction - Five tissues at different developmental stages including root, leaf, flower at anthesis, seed at 5 days after flowering (DAF) and seed at 12 DAF, representing different plant characteristics, were sampled and RNA was extracted using 15 TRIzol Reagent from Invitrogen [Hypertext Transfer Protocol://World Wide Web (dot) invitrogen (dot) com/content (dot) cfm?pageid=469]. For convenience, each microarray expression information tissue type has received a Set ID as summarized in Table 3 below.
Table 3
Arabidopsis transcriptom experimental sets
Expression Set | Set ID |
Root | A |
Leaf | B |
Flower | C |
Seed 5 DAF | D |
Seed 12 DAF | E |
Table 3. Provided are the Arabidopsis transcriptom experimental sets (A-E). DAF = days after flowering.
Approximately 30-50 mg of tissue was taken from samples. The weighed tissues were ground using pestle and mortar in liquid nitrogen and resuspended in 500 μΐ of TRIzol Reagent. To the homogenized lysate, 100 μΐ of chloroform was added followed by precipitation using isopropanol and two washes with 75 % ethanol. The
WO 2009/141824
PCT/IL2009/000508
2018200117 05 Jan 2018
RNA was eluted in 30 μΐ of RNase-free water. RNA samples were cleaned up using Qiagen’s RNeasy minikit clean-up protocol as per the manufacturer’s protocol.
Yield component and vigor related parameters assessment - eight out of the nine Arabidopsis ecotypes were used in each of 5 repetitive blocks (named A, B, C, D 5 and E), each containing 20 plants per plot were grown at control conditions greenhouse °C, 20:20:20 (weight ratios) N:P:K [nitrogen (N), phosphorus (P) and potassium (K)] fertilizer was added. During this time data was collected documented and analyzed. Additional data was collected through the seedling stage of plants grown at tissue culture in vertical grown transparent agar plates. Most of chosen parameters were 10 analyzed by digital imaging.
Digital imaging in Tissue culture - A laboratory image acquisition system, which consists of a digital reflex camera (Canon EOS 300D) attached with a 55 mm focal length lens (Canon EF-S series), mounted on a reproduction device (Kaiser RS), which included 4 light units (4x150 Watts light bulb) and located in a darkroom, was 15 used for capturing images of plantlets sawn in square agar plates.
Digital imaging in Greenhouse - The image capturing process was repeated every 3-4 days starting at day 7 till day 30. The same camera attached with a 24 mm focal length lens (Canon EF series), placed in a custom made iron mount, was used for capturing images of larger plants sawn in white tubs in an environmental controlled 20 greenhouse. The white tubs were square shape with measurements of 36 x 26.2 cm and
7.5 cm deep. During the capture process, the tubs were placed beneath the iron mount, while avoiding direct sun light and casting of shadows. This process was repeated every 3-4 days for up to 30 days.
An image analysis system was used, which consists of a personal desktop 25 computer (Intel P4 3.0
GHz processor) and a public domain program - ImageJ 1.37, Java based image processing program, which was developed at the U.S National Institutes of Health and is freely available on the internet at Hypertext Transfer Protocol://rsbweb (dot) nih (dot) gov/. Images were captured in resolution of 6 Mega Pixels (3072 x 2048 pixels) and 30 stored in a low compression JPEG (Joint Photographic Experts Group standard) format.
Next, analyzed data was saved to text files and processed using the JMP statistical analysis software (SAS institute).
WO 2009/141824
PCT/IL2009/000508
2018200117 05 Jan 2018
Leaf analysis - Using the digital analysis leaves data was calculated, including leaf number, area, perimeter, length and width. On day 30, 3-4 representative plants were chosen from each plot of blocks A, B and C. The plants were dissected, each leaf was separated and was introduced between two glass trays, a photo of each plant was 5 taken and the various parameters (such as leaf total area, laminar length etc.) were calculated from the images (Figures la-d). The blade circularity was calculated as laminar width divided by laminar length.
Root analysis - During 17 days, the different ecotypes were grown in transparent agar plates. The plates were photographed every 2 days starting at day 7 in 10 the photography room and the roots development was documented (Figures 2a-b). The growth rate was calculated according to the formula I as described above [Relative growth area rate = (Δ Area / At) * (1/ Area tO)J.
Vegetative growth rate analysis - The growth rate was calculated by dividing the area added (Δ Area) by the number of days for each interval (At). The analysis was 15 ended with the appearance of overlapping plants. The growth rate was calculated according to Formula IV.
Formula IV:
Growth rate = AArea / At.
For comparison between ecotypes the calculated rate was normalized using plant developmental stage as represented by the number of true leaves. In cases where plants with 8 leaves had been sampled twice (for example at day 10 and day 13), only the largest sample was chosen and added to the Anova comparison.
Seeds in siliques analysis - On day 70, 15-17 siliques were collected from each plot in blocks D and E. The chosen siliques were light brown color but still intact.
The siliques were opened in the photography room and the seeds were scatter on a glass tray, a high resolution digital picture was taken for each plot. Using the images the number of seeds per silique was determined.
Seeds average weight - At the end of the experiment all seeds from plots of blocks A-C were collected. An average weight of 0.02 grams was measured from each 30 sample, the seeds were scattered on a glass tray and a picture was taken. Using the digital analysis, the number of seeds in each sample was calculated.
WO 2009/141824
PCT/IL2009/000508
2018200117 05 Jan 2018
Oil percentage in seeds - At the end of the experiment all seeds from plots of blocks A-C were collected. Columbia seeds from 3 plots were mixed grounded and then mounted onto the extraction chamber. 210 ml of n-Hexane (Cat No. 080951 Biolab Ltd.) were used as the solvent. The extraction was performed for 30 hours at medium 5 heat 50 °C. Once the extraction has ended the n-Hexane was evaporated using the evaporator at 35 °C and vacuum conditions. The process was repeated twice. The information gained from the Soxhlet extractor (Soxhlet, F. Die gewichtsanalytische Bestimmung des Milchfettes, Polytechnisches J. (Dingier's) 1879, 232,461) was used to create a calibration curve for the Low Resonance NMR. The content of oil of all seed 10 samples was determined using the Low Resonance NMR (MARAN Ultra- Oxford Instrument) and its MultiQuant sowftware package.
Silique length analysis - On day 50 from sowing, 30 siliques from different plants in each plot were sampled in block A. The chosen siliques were green-yellow in color and were collected from the bottom parts of a grown plant’s stem. A digital 15 photograph was taken to determine silique's length.
Dry weight and seed yield - On day 80 from sowing, the plants from blocks AC were harvested and left to dry at 30 °C in a drying chamber. The biomass and seed weight of each plot was separated, measured and divided by the number of plants. Dry weight = total weight of the vegetative portion above ground (excluding roots) after 20 drying at 30 °C in a drying chamber; Seed yield per plant = total seed weight per plant (gr).
Oil yield - The oil yield was calculated using Formula V.
Formula V:
Seed Oil yield = Seed yield per plant (gr) * Oil % in seed
Harvest Index - The harvest index was calculated using Formula III as described above [Harvest Index = Average seed yield per plant/ Average dry weight].
Experimental Results
Nine different Arabidopsis ecotypes were grown and characterized for 18 parameters (named as vectors). Data parameters are summarized in Table 4, below.
WO 2009/141824
PCT/IL2009/000508
2018200117 05 Jan 2018
Table 4
Arabidopsis correlated parameters (vectors)
Correlated parameter with | Correlation ID |
Root length day 13 (cm) | 1 |
Root length day 7 (cm) | 2 |
Relative root growth ( cm /day) day 13 | 3 |
Fresh weight per plant (gr) at bolting stage | 4 |
Dry matter per plant (gr) | 5 |
Vegetative growth rate (cm2 / day) till 8 true leaves | 6 |
Blade circularity | 7 |
Lamina width (cm) | 8 |
Lamina length (cm) | 9 |
Total leaf area per plant (cm) | 10 |
1000 Seed weight (gr) | 11 |
Oil % per seed | 12 |
Seeds per silique | 13 |
Silique length (cm) | 14 |
Seed yield per plant (gr) | 15 |
Oil yield per plant (mg) | 16 |
Harvest Index | 17 |
Leaf width/length | 18 |
Table 4. Provided are the Arabidopsis correlated parameters 5 (correlation ID Nos. 1-18).
The characterized values are summarized in Tables 5 and 6 below.
Table 5
Arabidopsis ecotypes measured parameters
Ecotype | Seed yield per plant (gr) | Oil yield per plant (mg) | Oil% per seed | 1000 Seed weight (gr) | Dry matter per plant (gr) | Harvest Index | Total leaf area per plant (cm) | Seeds per silique | Silique length (cm) |
An-1 | 0.34 | 118.63 | 34.42 | 0.0203 | 0.64 | 0.53 | 46.86 | 45.44 | 1.06 |
Col-0 | 0.44 | 138.73 | 31.19 | 0.0230 | 1.27 | 0.35 | 109.89 | 53.47 | 1.26 |
Ct-1 | 0.59 | 224.06 | 38.05 | 0.0252 | 1.05 | 0.56 | 58.36 | 58.47 | 1.31 |
Cvi (N8580) | 0.42 | 116.26 | 27.76 | 0.0344 | 1.28 | 0.33 | 56.80 | 35.27 | 1.47 |
Gr-6 | 0.61 | 218.27 | 35.49 | 0.0202 | 1.69 | 0.37 | 114.66 | 48.56 | 1.24 |
Kondara | 0.43 | 142.11 | 32.91 | 0.0263 | 1.34 | 0.32 | 110.82 | 37.00 | 1.09 |
Ler-1 | 0.36 | 114.15 | 31.56 | 0.0205 | 0.81 | 0.45 | 88.49 | 39.38 | 1.18 |
Mt-0 | 0.62 | 190.06 | 30.79 | 0.0226 | 1.21 | 0.51 | 121.79 | 40.53 | 1.18 |
Shakdara | 0.55 | 187.62 | 34.02 | 0.0235 | 1.35 | 0.41 | 93.04 | 25.53 | 1.00 |
Table 5. Provided are the parameters measured in Arabidopsis ecotypes: Seed yield per plant (cm); oil yield per plant (mg); oil % per seed; 1000 seed weight (gr); dry matter per plant (gr); harvest index; Total leaf area per plant (cm); seeds per silique; Silique length (cm).
WO 2009/141824
PCT/IL2009/000508
2018200117 05 Jan 2018
Table 6
Arabidopsis ecotypes, additional measured parameters
Ecoty pe | Veg. GR | Relat root growth | Root length day 7 | Root length day 13 | Fresh weight per plant | Lam. Leng. | Lam. width | Leaf width/ length | Blade circulari ty |
An-1 | 0.313 | 0.631 | 0.937 | 4.419 | 1.510 | 2.767 | 1.385 | 0.353 | 0.509 |
Col-0 | 0.378 | 0.664 | 1.759 | 8.530 | 3.607 | 3.544 | 1.697 | 0.288 | 0.481 |
Ct-1 | 0.484 | 1.176 | 0.701 | 5.621 | 1.935 | 3.274 | 1.460 | 0.316 | 0.450 |
Cvi (N858 0) | 0.474 | 1.089 | 0.728 | 4.834 | 2.082 | 3.785 | 1.374 | 0.258 | 0.370 |
Gr-6 | 0.425 | 0.907 | 0.991 | 5.957 | 3.556 | 3.690 | 1.828 | 0.356 | 0.501 |
Konda ra | 0.645 | 0.774 | 1.163 | 6.372 | 4.338 | 4.597 | 1.650 | 0.273 | 0.376 |
Ler-l | 0.430 | 0.606 | 1.284 | 5.649 | 3.467 | 3.877 | 1.510 | 0.305 | 0.394 |
Mt-0 | 0.384 | 0.701 | 1.414 | 7.060 | 3.479 | 3.717 | 1.817 | 0.335 | 0.491 |
Shakda ra | 0.471 | 0.782 | 1.251 | 7.041 | 3.710 | 4.149 | 1.668 | 0.307 | 0.409 |
Table 6. Provided are the parameters measured in Arabidopsis ecotypes: Veg. GR = vegetative growth rate (cm2/day) until 8 true leaves; Relat. Root growth = relative root growth (cm/day); Root length day 7 (cm); Root length day 13 (cm); fresh weight per plant (gr) at bolting stage; Lam. Leng. = Lamima length (cm); Lam. Width = Lamina width (cm); Leaf width/length; Blade circularity.
Tables 7-9, below, provide the selected genes, the characterized parameters (which are used as x axis for correlation) and the correlated tissue transcriptom along with the correlation value (R, calculated using Pearson correlation).
Table 7
Arabidopsis selected genes and their correlation with yield (seed yield, oil yield, oil 15 content), biomass, growth rate and/or vigor components among different transcriptom sets
Gene Name | Cluster Name | Exp. Set | Corr. Vec. | R | Exp. Set | Corr. Vec. | R | Exp. Set | Corr. Vec. | R | Exp. Set | Corr. Vec. | R |
BDL1 12 | AT3G23 510 | B | 7 | 0.84 | D | 17 | 0.90 | D | 8 | -0.88 | D | 10 | 0.94 |
BDL1 13 | AT2G45 310 | B | 8 | 0.85 | D | 13 | 0.91 | D | 14 | 0.91 | B | 10 | 0.83 |
BDL1 14 | AT5G27 820 | B | 16 | 0.92 | D | 6 | 0.88 | B | 15 | 0.94 | |||
BDL1 15 | AT4G11 090 | C | 8 | 0.85 | A | 8 | 0.81 | C | 10 | 0.90 | B | 10 | 0.92 |
BDL1 16 | AT4G24 175 | B | 16 | 0.92 | B | 15 | 0.91 | ||||||
BDL1 19 | AT3G47 965 | D | 16 | 0.93 | D | 15 | 0.93 | ||||||
BDL1 20 | AT3G03 230 | D | 16 | 0.95 | D | 3 | 0.89 | D | 15 | 0.96 |
WO 2009/141824
PCT/IL2009/000508
2018200117 05 Jan 2018
Gene Name | Cluster Name | Exp. Set | Corr. Vec. | R | Exp. Set | Corr. Vec. | R | Exp. Set | Corr. Vec. | R | Exp. Set | Corr. Vec. | R |
BDL1 22 | AT3G49 000 | D | 17 | 0.96 | D | 8 | -0.92 | D | 10 | -0.96 | E | 6 | 0.83 |
BDL1 23 | AT2G21 860 | A | 16 | 0.82 | D | 13 | 0.92 | D | 14 | 0.94 | A | 15 | 0.86 |
BDL1 24 | AT5G51 590 | D | 12 | 0.93 | C | 16 | 0.93 | A | 1 | -0.85 | D | 2 | 0.91 |
BDL1 25 | AT3G16 180 | D | 16 | -0.91 | D | 15 | -0.93 | ||||||
BDL1 28 | AT1G60 770 | D | 5 | -0.86 | D | 17 | 0.82 | D | 8 | -0.91 | E | 14 | 0.88 |
BDL1 30 | AT3G03 870 | C | 9 | -0.82 | D | 13 | 0.85 | D | 14 | 0.94 | C | 6 | 0.85 |
BDL1 31 | AT4G27 450 | A | 1 | 0.92 | A | 2 | 0.91 | ||||||
BDL1 32 | AT4G23 730 | D | 13 | 0.90 | C | 14 | 0.94 | D | 14 | 0.91 | C | 3 | 0.81 |
BDL1 33 | AT3G06 150 | D | 13 | 0.86 | C | 14 | 0.90 | D | 14 | 0.92 | |||
BDL1 34 | AT3G28 420 | D | 13 | 0.92 | D | 14 | 0.91 | E | 3 | 0.81 | E | 11 | 0.80 |
BDL1 35 | AT3G18 600 | D | 12 | 0.96 | D | 16 | 0.87 | D | 3 | 0.93 | D | 2 | 0.81 |
BDL1 36 | AT3G22 990 | D | 12 | 0.90 | C | 16 | 0.83 | D | 16 | 0.81 | D | 3 | 0.89 |
BDL1 37 | AT5G14 530 | B | 12 | 0.83 | D | 12 | 0.83 | B | 16 | 0.83 | D | 16 | 0.81 |
BDL1 39 | AT1G29 800 | C | 13 | 0.87 | B | 13 | 0.85 | ||||||
BDL1 41 | AT1G29 980 | D | 18 | 0.90 | C | 16 | 0.81 | B | 16 | 0.81 | A | 3 | 0.83 |
BDL1 42 | AT2G39 110 | C | 16 | 0.82 | D | 16 | 0.83 | B | 3 | 0.86 | D | 3 | 0.90 |
BDL1 43 | AT1G62 810 | A | 13 | 0.94 | D | 13 | 0.82 | ||||||
BDL1 44 | AT3G14 890 | C | 16 | 0.81 | |||||||||
BDL1 45 | AT1G24 470 | C | 13 | 0.89 | B | 13 | 0.82 | D | 14 | 0.80 | |||
BDL1 46 | AT3G09 310 | C | 14 | 0.85 | C | 3 | 0.81 | B | 3 | 0.92 | A | 3 | 0.91 |
BDL1 48 | AT4G35 785 | D | 17 | 0.91 | D | 10 | -0.93 | D | 4 | -0.89 | B | 3 | 0.82 |
BDL4 2 | AT5G13 170 | B | 11 | 0.88 | |||||||||
BDL5 1 | AT5G64 260 | E | 9 | -0.81 | A | 8 | -0.82 | D | 13 | -0.83 | B | 14 | 0.82 |
BDL5 4 | AT2G41 090 | A | 6 | 0.82 | B | 3 | -0.86 | ||||||
BDL6 0 | AT2G45 200 | C | 7 | -0.88 | |||||||||
BDL6 5 | AT4G20 360 | B | 7 | -0.81 | B | 18 | -0.88 | B | 12 | -0.82 | D | 11 | 0.89 |
BDL7 8 | AT3G26 520 | D | 13 | 0.84 |
WO 2009/141824
PCT/IL2009/000508
2018200117 05 Jan 2018
Gene Name | Cluster Name | Exp. Set | Corr. Vec. | R | Exp. Set | Corr. Vec. | R | Exp. Set | Corr. Vec. | R | Exp. Set | Corr. Vec. | R |
BDL1 49 | AT5G15 750 | B | 14 | 0.83 | |||||||||
BDL1 49 | AT5G15 750 | A | 14 | 0.95 | B | 3 | 0.89 |
Table 7. Provided are Arabidopsis selected genes and their correlation with yield (seed yield, oil yield, oil content), biomass, growth rate and/or vigor components among different transcriptom sets. Corr. Vec. = correlation vector; Exp. Set = experimental set.
WO 2009/141824
PCT/IL2009/000508
Table 8
Arabidopsis selected genes and their correlation with yield (seed yield, oil yield, oil content), biomass, growth rate andtor vigor components among different transcriptom sets
2018200117 05 Jan 2018
Gene Name | Cluster Name | Exp. Set | Corr. Vec. | R | Exp. Set | Corr. Vec. | R | Exp. Set | Corr. Vec. | R | Exp. Set | Corr. Vec. | R |
BDL112 | AT3G23 510 | D | 4 | -0.84 | |||||||||
BDL113 | AT2G45 310 | ||||||||||||
BDL114 | AT5G27 820 | ||||||||||||
BDL115 | AT4G11 090 | A | 10 | 0.82 | D | 10 | 0.80 | C | 4 | 0.93 | B | 4 | 0.96 |
BDL116 | AT4G24 175 | ||||||||||||
BDL119 | AT3G47 965 | ||||||||||||
BDL120 | AT3G03 230 | ||||||||||||
BDL122 | AT3G49 000 | D | 4 | -0.84 | A | 11 | 0.88 | ||||||
BDL123 | AT2G21 860 | ||||||||||||
BDL124 | AT5G51 590 | C | 15 | 0.91 | |||||||||
BDL125 | AT3G16 180 | ||||||||||||
BDL128 | AT1G60 770 | D | 10 | -0.84 | A | 1 | -0.94 | D | 1 | -0.86 | A | 2 | -0.83 |
BDL130 | AT3GO3 870 | ||||||||||||
BDL131 | AT4G27 450 | ||||||||||||
BDL132 | AT4G23 730 | ||||||||||||
BDL133 | AT3G06 150 | ||||||||||||
BDL134 | AT3G28 420 | ||||||||||||
BDL135 | AT3G18 600 | ||||||||||||
BDL136 | AT3G22 990 | ||||||||||||
BDL137 | AT5G14 530 | C | 3 | 0.89 | D | 3 | 0.89 | ||||||
BDL139 | AT1G29 800 | ||||||||||||
BDL141 | AT1G29 980 | C | 15 | 0.84 | B | 15 | 0.85 | ||||||
BDL142 | AT2G39 110 | ||||||||||||
BDL143 | AT1G62 810 |
WO 2009/141824
PCT/IL2009/000508
2018200117 05 Jan 2018
Gene Name | Cluster Name | Exp. Set | Corr. Vec. | R | Exp. Set | Corr. Vec. | R | Exp. Set | Corr. Vec. | R | Exp. Set | Corr. Vec. | R |
BDL144 | AT3G14 890 | ||||||||||||
BDL145 | AT1G24 470 | ||||||||||||
BDL146 | AT3G09 310 | A | 2 | -0.81 | C | 11 | 0.83 | D | 11 | 0.81 | |||
BDL148 | AT4G35 785 | E | 1 | 0.88 | |||||||||
BDL42 | AT5G13 170 | ||||||||||||
BDL51 | AT5G64 260 | D | 14 | -0.88 | E | 6 | -0.82 | B | 11 | 0.87 | |||
BDL54 | AT2G41 090 | ||||||||||||
BDL60 | AT2G45 200 | ||||||||||||
BDL65 | AT4G20 360 | ||||||||||||
BDL78 | AT3G26 520 | ||||||||||||
BDL149 | AT5G15 750 | ||||||||||||
BDL149 | AT5G15 750 | D | 4 | -0.84 |
Table 8. Provided are Arabidopsis selected genes and their correlation with yield (seed yield, oil yield, oil content), biomass, growth rate and/or vigor components among different transcriptom sets. Corr. Vec. = correlation vector; Exp. Set = experimental set.
Table 9
Arabidopsis selected genes and their correlation with yield (seed yield, oil yield, oil content), biomass, growth rate and/or vigor components among different transcriptom sets
Gene Name | Cluster Name | Exp. Set | Corr. Vec. | R |
BDL112 | AT3G23510 | |||
BDL113 | AT2G45310 | |||
BDL114 | AT5G27820 | |||
BDL115 | AT4G11090 | A | 4 | 0.86 |
BDL116 | AT4G24175 | |||
BDL119 | AT3G47965 | |||
BDL120 | AT3G03230 | |||
BDL122 | AT3G49000 | |||
BDL123 | AT2G21860 | |||
BDL124 | AT5G51590 | |||
BDL125 | AT3G16180 | |||
BDL128 | AT1G60770 | |||
BDL130 | AT3G03870 | |||
BDL131 | AT4G27450 | |||
BDL132 | AT4G23730 | |||
BDL133 | AT3G06150 | |||
BDL134 | AT3G28420 |
WO 2009/141824
PCT/IL2009/000508
2018200117 05 Jan 2018
Gene Name | Cluster Name | Exp. Set | Corr. Vec. | R |
BDL135 | AT3G18600 | |||
BDL136 | AT3G22990 | |||
BDL137 | AT5G14530 | |||
BDL139 | AT1G29800 | |||
BDL141 | AT1G29980 | |||
BDL142 | AT2G39110 | |||
BDL143 | AT1G62810 | |||
BDL144 | AT3G14890 | |||
BDL145 | AT1G24470 | |||
BDL146 | AT3G09310 | |||
BDL148 | AT4G35785 | |||
BDL42 | AT5G13170 | |||
BDL51 | AT5G64260 | |||
BDL54 | AT2G41090 | |||
BDL60 | AT2G45200 | |||
BDL65 | AT4G20360 | |||
BDL78 | AT3G26520 | |||
BDL149 | AT5G15750 | |||
BDL149 | AT5G15750 |
Table 9. Provided are Arabidopsis selected genes and their correlation with yield (seed yield, oil yield, oil content), biomass, growth rate and/or vigor components among different transcriptom sets. Corr. Vec. = correlation vector; Exp. Set = experimental set.
Tables 10 and 11, below, provide data about the homologous of selected genes, the characterized parameters (which are used as x axis for correlation) and the correlated tissue transcriptom along with the correlation value (R, calculated using Pearson correlation).
Table 10
Homologous of Arabidopsis selected genes and their correlation with yield (seedyield, oil yield, oil content), biomass, growth rate and/or vigor components among different transcriptom sets
Gene Name | Cluster Name | Exp. Set | Corr. Vec. | R | Exp. Set | Corr. Vec. | R | Exp. Set | Corr. Vec. | R | Exp. Set | Corr. Vec. | R |
BDL110 HO | AT1G217 60 | D | 17 | 0.97 | D | 8 | -0.81 | B | 16 | 0.82 | D | 10 | -0.91 |
BDL113 HO | AT1G020 00 | B | 13 | -0.81 | |||||||||
BDL113 Hl | AT2G453 15 | E | 1 | 0.92 | |||||||||
BDL113 H2 | AT4G001 10 | B | 18 | -0.84 | E | 14 | 0.87 | E | 11 | 0.87 | |||
BDL120 HO | AT3G032 40 | D | 16 | 0.89 | C | 4 | -0.84 | D | 15 | 0.88 | |||
BDL78 H 0 | AT2G368 30 | B | 12 | -0.92 | C | 2 | -0.87 |
WO 2009/141824
PCT/IL2009/000508
Table 10. Provided are homologous of Arabidopsis selected genes and their correlation with yield (seed yield, oil yield, oil content), biomass, growth rate and/or vigor components among different transcriptom sets. Corr. Vec. = correlation vector; Exp. Set = experimental set.
2018200117 05 Jan 2018
Table 11
Homologous of Arabidopsis selected genes and their correlation with yield (seed yield, oil yield, oil content), biomass, growth rate andtor vigor components among different transcriptom sets
Gene Name | Cluster Name | Exp. Set | Corr. Vec. | R | Exp. Set | Corr. Vec. | R | Exp. Set | Corr. Vec. | R | Exp. Set | Corr. Vec. | R |
BDL110 HO | AT1G217 60 | D | 4 | -0.85 | B | 3 | 0.81 | A | 3 | 0.92 | B | 15 | 0.87 |
BDL113 HO | AT1G020 00 | ||||||||||||
BDL113 Hl | AT2G453 15 | ||||||||||||
BDL113 H2 | AT4G001 10 | ||||||||||||
BDL120 HO | AT3G032 40 | ||||||||||||
BDL78 H 0 | AT2G368 30 |
Table 11. Provided are homologous of Arabidopsis selected genes and their correlation with yield (seed yield, oil yield, oil content), biomass, growth rate and/or vigor components among different transcriptom sets. Con. Vec. = correlation vector; Exp. Set = experimental set.
EXAMPLE 4
GENE CLONING AND GENERA TION OF BINARY VECTORS FOR PLANT EXPRESSION
To validate their role in improving oil content, plant yield, seed yield, 20 biomass, growth rate, ABST, NUE and/or vigor, selected genes were over-expressed in plants, as follows.
Cloning strategy
Genes listed in Example 1 hereinabove were cloned into binary vectors for the generation of transgenic plants. For cloning, the full-length open reading frame (ORF) 25 was first identified. In case of ORF-EST clusters and in some cases already published mRNA sequences were analyzed to identify the entire open reading frame by comparing the results of several translation algorithms to known proteins from other plant species. To clone the full-length cDNAs, reverse transcription (RT) followed by polymerase chain reaction (PCR; RT-PCR) was performed on total RNA extracted from leaves,
WO 2009/141824
PCT/IL2009/000508
2018200117 05 Jan 2018 flowers, siliques or other plant tissues, growing under normal conditions. Total RNA was extracted as described in Example 2 above. Production of cDNA and PCR amplification was performed using standard protocols described elsewhere (Sambrook
J., E.F. Fritsch, and T. Maniatis. 1989. Molecular Cloning. A Laboratory Manual., 2nd
Ed. Cold Spring Harbor Laboratory Press, New York.) which are well known to those skilled in the art. PCR products were purified using PCR purification kit (Qiagen). In case where the entire coding sequence was not found, RACE kit from Ambion (RACE = _R_apid _A_ccess to _c_DNA _E_nds) was used to access the full cDNA transcript of the gene from the RNA samples described above. The RACE procedure was 10 performed for the genes BDL-108 (SEQ ID NO:726), BDL-110 (SEQ ID NO.728) and
BDL-111 (SEQ ID NO:730) using the primers sequences listed in Table 12, below. RACE products were cloned into high copy vector followed by sequencing. The information from the RACE procedure was used for cloning of the full length ORF of the corresponding genes.
Table 12
RACE primers used for sequencing of the identified genes of the invention
Gene Name | Primers used for amplification | High copy plasmid used for cloning of RACE products |
BDL108_Race | Fwd: BDL108 Outer Race (SEQ ID NO:853): GCTATACAACATGGGAGTTATACC | Topo TA |
BDL108_Race | Fwd: BDL108 Inner Race (SEQ ID NO:854): CTATCGACAGTGCTGGTACA | |
BDL108_Race | Rev:3' Race Outer Primer (SEQ ID NO:855): GCGAGCACAGAATTAATACGACT | |
BDL108_Race | Rev:3' Race Inner Primer (SEQ ID NO:856): CGCGGATCCGAATTAATACGACTCACTATAGG | |
BDL110_Race | Fwd: BDL110 Outer Race (SEQ ID NO:857): TGCAGTCTAAATACGATGGATCA | Topo TA |
BDL110_Race | Fwd: BDL110 Inner Race (SEQ ID NO:858): GAGTAGGAACACTTACATTCGA | |
BDL110_Race | Rev:3' Race Outer Primer (SEQ ID NO:859): GCGAGCACAGAATTAATACGACT | |
BDL110_Race | Rev:3' Race Inner Primer(SEQ ID NO:860) : cgcggatccgaattaatacgactcactAtagg | |
BDLlll_Race | Fwd: BDL111 Outer Race (SEQ ID NO:861): TCTCAAGAAGCTCTTCGTGGA | Topo TA |
BDLlll_Race | Fwd. BDLlll Inner Race (SEQ ID NO:862): GAGGAAGAATCTGAGCCGAT | |
BDLlll_Race | Rev:3' Race Outer Primer (SEQ ID NO:863): GCGAGCACAGAATTAATACGACT | |
BDLlll_Race | Rev:3' Race Inner Primer (SEQ ID NO:864): CGCGGATCCGAATTAATACGACTCACTATAGG |
WO 2009/141824
PCT/IL2009/000508
2018200117 05 Jan 2018
Table 12. Provided are the PCR primers used for RACE sequencing. Fwd = forward primer; Rev = reverse primer;
In case genomic DNA was cloned, as in the case of BDL119 gene, the gene 5 was amplified by direct PCR on genomic DNA extracted from leaf tissue using the DNAeasy kit (Qiagen Cat. No. 69104).
Usually, 2 sets of primers were synthesized for the amplification of each gene from a cDNA or a genomic sequence; an external set of primers and an internal set (nested PCR primers). When needed (e.g., when the first PCR reaction did not result in 10 a satisfactory product for sequencing), an additional primer (or two) of the nested PCR primers were used. Table 13 below provides primers used for cloning of selected genes.
WO 2009/141824
PCT/IL2009/000508
2018200117 05 Jan 2018
Table 13
The PCR primers used for cloning the genes of the invention
Gene Name | Restriction Enzymes used for cloning | Primers used for amplification |
BDL42 | Sall, Xbal | Fwd Nested: BDL42 NF Sall (SEQ ID NO:865) AATGTCGACAGAAAATGGGAGTCATGATCAA |
Fwd External: BDL42 EF Sall (SEQ ID NO:866) AATGTCGACTGCTATAGAAAATGGGAGTCATG | ||
Rev Nested: BDL42 NR Xbal (SEQ ID NO:867) TATCTAGATCATCAAACGGTTTCAGGACGAG | ||
Rev External: BDL42 ER Xbal (SEQ ID NO:868) TATCTAGATGACACTTCAAACGG'nTCAG | ||
BDL46 | Sall, Smal | Fwd Nested: BDL46 NF Sall (SEQ ID NO:869) ACGGTCGACACTTGATGACAATGGGCGAC |
Rev Nested: BDL46 NR Smal (SEQ ID NO:870) TCCCGGGTTATTACCTACAAGTAGATGATTCTACACC | ||
BDL51 | Xbal, SacI | Fwd: BDL51 F Xbal (SEQ ID NO:871) AATCTAGATCrCAATGGCTTCTAATTACCG |
Rev Nested: BDL51 NR SacI (SEQ ID NO:872) AGAGCTCGTGTCTTACTCACATCCCTTGG | ||
Rev External: BDL51 ER SacI (SEQ ID NO-.873) TGAGCTCTGCCACGTGTCITACTCACATC | ||
BDL52 | Sall, Xbal | Fwd: BDL52 F Sall (SEQ ID NO:874) AATGTCGACCTATAATGGCTGGAATGTGTTG |
Rev Nested: BDL52 NR Xbal (SEQ ID NO:875) TATCTAGATTACCCATACTGTTATAGATTTTTTCTC | ||
Rev External: BDL52 ER Xbal (SEQ ID NO:876) TATCTAGACATCAACAAAGGCAGCTAAATC | ||
BDL54 | Sall, Xbal | Fwd Nested: BDL54 NF Sall (SEQ ID NO:877) AATGTCGACAAACAATGGCGAATAAGTTCAC |
Rev Nested: BDL54 NR Xbal (SEQ ID NO:878) TATCTAGATCATCAAGAAAACAACGCTTCG | ||
BDL56 | Sall, Xbal | Fwd Nested: BDL56 NF Sall (SEQ ID NO:879) AGCGTCGACCAAATATGACTGTGATGAATCACC |
Fwd External: BDL56 EF Sall (SEQ ID NO:880) ATAGTCGACAAAGAGATCTTCACAAATATGACTG | ||
Rev Nested: BDL56 NR Xbal (SEQ ID NO: 881) TATCTAGACTACTATCTCTTATAAGTTGCAACCAAG | ||
Rev External: BDL56 ER Xbal (SEQ ID NO:882) TATCTAGAATAGAAATGGCAAAATGGGTG | ||
BDL59 | Sall, Xbal | Fwd Nested: BDL59 NF Sall (SEQ ID NO:883) AATGTCGACCTGCAATGGCTTCTCCTCTT |
Fwd External: BDL59 EF Sall (SEQ ID NO;884) TAAGTCGACGATCTCTCTCTGCACTCTCTGAC | ||
Rev Nested: BDL59 NR Xbal (SEQ ID NO:885) TATCTAGATCAATCTCAGACTCGAACGCGTG | ||
Rev External: BDL59 ER Xbal (SEQ ID NO:886) TATCTAGACTTCAACAATCTCAGACTCGAAC | ||
BDL60 | Sall, SacI | Fwd Nested: BDL60 NF Sall (SEQ ID NO:887) AGAGCTCAGGAAAATGACAGAATCGAGTC |
Fwd External: BDL60 EF Sall (SEQ ID NO:888) AATGTCGACGGAGAGGTTACTGATCTGAATTG | ||
Rev Nested: BDL60 NR SacI (SEQ ID NO:889) AGAGCTCAGGAAAATGACAGAATCGAGTC |
WO 2009/141824
PCT/IL2009/000508
2018200117 05 Jan 2018
Gene Name | Restriction Enzymes used for cloning | Primers used for amplification |
Rev External: BDL60 ER SacI (SEQ ID NO:890) TGAGCTCAGCTTAGGTGTATGAACATTCTG | ||
BDL65 | Sall, Smal | Fwd Nested: BDL65 NF Sall (SEQ ID NO:891) AATGTCGACTCCAATTCCATCTTCCCATG |
Fwd External: BDL65 EF Sall (SEQ ID NO:892) AATGTCGACCTCTCCTCTGCTCrCCAATTC | ||
Rev Nested: BDL65 NR Smal (SEQ ID NO:893) TCCCGGGTCATCATTCGAGGATCGTCCCA | ||
Rev External: BDL65 ER Smal (SEQ ID NO:894) TCCCGGGCTTATAATCATTCGAGGATCGT | ||
BDL67 | Sall, Smal | Fwd Nested: BDL67 NF Sall (SEQ ID NO:895) AATGTCGACGGATAATGGCTTCGTATGGC |
Rev Nested: BDL67_NR_SmaI (SEQ ID NO:896) TCCCGGGTTATCAGTTTCTCITGGCGATGA | ||
BDL68 | Sall, Xbal | Fwd Nested: BDL68 NF Sall (SEQ ID NO:897) TAGGTCGACTAGCCATGGACAACGAAGG |
Rev Nested: BDL68 NR Xbal (SEQ ID NO:898) TATCTAGAITAITAGCCACTAGGATTATCAAGTC | ||
BDL78 | Xbal, SacI | Fwd: BDL78 F Xbal (SEQ ID NO:899) AATCTAGATCCGATCATGCCGACCAG |
Rev Nested: BDL78 NR SacI new (SEQ ID N0:900) TGAGCTCTTATCAGTAATCGGTGGTAGGCA | ||
Rev External: BDL78 ER SacI (SEQ ID NO:901) TGAGCTCCAGATTAACAACGTTGAATFTGAC | ||
BDL82 | Sall, Xbal | Fwd Nested: BDL82 NF Sall (SEQ ID NO:902) AAGGTCGACCGAGAGAGACAGAGAGGTTTCG |
Fwd External: BDL82 EF Sall (SEQ ID NO:903) ATAGTCGACCGAAGTTTGAGCTAAGAATCC | ||
Rev Nested: BDL82 NR Xbal (SEQ ID NO:904) TATCTAGATTATTAITCTCCATGGTCGTGAAG | ||
Rev External: BDL82 ER Xbal (SEQ ID NO:905) TATCTAGATAGCTATTATTCTCCATGGTCG | ||
BDL89 | Sall, Xbal | Fwd Nested: BDL89 NF Sall (SEQ ID NO:906) AATGTCGACCCAGGATGAAGTTCATTTCTG |
Fwd External: BDL89 EF Sall (SEQ ID NO:907) AATGTCGACTCTCTCCATCTCCCATCCAG | ||
Rev Nested: BDL89 NR Xbal (SEQ ID NO:908) TATCTAGATCATCGCATCACTCAGTCAAACAAAC | ||
Rev External: BDL89 ER Xbal (SEQ ID NO:909) TATCTAGAGATGATAGAAGAGGTGACCGC | ||
BDL95short | Sall, SacI | Fwd : BDL95 Short F (SEQ ID NO:910) AATGTCGACGGCGAATGGCTGGATTTC |
Rev Nested: BDL95_NR_SacI (SEQ ID NO:911) TGAGCTCTTATCAGTCCTGATGTGTCTGCTG | ||
BDL100 | Sall, SacI | Fwd Nested: BDL100 NF Sall (SEQ ID NO:912) AATGTCGACAACAATGGAGAGCGAGATGGCG |
Fwd External: BDL100 EF Sall (SEQ ID NO:913) AATGTCGACGAGGAGGAACAAACAACTCATC | ||
Rev Nested: BDL100 NR SacI (SEQ ID NO:914) TGAGCTCTCATCAITGAATCATCGGATCACC | ||
Rev External: BDL100 ER sacI (SEQ ID NO:915) TGAGCTCGCAGGTCATTGAATCATCGG | ||
BDL106 | Xbal, SacI | -----Fwd Nested: BDL106 NF Xbal (SEO IDNGt9FG----- |
WO 2009/141824
PCT/IL2009/000508
2018200117 05 Jan 2018
Gene Name | Restriction Enzymes used for cloning | Primers used for amplification |
ATTCTAGAAAACCATGACCGTCGTCTC | ||
Fwd External: BDL106_EF_XbaI (SEQ ID NO:917) CTTCTAGAGGTCTCTTCrCAGATACTCATTCAC | ||
Rev Nested: BDL106 NR SacI (SEQ ID NO:918) TGAGCTCTTATTAGAATCTGCAGAAAGCTAG | ||
Rev External: BDL106 ER SacI (SEQ ID NO:919) TGAGCTCAGATGTCAAAGAGGGCTTACTC | ||
BDL108 | Sall, Xbal | Fwd Nested: BDL108 NF Sall (SEQ ID NO:920) AATGTCGACCAGTGATGAGGAAGCTCAAGA |
Fwd External: BDL108 EF Sall (SEQ ID NO:921) ATAGTCGACCGTTGTTTGCACCACCTTG | ||
Rev Nested: BDL108 NR Xbal (SEQ ID NO:922) TATCTAGATTATTAAGCAAGCATGTCGTAGTCA | ||
Rev External: BDL108 ER Xbal (SEQ ID NO:923) TCrCTAGATTAGATCITTTAAGCAAGCATGTCG | ||
BDL110 | Sall, Xbal | Fwd Nested: BDL11O NF Sall (SEQ ID NO:924) ACGGTCGACTCCACATGACITCAGATGCTC |
Fwd External: BDL110 EF Sall (SEQ ID NO:925) ACTGTCGACGAACATCACCCAATTCTCTAGC | ||
Rev Nested: BDL110 NR xbal (SEQ ID NO:926) TATCTAGACTACTAGCCGGTGACAAAGTAATC | ||
Rev External: BDL110 ER Xbal (SEQ ID NO:927) TATCTAGACTAATCGTTGGTTGATGTGTCACTCTAG | ||
BDL111 | EcoRV | Fwd Nested: BDL111 NF EcoRV(SEQ ID NO:928) TAGATATCAAAAGATGCAAGirGTITCrCC |
Fwd External: BDLlll_EF_EcoRV (SEQ ID NO:929) TAGATATCCTGTGTGTTTGTATTTATTTGGATC | ||
Rev Nested: BDL111 NR EcoRV(SEQ ID NO:930) TAGATATCTCATGATGATCAGTAAGGATGAACATTC | ||
Rev External: BDL111 ER EcoRV (SEQ ID NO:931) TAGATATCTCAGCAAGAAGGTGATGATCAGTAAGG | ||
BDL112 | Sall, Xbal | Fwd Nested: BDL112 NF SI (SEQ ID NO:932) TTGGTCGACCGTAGACACGTATTTTGAAGGG |
Fwd External: BDL112 EF SI (SEQ ID NO:933) TATGTCGACTTAATGGTAGACCGTAGACACG | ||
Rev Nested: BDL112 NR Xb (SEQ ID NO:934) CAATCTAGATTAATGCTCTCAAGAGACACAATAAGC | ||
Rev External: BDL112 ER Xb (SEQ ID NO:935) CITCTAGATTAGGTCATCAAATATTGTATAGATCG | ||
BDL113 GA | SacI, Xbal | Synthetic product |
BDL114 | Sall, Xbal | Fwd : BDL114_NF_S1 (SEQ ID NO:936) TTTGTCGACTCAGCTTCAGATGGTGATTCC |
Rev: BDL114 NR Xb (SEQ ID NO:937) TTTCrAGATCATCAGAGCAACTTGACACCAGC | ||
BDL115 | Smal, SacI | Fwd Nested: BDL115 NF Smal (SEQ ID NO:938) ACCCGGGAGAAGATGAAGCTAAAATGGGAA |
Fwd External: BDL115 EF Smal (SEQ ID NO:939) ACCCGGGGTATATCTCTCAGCGCGAGG | ||
Rev Nested: BDL115 NR SacI (SEQ ID NO:940) TGAGCTCTTATTA'nTACCGGTTCGACCATT | ||
Rev External: BDL115 ER SacI (SEQ ID NO:941) TGAGCTCTTAGCCATTGACTACATACAAGCAA | ||
BDL116 | EcoRV | -----Fwd Nested: BDL116 NF EcRV tSEO ID NO:942)----- |
WO 2009/141824
PCT/IL2009/000508
2018200117 05 Jan 2018
Gene Name | Restriction Enzymes used for cloning | Primers used for amplification |
TAGATATGACCTTGGAACGATTTTGCC | ||
Fwd External: BDL116 EF EcRV (SEQ ID NO:943) GAGATATCAAAGCTCTGACCTTGGAACG | ||
Rev Nested: BDL116 NR EcRV (SEQ ID NO:944) CAGATATCTTATCATAAGTACAAATCAGTCTGCTCAC | ||
Rev External: BDL116 ER EcRV(SEQ ID NO:945) TAGATATCTCACATTCATAAGTACAAATCAGTCTGC | ||
BDL119 | EcoRV | Fwd:BDL119 NF EcRV (SEQ ID NO:946) TTGATATCAGTTTCTCCGTCGACGATACC |
Rev:BDL119 NR EcRV (SEQ ID NO:947) AAGATATCGGTCAAGTACATAAGCTAATAGATG | ||
BDL120 | SacI, Sall | Fwd: BDL120 F Sall (SEQ ID NO.948) AATGTCGACAACAATGGTGCTTCTACTTGTGATTG |
Rev: BDL120 R SacI (SEQ ID NO:949) TGAGCTCTCACTTCCACTAGTCACTACAAGCG | ||
BDL122 | Sall, Xbal | Fwd:BDL122 NF SI (SEQ ID NO:950) CTGGTCGACACAGTATTGAGAGACTTCCrGGTG |
Rev: BDL122 NR Xba (SEQ ID NO:951) GCTTCTAGACAATGTGAACTAAATCGACC | ||
BDL123 | SacI | Fwd:BDL123 F Sac (SEQ ID NO:952) AGAGCTCGTnTCrrCGCCATGGC |
Rev: BDL123 R Sac (SEQ ID NO:953) TGAGCTCTTAAACAGTGACTACCACAGTGCA | ||
BDL124 | EcoRV | Fwd Nested: BDL124 NF EcRV (SEQ ID NO:954) TCGATATCGGAATCAGAATCTTTTCAGATGG |
Fwd External: BDL124_EF_EcRV (SEQ ID NO:955) CTGATATCGAGTTTCTCTTCCTTAATTGTCG | ||
Rev Nested: BDL124 NR EcRV (SEQ ID NO:956) TTGATATCATCATCAGCTTGGAACCTCG | ||
Rev External: BDL124 ER EcRV (SEQ ID NO:957) TAGATATCTCTTTCCATCGATCATCAGC | ||
BDL125 | Sall, Xbal | Fwd: BDL125 NF SI (SEQ ID NO:958) CTAGTCGACTAACAACAATGGAGAACCCTC |
Rev: BDL125 NR Xb (SEQ ID NO:959) ACTCTAGATTAATGATCAACCAATTGGTCTTAG | ||
BDL127 GA | SacI, Xbal | Synthetic product |
BDL128 | Xbal | Fwd: BDL128 NF Xbal (SEQ ID NO:960) TATCTAGAAGAAAATGGCGATGCGAC |
Rev: BDL128 NR Xbal (SEQ ID NO:961) TATCTAGATCATCACACATCCTGAGATACTTCATC | ||
BDL129 GA | SacI, Xbal | Synthetic product |
BDL130 GA | SacI, Xbal | Synthetic product |
BDL131 | Sall, Xbal | Fwd : BDL131 NF Sall (SEQ ID NO:962) AATGTCGACAGAGAAATGTTGGCTATCITCC |
Rev: BDL131 NR Xbal (SEQ ID NO:963) TATCTAGATCATCAGAGAGACCAATTGGCTTC | ||
BDL132 | Sall, Xbal | Fwd Nested: BDL132 NF Sall (SEQ ID NO:964) AATGTCGACTTTGAATGGAACCATCATCTG |
Fwd External: BDL132 EF Sall (SEQ ID NO:965) TTAGTCGACCTGAATCTGITTTTGAATGGAAC | ||
Rev Nested: BDL132 NR Xbal (SEQ ID NO:966) TATCTAGATTATTAGGTGGAAAGAACAAGCG | ||
Rev External: BDL132 ER Xbal (SEQ ID NO:967) |
WO 2009/141824
PCT/IL2009/000508
2018200117 05 Jan 2018
Gene Name | Restriction Enzymes used for cloning | Primers used for amplification |
TATCTAGATCAACAAGACAAGATAATGAAAGACACAG | ||
BDL133 | EcoRV | Fwd : BDL133 NF EcoRV(SEQ ID NO:968) TAGATATCTTAAAATGCCGGAGAAAGG |
Rev: BDL133_NR_EcoRV (SEQ ID NO:969) ATGATATCCTACTATCTTACACACAATGCATTCAG | ||
BDL134 GA | SacI, Xbal | Synthetic product |
BDL135 | Sall, Xbal | Fwd: BDL135 NF Sall (SEQ ID NO:970) ATAGTCGACGAAACATGGTTGAATCGGAC |
Rev: BDL135 NR Xbal (SEQ ID NO:971) TATCTAGATTAGACACnTATGCCTCCTTTGTAG | ||
BDL136 | Sall, SacI | Fwd: BDL136 NF SI (SEQ ID NO:972) AGCGTCGACTTAGAGAGAGATGCAGAAACGG |
Rev: BDL136_NR_Sc (SEQ ID NO:973) CGAGCTCCTAATCTAGAGAAGACTTTTACATGCC | ||
BDL137 GA | SacI, Xbal | Synthetic product |
BDL139 GA | SacI, Xbal | Synthetic product |
BDL141 GA | SacI, Xbal | Synthetic product |
BDL142 | Sall, Xbal | Fwd Nested : BDL142 NF Sall (SEQ ID NO:974) AATGTCGACCATCCTCATGAATAATTCTACATC |
Fwd External: BDL142 EF Sall (SEQ ID NO:975) ACTGTCGACGCATTCCATTCATCCTCATGA | ||
Rev Nested: BDL142 NR Xba (SEQ ID NO:976) ATTCTAGAGTGTGATTATCAGTTTGTTCrCTC | ||
Rev External: BDL142 ER Xbal (SEQ ID NO:977) ATTCTAGAGAAACGACAAGTGATTATAATGG | ||
BDL143 | Sall, BamHI | Fwd : BDL143 F Sall (SEQ ID NO:978) ACTGTCGACAACATGTTGTTTAACTGGACTAAG |
Rev Nested : BDL143 NR BamHI (SEQ ID NO:979) ATGGATCCTTACAGAACCGGTCAAGATGAAG | ||
Rev External: BDL143 ER BamHI (SEQ ID NO:980) ATGGATCCCAATAACTCGAACACGAACAAC | ||
BDL144 | EcoRV | Fwd: BDL144 F EcoRV (SEQ ID NO:981) TAGATATCAACAATGATTACAGTAGCCCCCTTC |
Rev Nested : BDL144 NR EcoRV (SEQ ID NO:982) atgAtatcctaacaagcacaagactgatacagc | ||
Rev External: BDL144 ER EcoRV (SEQ ID NO:983) atgatatccaaaagctagctactagtttcatcac | ||
BDL145 | Sall, Xbal | Fwd: BDL145 F Sal (SEQ ID NO:984) atagtcgacgaaagaaagagaaagcagaacatg |
Rev: BDL145 NR Xbal (SEQ ID NO:985) attctagatggaggagcaaatacaaacttg | ||
BDL146 | Sall, Xbal | Fwd: BDL146 F Sall (SEQ ID NO:986) aatgtcgacgaaacttggttttgagcttaac |
Rev Nested : BDL146_NR_Xbal (SEQ ID NO:987) ATTCTAGATCATCCCATTGCTTTCTCTAGTATTAG | ||
Rev External: BDL146 ER Xbal (SEQ ID NO:988) ATTCTAGATTAAATGTATCGCTCCAAAAGAC | ||
BDL148 | Sall, SacI | Fwd Nested : BDL148 NF Sall (SEQ ID NO:989) ACTGTCGACCTAATTCrCTCCGTCrCGATCG |
Fwd External: BDL148_EF_Sall (SEQ ID NO:990) ACTGTCGACGACTGAmTACGCnTATTGCTC | ||
Rev Nested : BDL148 NR NEW SacI (SEQ ID NO:991) GTGAGCTCTTAAACAGGTCATCTCGAGCCAC |
WO 2009/141824
PCT/IL2009/000508
2018200117 05 Jan 2018
Gene Name | Restriction Enzymes used for cloning | Primers used for amplification |
Rev External: BDL148 ER NEW Sacl (SEQ ID NO:992) GAGAGCrCCGTTGCCTGACAGAATCTTTG |
Table 13. Provided are the PCR primers used for cloning the genes described in Table 12 above. Fwd = forward primer; Rev = reverse primer; Nested = nested primer for PCR (internal primer); External = external primer for PCR.
Sequencing of the amplified PCR products was performed, using ABI 377 sequencer (Amersham Biosciences Inc). To facilitate cloning of the cDNAs/ genomic sequences, a 8-12 bp extension was added to the 5' of each primer. The primer extension includes an endonuclease restriction site. The restriction sites were selected using two 10 parameters: (a). The site did not exist in the cDNA sequence; and (b). The restriction sites in the forward and reverse primers were designed such that the digested cDNA is inserted in the sense formation into the binary vector utilized for transformation.
PCR products were digested with the restriction endonucleases (New England BioLabs Inc) according to the sites design in the primers (Table 13, above) and cloned 15 into binary vectors according to Table 14, below. RACE products were sequenced as described hereinbelow for BDL108, BDL 110 and BDL111.
Table 14
Restriction enzyme sites used to clone the identified genes into binary vector
Gene name | Binary vector | Restriction enzymes used for cloning into binary vectorFORWARD | Restriction enzymes used for cloning into binary vectorREVERSE | Restriction enzymes used for digesting the binary vector |
BDL42 | pBXYN | Sall | EcoRI | Sall, EcoRI |
BDL46 | pBXYN | Sall | Smal | Sall, Ecll36 |
BDL51 | pBXYN | Sall | EcoRI | Sall, EcoRI |
BDL52 | pBXYN | Sall | EcoRI | Sall, EcoRI |
BDL54 | pBXYN | Sall | EcoRI | Sall, EcoRI |
BDL56 | pBXYN | Sall | EcoRI | Sall, EcoRI |
BDL59 | pBXYN | Sall | EcoRI | Sall, EcoRI |
BDL60 | pBXYN | Sall | EcoRI | Sall, EcoRI |
BDL65 | pBXYN | Sall | Smal | Sall, Ecll36 |
BDL67 | pBXYN | Sall | Smal | Sall, Ecll36 |
BDL68 | pBXYN | Sall | Smal | Sall, Ecll36 |
BDL78 | pBXYN | Sall, | EcoRI | Sall, EcoRI |
BDL82 | pBXYN | Sall | EcoRI | Sall, EcoRI |
BDL89 | pBXYN | Sall | EcoRI | Sall, EcoRI |
BDL95 | pBXYN | Sall | EcoRI | Sall, EcoRI |
BDL100 | pBXYN | Sall | Sacl | Sall, Sacl |
WO 2009/141824
PCT/IL2009/000508
2018200117 05 Jan 2018
BDL106 | pBXYN | Sall | EcoRI | Sall, EcoRI |
BDL108 | pBXYN | Sall | EcoRI | Sall, EcoRI |
BDL110 | pBXYN | Sall | EcoRI | Sall, EcoRI |
BDL111 | pBXYN | EcoRV | EcoRV | Smal, Ecll36 |
BDL112 | pBXYN | Sall | EcoRI | Sall, EcoRI |
BDL114 | pBXYN | Sall | EcoRI | Sall, EcoRI |
BDL115 | pBXYN | Smal | SacI | Smal, SacI |
BDL116 | pBXYN | EcoRV | EcoRV | Smal, Ecll36 |
BDL119 | pBXYN | EcoRV | EcoRV | Smal, Ecll36 |
BDL120 | pBXYN | Sall | SacI | Sall, SacI |
BDL122 | pBXYN | Sall | EcoRI | Sall, EcoRI |
BDL123 | pBXYN | Sall | EcoRI | Sall, EcoRI |
BDL124 | pBXYN | EcoRV | EcoRV | Smal, Ecll36 |
BDL125 | pBXYN | Sall | EcoRI | Sall, EcoRI |
BDL128 | pBXYN | Sall | EcoRI | Sall, EcoRI |
BDL131 | pBXYN | Sall | EcoRI | Sall, EcoRI |
BDL132 | pBXYN | Sall | EcoRI | Sall, EcoRI |
BDL133 | pBXYN | EcoRV | EcoRV | Smal, Ecl 136 II |
BDL135 | pBXYN | Sall | EcoRI | Sall, EcoRI |
BDL136 | pBXYN | Sall | EcoRI | Sall, EcoRI |
BDL142 | pBXYN | Sall | EcoRI | Sall, EcoRI |
BDL143 | pBXYN | BamHI | Sall | Sall, Ecl 136II |
BDL144 | pBXYN | EcoRV | EcoRV | Smal, Ecl 136 II |
BDL145 | pBXYN | Sall | EcoRI | Sall, EcoRI |
BDL146 | pBXYN | Sall | EcoRI | Sall, EcoRI |
BDL148 | pBXYN | Sall | EcoRI | Sall, EcoRI |
BDL113 GA | pBXYN | SacI | Xbal | SacI, Xba I |
BDL127 GA | pBXYN | SacI | Xbal | SacI, Xba I |
BDL129 GA | pBXYN | SacI | Xbal | SacI, Xba I |
BDL130 GA | pBXYN | SacI | Xbal | SacI, Xba I |
BDL134 GA | pBXYN | SacI | Xbal | SacI, Xba I |
BDL137 GA | pBXYN | SacI | Xbal | SacI, Xba I |
BDL139 GA | pBXYN | SacI | Xbal | SacI, Xba I |
BDL141 GA | pBXYN | SacI | Xbal | SacI, Xba I |
Tab | le 14. |
Each digested PCR product was inserted into a high copy vector pBlue-script
KS plasmid vector [pBlue-script KS plasmid vector, Hypertext Transfer 5 Protocol://World Wide Web (dot) stratagene (dot) com/manuals/212205 (dot) pdf] or into plasmids originating from these vectors. In cases where the pGXN high copy vector (originated from pBlue-script KS) was used, the PCR product was inserted upstream to the NOS terminator (SEQ ID NO:776) originated from pBI 101.3 binary vector (GenBank Accession No. U12640, nucleotides 4356 to 4693, SEQ ID NO:776) and 10 downstream to the 35S promoter. In other cases (pKSJ_6669a), the At6669 promoter (SEQ ID NO:775) was already cloned into the pBlue-script KS so the gene was introduced downstream of the promoter (Table 15 below). In all cases, after
WO 2009/141824
PCT/IL2009/000508
2018200117 05 Jan 2018 confirmation of the sequence of the cloned genes, the cloned cDNA accompanied or not with the NOS terminator was introduced into the pGI binary vector [pBXYN containing the 35S CaMV promoter] according to Table 14, hereinabove, via digestion with an appropriate restriction endonucleases. In any case the insert was followed by single 5 copy of the NOS terminator (SEQ ID NO:776).
Table 15
Genes cloned from cDNA libraries or genomic DNA in a High copy number plasmid
Gene Name | High copy plasmid | Amplified from | Polynucleotide SEQ ID NO: | Polypeptide SEQ ID NO: | |
Organism | Origin | ||||
BDL42 | pGXN | Arabidopsis | mRNA | 692 | 86 |
BDL46 | pKS | Arabidopsis | mRNA | 693 | 87 |
BDL51 | pGXN | Arabidopsis | mRNA | 694 | 88 |
BDL52 | pGXN | Tomato | mRNA | 695 | 713 |
BDL54 | pGXN | Arabidopsis | mRNA | 696 | 90 |
BDL56 | pGXN | Arabidopsis | mRNA | 697 | 91 |
BDL59 | pGXN | Arabidopsis | mRNA | 698 | 92 |
BDL60 | pGXN | Arabidopsis | mRNA | 699 | 93 |
BDL65 | pKS | Arabidopsis | mRNA | 700 | 94 |
BDL67 | pKS | Arabidopsis | mRNA | 701 | 714 |
BDL68 | pKS | Arabidopsis | mRNA | 702 | 96 |
BDL78 | pGXN | Arabidopsis | mRNA | 703 | 97 |
BDL82 | pGXN | Arabidopsis | mRNA | 704 | 98 |
BDL89 | pGXN | Rice | mRNA | 705 | 99 |
BDL95 | pGXN | Rice | mRNA | 706 | 715 |
BDL100 | pGXN | Rice | mRNA | 657 | 707 |
BDL106 | pGXN | Canola | mRNA | 658 | 52 |
BDL108 | pGXN | Canola | mRNA | 659 | 708 |
BDL110 | pGXN | Canola | mRNA | 660 | 709 |
BDL111 | pKSJ 6669a | Canola | mRNA | 661 | 710 |
BDL112 | pGXN | Arabidopsis | mRNA | 662 | 56 |
BDL114 | pGXN | Arabidopsis | mRNA | 664 | 58 |
BDL115 | pKSJ | Arabidopsis | mRNA | 665 | 59 |
BDL116 | pKSJ 6669a | Arabidopsis | mRNA | 666 | 60 |
BDL119 | pKSJ_6669a | Arabidopsis | Genomic DNA | 667 | 711 |
BDL120 | pGXN | Arabidopsis | mRNA | 668 | 62 |
BDL122 | pGXN | Arabidopsis | mRNA | 669 | 63 |
BDL123 | pGXN | Arabidopsis | mRNA | 670 | 64 |
BDL124 | pKSJ 6669a | Arabidopsis | mRNA | 671 | 65 |
BDL125 | pGXN | Arabidopsis | mRNA | 672 | 66 |
BDL128 | pGXN | Arabidopsis | mRNA | 674 | 68 |
BDL131 | pGXN | Arabidopsis | mRNA | 677 | 71 |
BDL132 | pGXN | Arabidopsis | mRNA | 678 | 72 |
BDL133 | pKSJ 6669a | Arabidopsis | mRNA | 679 | 73 |
BDL135 | pGXN | Arabidopsis | mRNA | 681 | 75 |
BDL136 | pGXN | Arabidopsis | mRNA | 682 | 76 |
BDL142 | pGXN | Arabidopsis | mRNA | 686 | 80 |
WO 2009/141824
PCT/IL2009/000508
2018200117 05 Jan 2018
Gene Name | High copy plasmid | Amplified from | Polynucleotide SEQ ID NO : | Polypeptide SEQ ID NO: | |
Organism | Origin | ||||
BDL143 | pKSJ | Arabidopsis | mRNA | 687 | 81 |
BDL144 | pKSJ 6669a | Arabidopsis | mRNA | 688 | 82 |
BDL145 | pGXN | Arabidopsis | mRNA | 689 | 83 |
BDL146 | pGXN | Arabidopsis | mRNA | 690 | 84 |
BDL148 | pGXN | Arabidopsis | mRNA | 691 | 85 |
BDL113 GA | pGA4 | Synthetic | GeneArt | 663 | 57 |
BDL127_GA | pCR4BluntTOPO | Synthetic | GeneArt | 673 | 67 |
BDL129 GA | pGA4 | Synthetic | GeneArt | 675 | 69 |
BDL130 GA | pGA14 | Synthetic | GeneArt | 676 | 712 |
BDL134 GA | pGA4 | Synthetic | GeneArt | 680 | 74 |
BDL137 GA | pGA18 | Synthetic | GeneArt | 683 | 77 |
BDL139 GA | pGA15 | Synthetic | GeneArt | 684 | 78 |
BDL141 GA | pGA4 | Synthetic | GeneArt | 685 | 79 |
Table 15: Cloned and synthetic genes are provided along with the sequence identifiers of their polynucleotides and polypeptides. Also provided are the source organism, tissue and the cloning vectors.
The digested products and the linearized plasmid vector were ligated using T4
DNA ligase enzyme (Roche, Switzerland). The plasmid pPI was constructed by inserting a synthetic poly-(A) signal sequence, originating from pGL3 basic plasmid vector (Promega, Acc No U47295; bp 4658-4811) into the Hindlll restriction site of the binary vector pBI101.3 (Clontech, Acc. No. U12640). pGI (Figure 3) is similar to pPI, but the original gene in the backbone, the GUS gene, was replaced by the GUS-Intron gene followed by the NOS terminator (SEQ ID NO:776) (Vancanneyt. G, et al MGG 220, 245-50,1990). pGI was used to clone the polynucleotide sequences, initially under the control of 35S promoter [Odell, JT, et al. Nature 313, 810 - 812 (28 February 1985); SEQ ID NO:777.
Selected DNA sequences were synthesized by a commercial supplier GeneArt, 15 GmbH [Hypertext Transfer Protocol://World Wide Web (dot) geneart (dot) com/)].
Synthetic DNA is designed in silico. Suitable restriction enzymes sites were added to the cloned sequences at the 5' end and at the 3' end to enabled later cloning into the pBXYN binary downstream of the CaMV 35S promoter (SEQ ID NO: 777).
Optimization of genes for expression in dicotyledonous plants - To optimize 20 the coding sequence (in silico design), codon-usage Tables calculated from plant transcriptoms were used [example of such Tables can be found in the Codon Usage Database available online at Hypertext Transfer Protocol ://World Wide Web (dot) kazusa (dot) or (dot) jp/codon/]. The optimized coding sequences were designed in a way that no changes are introduced in the encoded amino acid sequence (of selected
WO 2009/141824
PCT/IL2009/000508
2018200117 05 Jan 2018 polypeptides from Table 1, Example 1) while using codons preferred for expression in dicotyledonous plants mainly Arabidopsis, Tomato, Canola and Soya while avoiding rare codons for Arabidopsis; and monocotyledonous plants such as maize. Such optimized sequences promote better translation rate and therefore higher protein 5 expression levels. The genes for which codon optimized synthetic (artificial) sequences were prepared are: BDL-113 (SEQ ID NO:663 polynucleotide, SEQ ID NO:57 polypeptide), BDL-127 (SEQ ID NO:673 polynucleotide, SEQ ID NO:67 polypeptide), BDL-129 (SEQ ID NO:675 polynucleotide, SEQ ID NO:69 polypeptide), BDL-130 (SEQ ID NO:676 polynucleotide, SEQ ID NO:712 polypeptide), BDL-134 (SEQ ID 10 NO:680 polynucleotide, SEQ ID NO:74 polypeptide), BDL-137 (SEQ ID NO:683 polynucleotide, SEQ ID NO:77 polypeptide), BDL-139 (SEQ ID NO:684 polynucleotide, SEQ ID NO:78 polypeptide), BDL-141 (SEQ ID NO:685 polynucleotide, SEQ ID NO:79 polypeptide).
Several polynucleotide sequences of the selected genes were cloned 15 downstream of the CaMV 35S promoter (SEQ ID NO:777), the Arabidopsis At6669 promoter (SEQ ID NO:775) or the Napin seed specific promoter (SEQ ID NO:778).
The Napin (SEQ ID NO:778) promoter, which originates from Brassica napus, is characterized by a seed specific promoter activity [Stuitje A. R. et. al. Plant Biotechnology Journal 1 (4): 301-309]. The Napin promoter was amplified by direct 20 PCR on genomic DNA extracted from leaf tissue [using the DNAeasy kit (Qiagen Cat.
No. 69104)] using the following PCR primers: Napin F Hind\W 5'ATAAGCTTATTGATTCCTTTAAAGACTTATGTT (SEQ ID NO:993) and Napin R Sall 5'- TCGTCGACGGGTGTATGTTTTTAATCTTGTTT (SEQ ID NO:994). An example of a gene cloned downstream of the Napin promoter sequence is BDL65 (SEQ 25 ID NO:700).
For 9 genes, namely BDL52, BDL67, BDL95, BDL100, BDL108, BDL110, BDL111, BDL119 and BDL130, the protein translation of the amplified cDNA sequence did not match the initial bioinformatics prediction of the protein sequences. The polypeptide sequences encoded by the cloned and their sequence identifiers are as 30 follows: BDL52 (SEQ ID NO:713), BDL67 (SEQ ID NO:714), BDL95 (SEQ ID NO:715), BDL100 (SEQ ID NO:707), BDL108 (SEQ ID NO:708), BDL110 (SEQ ID NQ:709), BDL111 (SEQ ID NQ:710), BDL119 (SEQ ID NO:711) and BDL130 (SEQ
WO 2009/141824
PCT/IL2009/000508
2018200117 05 Jan 2018
ID NO:712). Note that the BDL119 gene is predicted to be a non-coding RNA (e.g., a regulatory RNA). The BDL119 polynucleotide was cloned from a genomic DNA and BDL119 cDNA is provided in SEQ ID NO:667.
EXAMPLE 5
PRODUCING TRANSGENIC ARABIDOPSIS PLANTS EXPRESSING THE IDENTIFIED POLYNUCLEOTIDES OF THE INVENTION
Materials and Experimental Methods
Plant transformation - The Arabidopsis thaliana var Columbia (To plants) were transformed according to the Floral Dip procedure [Clough SJ, Bent AF. (1998) Floral dip: a simplified method for Agrobacterium-mediated transformation of Arabidopsis thaliana. Plant J. 16(6): 735-43; and Desfeux C, Clough SJ, Bent AF. (2000) Female reproductive tissues are the primary targets of Agrobacterium-mediated transformation by the Arabidopsis floral-dip method. Plant Physiol. 123(3): 895-904] with minor modifications. Briefly, Arabidopsis thaliana Columbia (ColO) To plants were sown in 250 ml pots filled with wet peat-based growth mix. The pots were covered with aluminum foil and a plastic dome, kept at 4 °C for 3-4 days, then uncovered and incubated in a growth chamber at 18-24 °C under 16/8 hours light/dark cycles. The To plants were ready for transformation six days before anthesis.
Single colonies of Agrobacterium carrying the binary vectors harboring the seed oil genes were cultured in LB medium supplemented with kanamycin (50 mg/L) and gentamycin (50 mg/L). The cultures were incubated at 28 °C for 48 hours under vigorous shaking and centrifuged at 4000 rpm for 5 minutes. The pellets comprising Agrobacterium cells were resuspended in a transformation medium which contained half-strength (2.15 g/L) Murashige-Skoog (Duchefa); 0.044 μΜ benzylamino purine (Sigma); 112 pg/L B5 Gambourg vitamins (Sigma); 5 % sucrose; and 0.2 ml/L Silwet L-77 (OSI Specialists, CT) in double-distilled water, at pH of 5.7.
Transformation of To plants was performed by inverting each plant into an Agrobacterium suspension such that the above ground plant tissue was submerged for 30 3-5 seconds. Each inoculated To plant was immediately placed in a plastic tray, then covered with clear plastic dome to maintain humidity and was kept in the dark at room temperature for 18 hours to facilitate infection and transformation. Transformed
WO 2009/141824
PCT/IL2009/000508
2018200117 05 Jan 2018 (transgenic) plants were then uncovered and transferred to a greenhouse for recovery and maturation. The transgenic To plants were grown in the greenhouse for 3-5 weeks until siliques were brown and dry, then seeds were harvested from plants and kept at room temperature until sowing.
For generating Ti and T2 transgenic plants harboring the genes, seeds collected from transgenic To plants were surface-sterilized by soaking in 70 % ethanol for 1 minute, followed by soaking in 5 % sodium hypochlorite and 0.05 % triton for 5 minutes. The surface-sterilized seeds were thoroughly washed in sterile distilled water then placed on culture plates containing half-strength Murashig-Skoog (Duchefa); 2 % sucrose; 0.8 % plant agar; 50 mM kanamycin; and 200 mM carbenicylin (Duchefa).
The culture plates were incubated at 4 °C for 48 hours then transferred to a growth room at 25 °C for an additional week of incubation. Vital Ti Arabidopsis plants were transferred to a fresh culture plates for another week of incubation. Following incubation the Ti plants were removed from culture plates and planted in growth mix 15 contained in 250 ml pots. The transgenic plants were allowed to grow in a greenhouse to maturity. Seeds harvested from Ti plants were cultured and grown to maturity as T2 plants under the same conditions as used for culturing and growing the Ti plants.
EXAMPLE 6
IDENTIFICA TION OF NOVEL PROMOTERS
Constitutive promoters allow continuous expression of genes regulated thereby throughout the plant. A widely used example for a constitutive promoter is the CaMV35S promoter from cauliflower mosaic virus (SEQ ID NO:777).
One of the important requirements for an engineered plant is to activate the 25 gene-of-interest in the right tissue or organ, and/or at the appropriate time (e.g., a certain developmental stage, under certain environmental conditions). For example, in order to influence a unique tissue such as seed, the gene-of-interest may be induced for expression (activated) at a certain developmental stage such as pre embryo fertilization, post fertilization, early or late embryogenesis. For example, to improve yield and/or oil 30 content of a plant, the expression of the gene-of-interest may be regulated by a promoter having an expression pattern appropriate for seed development. Thus, the combination of a target gene with specific promoters such as developmental specific promoter (such
WO 2009/141824
PCT/IL2009/000508
2018200117 05 Jan 2018 as seed, carpel, stem, seedling) may increase the desired effect of the gene (e.g., improve yield and/or oil content) and may avoid undesired influence of the gene on other biological processes in other tissues, for example, cell structure, plant architecture.
The present inventors have isolated and validated novel developmental specific promoters from different stages of plant development and/or plant tissues, having different levels of gene expression. The following description summarizes the process of selection and cloning of the novel Arabidopsis promoters.
Cloning and analysis of promoters - The novel Arabidopsis promoters of the invention were selected based on the expression profile of the native genes positioned 10 downstream (3’) to the promoter sequences (see Table 16, below).
Table 16
Expression profile based on microarray analysis
Gene 3' to the promoter | AT1G3086 0 | AT2G311 60 | AT2G39 640 | AT3G21380 | AT3G24 510 | AT3G61 040 | AT4G15 975 |
Description of gene product | expressed protein | Protein of unknown function (DUF640) | Glycosy 1 hydrolas e family 17 protein | similar to jacalin lectin family protein [Arabidopsis thaliana] (TAIR:Atlg52 040.1) | Encodes a defensin -like (DEFL) family protein | cytochro me P450 family protein | Zinc finger, C3HC4 type (RING finger) |
Specificity/ normalized expression level | Seed | Stem | Seed | Seed | Carpel | Seed | Seedling |
carpels | 28.89 | 6.89 | 35.03 | 50.33 | 462.3 | 23.75 | 16.29 |
cauline | 58.82 | 26.06 | 18.62 | 8.48 | 4 | 40.36 | 4 |
cotyledons | 27.56 | 35.91 | 30.1 | 4 | 4.59 | 36.86 | 39.32 |
flower | 21.59 | 97.92 | 35.48 | 32.46 | 23.73 | 26.94 | 18.92 |
hypocotyl | 48.59 | 782.8 | 30.62 | 31.39 | 6.32 | 27.57 | 31.21 |
inflorescen ce | 23.93 | 643.83 | 24.23 | 39.18 | 4 | 32.95 | 4 |
leaf | 9.61 | 41.3 | 25 | 7.73 | 5.95 | 42.8 | 23.3 |
pedicels | 4 | 12.22 | 22.78 | 13.35 | 4.12 | 39.68 | 20.16 |
petals | 4 | 16 | 41.7 | 14 | 4.48 | 36.9 | 17.2 |
petiole | 4 | 174.5 | 15.23 | 20.1 | 4 | 55.57 | 28.04 |
pollen | 56.49 | 16.3 | 36.44 | 19.85 | 4 | 16.31 | 20.17 |
root | 20 | 91.6 | 39 | 38.2 | 6.91 | 35.8 | 19.3 |
rosette | 8.19 | 37.84 | 26.28 | 17.49 | 4.78 | 33.78 | 27.05 |
seed | 1172.9 | 52.49 | 30.41 | 1702.9 | 10.89 | 1186.5 | 24.34 |
seedling | 16.78 | 65.72 | 30.6 | 19.9 | 6.92 | 37.95 | 81.98 |
sepals | 77.8 | 19.3 | 30 | 9.09 | 4 | 53.9 | 13.2 |
shoot | 19.22 | 631.3 | 26.5 | 34.29 | 4.84 | 26.34 | 21.36 |
siliques | 61.36 | 60.56 | 132.9 | 16.83 | 698.8 | 39.27 | 22.16 |
WO 2009/141824
PCT/IL2009/000508
2018200117 05 Jan 2018
Gene 3' to the promoter | AT1G3086 0 | AT2G311 60 | AT2G39 640 | AT3G21380 | AT3G24 510 | AT3G61 040 | AT4G15 975 |
stamen | 66.15 | 17.04 | 32.04 | 62.88 | 4 | 20.98 | 21.67 |
stem | 24.18 | 449.5 | 18.17 | 15.99 | 6.77 | 38.93 | 5.62 |
Table 16. Provided are the results of a microarray expression profile of genes (GenBank
Accession NOs.) positioned 3' of the identified promoters. Shown are the tissue specificity of the promoters and the normalized expression levels of each gene in the specific tissue.
Table 17, hereinbelow, provides the sequence identifiers of the novel promoters of the invention, along with the sequence identifiers of the genes and the polypeptides encoded thereby positioned downstream of the novel promoters of the invention.
Table 17
Identification of novel promoters
Promoter designation (SEQ ID NO:) | The polynucleotides (GenBank Accession Nos. and SEQ ID NO:) positioned downstream of the identified promoters | The polypeptides (GenBank Accession Nos. and SEQ ID NO:) encoded by the polynucleotides positioned downstream of the identified promoters | Promoter length (bp) |
PrBDL40 L (SEQ ID NO:779) | AT1G30860 (SEQ ID NO:793) | AT1G3O86O_P1 SEQ ID NO:800 | 2970 |
PrBDL40 S (SEQ ID NO:780) | AT1G30860 (SEQ ID NO:793) | AT1G3O86O_P1 SEQ ID NO:800 | 2238 |
PrBDL34 L (SEQ ID NO:781) | AT2G31160 (SEQ ID NO:794) | AT2G31160_Pl SEQ ID NO:801 | 3097 |
PrBDL34 S (SEQ ID NO:782) | AT2G31160 (SEQ ID NO:794) | AT2G3116O_P1 SEQ ID NO:801 | 3000 |
PrBDL36 L (SEQ ID NO:783) | AT2G39640 (SEQ ID NO:795) | AT2G3964O_P1 SEQ ID NO:802 | 2889 |
PrBDL36 S (SEQ ID NO:784) | AT2G39640 (SEQ ID NO:795) | AT2G3964O_P1 SEQ ID NO:802 | 831 |
PrBDL38 L (SEQ ID NO:785) | AT3G21380 (SEQ ID NO:796) | AT3G2138O_P1 SEQ ID NO:803 | 3000 |
PrBDL38 S (SEQ ID NO:786) | AT3G21380 (SEQ ID NO:796) | AT3G2138O_P1 SEQ ID NO:803 | 880 |
PrBDL37 L (SEQ ID NO.-787) | AT3G24510 (SEQ ID NO:797) | AT3G2451O_P1 SEQ ID NO:804 | 3000 |
PrBDL37 S (SEQ ID NO:788) | AT3G24510 (SEQ ID NO:797) | AT3G2451O_P1 SEQ ID NQ:804 | 1423 |
WO 2009/141824
PCT/IL2009/000508
2018200117 05 Jan 2018
Promoter designation (SEQ ID NO .) | The polynucleotides (GenBank Accession Nos. and SEQ ID NO:) positioned downstream of the identified promoters | The polypeptides (GenBank Accession Nos. and SEQ ID NO:) encoded by the polynucleotides positioned downstream of the identified promoters | Promoter length (bp) |
PrBDL39 L (SEQ ID NO:789) | AT3G61040 (SEQ ID NO:798) | AT3G61040_Pl SEQ ID NO:805 | 3000 |
PrBDL39 S (SEQ ID NO:790) | AT3G61040 (SEQ ID NO:798) | AT3G61040 P1 SEQ ID NO:805 | 1159 |
PrBDL35 L (SEQ ID NO:791) | AT4G15975 (SEQ ID NO:799) | AT4G15975_P1 SEQ ID NO:806 | 2881 |
PrBDL35 S (SEQ ID NO:792) | AT4G15975 (SEQ ID NO:799) | AT4G15975_P1 SEQ ID NQ:806 | 942 |
Table 17. Provided are the identified promoters, their length and sequence identifiers along with the genes found downstream to the promoters.
Construction ofpromoter: :GUS fusion nucleic acid construct for analysis of expression pattern of the identified promoters — For cloning of each of the promoter sequences two sets of primers that span the predicted promoter sequence were designed. The short sequence of the promoter was amplified using a 3' primer sequence selected near the start codon of the coding sequence of the downstream gene (which is located downstream to the promoter sequences) and a 5' primer sequence selected from the 10 sequence that is downstream to the adjacent upstream gene. The long sequence of the promoter was using a 3' primer sequence selected from the start of the untranslated region (5TJTR) of the gene downstream of the promoter and a 5' primer sequence located 3 kb upstream of the 3' primer (See Table 18, below). Each promoter sequences was translationally fused to the GUS coding sequence (a reporter gene).
All sequences were amplified by PCR. The PCR products were purified using
Mini Elute PCR purification kit (Qiagen) and sequencing of the amplified PCR products was performed, using ABI377 sequencer (Applied Biosystems). To facilitate cloning of the promoter sequences, a 8-12 bp extension was added to the 5’ of each primer. The primer extension includes an endonuclease restriction site. The restriction sites are 20 selected using two parameters: a.) The site does not exist in the promoter sequence, b.) The restriction sites in the forward and reverse primers are designed so the digested genomic DNA is inserted in the sense formation into the binary vector utilized for transformation. For instance, the pGI plasmid vector was constructed by inserting a
WO 2009/141824
PCT/IL2009/000508
2018200117 05 Jan 2018 synthetic poly-(A) signal sequence, originating from pGL3 basic plasmid vector (Promega, Acc. No. U47295; bp 4658-4811) into the Hindil! restriction site of the binary vector pBI101.3 (Clontech, Acc. No. U12640) and GUS-Intron gene (Vancanneyt. G, et al MGG 220, 245-50, 1990). Another plasmid vector used for 5 cloning was the pMBLArt (Gleave AP. Plant Mol Biol. 1992 Dec;20(6): 1203-7).
The digested PCR products were first subcloned into pBlue-script KS [(originated from the pBlue-script KS plasmid vector www.stratagene.com/manuals/212205.pdf)] followed by cloning into pGI binary vector with the GUS-Intron gene (Vancanneyt. G, et al MGG 220, 245-50, 1990) and the NOS 10 terminator originated from pBI 101.3 binary vector (GenBank Accession No. U12640;
GI.529333 nucleotides 4356 to 4693, SEQ ID NO:776). Some of the PCR products were first sublcloned pBlue-script KS [(originated from the pBlue-script KS plasmid vector www.stratagene.com/manuals/212205.pdf)] with the GUS-Intron gene (Vancanneyt. G, et al MGG 220, 245-50,1990) and the NOS terminator originated from 15 pBI 101.3 binary vector followed by cloning the entire cassette into the binary vector pMBLArt (according to Table 19). The digested PCR product and the linearized plasmid vector were ligated using T4 DNA ligase enzyme (Roche, Switzerland). The primers used for cloning are provided in Table 18.
Table 18
Primers used for the cloning of the novel promoters
Promoter Name | Restriction Enzymes used for cloning | Primers used for amplification/SEQ ID NO: |
PrBDL34_L | PstI, Sall | Fwd: PrBDL34 EF PstI - ATCTGCAGGAAATTGGAAAAGGGTTTAAC/SEQ ID NO.-995 |
Rev: PrBDL34 ER Sall- ATTGTCGACGATTAGTTCTTGATTCITGATCTTTC/SEQ ID NO:996 | ||
PrBDL35 L | Hindlll, Sall | Fwd: PrBDL 35 F Hindlll - ATAAAGCTTCATTGACTTGAGATTCAGTTCATG /SEQ ID NO:997 |
Rev: PrBDL 35 R Sall ATTGTCGACAGAGAAGTGAATGAAGATTTTAGG /SEQ ID NO:98 | ||
PrBDL36 L | Sall, Xbal | Fwd: PrBDL 36 F Sall AATGTCGACCGAATCAATACGTAACTTTCAATC /SEQ ID NO:999 |
Rev: PrBDL 36 R XbaI - |
WO 2009/141824
PCT/IL2009/000508
2018200117 05 Jan 2018
Promoter Name | Restriction Enzymes used for cloning | Primers used for amplificationjSEQ ID NO: |
TATCTAGATGCITrGITrrGTTTTGTTTTG /SEQ ID N0:1000 | ||
PrBDL37_S | Hindlll, Sall | Fwd: PrBDL37 Short F Hindlll ACTAAGCTTGACTTGATACTAACGAGGAAATG /SEQ ID NO:001 |
Rev: PrBDL37 Short R Sall - TGTGTCGACnTCAAATTTITAGAATGGGAG /SEQ ID NO.-1002 | ||
PrBDL38_S | PstI, Sall | Fwd: PrBDL38 Short Fl PstI- AACTGCAGAGCTCACGAGTGTGTTTTTGG /SEQ ID NO.1003 |
Rev: PrBDL38 Short R Sall- ATTGTCGACTGTATCTGATCATATCTTACCGG / SEQ ID NO: 1004 | ||
PrBDL39 L | Hindlll, Smal | Fwd: PrBDL 39 F Hindlll - ATTAAGCTTCCTGCAACAATGATTTAITATG /SEQ ID NO:1005 |
Rev: PrBDL 39 R Smal TCCCGGGCTAATATTATGCACGCTTCGTC /SEQ ID NO.T006 | ||
PrBDL40L | Hindlll, Sall | Fwd: PrBDL 40 F Hindlll- TATAAGCTTCATCTCGGACTTGATATCGTC /SEQ ID NO.-1007 |
Rev: PrBDL 40 R Sall 1 - ATTGTCGACGAATCGAACAAACGAACATAAA /SEQ IDNQ:1008 |
Table 18.
Table 19, hereinbelow, provides the cloning vectors used to clone each of the identified promoters.
Table 19
Promoters cloned into different binary vectors
Promoter | Cloned In pGI | Cloned In pMBLArt |
PrBDL40 L | V | |
PrBDL34 L | V | |
PrBDL36 L | V | |
PrBDL38 S | V | |
PrBDL37 S | V | |
PrBDL39 L | V | |
PrBDL35 L | V |
Table 19: Provided are the promoter designations (sequence identifiers are given in Table 17, above) and the vectors used for their cloning. V indicates that the promoter was cloned in the noted vector.
WO 2009/141824
PCT/IL2009/000508
2018200117 05 Jan 2018
Constructs were transformed into Arabidopsis plants as described in Example 5 above and expression analysis based on the monitoring the expression level of the GUS gene (GUS staining) was performed essentially as described in Jefferson RA. et. al. 1987 EMBO J 6 (13), 3901-3907; and Meissner et. al. 2000 Plant Journal 22 (3), 5 265-274.
The level of GUS staining was determined according to the intensity of the blue color. Table 20, below, provides the coloring level of GUS staining.
Table 20
Coloring level | |
no color | 0 |
medium - | 2 |
medium dark | 3 |
medium + | 4 |
darkest | 5 |
Table 20: The index of blue color intensity.
Table 21, hereinbelow, describes the expression pattern of the cloned 15 promoters.
Table 21
Expression pattern of developmental stage promoters
Promoter | Promoter SEQ ID NO: | Event | Small flowers | Large flowers | Leaves | Stalk | Siliques |
pMBL GI | 777 | 5681.1 | 4-5 | 2 | 3 | 2-5 | 2-5 |
pMBL GI | 777 | 5681.2 | 4-5 | 2 | 2-3 | 2-5 | 3-5 |
pMBL GI | 777 | 5681.3 | 4-5 | 2 | 3 | 2-5 | 2-5 |
pMBL GI | 777 | 5681.4 | 4-5 | 2 | 3 | 3-5 | 3-5 |
pMBL GI | 777 | 5681.5 | 4-5 | 2 | 3 | 2-5 | 2-5 |
pM PrBDL 40 YN | 779 | 6552.1 | 0 | 0 | 1 | 1-3 | 1 |
pM PrBDL 40 YN | 779 | 6552.2 | 0 | 0 | 1 | 0-2 | 0 |
pM PrBDL 40 YN | 779 | 6552.3 | 3 | 3 | 3 | 3 | 3 |
pM PrBDL 40 YN | 779 | 6552.4 | 0 | 5 | 1 | 5 | 0 |
pM PrBDL 40 YN | 779 | 6554.1 | 0 | 0 | 0 | 0-1 | 0 |
pM PrBDL 40 YN | 779 | 6554.2 | 1 | 4 | 0-5 | 3 | 0 |
WO 2009/141824
PCT/IL2009/000508
2018200117 05 Jan 2018
Promoter | Promoter SEQ ID NO: | Event | Small flowers | Large flowers | Leaves | Stalk | Siliques |
pM PrBDL 40 YN | 779 | 6554.3 | 0 | 4 | 0-5 | 5 | 0 |
pM_PrBDL 40 YN | 779 | 6554.4 | 0 | 1-2 | 0-2 | 0 | 0 |
pM PrBDL 39 YN | 789 | 6501.1 | 0 | 0 | 0 | 0 | 0 |
pM PrBDL 39 YN | 789 | 6501.2 | 1 | 0 | 0 | 0 | 0 |
pM PrBDL 39 YN | 789 | 6501.3 | 0 | 0 | 0 | 0 | 0 |
pM PrBDL 39 YN | 789 | 6501.4 | 0 | 0 | 0 | 0 | 0 |
pM PrBDL 39 YN | 789 | 6501.5 | 0 | 0 | 0 | 0 | 0 |
pM PrBDL 39 YN | 789 | 6502.1 | 0 | 0 | 0 | 0 | 0 |
pM PrBDL 39 YN | 789 | 6502.2 | 0 | 0 | 0 | 0 | 0 |
pM PrBDL 39 YN | 789 | 6502.3 | 0 | 0 | 0 | 0 | 0 |
pM PrBDL 39 YN | 789 | 6502.4 | 0 | 0 | 0 | 0 | 0 |
pM PrBDL 39 YN | 789 | 6502.5 | 0 | 0 | 0 | 0 | 0 |
pM PrBDL 35 YN | 791 | 6512.1 | 0 | 0 | 0 | 0 | 0 |
pM PrBDL 35 YN | 791 | 6512.2 | 0 | 0 | 0 | 0 | 0 |
pM PrBDL 35 YN | 791 | 6512.3 | 0 | 0 | 0 | 0 | 3 |
pM PrBDL 35 YN | 791 | 6512.4 | 0 | 0 | 0 | 0 | 0 |
pM PrBDL 35 YN | 791 | 6512.5 | 0 | 0 | 0 | 0 | 0 |
pM PrBDL 35 YN | 791 | 6511.1 | 0 | 0 | 0 | 0 | 0 |
pM PrBDL 35 YN | 791 | 6511.2 | 0 | o | 0 | 0 | 3-5 |
pM PrBDL 35 YN | 791 | 6511.3 | 0 | 0 | 0 | 0 | 1-2 |
pM PrBDL 35 YN | 791 | 6511.4 | 0 | 0 | 0 | 0 | 0 |
pM PrBDL 35 YN | 791 | 6511.5 | 0 | 0 | 0 | 0 | 0 |
WT | 0 | 0 | 0 | 0 | 0 |
Table 21. “pM” or “pMBL” refer to the binary vector pMBLArt which includes the CaMV35S promoter (SEQ ID NO:777). “Y” or “GI” refer to GUS intron. “N” refers to NOS terminator. pMBL_GI serves as a positive control. PrBDL40 = SEQ ID NO;779 (L); PrBDL39 = SEQ ID NO:789 (L)); PrBDL35 = SEQ ID NO:791 (L)
WO 2009/141824
PCT/IL2009/000508
2018200117 05 Jan 2018
100
These results demonstrate that the novel promoters of the invention are capable of directing expression of a heterologous polynucleotide in a host cell in a tissue specific and/or developmental stage-specific manner.
EXAMPLE 7
IMPROVED TRANSGENIC PLANT PERFORMANCE
To analyze the effect of expression of the isolated polynucleotides in plants, plants were grown in pots with an adequate amount of nutrients and water. The plants were analyzed for their overall size, growth rate, time to inflorescence emergence (bolting) and flowering, seed yield, weight of 1,000 seeds, dry matter and harvest index 10 [(HI) seed yield/ dry matter]. Transgenic plants performance was compared to control plants grown in parallel under the same conditions. Mock- transgenic plants with an empty vector or expressing the uidA reporter gene (GUS-Intron) under the same promoter were used as control.
Parameters were measured as described in Example 3 above.
Statistical analyses - Plant growth rate, plant area, time to bolt, time to flower, weight of 1,000 seeds, seed yield, oil yield, dry matter, and harvest index area data were analyzed using t-test. To identify outperforming genes and constructs, results from mix of transformation events or independent events were analyzed. For gene versus control analysis t- test was applied, using significance of p < 0.1. The JMP statistics software package was used (Version 5.2.1, SAS Institute Inc., Cary, NC, USA).
Experimental Results
Plants expressing the polynucleotides of the invention were assayed for a number of commercially desired traits. Table 22 provides the parameters measured in a tissue culture assay (results are presented in Table 23).
Table 22
Parameter symbol used in result Table 23 | Parameter name |
1 | Leaf Area time point 1 |
2 | Leaf Area time point 2 |
3 | Leaf Area time point 3 |
4 | Roots Length time point 1 |
5 | Roots Length time point 2 |
6 | Roots Length time point 3 |
WO 2009/141824
PCT/IL2009/000508
2018200117 05 Jan 2018
101
Parameter symbol used in result Table 23 | Parameter name |
7 | Roots Coverage time point 1 |
8 | Roots Coverage time point 2 |
9 | Roots Coverage time point 3 |
10 | RGR of Leaf Area time point 2 |
11 | RGR of Leaf Area time point 3 |
12 | RGR of Roots Coverage time point 2 |
13 | RGR of Roots Coverage time point 3 |
14 | RGR of Roots Length time point 2 |
15 | RGR of Roots Length time point 3 |
16 | Fresh Weight |
17 | Dry Weight |
Table 22. RGR = relative growth rate.
Analysis of plants in tissue culture assay - Table 23, hereinbelow, depicts analyses of seed yield in plants overexpressing the polynucleotides of the invention 5 under the regulation of the constitutive 35S (SEQ ID NO:777) or At6669 (SEQ ID NO:775) promoters. In cases where a certain event appears more than once, the event was tested in several independent experiments.
Table 23
Results obtained in a tissue culture assay
Gene | Ev. | Par. | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 | 16 | 17 |
BDL 100 | 7872. 2 | P | 0.10 | 0.07 | 0.34 | 0.17 | |||||||||||||
BDL 100 | 7872. 2 | Av | 1.15 | 1.77 | 1.24 | 1.40 | |||||||||||||
BDL 100 | 7872. 3 | P | 0.22 | 0.19 | 0.01 | ||||||||||||||
BDL 100 | 7872. 3 | Av | 1.10 | 1.46 | 1.63 | ||||||||||||||
BDL 100 | 7873. 2 | P | 0.16 | 0.75 | 0.02 | 0.51 | 0.01 | ||||||||||||
BDL 100 | 7873. 2 | Av | 1.12 | 1.13 | 1.94 | 1.17 | 1.75 | ||||||||||||
BDL 100 | 7873. 3 | P | 0.24 | 0.09 | 0.01 | ||||||||||||||
BDL 100 | 7873. 3 | Av | 1.16 | 1.47 | 1.76 | ||||||||||||||
BDL 100 | 7873. 4 | P | 0.20 | 0.06 | 0.16 | 0.01 | 0.06 | ||||||||||||
BDL 100 | 7873. 4 | Av | 1.12 | 1.25 | 1.22 | 1.17 | 1.12 |
WO 2009/141824
PCT/IL2009/000508
2018200117 05 Jan 2018
102
Gene | Ev. | Par. | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 | 16 | 17 |
BDL 108 | 8122. 1 | P | 0.20 | 0.24 | 0.50 | 0.11 | |||||||||||||
BDL 108 | 8122. 1 | Av | 1.38 | 1.35 | 1.32 | 1.58 | |||||||||||||
BDL 108 | 8122. 2 | P | 0.09 | 0.09 | 0.12 | ||||||||||||||
BDL 108 | 8122. 2 | Av | 1.83 | 1.47 | 1.27 | ||||||||||||||
BDL 108 | 8123. 5 | P | 0.77 | 0.32 | |||||||||||||||
BDL 108 | 8123. 5 | Av | 1.13 | 1.31 | |||||||||||||||
BDL 108 | 8123. 6 | P | |||||||||||||||||
BDL 108 | 8123. 6 | Av | |||||||||||||||||
BDL 110 | 8092. 1 | P | 0. 05 | 0. 4 1 | 0.13 | 0.42 | 0.31 | 0.31 | |||||||||||
BDL 110 | 8092. 1 | Av | 1. 23 | 1. 1 3 | 1.39 | 1.16 | 1.15 | 1.33 | |||||||||||
BDL 110 | 8092. 2 | P | 0.35 | 0.22 | 0.13 | 0.18 | 0.04 | ||||||||||||
BDL 110 | 8092. 2 | Av | 1.22 | 3.01 | 1.25 | 2.69 | 1.33 | ||||||||||||
BDL 110 | 8092. 5 | P | 0. 0 0 | 0. 01 | 0. 00 | 0.01 | 0.18 | 0.16 | 0.11 | 0.33 | 0.01 | ||||||||
BDL 110 | 8092. 5 | Av | 1. 8 6 | 1. 30 | 1. 53 | 1.40 | 2.04 | 1.58 | 2.58 | 1.11 | 2.24 | ||||||||
BDL 110 | 8095. 2 | P | 0. 0 0 | 0.05 | 0.22 | 0.00 | 0.03 | 0.10 | |||||||||||
BDL 110 | 8095. 2 | Av | 1. 5 3 | 1.47 | 1.23 | 1.62 | 1.40 | 1.56 | |||||||||||
BDL 110 | 8722. 3 | P | 0.07 | 0.01 | 0.22 | 0.05 | 0.06 | 0.16 | |||||||||||
BDL 110 | 8722. 3 | Av | 1.36 | 2.31 | 1.14 | 2.47 | 1.28 | 1.47 | |||||||||||
BDL 114 | 7741. 3 | P | 0.07 | 0.66 | 0.01 | 0.01 | 0.02 | 0.15 | |||||||||||
BDL 114 | 7741. 3 | Av | 1.51 | 1.17 | 1.84 | 1.51 | 1.75 | 1.37 | |||||||||||
BDL 114 | 7741. 6 | P | 0. 2 4 | 0. 3 4 | 0. 6 4 | 0.00 | 0.25 | ||||||||||||
BDL 114 | 7741. 6 | Av | 1. 1 4 | 1. 2 2 | 1. 1 3 | 1.40 | 1.23 | ||||||||||||
BDL 114 | 7742. 1 | P | 0. 3 6 | 0. 2 6 | 0. 1 9 | 0.62 | 0.14 | 0.06 | 0.51 |
WO 2009/141824
PCT/IL2009/000508
2018200117 05 Jan 2018
103
Gene | Ev. | Par. | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 75 | 16 | 17 |
BDL 114 | 7742. 1 | Av | 1. 1 2 | 1. 1 5 | 1. 3 2 | 1.14 | 1.29 | 1.49 | 1.16 | ||||||||||
BDL 114 | 7742. 3 | P | 0.17 | 0.69 | 0.08 | 0.09 | 0.08 | 0.01 | |||||||||||
BDL 114 | 7742. 3 | Av | 1.28 | 1.24 | 2.68 | 2.00 | 2.89 | 1.80 | |||||||||||
BDL 114 | 7742. 5 | P | 0.24 | 0.37 | 0.31 | 0.06 | 0.59 | 0.06 | |||||||||||
BDL 114 | 7742. 5 | Av | 1.22 | 1.40 | 1.47 | 2.31 | 1.27 | 2.05 | |||||||||||
BDL 116 | 7481. 2 | P | 0.32 | 0.06 | 0.16 | 0.04 | |||||||||||||
BDL 116 | 7481. 2 | Av | 1.34 | 1.59 | 1.27 | 1.14 | |||||||||||||
BDL 116 | 7481. 7 | P | 0.03 | 0.21 | 0.01 | 0.07 | |||||||||||||
BDL 116 | 7481. 7 | Av | 1.85 | 1.44 | 2.11 | 1.59 | |||||||||||||
BDL 116 | 7481. 8 | P | 0. 3 0 | 0. 1 3 | 0. 2 4 | 0. 5 9 | 0.30 | 0.42 | 0.27 | 0.36 | 0.62 | 0.17 | |||||||
BDL 116 | 7481. 8 | Av | 1. 2 5 | 1. 4 0 | 1. 2 6 | 1. 1 5 | 1.34 | 1.26 | 1.16 | 1.17 | 1.12 | 1.20 | |||||||
BDL 116 | 7482. 2 | P | 0.46 | 0.62 | 0.22 | 0.35 | 0.02 | 0.17 | |||||||||||
BDL 116 | 7482. 2 | Av | 1.11 | 1.16 | 1.40 | 1.56 | 1.44 | 1.58 | |||||||||||
BDL 116 | 7485. 1 | P | 0.21 | 0.26 | 0.20 | 0.03 | 0.10 | ||||||||||||
BDL 116 | 7485. 1 | Av | 1.27 | 1.78 | 1.47 | 2.06 | 1.44 | ||||||||||||
BDL 120 | 7891. 3 | P | D.12 | 0.07 | 0.01 | 0.01 | |||||||||||||
BDL 120 | 7891. 3 | Av | 1.35 | 1.41 | 1.63 | 1.52 | |||||||||||||
BDL 120 | 7892. 4 | P | 0.28 | 0.42 | 0.04 | 0.15 | 0.02 | 0.03 | |||||||||||
BDL 120 | 7892. 4 | Av | 1.15 | 1.12 | 2.33 | 1.44 | 2.49 | 1.70 | |||||||||||
BDL 120 | 7892. 6 | P | 0.03 | 0.77 | 0.02 | ||||||||||||||
BDL 120 | 7892. 6 | Av | 1.63 | 1.12 | 1.44 | ||||||||||||||
BDL 120 | 7893. 2 | P | 0.36 | 0.17 | 0.57 | 0.06 | 0.28 | ||||||||||||
BDL 120 | 7893. 2 | Av | 1.27 | 1.96 | 1.14 | 1.86 | 1.26 | ||||||||||||
BDL 120 | 7893. 5 | P | 0.30 | 0.45 | |||||||||||||||
BDL 120 | 7893. 5 | Av | 1.73 | 1.49 | |||||||||||||||
BDL 123 | 8082. 1 | P | 0.05 | 0.54 | 0.07 | 0.17 | 0.11 |
WO 2009/141824
PCT/IL2009/000508
2018200117 05 Jan 2018
104
Gene | Ev. | Par. | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 | 16 | 17 |
BDL 123 | 8082. 1 | Av | 1.37 | 1.19 | 1.38 | 1.58 | 1.59 | ||||||||||||
BDL 123 | 8082. 3 | P | 0.27 | 0.12 | 0.33 | 0.01 | 0.43 | ||||||||||||
BDL 123 | 8082. 3 | Av | 1.64 | 1.75 | 1.41 | 1.85 | 1.18 | ||||||||||||
BDL 123 | 8082. 6 | P | 0.03 | 0.07 | 0.07 | 0.01 | |||||||||||||
BDL 123 | 8082. 6 | Av | 1.67 | 1.52 | 2.05 | 1.62 | |||||||||||||
BDL 123 | 8083. 2 | P | 0.07 | 0.35 | 0.45 | 0.31 | 0.07 | ||||||||||||
BDL 123 | 8083. 2 | Av | 1.25 | 1.62 | 1.50 | 1.67 | 1.86 | ||||||||||||
BDL 123 | 8083. 3 | P | 0.20 | 0.72 | 0.11 | 0.34 | 0.18 | ||||||||||||
BDL 123 | 8083. 3 | Av | 1.34 | 1.12 | 1.57 | 1.28 | 1.51 | ||||||||||||
BDL 125 | 7491. 1 | P | 0.30 | 0.36 | 0.26 | ||||||||||||||
BDL 125 | 7491. 1 | Av | 1.16 | 1.46 | 1.38 | ||||||||||||||
BDL 125 | 7491. 5 | P | 0.16 | 0.03 | 0.43 | 0.01 | |||||||||||||
BDL 125 | 7491. 5 | Av | 1.24 | 2.32 | 1.28 | 2.15 | |||||||||||||
BDL 125 | 7492. 5 | P | 0.29 | D.03 | 0.22 | 0.00 | 0.04 | ||||||||||||
BDL 125 | 7492. 5 | Av | 1.22 | 2.17 | 1.54 | 2.83 | 1.61 | ||||||||||||
BDL 125 | 7494. 1 | P | 0. 0 4 | 0. 0 7 | 0.05 | 0.14 | 0.30 | 0.08 | 0.23 | ||||||||||
BDL 125 | 7494. 1 | Av | 1. 2 1 | 1. 2 0 | 1.41 | 1.43 | 1.81 | 2.60 | 1.45 | ||||||||||
BDL 125 | 7495. 5 | P | 0.36 | 0.51 | 0.05 | 0.09 | 0.05 | 0.00 | |||||||||||
BDL 125 | 7495. 5 | Av | 1.12 | 1.10 | 3.54 | 1.45 | 3.05 | 1.82 | |||||||||||
BDL 128 | 7711. 3 | P | 0.37 | ||||||||||||||||
BDL 128 | 7711. 3 | Av | 1.35 | ||||||||||||||||
BDL 128 | 8361. 5 | P | 0.13 | 0.08 | 0.10 | 0.09 | |||||||||||||
BDL 128 | 8361. 5 | Av | 1.74 | 1.43 | 1.91 | 1.66 | |||||||||||||
BDL 128 | 8362. 2 | P | 0.32 | 0.18 | 0.35 | ||||||||||||||
BDL 128 | 8362. 2 | Av | 1.17 | 1.31 | 1.36 | ||||||||||||||
BDL 128 | 8363. 2 | P | 0.04 | 0.30 | 0.05 | 0.15 | 0.00 |
WO 2009/141824
PCT/IL2009/000508
2018200117 05 Jan 2018
105
Gene | Ev. | Par. | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 | 16 | 17 |
BDL 128 | 8363. 2 | Av | 1.24 | 137 | 1.46 | 1.83 | 1.46 | ||||||||||||
BDL 128 | 8365. 2 | P | 0.02 | 0.01 | 0.11 | ||||||||||||||
BDL 128 | 8365. 2 | Av | 1.70 | 3.04 | 2.64 | ||||||||||||||
BDL 129 | 7691. 2 | P | 0. 1 3 | 0. 40 | 0. 35 | 0.54 | 0.63 | 0.00 | 0.18 | 0.03 | 0.52 | 0.00 | 0.09 | ||||||
BDL 129 | 7691. 2 | Av | 1. 4 0 | 1. 30 | 1. 34 | 1.27 | 1.14 | 2.99 | 1.77 | 2.10 | 1.17 | 1.83 | 1.73 | ||||||
BDL 129 | 7692. 2 | P | 0. 10 | 0.16 | 0.01 | 0.00 | 0.03 | 0.00 | 0.03 | D.09 | |||||||||
BDL 129 | 7692. 2 | Av | 1. 16 | 1.29 | 3.43 | 1.85 | 1.82 | 1.71 | 1.85 | 1.42 | |||||||||
BDL 129 | 7692. 5 | P | 0.03 | 0.09 | 0.08 | ||||||||||||||
BDL 129 | 7692. 5 | Av | 1.37 | 1.71 | 1.61 | ||||||||||||||
BDL 129 | 7693. 1 | P | 0.51 | 0.00 | 0.27 | 0.00 | 0.27 | ||||||||||||
BDL 129 | 7693. 1 | Av | 1.37 | 2.05 | 1.58 | 1.82 | 1.52 | ||||||||||||
BDL 129 | 7693. 4 | P | 0.07 | 0.09 | 0.05 | 0.13 | |||||||||||||
BDL 129 | 7693. 4 | Av | 2.43 | 1.83 | 1.69 | 1.60 | |||||||||||||
BDL 130 | 7661. 7 | P | 0. 0 6 | 0. 01 | 0. 00 | 0.00 | 0.02 | 0.12 | 0.04 | 0.01 | 0.01 | 0.27 | |||||||
BDL 130 | 7661. 7 | Av | 1. 2 2 | 1. 14 | 1. 32 | 1.45 | 3.08 | 1.79 | 2.15 | 1.58 | 1.88 | 1.23 | |||||||
BDL 130 | 7663. 1 | P | 0. 03 | 0. 25 | 0.00 | 0.00 | 0.00 | 0.67 | |||||||||||
BDL 130 | 7663. 1 | Av | 1. 24 | 1. 20 | 1.40 | 1.41 | 1.53 | 1.10 | |||||||||||
BDL 130 | 7663. 3 | P | 0.06 | 0.42 | 0.01 | 0.62 | 0.01 | ||||||||||||
BDL 130 | 7663. 3 | Av | 1.60 | 1.29 | 2.93 | 1.14 | 1.96 | ||||||||||||
BDL 130 | 7663. 6 | P | 0.12 | 0.03 | 0.08 | 0.04 | 0.00 | ||||||||||||
BDL 130 | 7663. 6 | Av | 1.21 | 2.28 | 1.75 | 1.98 | 1.79 | ||||||||||||
BDL 130 | 7664. 5 | P | 0. 3 3 | 0. 03 | 0. 00 | 0. 1 0 | 0. 0 7 | 0.26 | 0.00 | 0.02 | 0.00 | 0.00 | 0.51 | ||||||
BDL 130 | 7664. 5 | Av | 1. 1 1 | 1. 35 | 1. 35 | 1. 1 6 | 1. 1 9 | 1.11 | 1.31 | 1.33 | 1.37 | 1.42 | 1.10 | ||||||
BDL 130 | 8572. 4 | P | 0. 0 1 | 0. 07 | 0. 07 | 0.23 | 0.05 | 0.00 | 0.10 | 0.00 | 0.00 | 0.01 |
WO 2009/141824
PCT/IL2009/000508
2018200117 05 Jan 2018
106
Gene | Ev. | Par. | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 | 16 | 17 |
BDL 130 | 8572. 4 | Av | 1. 4 7 | 1. 18 | 1. 29 | 1.20 | 2.51 | 2.92 | 1.72 | 2.16 | 2.33 | 2.68 | |||||||
BDL 130 | 8573. 5 | P | 0. 35 | 0. 08 | 0. 3 2 | 0.15 | 0.29 | 0.28 | 0.09 | 0.09 | 0.04 | 0.18 | |||||||
BDL 130 | 8573. 5 | Av | 1. 12 | 1. 21 | 1. 1 3 | 1.28 | 1.22 | 1.30 | 1.91 | 1.33 | 1.36 | 1.24 | |||||||
BDL 130 | 8574. 2 | P | 0.39 | 0.46 | 0.23 | 0.28 | 0.05 | 0.06 | 0.16 | D.10 | |||||||||
BDL 130 | 8574. 2 | Av | 1.17 | 1.15 | 1.28 | 1.44 | 1.84 | 1.64 | 1.37 | 1.60 | |||||||||
BDL 130 | 8574. 4 | P | 0. 0 3 | 0. 05 | 0. 01 | 0. 3 7 | 0. 1 3 | 0. 0 5 | 0. 1 7 | 0.03 | 0.02 | 0.14 | 0.61 | 0.55 | 0.05 | 0.05 | |||
BDL 130 | 8574. 4 | Av | 1. 4 6 | 1. 50 | 1. 65 | 1. 4 0 | 1. 3 5 | 1. 3 2 | 1. 9 8 | 2.00 | 2.05 | 1.25 | 1.12 | 1.14 | 2.26 | 2.30 | |||
BDL 130 | 8575. 1 | P | 0. 0 0 | 0. 00 | 0. 00 | 0. 1 1 | 0. 0 8 | 0. 0 0 | 0.03 | 0.02 | 0.13 | 0.03 | 0.13 | 0.00 | 0.31 | ||||
BDL 130 | 8575. 1 | Av | 1. 4 4 | 1. 51 | 1. 56 | 1. 2 1 | 1. 2 8 | 1. 5 0 | 1.94 | 1.88 | 1.32 | 1.35 | 1.20 | 2.07 | 1.59 | ||||
BDL 131 | 8631. 1 | P | 0. 0 2 | 0.40 | 0.06 | 0.05 | 0.00 | ||||||||||||
BDL 131 | 8631. 1 | Av | 1. 3 6 | 1.23 | 1.77 | 1.82 | 1.65 | ||||||||||||
BDL 131 | 8632. 2 | P | 0. 0 1 | 0. 01 | 0. 01 | 0. 2 4 | 0. 1 5 | 0.25 | 0.03 | 0.03 | 0.20 | 0.00 | 0.03 | 0.05 | |||||
BDL 131 | 8632. 2 | Av | 1. 6 1 | 1. 64 | 1. 66 | 1. 2 0 | 1. 1 9 | 1.30 | 1.60 | 2.05 | 1.58 | 1.65 | 3.33 | 2.82 | |||||
BDL 131 | 8633. 2 | P | 0. 1 4 | 0.39 | 0.48 | 0.05 | 0.14 | 0.11 | 0.08 | ||||||||||
BDL 131 | 8633. 2 | Av | 1. 1 2 | 1.21 | 1.22 | 2.07 | 1.20 | 1.38 | 1.74 | ||||||||||
BDL 131 | 8634. 2 | P | 0. 0 0 | 0. 13 | 0. 08 | 0.13 | 0.22 | 0.03 | 0.00 | 0.00 | 0.01 | 0.00 | 0.00 | ||||||
BDL 131 | 8634. 2 | Av | 1. 3 4 | 1. 23 | 1. 35 | 1.27 | 1.23 | 2.70 | 2.39 | 2.04 | 1.54 | 2.04 | 2.49 | ||||||
BDL 131 | 8635. 4 | P | 0. 0 0 | 0. 15 | 0. 23 | 0. 0 8 | 0. 1 2 | 0. 1 8 | 0. 1 2 | 0.09 | 0.11 | 0.49 | 0.30 | 0.27 | 0.51 | 0.05 | 0.03 | ||
BDL 131 | 8635. 4 | Av | 1. 2 4 | 1. 41 | 1. 70 | 1. 1 4 | 1. 2 6 | 1. 2 8 | 1. 3 5 | 1.77 | 1.79 | 1.20 | 1.34 | 1.41 | 1.17 | 1.68 | 2.07 |
WO 2009/141824
PCT/IL2009/000508
2018200117 05 Jan 2018
107
Gene | Ev. | Par. | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 | 16 | 17 |
BDL 133 | 8542. 2 | P | 0.45 | 0.47 | 3.52 | ||||||||||||||
BDL 133 | 8542. 2 | Av | 1.10 | 1.11 | 1.20 | ||||||||||||||
BDL 133 | 8542. 3 | P | 0. 04 | 0. 02 | 0. 0 2 | 0. 0 0 | 0.02 | 0.01 | 0.05 | 0.21 | D.01 | 0.16 | 0.01 | 0.03 | 0.10 | 3.00 | |||
BDL 133 | 8542. 3 | Av | 1. 41 | 1. 72 | 1. 3 0 | 1. 4 7 | 1.84 | 2.02 | 1.48 | 1.53 | 1.95 | 1.24 | 1.45 | 1.42 | 1.69 | 1.85 | |||
BDL 133 | 8543. 4 | P | 0. 1 6 | 0. 10 | 0. 17 | 0.59 | 0.17 | 0.17 | 0.01 | 0.41 | 0.00 | 0.09 | 3.15 | ||||||
BDL 133 | 8543. 4 | Av | 1. 2 1 | 1. 36 | 1. 43 | 1.18 | 1.18 | 1.39 | 1.91 | 1.25 | 1.58 | 2.03 | 1.73 | ||||||
BDL 133 | 8544. 3 | P | 0. 2 2 | 0. 26 | 0. 17 | 0. 1 4 | 0. 0 4 | 0. 5 1 | 0.23 | 0.07 | 0.30 | 0.26 | 0.31 | 0.35 | 0.29 | 0.38 | 3.17 | ||
BDL 133 | 8544. 3 | Av | 1. 3 2 | 1. 23 | 1. 30 | 1. 1 6 | 1. 2 0 | 1. 2 4 | 1.39 | 1.51 | 1.15 | 1.21 | 1.28 | 1.18 | 1.17 | 1.21 | 1.46 | ||
BDL 133 | 8545. 3 | P | 0. 0 7 | 0. 01 | 0. 00 | 0. 5 1 | 0. 2 4 | 0.18 | 0.07 | 0.51 | 0.05 | 0.04 | 0.04 | 0.17 | 0.00 | 3.00 | |||
BDL 133 | 8545. 3 | Av | 1. 5 1 | 1. 68 | 1. 63 | 1. 1 0 | 1. 1 8 | 1.44 | 1.81 | 1.32 | 2.76 | 1.55 | 2.12 | 1.26 | 2.51 | 3.55 | |||
BDL 134 | 7671. 2 | P | 0.69 | 0.61 | 0.21 | 0.07 | |||||||||||||
BDL 134 | 7671. 2 | Av | 1.12 | 1.17 | 1.30 | 1.42 | |||||||||||||
BDL 134 | 7672. 5 | P | 0.33 | 0.63 | 0.24 | 0.08 | 0.20 | 0.04 | |||||||||||
BDL 134 | 7672. 5 | Av | 1.16 | 1.11 | 1.27 | 1.47 | 1.56 | 1.71 | |||||||||||
BDL 134 | 7673. 1 | P | 0.40 | 0.12 | 0.00 | 0.43 | |||||||||||||
BDL 134 | 7673. 1 | Av | 1.13 | 1.29 | 1.74 | 1.24 | |||||||||||||
BDL 134 | 7673. 2 | P | 0.44 | 0.00 | 0.03 | ||||||||||||||
BDL 134 | 7673. 2 | Av | 1.33 | 2.67 | 2.32 | ||||||||||||||
BDL 135 | 7723. 9 | P | 0. 0 2 | 0. 2 2 | 0. 0 4 | 0.00 | 0.08 | ||||||||||||
BDL 135 | 7723. 9 | Av | 1. 8 7 | 1. 2 3 | 2. 1 1 | 1.62 | 1.19 | ||||||||||||
BDL 135 | 8782. 2 | P | 0.33 | 0.39 | 0.44 | 0.10 | 0.00 | 0.29 | |||||||||||
BDL 135 | 8782. 2 | Av | 1.30 | 1.81 | 1.43 | 1.73 | 1.75 | 1.20 |
WO 2009/141824
PCT/IL2009/000508
2018200117 05 Jan 2018
108
Gene | Ev. | Par. | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 | 16 | 17 |
BDL 135 | 8783. 1 | P | 0. 0 0 | 0. 0 0 | 0. 0 0 | 0. 0 0 | 0.00 | 0.09 | 0.00 | 0.23 | |||||||||
BDL 135 | 8783. 1 | Av | 2. 7 0 | 2. 4 0 | 1. 8 5 | 3. 9 4 | 2.48 | 1.80 | 1.68 | 1.20 | |||||||||
BDL 135 | 8783. 2 | P | 0.32 | 0.48 | |||||||||||||||
BDL 135 | 8783. 2 | Av | 1.74 | 1.18 | |||||||||||||||
BDL 135 | 8785. 5 | P | 0. 0 2 | 0. 07 | 0. 14 | 0. 1 0 | 0. 0 1 | 0. 0 2 | 0. 0 3 | 0.03 | 0.05 | 0.20 | 0.32 | ||||||
BDL 135 | 8785. 5 | Av | 1. 1 6 | 1. 28 | 1. 33 | 1. 6 7 | 1. 9 6 | 1. 7 6 | 1. 6 6 | 2.53 | 2.26 | 1.17 | 1.20 | ||||||
BDL 137 | 7701. 2 | P | 0.25 | 0.07 | 0.22 | 0.09 | 0.10 | ||||||||||||
BDL 137 | 7701. 2 | Av | 1.14 | 1.48 | 1.61 | 1.91 | 1.68 | ||||||||||||
BDL 137 | 7701. 5 | P | 0.33 | 0.02 | 0.21 | 0.03 | |||||||||||||
BDL 137 | 7701. 5 | Av | 2.23 | 1.36 | 1.92 | 1.44 | |||||||||||||
BDL 137 | 7702. 1 | P | 0.30 | 0.32 | 0.27 | 0.05 | 0.40 | 0.08 | |||||||||||
BDL 137 | 7702. 1 | Av | 1.21 | 1.44 | 1.49 | 1.96 | 1.41 | 1.87 | |||||||||||
BDL 137 | 7703. 3 | P | 0. 10 | 0. 16 | 0. 1 2 | 0.51 | 0.31 | 0.03 | 0.13 | 0.03 | 0.08 | ||||||||
BDL 137 | 7703. 3 | Av | 1. 13 | 1. 15 | 1. 1 5 | 1.12 | 1.20 | 1.95 | 1.17 | 2.59 | 1.26 | ||||||||
BDL 137 | 7703. 7 | P | 0.38 | 0.19 | 0.34 | 0.15 | 0.05 | ||||||||||||
BDL 137 | 7703. 7 | Av | 1.24 | 2.04 | 2.78 | 2.12 | 1.86 | ||||||||||||
BDL 139 | 8581. 5 | P | 0. 38 | 0.23 | 0.30 | 0.10 | 0.01 | 0.15 | 0.09 | 0.05 | 0.02 | ||||||||
BDL 139 | 8581. 5 | Av | 1. 14 | 1.16 | 1.20 | 1.58 | 1.54 | 1.35 | 1.37 | 1.57 | 1.68 | ||||||||
BDL 139 | 8581. 5 | P | 0.57 | ||||||||||||||||
BDL 139 | 8581. 5 | Av | 1.21 | ||||||||||||||||
BDL 139 | 8581. 6 | P | 0. 0 1 | 0. 01 | 0. 07 | 0. 2 8 | 0.19 | 0.56 | 0.36 | 0.12 | 0.31 | 0.00 | 0.00 | ||||||
BDL 139 | 8581. 6 | Av | 1. 9 0 | 2. 16 | 1. 46 | 1. 1 0 | 1.45 | 1.17 | 1.22 | 2.54 | 1.35 | 2.79 | 4.10 | ||||||
BDL 139 | 8581. 6 | P | 0. 32 | 0. 43 | 0.10 | 0.01 |
WO 2009/141824
PCT/IL2009/000508
2018200117 05 Jan 2018
109
Gene | Ev. | Par. | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 | 16 | 17 |
BDL 139 | 8581. 6 | Av | 1. 11 | 1. 14 | 1.64 | 1.85 | |||||||||||||
BDL 139 | 8583. 1 | P | 0. 24 | 0.09 | 0.12 | 0.00 | 0.00 | 0.03 | 0.00 | 0.22 | |||||||||
BDL 139 | 8583. 1 | Av | 1. 13 | 1.18 | 1.27 | 2.25 | 2.43 | 1.50 | 2.22 | 1.36 | |||||||||
BDL 139 | 8583. 1 | P | 0.20 | 0.59 | 0.36 | 0.27 | |||||||||||||
BDL 139 | 8583. 1 | Av | 1.24 | 1.12 | 1.10 | 1.26 | |||||||||||||
BDL 139 | 8584. 1 | P | 0. 31 | 0.59 | 0.23 | 0.06 | 0.00 | 0.09 | 0.01 | 0.00 | |||||||||
BDL 139 | 8584. 1 | Av | 1. 18 | 1.12 | 1.30 | 1.87 | 1.59 | 1.37 | 1.70 | 1.77 | |||||||||
BDL 139 | 8584. 1 | P | 0.46 | 0.04 | 0.02 | 0.00 | 0.14 | ||||||||||||
BDL 139 | 8584. 1 | Av | 1.35 | 1.66 | 1.57 | 1.58 | 1.32 | ||||||||||||
BDL 139 | 8585. 2 | P | 0. 0 0 | 0. 01 | 0. 02 | 0.35 | 0.05 | 0.05 | 0.03 | 0.05 | 0.11 | ||||||||
BDL 139 | 8585. 2 | Av | 1. 6 1 | 1. 52 | 1. 49 | 1.27 | 3.34 | 2.30 | 2.18 | 1.60 | 2.38 | ||||||||
BDL 139 | 8585. 2 | P | 0. 3 2 | 0. 23 | 0.16 | 0.13 | 0.17 | 0.20 | 0.03 | ||||||||||
BDL 139 | 8585. 2 | Av | 1. 1 4 | 1. 22 | 1.42 | 1.33 | 1.29 | 2.06 | 1.83 | ||||||||||
BDL 141 | 8641. 3 | P | 0. 0 2 | 0. 06 | 0. 01 | 0. 0 9 | 0. 1 0 | 0.16 | 0.11 | 0.00 | 0.00 | 0.01 | |||||||
BDL 141 | 8641. 3 | Av | 1. 8 2 | 1. 82 | 1. 78 | 1. 5 1 | 1. 4 2 | 2.17 | 1.93 | 2.54 | 1.95 | 3.77 | |||||||
BDL 141 | 8641. 3 | P | 0. 49 | 0. 10 | 0.45 | 0.10 | 0.49 | 0.52 | 0.10 | 0.10 | |||||||||
BDL 141 | 8641. 3 | Av | 1. 10 | 1. 43 | 1.10 | 1.69 | 1.13 | 1.12 | 1.51 | 1.83 | |||||||||
BDL 141 | 8641. 4 | P | 0.50 | 0.01 | 0.14 | 0.02 | 0.11 | 0.17 | |||||||||||
BDL 141 | 8641. 4 | Av | 1.11 | 2.36 | 3.23 | 1.98 | 1.74 | 1.90 | |||||||||||
BDL 141 | 8641. 4 | P | 0. 10 | 0.12 | 0.21 | 0.05 | 0.42 | 0.10 | 0.08 | 0.05 | |||||||||
BDL 141 | 8641. 4 | Av | 1. 18 | 1.66 | 1.35 | 1.98 | 1.13 | 1.19 | 1.27 | 1.64 | |||||||||
BDL 141 | 8642. 3 | P | 0. 0 1 | 0. 05 | 0. 01 | 0.13 | 0.18 | 0.01 | 0.03 | 0.03 | 0.02 | 0.00 | |||||||
BDL 141 | 8642. 3 | Av | 1. 4 9 | 1. 32 | 1. 45 | 1.33 | 1.23 | 1.98, | 1.68 | 1.43 | 1.35 | 2.64 |
WO 2009/141824
PCT/IL2009/000508
2018200117 05 Jan 2018
110
Gene | Ev. | Par. | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 | 16 | 17 |
BDL 141 | 8642. 3 | P | 0.46 | 0.02 | |||||||||||||||
BDL 141 | 8642. 3 | Av | 1.26 | 1.66 | |||||||||||||||
BDL 141 | 8642. 6 | P | 0.24 | 0.15 | 0.22 | 0.24 | 0.15 | 0.08 | |||||||||||
BDL 141 | 8642. 6 | Av | 1.25 | 1.45 | 1.24 | 1.20 | 1.19 | 1.83 | |||||||||||
BDL 141 | 8642. 6 | P | 0.31 | ||||||||||||||||
BDL 141 | 8642. 6 | Av | 1.30 | ||||||||||||||||
BDL 141 | 8643. 3 | P | 0. 0 0 | 0. 07 | 0. 08 | 0.63 | 0.22 | 0.06 | 0.11 | 0.01 | 0.19 | 0.00 | |||||||
BDL 141 | 8643. 3 | Av | 1. 4 9 | 1. 31 | 1. 33 | 1.15 | 1.51 | 1.47 | 1.68 | 1.49 | 1.27 | 3.80 | |||||||
BDL 141 | 8643. 3 | P | 0.24 | 0.43 | 0.14 | ||||||||||||||
BDL 141 | 8643. 3 | Av | 1.38 | 1.21 | 1.38 | ||||||||||||||
BDL 142 | 8283. 2 | P | |||||||||||||||||
BDL 142 | 8283. 2 | Av | |||||||||||||||||
BDL 142 | 8284. 1 | P | 0.60 | 0.18 | 0.11 | 0.11 | |||||||||||||
BDL 142 | 8284. 1 | Av | 1.10 | 1.17 | 1.47 | 1.36 | |||||||||||||
BDL 142 | 8285. 1 | P | 0. 07 | 0. 2 2 | 0. 0 6 | 0. 0 3 | 0. 0 8 | 0.00 | 0.01 | 0.19 | 0.42 | ||||||||
BDL 142 | 8285. 1 | Av | 1. 51 | 1. 2 2 | 1. 3 5 | 1. 3 6 | 2. 4 3 | 2.18 | 1.75 | 2.62 | 1.22 | ||||||||
BDL 142 | 8285. 3 | P | 0.18 | 0.13 | 0.65 | 0.06 | 0.19 | ||||||||||||
BDL 142 | 8285. 3 | Av | 1.22 | 1.65 | 1.13 | 1.89 | 1.24 | ||||||||||||
BDL 142 | 8285. 5 | P | 0. 48 | 0. 3 8 | 0. 1 5 | 0.42 | 0.33 | 0.60 | |||||||||||
BDL 142 | 8285. 5 | Av | 1. 11 | 1. 1 1 | 1. 2 9 | 1.15 | 1.22 | 1.11 | |||||||||||
BDL 143 | 8411. 1 | P | 0.22 | 0.31 | 0.02 | 0.02 | |||||||||||||
BDL 143 | 8411. 1 | Av | 1.51 | 1.22 | 2.08 | 1.50 | |||||||||||||
BDL 143 | 8412. 2 | P | 0.28 | 0.08 | |||||||||||||||
BDL 143 | 8412. 2 | Av | 1.59 | 2.30 |
WO 2009/141824
PCT/IL2009/000508
2018200117 05 Jan 2018
111
Gene | Ev. | Par. | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 | 16 | 17 |
BDL 143 | 8413. 3 | P | 0.04 | 0.49 | 0.14 | 0.43 | 0.23 | ||||||||||||
BDL 143 | 8413. 3 | Av | 1.49 | 1.22 | 1.39 | 1.31 | 1.30 | ||||||||||||
BDL 143 | 8414. 4 | P | 0.69 | 0.17 | 0.59 | 0.01 | |||||||||||||
BDL 143 | 8414. 4 | Av | 1.27 | 1.42 | 1.25 | 1.84 | |||||||||||||
BDL 143 | 8414. 5 | P | 0.17 | 0.31 | 0.42 | 0.12 | |||||||||||||
BDL 143 | 8414. 5 | Av | 1.28 | 1.21 | 1.10 | 1.40 | |||||||||||||
BDL 144 | 8381. 3 | P | 0.53 | 0.03 | 0.11 | ||||||||||||||
BDL 144 | 8381. 3 | Av | 1.15 | 1.85 | 1.39 | ||||||||||||||
BDL 144 | 8382. 2 | P | 0. 2 2 | 0. 24 | 0. 40 | 0.45 | 0.36 | 0.16 | 0.32 | 0.08 | 0.01 | 0.20 | |||||||
BDL 144 | 8382. 2 | Av | 1. 3 6 | 1. 61 | 1. 34 | 1.37 | 1.31 | 2.95 | 1.30 | 1.73 | 1.55 | 1.20 | |||||||
BDL 144 | 8384. 4 | P | 0. 04 | 0.33 | 0.01 | 0.01 | |||||||||||||
BDL 144 | 8384. 4 | Av | 1. 42 | 2.46 | 2.51 | 1.97 | |||||||||||||
BDL 144 | 8385. 1 | P | 0.13 | 0.06 | 0.02 | 0.27 | 0.03 | ||||||||||||
BDL 144 | 8385. 1 | Av | 1.59 | 1.51 | 2.26 | 1.36 | 1.60 | ||||||||||||
BDL 145 | 8233. 2 | P | 0.08 | 0.11 | 0.00 | ||||||||||||||
BDL 145 | 8233. 2 | Av | 1.39 | 1.61 | 1.42 | ||||||||||||||
BDL 145 | 8233. 3 | P | 0.57 | 0.24 | 0.21 | 0.04 | 0.00 | ||||||||||||
BDL 145 | 8233. 3 | Av | 1.12 | 1.71 | 1.43 | 2.15 | 1.51 | ||||||||||||
BDL 145 | 8235. 3 | P | 0.40 | 0.31 | 0.01 | ||||||||||||||
BDL 145 | 8235. 3 | Av | 1.18 | 1.34 | 1.55 | ||||||||||||||
BDL 145 | 8731. 3 | P | 0.81 | 0.41 | 0.47 | 0.12 | 0.21 | ||||||||||||
BDL 145 | 8731. 3 | Av | 1.12 | 1.45 | 1.36 | 1.60 | 1.52 | ||||||||||||
BDL 145 | 8734. 2 | P | 0.09 | 0.32 | 0.02 | 0.00 | |||||||||||||
BDL 145 | 8734. 2 | Av | 2.95 | 1.16 | 2.57 | 1.38 | |||||||||||||
BDL 146 | 8241. 1 | P | 0. 11 | 0. 03 | 0.07 | 0.67 | 0.06 | 0.01 | 0.08 | 0.00 | 0.08 | 0.64 | |||||||
BDL 146 | 8241. 1 | Av | 1. 18 | 1. 28 | 1.20 | 1.12 | 1.85 | 1.52 | 1.50 | 1.52 | 1.37 | 1.11 |
WO 2009/141824
PCT/IL2009/000508
2018200117 05 Jan 2018
112
Gene | Ev. | Par. | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 | 16 | 17 |
BDL 146 | 8241. 3 | P | 0.06 | 0.17 | D.25 | 0.01 | 0.00 | ||||||||||||
BDL 146 | 8241. 3 | Av | 1.45 | 1.23 | 1.18 | 4.78 | 3.57 | ||||||||||||
BDL 146 | 8244. 4 | P | 0. 0 0 | 0. 01 | 0. 04 | 0.03 | 0.53 | 0.09 | 0.06 | 0.02 | |||||||||
BDL 146 | 8244. 4 | Av | 1. 7 6 | 1. 74 | 1. 66 | 1.45 | 1.45 | 1.43 | 1.52 | 1.78 | |||||||||
BDL 146 | 8244. 7 | P | 0.12 | 0.31 | 0.00 | 0.05 | 0.01 | 0.02 | |||||||||||
BDL 146 | 8244. 7 | Av | 1.57 | 1.15 | 2.44 | 2.61 | 2.07 | 2.32 | |||||||||||
BDL 146 | 8245. 5 | P | 0. 0 2 | 0. 01 | 0. 01 | 0.22 | 0.40 | 0.00 | 0.13 | ||||||||||
BDL 146 | 8245. 5 | Av | 1. 2 3 | 1. 43 | 1. 32 | 1.26 | 1.12 | 1.33 | 1.32 | ||||||||||
BDL 42 | 7771. 3 | P | 0. 20 | 0. 01 | 0. 2 9 | 0. 0 6 | 0.41 | 0.04 | 0.17 | 0.01 | 0.17 | 0.18 | 0.02 | 0.04 | 0.09 | ||||
BDL 42 | 7771. 3 | Av | 1. 14 | 1. 50 | 1. 1 5 | 1. 2 5 | 1.27 | 1.67 | 1.34 | 1.55 | 2.06 | 1.37 | 1.80 | 1.30 | 1.36 | ||||
BDL 42 | 7771. 5 | P | 0.43 | 0.05 | 0.12 | 0.00 | |||||||||||||
BDL 42 | 7771. 5 | Av | 1.51 | 1.15 | 3.36 | 1.69 | |||||||||||||
BDL 42 | 7772. 6 | P | 0. 0 0 | 0. 0 0 | 0.01 | 0.10 | |||||||||||||
BDL 42 | 7772. 6 | Av | 1. 8 5 | 3. 3 1 | 1.43 | 1.34 | |||||||||||||
BDL 42 | 7774. 1 | P | 0.01 | 0.01 | 0.02 | ||||||||||||||
BDL 42 | 7774. 1 | Av | 1.57 | 4.16 | 2.03 | ||||||||||||||
BDL 42 | 7774. 5 | P | 0. 5 5 | 0.63 | 0.02 | 0.20 | 0.24 | 0.06 | 0.44 | ||||||||||
BDL 42 | 7774. 5 | Av | 1. 1 1 | 1.14 | 1.56 | 2.36 | 1.66 | 2.21 | 1.23 | ||||||||||
BDL 51 | 8021. 1 | P | 0.25 | 0.01 | 0.01 | ||||||||||||||
BDL 51 | 8021. 1 | Av | 1.14 | 1.92 | 1.50 | ||||||||||||||
BDL 51 | 8022. 4 | P | 0.06 | 0.02 | 0.01 | ||||||||||||||
BDL 51 | 8022. 4 | Av | 1.15 | 1.80 | 1.59 |
WO 2009/141824
PCT/IL2009/000508
2018200117 05 Jan 2018
113
Gene | Ev. | Par. | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 75 | 16 | 17 |
BDL 51 | 8022. 5 | P | 0.24 | 0.00 | 0.06 | 0.00 | |||||||||||||
BDL 51 | 8022. 5 | Av | 1.11 | 1.27 | 2.05 | 1.84 | |||||||||||||
BDL 51 | 8022. 7 | P | 0. 08 | 0. 0 0 | 0. 1 8 | 0. 2 5 | 0. 0 0 | 0.02 | 0.03 | 0.34 | 0.16 | ||||||||
BDL 51 | 8022. Ί | Av | 1. 22 | 1. 8 0 | 1. 1 8 | 1. 1 4 | 3. 3 6 | 1.71 | 1.53 | 1.30 | 1.34 | ||||||||
BDL 51 | 8024. 4 | P | 0.02 | 0.46 | 0.04 | ||||||||||||||
BDL 51 | 8024. 4 | Av | 1.20 | 1.25 | 1.38 | ||||||||||||||
BDL 51 | 8024. 7 | P | 0. 0 2 | 0.05 | 0.02 | ||||||||||||||
BDL 51 | 8024. 7 | Av | 1. 3 4 | 1.45 | 1.39 | ||||||||||||||
BDL 52 | 7861. 1 | P | 0. 0 5 | 0. 44 | 0.08 | 0.10 | 0.12 | 0.02 | 0.04 | 0.38 | |||||||||
BDL 52 | 7861. 1 | Av | 1. 2 6 | 1. 20 | 1.73 | 3.22 | 1.90 | 2.82 | 1.37 | 1.19 | |||||||||
BDL 52 | 7863. 2 | P | 0. 0 0 | 0. 55 | 0.52 | 0.16 | 0.29 | D.08 | |||||||||||
BDL 52 | 7863. 2 | Av | 1. 4 2 | 1. 14 | 1.17 | 1.31 | 1.32 | 1.47 | |||||||||||
BDL 52 | 7864. 2 | P | 0. 1 0 | 0.26 | 0.57 | 0.22 | |||||||||||||
BDL 52 | 7864. 2 | Av | 1. 2 2 | 3.45 | 1.10 | 2.55 | |||||||||||||
BDL 52 | 7864. 3 | P | 0. 0 0 | 0. 2 7 | 0. 0 1 | 0.41 | 0.46 | ||||||||||||
BDL 52 | 7864. 3 | Av | 1. 2 8 | 1. 1 1 | 1. 7 6 | 1.16 | 1.12 | ||||||||||||
BDL 52 | 7864. 5 | P | 0. 2 7 | 0. 47 | 0.10 | ||||||||||||||
BDL 52 | 7864. 5 | Av | 1. 1 9 | 1. 10 | 1.12 | ||||||||||||||
BDL 59 | 7792. 1 | P | |||||||||||||||||
BDL 59 | 7792. 1 | Av | |||||||||||||||||
BDL 59 | 7792. 2 | P | 0.20 |
WO 2009/141824
PCT/IL2009/000508
2018200117 05 Jan 2018
114
Gene | Ev. | Par. | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 | 16 | 17 |
BDL 59 | 7792. 2 | Av | 1.27 | ||||||||||||||||
BDL 59 | 7792. 3 | P | |||||||||||||||||
BDL 59 | 7792. 3 | Av | |||||||||||||||||
BDL 59 | 7793. 3 | P | 0.01 | 0.00 | 0.04 | ||||||||||||||
BDL 59 | 7793. 3 | Av | 1.76 | 1.65 | 1.45 | ||||||||||||||
BDL 59 | 7794. 1 | P | 0.12 | ||||||||||||||||
BDL 59 | 7794. 1 | Av | 1.15 | ||||||||||||||||
BDL 65 | 7824. 1 | P | 0.08 | 0.11 | |||||||||||||||
BDL 65 | 7824. 1 | Av | 1.79 | 1.37 | |||||||||||||||
BDL 65 | 7825. 2 | P | 0. 1 8 | 0.48 | |||||||||||||||
BDL 65 | 7825. 2 | Av | 1. 1 2 | 1.16 | |||||||||||||||
BDL 65 | 8761. 1 | P | 0.16 | 0.07 | 0.04 | 0.66 | |||||||||||||
BDL 65 | 8761. 1 | Av | 2.09 | 1.51 | 1.39 | 1.11 | |||||||||||||
BDL 65 | 8762. 3 | P | 0. 1 0 | 0.15 | 0.70 | ||||||||||||||
BDL 65 | 8762. 3 | Av | 1. 1 4 | 1.27 | 1.15 | ||||||||||||||
BDL 65 | 8764. 1 | P | 0.08 | 0.03 | 0.39 | 0.00 | 0.39 | ||||||||||||
BDL 65 | 8764. 1 | Av | 1.42 | 1.81 | 1.10 | 1.98 | 1.46 | ||||||||||||
BDL 67 | 7901. 5 | P | 0.18 | 0.16 | |||||||||||||||
BDL 67 | 7901. 5 | Av | 1.71 | 1.58 | |||||||||||||||
BDL 67 | 7902. 3 | P | 0.07 | 0.10 | 0.00 | ||||||||||||||
BDL 67 | 7902. 3 | Av | 1.20 | 1.22 | 1.49 | ||||||||||||||
BDL 67 | 7902. 7 | P | 0.06 | 0.03 | 0.50 | 0.08 | 0.35 | 0.27 | |||||||||||
BDL 67 | 7902. 7 | Av | 1.42 | 5.05 | 1.16 | 4.84 | 1.19 | 1.23 | |||||||||||
BDL 67 | 7903. 3 | P | 0.00 | 0.19 | |||||||||||||||
BDL 67 | 7903. 3 | Av | 1.40 | 1.21 |
WO 2009/141824
PCT/IL2009/000508
2018200117 05 Jan 2018
115
Gene | Ev. | Par. | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 | 16 | 17 |
BDL 67 | 7903. 5 | P | 0. 0 1 | 0.01 | D.29 | 0.02 | |||||||||||||
BDL 67 | 7903. 5 | Av | 1. 2 6 | 1.34 | 1.35 | 2.25 | |||||||||||||
BDL 68 | 7761. 3 | P | 0. 1 1 | 0. 2 4 | |||||||||||||||
BDL 68 | 7761. 3 | Av | 1. 1 6 | 1. 1 3 | |||||||||||||||
BDL 68 | 7761. 5 | P | 0.02 | 0.01 | 0.68 | ||||||||||||||
BDL 68 | 7761. 5 | Av | 1.79 | 1.42 | 1.16 | ||||||||||||||
BDL 68 | 7761. 9 | P | |||||||||||||||||
BDL 68 | 7761. 9 | Av | |||||||||||||||||
BDL 68 | 7764. 1 | P | 0.49 | ||||||||||||||||
BDL 68 | 7764. 1 | Av | 1.16 | ||||||||||||||||
BDL 68 | 7765. 2 | P | 0. 1 1 | 0.10 | 0.03 | 0.26 | 0.25 | 0.22 | |||||||||||
BDL 68 | 7765. 2 | Av | 1. 2 3 | 1.51 | 1.84 | 1.40 | 1.43 | 1.37 | |||||||||||
BDL 78 | 7911. 11 | P | 0. 47 | 0. 27 | 0. 0 7 | 0.18 | 0.01 | 0.24 | 0.04 | 0.01 | |||||||||
BDL 78 | 7911. 11 | Av | 1. 10 | 1. 16 | 1. 1 6 | 1.19 | 1.58 | 1.16 | 1.24 | 1.36 | |||||||||
BDL 78 | 7911. 8 | P | 0. 53 | 0.04 | 0.05 | 0.22 | 0.05 | 0.08 | 0.09 | ||||||||||
BDL 78 | 7911. 8 | Av | 1. 12 | 1.31 | 2.55 | 1.36 | 1.87 | 1.47 | 1.63 | ||||||||||
BDL 78 | 7912. 6 | P | 0. 00 | 0. 03 | 0.44 | 0.29 | 0.22 | 0.04 | 0.00 | 0.00 | 0.53 | ||||||||
BDL 78 | 7912. 6 | Av | 1. 16 | 1. 25 | 1.13 | 1.23 | 2.15 | 1.85 | 1.30 | 1.82 | 1.16 | ||||||||
BDL 78 | 7913. 6 | P | 0.61 | 0.27 | 0.20 | 0.20 | 0.47 | ||||||||||||
BDL 78 | 7913. 6 | Av | 1.16 | 1.83 | 1.50 | 1.35 | 1.16 | ||||||||||||
BDL 78 | 7913. 8 | P | 0. 34 | 0. 43 | 0.01 | 0.11 | 0.02 | 0.39 | |||||||||||
BDL 78 | 7913. 8 | Av | 1. 14 | 1. 13 | 1.57 | 1.28 | 1.39 | 4.27 | |||||||||||
BDL 78 | 7913. 9 | P | 0.00 | 0.05 | 0.08 | 0.22 |
WO 2009/141824
PCT/IL2009/000508
2018200117 05 Jan 2018
116
Gene | Ev. | Par. | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | IS | 16 | 17 |
BDL 78 | 7913. 9 | Av | 2.56 | 1.75 | 1.56 | 1.40 | |||||||||||||
BDL 82 | 7801. 1 | P | 0.05 | 0.00 | |||||||||||||||
BDL 82 | 7801. 1 | Av | 1.97 | 1.57 | |||||||||||||||
BDL 82 | 7801. 2 | P | 0.11 | 0.21 | D.83 | 0.33 | |||||||||||||
BDL 82 | 7801. 2 | Av | 1.13 | 1.14 | 1.12 | 1.33 | |||||||||||||
BDL 82 | 7801. 3 | P | 0.00 | 0.20 | 0.01 | ||||||||||||||
BDL 82 | 7801. 3 | Av | 1.32 | 1.78 | 1.69 | ||||||||||||||
BDL 82 | 7801. 3 | P | 0.09 | 0.00 | 0.02 | ||||||||||||||
BDL 82 | 7801. 3 | Av | 2.47 | 5.03 | 2.49 | ||||||||||||||
BDL 82 | 7802. 2 | P | 0.00 | 0.02 | 0.00 | ||||||||||||||
BDL 82 | 7802. 2 | Av | 1.62 | 3.16 | 2.56 | ||||||||||||||
BDL 82 | 7802. 2 | P | 0.58 | ||||||||||||||||
BDL 82 | 7802. 2 | Av | 1.11 | ||||||||||||||||
BDL 82 | 7802. 3 | P | 0.22 | 0.07 | 0.02 | ||||||||||||||
BDL 82 | 7802. 3 | Av | 1.33 | 1.67 | 1.46 | ||||||||||||||
BDL 82 | 7803. 4 | P | 0.11 | 0.28 | 0.03 | ||||||||||||||
BDL 82 | 7803. 4 | Av | 1.51 | 1.28 | 1.36 | ||||||||||||||
BDL 82 | 7803. 8 | P | 0.11 | 0.12 | 0.03 | 0.41 | 0.40 | ||||||||||||
BDL 82 | 7803. 8 | Av | 1.55 | 1.90 | 2.13 | 1.37 | 1.15 | ||||||||||||
BDL 82 | 7803. 9 | P | 0.00 | 0.06 | 0.33 | 0.35 | 0.37 | 0.41 | 0.01 | ||||||||||
BDL 82 | 7803. 9 | Av | 1.27 | 1.27 | 1.15 | 1.33 | 1.34 | 1.16 | 1.17 | ||||||||||
BDL 82 | 7803. 9 | P | 0.31 | 0.12 | 0.16 | 0.05 | 0.43 | ||||||||||||
BDL 82 | 7803. 9 | Av | 1.12 | 2.57 | 1.28 | 2.36 | 1.13 | ||||||||||||
BDL 82 | 7808. 6 | P | 0. 0 0 | 0. 02 | 0. 05 | 0. 0 4 | 0.10 | 0.14 | 0.17 | 0.08 | 0.08 | ||||||||
BDL 82 | 7808. 6 | Av | 1. 5 0 | 1. 18 | 1. 22 | 1. 2 9 | 1.42 | 2.35 | 1.48 | 2.32 | 1.26 | ||||||||
BDL 89 | 7812. 2 | P | 0.07 | 0.00 | 0.00 | 0.01 | 0.00 |
WO 2009/141824
PCT/IL2009/000508
2018200117 05 Jan 2018
117
Gene | Ev. | Par. | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 | 16 | 17 |
BDL 89 | 7812. 2 | Av | 1.16 | 1.75 | 1.41 | 1.50 | 1.35 | ||||||||||||
BDL 89 | 7812. 5 | P | 0.16 | 0.04 | 0.01 | ||||||||||||||
BDL 89 | 7812. 5 | Av | 1.43 | 3.01 | 2.30 | ||||||||||||||
BDL 89 | 7814. 1 | P | 0.05 | D.64 | 0.07 | 0.07 | |||||||||||||
BDL 89 | 7814. 1 | Av | 1.17 | 1.13 | 1.60 | 1.57 | |||||||||||||
BDL 89 | 7814. 4 | P | 0.19 | 0.12 | 0.12 | ||||||||||||||
BDL 89 | 7814. 4 | Av | 1.40 | 1.39 | 1.39 | ||||||||||||||
BDL 89 | 7814. 5 | P | 0.11 | 0.28 | D.41 | 0.02 | 0.37 | 0.05 | |||||||||||
BDL 89 | 7814. 5 | Av | 1.30 | 1.16 | 2.04 | 2.01 | 1.21 | 1.68 | |||||||||||
BDL 95 | 7841. 2 | P | 0.03 | 0.55 | 0.16 | 0.70 | 0.08 | ||||||||||||
BDL 95 | 7841. 2 | Av | 1.21 | 1.23 | 1.40 | 1.10 | 1.37 | ||||||||||||
BDL 95 | 7842. 12 | P | 0. 41 | 0.02 | 0.10 | 0.31 | 0.17 | 0.36 | 0.02 | ||||||||||
BDL 95 | 7842. 12 | Av | 1. 12 | 1.26 | 1.26 | 1.28 | 1.27 | 1.17 | 1.46 | ||||||||||
BDL 95 | 7842. 2 | P | 0.11 | 0.34 | 0.00 | ||||||||||||||
BDL 95 | 7842. 2 | Av | 1.30 | 1.19 | 1.34 | ||||||||||||||
BDL 95 | 7842. 8 | P | 0.18 | 0.14 | 0.00 | 0.33 | 0.06 | ||||||||||||
BDL 95 | 7842. 8 | Av | 1.22 | 1.22 | 1.63 | 1.19 | 1.49 | ||||||||||||
BDL 95 | 7843. 4 | P | 0.02 | 0.04 | 0.01 | ||||||||||||||
BDL 95 | 7843. 4 | Av | 1.58 | 2.93 | 2.20 |
Table 23. “P” = P-value; “Av” = ratio between the averages of event and control. Note that when the average ratio is higher than “1” the effect of exogenous expression of the gene is an increase of the desired trait; “Par” = Parameter according to the parameters listed in Table 22 above; “Ev” = event.
Greenhouse assays - Tables 25, 26 and 27 represent experiments that were done using greenhouse assays. Table 24 specifies the parameters that were measured in the green house assays and which are presented in Tables 25, 26 and 27. In cases where a certain event appears more than once, the event was tested in several independent 10 experiments.
WO 2009/141824
PCT/IL2009/000508
2018200117 05 Jan 2018
118
Table 24
Parameter symbol in result Tables 25,26 and 27 | Parameter name | Parameter symbol in result Tables 25, 26 and 27 | Parameter name |
1 | Rosette Diameter Time point 1 | 31 | Petiole Relative Area Time point 3 |
2 | Rosette Diameter Time point 2 | 32 | Petiole Relative Area Time point 4 |
3 | Rosette Diameter Time point 3 | 33 | RGR of Leaf Blade Area Time point 2 |
4 | Rosette Diameter Time point 4 | 34 | RGR of Leaf Blade Area Time point 3 |
5 | Rosette Area Time point 1 | 35 | RGR of Leaf Blade Area Time point 4 |
6 | Rosette Area Time point 2 | 36 | RGR of Leaf Number Time point 2 |
7 | Rosette Area Time point 3 | 37 | RGR of Leaf Number Time point 3 |
8 | Rosette Area Time point 4 | 38 | RGR of Leaf Number Time point 4 |
9 | Plot Coverage Time point 1 | 39 | RGR of Rosette Area Time point 2 |
10 | Plot Coverage Time point 2 | 40 | RGR of Rosette Area Time point 3 |
11 | Plot Coverage Time point 3 | 41 | RGR of Rosette Area Time point 4 |
12 | Plot Coverage Time point 4 | 42 | RGR of Rosette Diameter Time point 2 |
13 | Leaf Number Time point 1 | 43 | RGR of Rosette Diameter Time point 3 |
14 | Leaf Number Time point 2 | 44 | RGR of Rosette Diameter Time point 4 |
15 | Leaf Number Time point 3 | 45 | RGR of Plot Coverage Time point 2 |
16 | Leaf Number Time point 4 | 46 | RGR of Plot Coverage Time point 3 ; |
17 | Leaf Blade Area Time point 1 | 47 | RGR of Plot Coverage Time point 4 |
18 | Leaf Blade Area Time point 2 | 48 | Bolting |
19 | Leaf Blade Area Time point 3 | 49 | Flowering |
20 | Leaf Blade Area Time point 4 | 50 | Dry Weight |
21 | Leaf Petiole Area Time point 1 | 51 | Seed Yield |
22 | Leaf Petiole Area Time point 2 | 52 | Harvest Index |
23 | Leaf Petiole Area Time point 3 | 53 | 1000 Seeds Weight |
24 | Leaf Petiole Area Time point 4 | 54 | oil content |
25 | Blade Relative Area Time point 1 | 55 | Fresh Weight |
26 | Blade Relative Area |
WO 2009/141824
PCT/IL2009/000508
2018200117 05 Jan 2018
119
Parameter symbol in result Tables 25,26 and 27 | Parameter name | Parameter symbol in result Tables 25,26 and 27 | Parameter name |
Time point 2 | |||
27 | Blade Relative Area Time point 3 | ||
28 | Blade Relative Area Time point 4 | ||
29 | Petiole Relative Area Time point 1 | ||
30 | Petiole Relative Area Time point 2 |
Table 24.
Table 25
Gene | Ev. | Par. | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 | 16 | 17 |
BDL 95 | 7841. 5 | P | |||||||||||||||||
BDL 95 | 7841. 5 | Av. | |||||||||||||||||
BDL 95 | 7842. 12 | P | |||||||||||||||||
BDL 95 | 7842. 12 | Av. | |||||||||||||||||
BDL 95 | 7842. 2 | P | 0.35 | ||||||||||||||||
BDL 95 | 7842. 2 | Av. | 1.12 | ||||||||||||||||
BDL 95 | 7842. 8 | P | |||||||||||||||||
BDL 95 | 7842. 8 | Av. | |||||||||||||||||
BDL 95 | 7843. 4 | P | |||||||||||||||||
BDL 95 | 7843. 4 | Av. | |||||||||||||||||
BDL 100 | 7871. 2 | P | |||||||||||||||||
BDL 100 | 7871. 2 | Av. | |||||||||||||||||
BDL 100 | 7872. 2 | P | |||||||||||||||||
BDL 100 | 7872. 2 | Av. | |||||||||||||||||
BDL 100 | 7872. 3 | P | 0.35 | 0.31 | 0.53 | 0.33 | 0.10 | 0.31 | 0.53 | 0.33 | 0.10 | 0.23 | 0.02 | 0.23 | |||||
BDL 100 | 7872. 3 | Av. | 1.11 | 1.38 | 1.21 | 1.19 | 1.20 | 1.38 | 1.21 | 1.19 | 1.20 | 1.13 | 1.08 | 1.38 | |||||
BDL 100 | 7873. 3 | P | |||||||||||||||||
BDL 100 | 7873. 3 | Av. |
WO 2009/141824
PCT/IL2009/000508
2018200117 05 Jan 2018
120
Gene | Ev. | Par. | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 | 16 | 17 |
BDL 100 | 7873. 4 | P | 0.43 | 0.23 | 0.57 | 0.53 | 0.23 | 0.57 | 0.53 | 0.39 | |||||||||
BDL 100 | 7873. 4 | Av. | 1.11 | 1.23 | 1.12 | 1.14 | 1.23 | 1.12 | 1.14 | 1.15 | |||||||||
BDL 106 | 7881. 1 | P | 0.24 | 0.24 | |||||||||||||||
BDL 106 | 7881. 1 | Av. | 1.13 | 1.13 | |||||||||||||||
BDL 106 | 7881. 4 | P | |||||||||||||||||
BDL 106 | 7881. 4 | Av. | |||||||||||||||||
BDL 106 | 7882. 6 | P | |||||||||||||||||
BDL 106 | 7882. 6 | Av. | |||||||||||||||||
BDL 106 | 7884. 1 | P | |||||||||||||||||
BDL 106 | 7884. 1 | Av. | |||||||||||||||||
BDL 106 | 7884. 9 | P | |||||||||||||||||
BDL 106 | 7884. 9 | Av. | |||||||||||||||||
BDL 106 | 7881. 1 | P | |||||||||||||||||
BDL 106 | 7881. 1 | Av. | |||||||||||||||||
BDL 106 | 7881. 2 | P | |||||||||||||||||
BDL 106 | 7881. 2 | Av. | |||||||||||||||||
BDL 106 | 7882. 2 | P | 0.79 | 0.79 | 0.04 | ||||||||||||||
BDL 106 | 7882. 2 | Av. | 1.13 | 1.13 | 1.17 | ||||||||||||||
BDL 106 | 7882. 4 | P | |||||||||||||||||
BDL 106 | 7882. 4 | Av. | |||||||||||||||||
BDL 106 | 7882. 5 | P | |||||||||||||||||
BDL 106 | 7882. 5 | Av. | |||||||||||||||||
BDL 108 | 8122. 2 | P | |||||||||||||||||
BDL 108 | 8122. 2 | Av. | |||||||||||||||||
BDL 108 | 8122. 3 | P | 0.02 | 0.42 | |||||||||||||||
BDL 108 | 8122. 3 | Av. | 1.10 | 1.11 | |||||||||||||||
BDL 108 | 8123. 1 | P |
WO 2009/141824
PCT/IL2009/000508
2018200117 05 Jan 2018
121
Gene | Ev. | Par. | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 | 16 | 17 |
BDL 108 | 8123. 1 | Av. | |||||||||||||||||
BDL 108 | 8123. 2 | P | |||||||||||||||||
BDL 108 | 8123. 2 | Av. | |||||||||||||||||
BDL 108 | 8123. 5 | P | |||||||||||||||||
BDL 108 | 8123. 5 | Av. | |||||||||||||||||
BDL 108 | 8121. 1 | P | |||||||||||||||||
BDL 108 | 8121. 1 | Av. | |||||||||||||||||
BDL 108 | 8121. 3 | P | |||||||||||||||||
BDL 108 | 8121. 3 | Av. | |||||||||||||||||
BDL 108 | 8121. 4 | P | |||||||||||||||||
BDL 108 | 8121. 4 | Av. | |||||||||||||||||
BDL 108 | 8122. 7 | P | |||||||||||||||||
BDL 108 | 8122. 7 | Av. | |||||||||||||||||
BDL 108 | 8123. 7 | P | |||||||||||||||||
BDL 108 | 8123. 7 | Av. | |||||||||||||||||
BDL 110 | 8092. 1 | P | 0.46 | 0.01 | 0.56 | 0.56 | 0.46 | ||||||||||||
BDL 110 | 8092. 1 | Av. | 1.13 | 1.43 | 1.17 | 1.17 | 1.27 | ||||||||||||
BDL 110 | 8092. 2 | P | 0.15 | ||||||||||||||||
BDL 110 | 8092. 2 | Av. | 1.21 | ||||||||||||||||
BDL 110 | 8092. 5 | P | 0.10 | 0.01 | 0.28 | 0.00 | 0.30 | 0.11 | 0.53 | 0.05 | 0.10 | ||||||||
BDL 110 | 8092. 5 | Av. | 1.27 | 1.52 | 1.26 | 1.17 | 1.11 | 1.19 | 1.19 | 1.11 | 1.35 | ||||||||
BDL 110 | 8095. 2 | P | 0.01 | 0.21 | 0.21 | 0.05 | |||||||||||||
BDL 110 | 8095. 2 | Av. | 1.44 | 1.23 | 1.23 | 1.45 | |||||||||||||
BDL 111 | 8102. 7 | P | |||||||||||||||||
BDL 111 | 8102. 7 | Av. | |||||||||||||||||
BDL 111 | 8103. 1 | P | |||||||||||||||||
BDL 111 | 8103. 1 | Av. |
WO 2009/141824
PCT/IL2009/000508
2018200117 05 Jan 2018
122
Gene | Ev. | Par. | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 | 16 | 17 |
BDL 111 | 8103. 2 | P | |||||||||||||||||
BDL 111 | 8103. 2 | Av. | |||||||||||||||||
BDL 111 | 8103. 4 | P | |||||||||||||||||
BDL 111 | 8103. 4 | Av. | |||||||||||||||||
BDL 111 | 8103. 5 | P | 0.04 | ||||||||||||||||
BDL 111 | 8103. 5 | Av. | 1.04 | ||||||||||||||||
BDL 111 | 8102. 7 | P | |||||||||||||||||
BDL 111 | 8102. 7 | Av. | |||||||||||||||||
BDL 111 | 8103. 1 | P | 0.41 | 0.56 | 0.39 | 0.67 | 0.55 | 0.67 | 0.55 | ||||||||||
BDL 111 | 8103. 1 | Av. | 1.11 | 1.13 | 1.10 | 1.12 | 1.15 | 1.12 | 1.15 | ||||||||||
BDL 111 | 8103. 2 | P | |||||||||||||||||
BDL 111 | 8103. 2 | Av. | |||||||||||||||||
BDL 111 | 8103. 4 | P | |||||||||||||||||
BDL 111 | 8103. 4 | Av. | |||||||||||||||||
BDL 111 | 8103. 5 | P | |||||||||||||||||
BDL 111 | 8103. 5 | Av. | |||||||||||||||||
BDL 112 | 7502. 1 | P | |||||||||||||||||
BDL 112 | 7502. 1 | Av. | |||||||||||||||||
BDL 112 | 7502. 14 | P | |||||||||||||||||
BDL 112 | 7502. 14 | Av. | |||||||||||||||||
BDL 112 | 7502. 4 | P | |||||||||||||||||
BDL 112 | 7502. 4 | Av. | |||||||||||||||||
BDL 112 | 7502. 7 | P | |||||||||||||||||
BDL 112 | 7502. 7 | Av. | |||||||||||||||||
BDL 112 | 7502. 9 | P | |||||||||||||||||
BDL 112 | 7502. 9 | Av. | |||||||||||||||||
BDL 112 | 7502. 1 | P | 0.01 |
WO 2009/141824
PCT/IL2009/000508
2018200117 05 Jan 2018
123
Gene | Ev. | Par. | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 | 16 | 17 |
BDL 112 | 7502. 1 | Av. | 1.36 | ||||||||||||||||
BDL 112 | 7502. 4 | P | |||||||||||||||||
BDL 112 | 7502. 4 | Av. | |||||||||||||||||
BDL 112 | 7502. 7 | P | |||||||||||||||||
BDL 112 | 7502. 7 | Av. | |||||||||||||||||
BDL 112 | 7502. 8 | P | |||||||||||||||||
BDL 112 | 7502. 8 | Av. | |||||||||||||||||
BDL 112 | 7502. 9 | P | |||||||||||||||||
BDL 112 | 7502. 9 | Av. | |||||||||||||||||
BDL 113 | 7683. 4 | P | |||||||||||||||||
BDL 113 | 7683. 4 | Av. | |||||||||||||||||
BDL 113 | 7683. 6 | P | |||||||||||||||||
BDL 113 | 7683. 6 | Av. | |||||||||||||||||
BDL 113 | 7684. 3 | P | |||||||||||||||||
BDL 113 | 7684. 3 | Av. | |||||||||||||||||
BDL 113 | 7684. 6 | P | |||||||||||||||||
BDL 113 | 7684. 6 | Av. | |||||||||||||||||
BDL 113 | 7684. 7 | P | |||||||||||||||||
BDL 113 | 7684. 7 | Av. | |||||||||||||||||
BDL 113 | 7683. 1 | P | |||||||||||||||||
BDL 113 | 7683. 1 | Av. | |||||||||||||||||
BDL 113 | 7683. 11 | P | |||||||||||||||||
BDL 113 | 7683. 11 | Av. | |||||||||||||||||
BDL 113 | 7683. 4 | P | |||||||||||||||||
BDL 113 | 7683. 4 | Av. | |||||||||||||||||
BDL 113 | 7684. 1 | P | |||||||||||||||||
BDL 113 | 7684. 1 | Av. |
WO 2009/141824
PCT/IL2009/000508
2018200117 05 Jan 2018
124
Gene | Ev. | Par. | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 | 16 | 17 |
BDL 113 | 7684. 5 | P | |||||||||||||||||
BDL 113 | 7684. 5 | Av. | |||||||||||||||||
BDL 114 | 7741. 3 | P | |||||||||||||||||
BDL 114 | 7741. 3 | Av. | |||||||||||||||||
BDL 114 | 7741. 6 | P | 0.44 | ||||||||||||||||
BDL 114 | 7741. 6 | Av. | 1.10 | ||||||||||||||||
BDL 114 | 7742. 1 | P | |||||||||||||||||
BDL 114 | 7742. 1 | Av. | |||||||||||||||||
BDL 114 | 7742. 3 | P | |||||||||||||||||
BDL 114 | 7742. 3 | Av. | |||||||||||||||||
BDL 114 | 7742. 5 | P | |||||||||||||||||
BDL 114 | 7742. 5 | Av. | |||||||||||||||||
BDL 115 | 8152. 3 | P | 0.09 | ||||||||||||||||
BDL 115 | 8152. 3 | Av. | 1.13 | ||||||||||||||||
BDL 115 | 8152. 4 | P | 0.18 | 0.24 | 0.06 | ||||||||||||||
BDL 115 | 8152. 4 | Av. | 1.13 | 1.12 | 1.13 | ||||||||||||||
BDL 115 | 8154. 1 | P | |||||||||||||||||
BDL 115 | 8154. 1 | Av. | |||||||||||||||||
BDL 115 | 8155. 2 | P | 0.46 | ||||||||||||||||
BDL 115 | 8155. 2 | Av. | 1.11 | ||||||||||||||||
BDL 115 | 8155. 4 | P | |||||||||||||||||
BDL 115 | 8155. 4 | Av. | |||||||||||||||||
BDL 115 | 8152. 3 | P | |||||||||||||||||
BDL 115 | 8152. 3 | Av. | |||||||||||||||||
BDL 115 | 8152. 4 | P | |||||||||||||||||
BDL 115 | 8152. 4 | Av. | |||||||||||||||||
BDL 115 | 8154. 1 | P |
WO 2009/141824
PCT/IL2009/000508
2018200117 05 Jan 2018
125
Gene | Ev. | Par. | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 | 16 | 17 |
BDL 115 | 8154. 1 | Av. | |||||||||||||||||
BDL 115 | 8155. 2 | P | |||||||||||||||||
BDL 115 | 8155. 2 | Av. | |||||||||||||||||
BDL 115 | 8155. 4 | P | 0.06 | ||||||||||||||||
BDL 115 | 8155. 4 | Av. | 1.15 | ||||||||||||||||
BDL 116 | 7481. 2 | P | |||||||||||||||||
BDL 116 | 7481. 2 | Av. | |||||||||||||||||
BDL 116 | 7481. 7 | P | |||||||||||||||||
BDL 116 | 7481. 7 | Av. | |||||||||||||||||
BDL 116 | 7481. 8 | P | |||||||||||||||||
BDL 116 | 7481. 8 | Av. | |||||||||||||||||
BDL 116 | 7482. 2 | P | |||||||||||||||||
BDL 116 | 7482. 2 | Av. | |||||||||||||||||
BDL 116 | 7485. 1 | P | |||||||||||||||||
BDL 116 | 7485. 1 | Av. | |||||||||||||||||
BDL 119 | 7732. 2 | P | 0.41 | ||||||||||||||||
BDL 119 | 7732. 2 | Av. | 1.16 | ||||||||||||||||
BDL 119 | 7733. 2 | P | 0.18 | ||||||||||||||||
BDL 119 | 7733. 2 | Av. | 1.20 | ||||||||||||||||
BDL 119 | 7734. 1 | P | |||||||||||||||||
BDL 119 | 7734. 1 | Av. | |||||||||||||||||
BDL 119 | 7734. 5 | P | 0.08 | ||||||||||||||||
BDL 119 | 7734. 5 | Av. | 1.26 | ||||||||||||||||
BDL 119 | 7734. 7 | P | 0.07 | 0.00 | 0.08 | 0.64 | 0.39 | 0.64 | 0.39 | 0.53 | |||||||||
BDL 119 | 7734. 7 | Av. | 1.33 | 1.57 | 1.09 | 1.13 | 1.19 | 1.13 | 1.19 | 1.27 | |||||||||
BDL 120 | 7891. 3 | P | |||||||||||||||||
BDL 120 | 7891. 3 | Av. |
WO 2009/141824
PCT/IL2009/000508
2018200117 05 Jan 2018
126
Gene | Ev. | Par. | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 | 16 | 17 |
BDL 120 | 7892. 4 | P | |||||||||||||||||
BDL 120 | 7892. 4 | Av. | |||||||||||||||||
BDL 120 | 7892. 6 | P | |||||||||||||||||
BDL 120 | 7892. 6 | Av. | |||||||||||||||||
BDL 120 | 7893. 2 | P | |||||||||||||||||
BDL 120 | 7893. 2 | Av. | |||||||||||||||||
BDL 120 | 7893. 5 | P | 0.14 | 0.52 | 0.12 | 0.34 | 0.43 | 0.52 | 0.12 | 0.34 | 0.43 | 0.26 | 0.00 | 0.35 | |||||
BDL 120 | 7893. 5 | Av. | 1.18 | 1.13 | 1.28 | 1.19 | 1.17 | 1.13 | 1.28 | 1.19 | 1.17 | 1.14 | 1.10 | 1.13 | |||||
BDL 122 | 7513. 1 | P | |||||||||||||||||
BDL 122 | 7513. 1 | Av. | |||||||||||||||||
BDL 122 | 7513. 1 | P | 0.07 | ||||||||||||||||
BDL 122 | 7513. 1 | Av. | 1.09 | ||||||||||||||||
BDL 122 | 7513. 14 | P | |||||||||||||||||
BDL 122 | 7513. 14 | Av. | |||||||||||||||||
BDL 122 | 7513. 9 | P | |||||||||||||||||
BDL 122 | 7513. 9 | Av. | |||||||||||||||||
BDL 122 | 7514. 3 | P | 0.25 | 0.51 | 0.47 | 0.11 | 0.27 | 0.28 | 0.20 | 0.07 | 0.07 | 0.01 | 0.33 | ||||||
BDL 122 | 7514. 3 · | Av. | 1.29 | 1.18 | 1.14 | 1.35 | 1.36 | 1.34 | 1.17 | 1.17 | 1.15 | 1.25 | 1.21 | ||||||
BDL 122 | 7513. 1 | P | 0.02 | 0.06 | 0.08 | 0.03 | 0.07 | 0.23 | 0.23 | 0.03 | 0.07 | 0.23 | 0.23 | 0.02 | |||||
BDL 122 | 7513. 1 | Av. | 1.18 | 1.13 | 1.13 | 1.25 | 1.20 | 1.12 | 1.12 | 1.25 | 1.20 | 1.12 | 1.12 | 1.17 | |||||
BDL 122 | 7513. 14 | P | |||||||||||||||||
BDL 122 | 7513. 14 | Av. | |||||||||||||||||
BDL 122 | 7513. 9 | P | 0.28 | 0.19 | 0.19 | ||||||||||||||
BDL 122 | 7513. 9 | Av. | 1.14 | 1.12 | 1.12 | ||||||||||||||
BDL 122 | 7514. 3 | P | |||||||||||||||||
BDL 122 | 7514. 3 | Av. | |||||||||||||||||
BDL 123 | 8082. 1 | P | 0.21 | 0.32 | 0.20 | 0.25 | 0.32 | 0.20 | 0.25 | 0.26 |
WO 2009/141824
PCT/IL2009/000508
2018200117 05 Jan 2018
127
Gene | Ev. | Par. | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 75 | 16 | 17 |
BDL 123 | 8082. 1 | Av. | 1.15 | 1.21 | 1.17 | 1.12 | 1.21 | 1.17 | 1.12 | 1.20 | |||||||||
BDL 123 | 8082. 3 | P | 0.00 | 0.00 | 0.02 | 0.05 | 0.00 | 0.02 | 0.05 | 0.01 | 0.00 | 0.00 | |||||||
BDL 123 | 8082. 3 | Av. | 1.23 | 1.32 | 1.25 | 1.23 | 1.32 | 1.25 | 1.23 | 1.26 | 1.16 | 1.18 | |||||||
BDL 123 | 8082. 6 | P | 0.16 | 0.24 | 0.24 | 0.20 | |||||||||||||
BDL 123 | 8082. 6 | Av. | 1.13 | 1.11 | 1.11 | 1.12 | |||||||||||||
BDL 123 | 8083. 2 | P | |||||||||||||||||
BDL 123 | 8083. 2 | Av. | |||||||||||||||||
BDL 123 | 8083. 3 | P | 0.00 | 0.00 | 0.02 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.03 | 0.29 | 0.01 | 0.00 | ||||
BDL 123 | 8083. 3 | Av. | 1.33 | 1.19 | 1.18 | 1.64 | 1.46 | 1.44 | 1.64 | 1.46 | 1.44 | 1.30 | 1.10 | 1.12 | 1.46 | ||||
BDL 124 | 8482. 1 | P | |||||||||||||||||
BDL 124 | 8482. 1 | Av. | |||||||||||||||||
BDL 125 | 7491. 1 | P | 0.00 | 0.08 | 0.34 | 0.18 | 0.08 | 0.34 | 0.18 | 0.00 | |||||||||
BDL 125 | 7491. 1 | Av. | 1.24 | 1.29 | 1.23 | 1.20 | 1.29 | 1.23 | 1.20 | 1.28 | |||||||||
BDL 125 | 7491. 5 | P | 0.58 | 0.58 | 0.23 | ||||||||||||||
BDL 125 | 7491. 5 | Av. | 1.13 | 1.13 | 1.12 | ||||||||||||||
BDL 125 | 7492. 5 | P | |||||||||||||||||
BDL 125 | 7492. 5 | Av. | |||||||||||||||||
BDL 125 | 7494. 1 | P | 0.00 | ||||||||||||||||
BDL 125 | 7494. 1 | Av. | 1.12 | ||||||||||||||||
BDL 125 | 7495. 5 | P | |||||||||||||||||
BDL 125 | 7495. 5 | Av. | |||||||||||||||||
BDL 128 | 7711. 3 | P | 0.26 | ||||||||||||||||
BDL 128 | 7711. 3 | Av. | 1.14 | ||||||||||||||||
BDL 128 | 8361. 5 | P | 0.07 | 0.28 | 0.28 | 0.43 | |||||||||||||
BDL 128 | 8361. 5 | Av. | 1.10 | 1.14 | 1.14 | 1.12 | |||||||||||||
BDL 128 | 8362. 2 | P | 0.00 | 0.05 | 0.16 | 0.02 | 0.23 | 0.25 | 0.11 | 0.06 | 0.01 | ||||||||
BDL 128 | 8362. 2 | Av. | 1.21 | 1.10 | 1.12 | 1.24 | 1.14 | 1.16 | 1.18 | 1.08 | 1.15 |
WO 2009/141824
PCT/IL2009/000508
2018200117 05 Jan 2018
128
Gene | Ev. | Par. | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 | 16 | 17 |
BDL 128 | 8363. 2 | P | |||||||||||||||||
BDL 128 | 8363. 2 | Av. | |||||||||||||||||
BDL 128 | 8365. 2 | P | |||||||||||||||||
BDL 128 | 8365. 2 | Av. | |||||||||||||||||
BDL 129 | 7691. 4 | P | |||||||||||||||||
BDL 129 | 7691. 4 | Av. | |||||||||||||||||
BDL 129 | 7691. 6 | P | |||||||||||||||||
BDL 129 | 7691. 6 | Av. | |||||||||||||||||
BDL 129 | 7692. 2 | P | 0.14 | 0.00 | 0.41 | ||||||||||||||
BDL 129 | 7692. 2 | Av. | 1.11 | 1.12 | 1.15 | ||||||||||||||
BDL 129 | 7692. 6 | P | |||||||||||||||||
BDL 129 | 7692. 6 | Av. | |||||||||||||||||
BDL 129 | 7693. 1 | P | |||||||||||||||||
BDL 129 | 7693. 1 | Av. | |||||||||||||||||
BDL 130 | 7663. 1 | P | 0.03 | 0.53 | |||||||||||||||
BDL 130 | 7663. 1 | Av. | 1.33 | 1.15 | |||||||||||||||
BDL 130 | 7663. 3 | P | |||||||||||||||||
BDL 130 | 7663. 3 | Av. | |||||||||||||||||
BDL 130 | 7663. 6 | P | 0.00 | 0.73 | 0.26 | ||||||||||||||
BDL 130 | 7663. 6 | Av. | 1.49 | 1.12 | 1.37 | ||||||||||||||
BDL 130 | 7664. 5 | P | 0.31 | 0.02 | 0.52 | 0.66 | 0.38 | ||||||||||||
BDL 130 | 7664. 5 | Av. | 1.17 | 1.51 | 1.28 | 1.22 | 1.40 | ||||||||||||
BDL 131 | 7461. 2 | P | 0.00 | 0.20 | 0.00 | 0.13 | 0.01 | 0.05 | 0.00 | 0.13 | 0.01 | 0.05 | 0.08 | ||||||
BDL 131 | 7461. 2 | Av. | 1.21 | 1.13 | 1.41 | 1.13 | 1.34 | 1.26 | 1.41 | 1.13 | 1.34 | 1.26 | 1.53 | ||||||
BDL 131 | 7461. 4 | P | 0.01 | 0.01 | 0.05 | 0.05 | 0.17 | 0.22 | 0.24 | 0.41 | 0.58 | 0.47 | 0.01 | 0.02 | 0.06 | 0.02 | |||
BDL 131 | 7461. 4 | Av. | 1.27 | 1.42 | 1.18 | 1.19 | 1.18 | 1.33 | 1.11 | 1.12 | 1.11 | 1.12 | 1.12 | 1.09 | 1.08 | 1.38 | |||
BDL 131 | 7462. 2 | P | 0.00 | 0.04 | 0.08 | 0.05 | 0.35 | 0.03 | 0.11 | 0.00 | 0.35 | 0.03 | 0.11 | 0.00 | 0.36 | 0.25 | 0.33 |
WO 2009/141824
PCT/IL2009/000508
2018200117 05 Jan 2018
129
Gene | Ev. | Par. | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 | 16 | 17 |
BDL 131 | 7462. 2 | Av. | 1.37 | 1.21 | 1.15 | 1.11 | 1.43 | 1.50 | 1.39 | 1.31 | 1.43 | 1.50 | 1.39 | 1.31 | 1.14 | 1.17 | 1.40 | ||
BDL 131 | 7463. 4 | P | 0.01 | 0.13 | 0.15 | 0.13 | 0.15 | 0.06 | 0.21 | ||||||||||
BDL 131 | 7463. 4 | Av. | 1.13 | 1.13 | 1.15 | 1.13 | 1.15 | 1.04 | 1.12 | ||||||||||
BDL 131 | 7464. 5 | P | 0.05 | ||||||||||||||||
BDL 131 | 7464. 5 | Av. | 1.06 | ||||||||||||||||
BDL 132 | 7471. 1 | P | 0.00 | 0.28 | 0.06 | 0.35 | 0.30 | 0.11 | 0.22 | 0.30 | 0.11 | 0.22 | 0.43 | 0.09 | 0.02 | ||||
BDL 132 | 7471. 1 | Av. | 1.27 | 1.22 | 1.20 | 1.12 | 1.50 | 1.33 | 1.23 | 1.50 | 1.33 | 1.23 | 1.23 | 1.12 | 1.14 | ||||
BDL 132 | 7471. 4 | P | 0.07 | 0.31 | 0.14 | 0.56 | 0.28 | 0.09 | 0.07 | 0.56 | 0.28 | 0.09 | 0.07 | 0.19 | 0.08 | ||||
BDL 132 | 7471. 4 | Av. | 1.08 | 1.11 | 1.12 | 1.15 | 1.27 | 1.21 | 1.19 | 1.15 | 1.27 | 1.21 | 1.19 | 1.14 | 1.18 | ||||
BDL 132 | 7472. 4 | P | |||||||||||||||||
BDL 132 | 7472. 4 | Av. | |||||||||||||||||
BDL 132 | 7473. 1 | P | 0.02 | 0.06 | 0.03 | 0.13 | 0.03 | 0.13 | |||||||||||
BDL 132 | 7473. 1 | Av. | 1.12 | 1.09 | 1.31 | 1.15 | 1.31 | 1.15 | |||||||||||
BDL 132 | 7474. 4 | P | |||||||||||||||||
BDL 132 | 7474. 4 | Av. | |||||||||||||||||
BDL 132 | 7471. 1 | P | |||||||||||||||||
BDL 132 | 7471. 1 | Av. | |||||||||||||||||
BDL 132 | 7471. 4 | P | |||||||||||||||||
BDL 132 | 7471. 4 | Av. | |||||||||||||||||
BDL 132 | 7472. 4 | P | |||||||||||||||||
BDL 132 | 7472. 4 | Av. | |||||||||||||||||
BDL 132 | 7473. 1 | P | |||||||||||||||||
BDL 132 | 7473. 1 | Av. | |||||||||||||||||
BDL 132 | 7475. 4 | P | |||||||||||||||||
BDL 132 | 7475. 4 | Av. | |||||||||||||||||
BDL 133 | 8161. 1 | P | 0.27 | ||||||||||||||||
BDL 133 | 8161. 1 | Av. | 1.34 |
WO 2009/141824
PCT/IL2009/000508
2018200117 05 Jan 2018
130
Gene | Ev. | Par. | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 | 16 | 17 |
BDL 133 | 8161. 2 | P | 0.07 | 0.00 | 0.03 | 0.01 | 0.28 | 0.05 | 0.02 | 0.46 | |||||||||
BDL 133 | 8161. 2 | Av. | 1.29 | 1.52 | 1.48 | 1.16 | 1.13 | 1.39 | 1.58 | 1.12 | |||||||||
BDL 133 | 8161. 3 | P | 0.06 | 0.32 | 0.32 | ||||||||||||||
BDL 133 | 8161. 3 | Av. | 1.47 | 1.13 | 1.13 | ||||||||||||||
BDL 133 | 8161. 4 | P | 0.15 | ||||||||||||||||
BDL 133 | 8161. 4 | Av. | 1.32 | ||||||||||||||||
BDL 133 | 8162. 1 | P | 0.07 | ||||||||||||||||
BDL 133 | 8162. 1 | Av. | 1.26 | ||||||||||||||||
BDL 133 | 8162. 3 | P | 0.03 | 0.31 | |||||||||||||||
BDL 133 | 8162. 3 | Av. | 1.34 | 1.21 | |||||||||||||||
BDL 133 | 8162. 5 | P | 0.30 | 0.00 | 0.24 | 0.02 | 0.01 | 0.24 | 0.02 | 0.01 | 0.17 | ||||||||
BDL 133 | 8162. 5 | Av. | 1.15 | 1.53 | 1.27 | 1.17 | 1.22 | 1.27 | 1.17 | 1.22 | 1.45 | ||||||||
BDL 133 | 8163. 2 | P | 0.27 | 0.59 | |||||||||||||||
BDL 133 | 8163. 2 | Av. | 1.33 | 1.29 | |||||||||||||||
BDL 134 | 7671. 2 | P | |||||||||||||||||
BDL 134 | 7671. 2 | Av. | |||||||||||||||||
BDL 134 | 7672. 1 | P | |||||||||||||||||
BDL 134 | 7672. 1 | Av. | |||||||||||||||||
BDL 134 | 7673. 1 | P | |||||||||||||||||
BDL 134 | 7673. 1 | Av. | |||||||||||||||||
BDL 134 | 7673. 2 | P | 0.21 | ||||||||||||||||
BDL 134 | 7673. 2 | Av. | 1.19 | ||||||||||||||||
BDL 135 | 7722. 1 | P | 0.03 | 0.55 | |||||||||||||||
BDL 135 | 7722. 1 | Av. | 1.35 | 1.12 | |||||||||||||||
BDL 135 | 7723. 1 | P | 0.01 | ||||||||||||||||
BDL 135 | 7723. 1 | Av. | 1.40 | ||||||||||||||||
BDL 135 | 7723. 3 | P | 0.27 |
WO 2009/141824
PCT/IL2009/000508
2018200117 05 Jan 2018
131
Gene | Ev. | Par. | J | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 | 16 | 17 |
BDL 135 | 7723. 3 | Av. | 1.17 | ||||||||||||||||
BDL 135 | 7723. 8 | P | 0.11 | ||||||||||||||||
BDL 135 | 7723. 8 | Av. | 1.31 | ||||||||||||||||
BDL 135 | 7723. 9 | P | 0.35 | 0.00 | 0.36 | 0.37 | 0.03 | 0.01 | 0.36 | 0.37 | 0.03 | 0.01 | 0.24 | ||||||
BDL 135 | 7723. 9 | Av. | 1.18 | 1.57 | 1.41 | 1.17 | 1.15 | 1.17 | 1.41 | 1.17 | 1.15 | 1.17 | 1.54 | ||||||
BDL 136 | 7751. 4 | P | 0.36 | 0.01 | 0.55 | ||||||||||||||
BDL 136 | 7751. 4 | Av. | 1.17 | 1.39 | 1.12 | ||||||||||||||
BDL 136 | 7751. 5 | P | 0.25 | ||||||||||||||||
BDL 136 | 7751. 5 | Av. | 1.16 | ||||||||||||||||
BDL 136 | 7751. 8 | P | 0.06 | 0.01 | 0.33 | 0.18 | 0.06 | 0.17 | 0.20 | 0.18 | 0.06 | 0.17 | 0.20 | 0.24 | 0.36 | 0.06 | |||
BDL 136 | 7751. 8 | Av. | 1.31 | 1.65 | 1.16 | 1.25 | 1.33 | 1.28 | 1.33 | 1.25 | 1.33 | 1.28 | 1.33 | 1.24 | 1.13 | 1.11 | |||
BDL 136 | 7752. 6 | P | 0.01 | 0.10 | |||||||||||||||
BDL 136 | 7752. 6 | Av. | 1.44 | 1.36 | |||||||||||||||
BDL 137 | 7701. 2 | P | 0.00 | 0.30 | 0.29 | 0.30 | 0.29 | ||||||||||||
BDL 137 | 7701. 2 | Av. | 1.51 | 1.16 | 1.13 | 1.16 | 1.13 | ||||||||||||
BDL 137 | 7701. 5 | P | 0.09 | ||||||||||||||||
BDL 137 | 7701. 5 | Av. | 1.34 | ||||||||||||||||
BDL 137 | 7701. 6 | P | 0.06 | 0.67 | |||||||||||||||
BDL 137 | 7701. 6 | Av. | 1.44 | 1.21 | |||||||||||||||
BDL 137 | 7702. 1 | P | |||||||||||||||||
BDL 137 | 7702. 1 | Av. | |||||||||||||||||
BDL 137 | 7703. 2 | P | 0.06 | ||||||||||||||||
BDL 137 | 7703. 2 | Av. | 1.38 | ||||||||||||||||
BDL 137 | 7703. 3 | P | 0.16 | ||||||||||||||||
BDL 137 | 7703. 3 | Av. | 1.20 | ||||||||||||||||
BDL 137 | 7703. 7 | P | 0.13 | 0.46 | |||||||||||||||
BDL 137 | 7703. 7 | Av. | 1.36 | 1.27 |
WO 2009/141824
PCT/IL2009/000508
2018200117 05 Jan 2018
132
Gene | Ev. | Par. | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 | 16 | 17 |
BDL 139 | 8131. 1 | P | |||||||||||||||||
BDL 139 | 8131. 1 | Av. | |||||||||||||||||
BDL 139 | 8131. 2 | P | |||||||||||||||||
BDL 139 | 8131. 2 | Av. | |||||||||||||||||
BDL 139 | 8132. 7 | P | |||||||||||||||||
BDL 139 | 8132. 7 | Av. | |||||||||||||||||
BDL 139 | 8133. 2 | P | |||||||||||||||||
BDL 139 | 8133. 2 | Av. | |||||||||||||||||
BDL 141 | 8141. 2 | P | 0.06 | 0.30 | |||||||||||||||
BDL 141 | 8141. 2 | Av. | 1.39 | 1.21 | |||||||||||||||
BDL 141 | 8142. 2 | P | |||||||||||||||||
BDL 141 | 8142. 2 | Av. | |||||||||||||||||
BDL 142 | 8282. 1 | P | 0.18 | ||||||||||||||||
BDL 142 | 8282. 1 | Av. | 1.34 | ||||||||||||||||
BDL 142 | 8283. 1 | P | 0.11 | ||||||||||||||||
BDL 142 | 8283. 1 | Av. | 1.24 | ||||||||||||||||
BDL 142 | 8283. 2 | P | 0.01 | 0.47 | 0.47 | 0.06 | |||||||||||||
BDL 142 | 8283. 2 | Av. | 1.45 | 1.18 | 1.18 | 1.42 | |||||||||||||
BDL 142 | 8284. 1 | P | 0.02 | ||||||||||||||||
BDL 142 | 8284. 1 | Av. | 1.36 | ||||||||||||||||
BDL 142 | 8285. 3 | P | 0.13 | ||||||||||||||||
BDL 142 | 8285. 3 | Av. | 1.23 | ||||||||||||||||
BDL 142 | 8285. 5 | P | 0.49 | 0.06 | 0.51 | 0.57 | 0.51 | 0.57 | 0.24 | ||||||||||
BDL 142 | 8285. 5 | Av. | 1.10 | 1.53 | 1.12 | 1.11 | 1.12 | 1.11 | 1.24 | ||||||||||
BDL 143 | 8411. 1 | P | 0.33 | 0.00 | 0.28 | 0.03 | 0.00 | 0.06 | 0.28 | 0.03 | 0.00 | 0.06 | 0.30 | 0.08 | 0.03 | ||||
BDL 143 | 8411. 1 | Av. | 1.18 | 1.73 | 1.47 | 1.36 | 1.28 | 1.32 | 1.47 | 1.36 | 1.28 | 1.32 | 1.51 | 1.12 | 1.17 | ||||
BDL 143 | 8411. 5 | P | 0.37 | 0.04 | 0.64 |
WO 2009/141824
PCT/IL2009/000508
2018200117 05 Jan 2018
133
Gene | Ev. | Par. | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 | 16 | 17 |
BDL 143 | 8411. 5 | Av. | 1.13 | 1.37 | 1.12 | ||||||||||||||
BDL 143 | 8412. 2 | P | 0.24 | ||||||||||||||||
BDL 143 | 8412. 2 | Av. | 1.20 | ||||||||||||||||
BDL 143 | 8412. 4 | P | |||||||||||||||||
BDL 143 | 8412. 4 | Av. | |||||||||||||||||
BDL 143 | 8413. 3 | P | 0.21 | ||||||||||||||||
BDL 143 | 8413. 3 | Av. | 1.18 | ||||||||||||||||
BDL 143 | 8414. 4 | P | 0.35 | ||||||||||||||||
BDL 143 | 8414. 4 | Av. | 1.35 | ||||||||||||||||
BDL 143 | 8414. 5 | P | 0.19 | ||||||||||||||||
BDL 143 | 8414. 5 | Av. | 1.19 | ||||||||||||||||
BDL 144 | 8384. 1 | P | 0.05 | ||||||||||||||||
BDL 144 | 8384. 1 | Av. | 1.30 | ||||||||||||||||
BDL 144 | 8384. 5 | P | 0.06 | ||||||||||||||||
BDL 144 | 8384. 5 | Av. | 1.29 | ||||||||||||||||
BDL 144 | 8385. 1 | P | |||||||||||||||||
BDL 144 | 8385. 1 | Av. | |||||||||||||||||
BDL 145 | 8233. 2 | P | 0.10 | ||||||||||||||||
BDL 145 | 8233. 2 | Av. | 1.26 | ||||||||||||||||
BDL 145 | 8233. 3 | P | |||||||||||||||||
BDL 145 | 8233. 3 | Av. | |||||||||||||||||
BDL 145 | 8235. 1 | P | 0.13 | ||||||||||||||||
BDL 145 | 8235. 1 | Av. | 1.24 | ||||||||||||||||
BDL 145 | 8235. 3 | P | |||||||||||||||||
BDL 145 | 8235. 3 | Av. | |||||||||||||||||
BDL 145 | 8235. 4 | P | |||||||||||||||||
BDL 145 | 8235. 4 | Av. |
WO 2009/141824
PCT/IL2009/000508
2018200117 05 Jan 2018
134
Gene | Ev. | Par. | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 | 16 | 17 |
BDL 146 | 8241. 1 | P | 0.42 | 0.13 | 0.32 | 0.60 | 0.32 | 0.60 | 0.15 | ||||||||||
BDL 146 | 8241. 1 | Av. | 1.12 | 1.46 | 1.18 | 1.13 | 1.18 | 1.13 | 1.30 | ||||||||||
BDL 146 | 8241. 3 | P | 0.08 | ||||||||||||||||
BDL 146 | 8241. 3 | Av. | 1.28 | ||||||||||||||||
BDL 146 | 8243. 2 | P | 0.06 | 0.55 | |||||||||||||||
BDL 146 | 8243. 2 | Av. | 1.37 | 1.12 | |||||||||||||||
BDL 146 | 8243. 5 | P | 0.45 | ||||||||||||||||
BDL 146 | 8243. 5 | Av. | 1.21 | ||||||||||||||||
BDL 146 | 8244. 4 | P | 0.07 | 0.33 | 0.27 | 0.42 | 0.33 | 0.27 | 0.42 | 0.21 | |||||||||
BDL 146 | 8244. 4 | Av. | 1.57 | 1.16 | 1.26 | 1.22 | 1.16 | 1.26 | 1.22 | 1.11 | |||||||||
BDL 146 | 8244. 7 | P | 0.47 | ||||||||||||||||
BDL 146 | 8244. 7 | Av. | 1.10 | ||||||||||||||||
BDL 146 | 8245. 2 | P | 0.02 | ||||||||||||||||
BDL 146 | 8245. 2 | Av. | 1.35 | ||||||||||||||||
BDL 146 | 8245. 5 | P | 0.32 | 0.00 | 0.23 | 0.21 | 0.47 | 0.23 | 0.21 | 0.47 | 0.05 | ||||||||
BDL 146 | 8245. 5 | Av. | 1.16 | 1.51 | 1.21 | 1.13 | 1.11 | 1.21 | 1.13 | 1.11 | 1.45 | ||||||||
BDL 42 | 7771. 1 | P | |||||||||||||||||
BDL 42 | 7771. 1 | Av. | |||||||||||||||||
BDL 42 | 7772. 1 | P | |||||||||||||||||
BDL 42 | 7772. 1 | Av. | |||||||||||||||||
BDL 42 | 7772. 7 | P | |||||||||||||||||
BDL 42 | 7772. 7 | Av. | |||||||||||||||||
BDL 42 | 7774. 1 | P | |||||||||||||||||
BDL 42 | 7774. 1 | Av. | |||||||||||||||||
BDL 42 | 7774. 2 | P | |||||||||||||||||
BDL 42 | 7774. 2 | Av. | |||||||||||||||||
BDL 42 | 7774. 4 | P | 0.56 |
WO 2009/141824
PCT/IL2009/000508
2018200117 05 Jan 2018
135
Gene | Ev. | Par. | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 | 16 | 17 |
BDL 42 | 7774. 4 | Av. | 1.11 | ||||||||||||||||
BDL 46 | 7833. 3 | P | |||||||||||||||||
BDL 46 | 7833. 3 | Av. | |||||||||||||||||
BDL 46 | 7833. 4 | P | 0.27 | 0.10 | |||||||||||||||
BDL 46 | 7833. 4 | Av. | 1.10 | 1.08 | |||||||||||||||
BDL 46 | 7833. 5 | P | |||||||||||||||||
BDL 46 | 7833. 5 | Av. | |||||||||||||||||
BDL 46 | 7833. 6 | P | |||||||||||||||||
BDL 46 | 7833. 6 | Av. | |||||||||||||||||
BDL 46 | 7834. 1 | P | |||||||||||||||||
BDL 46 | 7834. 1 | Av. | |||||||||||||||||
BDL 46 | 7833. 1 | P | |||||||||||||||||
BDL 46 | 7833. 1 | Av. | |||||||||||||||||
BDL 46 | 7833. 3 | P | |||||||||||||||||
BDL 46 | 7833. 3 | Av. | |||||||||||||||||
BDL 46 | 7833. 4 | P | |||||||||||||||||
BDL 46 | 7833. 4 | Av. | |||||||||||||||||
BDL 46 | 7833. 5 | P | |||||||||||||||||
BDL 46 | 7833. 5 | Av. | |||||||||||||||||
BDL 46 | 7834. 4 | P | 0.19 | ||||||||||||||||
BDL 46 | 7834. 4 | Av. | 1.25 | ||||||||||||||||
BDL 51 | 7291. 1 | P | |||||||||||||||||
BDL 51 | 7291. 1 | Av. | |||||||||||||||||
BDL 51 | 8021. 1 | P | |||||||||||||||||
BDL 51 | 8021. 1 | Av. | |||||||||||||||||
BDL 51 | 8022. 4 | P | |||||||||||||||||
BDL 51 | 8022. 4 | Av. |
WO 2009/141824
PCT/IL2009/000508
2018200117 05 Jan 2018
136
Gene | Ev. | Par. | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 | 16 | 17 |
BDL 51 | 8022. 5 | P | |||||||||||||||||
BDL 51 | 8022. 5 | Av. | |||||||||||||||||
BDL 51 | 8024. 4 | P | |||||||||||||||||
BDL 51 | 8024. 4 | Av. | |||||||||||||||||
BDL 51 | 8024. 7 | P | |||||||||||||||||
BDL 51 | 8024. 7 | Av. | |||||||||||||||||
BDL 52 | 7861. 1 | P | 0.02 | ||||||||||||||||
BDL 52 | 7861. 1 | Av. | 1.08 | ||||||||||||||||
BDL 52 | 7861. 5 | P | |||||||||||||||||
BDL 52 | 7861. 5 | Av. | |||||||||||||||||
BDL 52 | 7863. 2 | P | 0.17 | ||||||||||||||||
BDL 52 | 7863. 2 | Av. | 1.12 | ||||||||||||||||
BDL 52 | 7864. 5 | P | 0.14 | 0.14 | 0.14 | 0.14 | |||||||||||||
BDL 52 | 7864. 5 | Av. | 1.16 | 1.12 | 1.16 | 1.12 | |||||||||||||
BDL 54 | 7781. 1 | P | |||||||||||||||||
BDL 54 | 7781. 1 | Av. | |||||||||||||||||
BDL 54 | 7781. 4 | P | |||||||||||||||||
BDL 54 | 7781. 4 | Av. | |||||||||||||||||
BDL 54 | 7784. 3 | P | |||||||||||||||||
BDL 54 | 7784. 3 | Av. | |||||||||||||||||
BDL 54 | 7784. 5 | P | |||||||||||||||||
BDL 54 | 7784. 5 | Av. | |||||||||||||||||
BDL 54 | 7785. 4 | P | |||||||||||||||||
BDL 54 | 7785. 4 | Av. | |||||||||||||||||
BDL 54 | 7781. 1 | P | |||||||||||||||||
BDL 54 | 7781. 1 | Av. | |||||||||||||||||
BDL 54 | 7781. 4 | P |
WO 2009/141824
PCT/IL2009/000508
2018200117 05 Jan 2018
137
Gene | Ev. | Par. | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 | 16 | 17 |
BDL 54 | 7781. 4 | Av. | |||||||||||||||||
BDL 54 | 7784. 3 | P | |||||||||||||||||
BDL 54 | 7784. 3 | Av. | |||||||||||||||||
BDL 54 | 7785. 4 | P | |||||||||||||||||
BDL 54 | 7785. 4 | Av. | |||||||||||||||||
BDL 54 | 7785. 8 | P | |||||||||||||||||
BDL 54 | 7785. 8 | Av. | |||||||||||||||||
BDL 56 | 7181. 2 | P | |||||||||||||||||
BDL 56 | 7181. 2 | Av. | |||||||||||||||||
BDL 56 | 8301. 1 | P | 0.00 | 0.05 | 0.04 | 0.04 | 0.31 | 0.00 | 0.02 | 0.02 | 0.31 | 0.00 | 0.02 | 0.02 | 0.38 | 0.07 | 0.02 | 0.28 | |
BDL 56 | 8301. 1 | Av. | 1.26 | 1.18 | 1.21 | 1.12 | 1.36 | 1.33 | 1.33 | 1.33 | 1.36 | 1.33 | 1.33 | 1.33 | 1.16 | 1.09 | 1.09 | 1.32 | |
BDL 56 | 8301. 3 | P | |||||||||||||||||
BDL 56 | 8301. 3 | Av. | |||||||||||||||||
BDL 56 | 8304. 1 | P | 0.14 | 0.04 | 0.45 | 0.09 | 0.06 | 0.45 | 0.09 | 0.06 | 0.58 | 0.06 | 0.17 | 0.39 | |||||
BDL 56 | 8304. 1 | Av. | 1.19 | 1.11 | 1.28 | 1.17 | 1.16 | 1.28 | 1.17 | 1.16 | 1.14 | 1.09 | 1.12 | 1.23 | |||||
BDL 56 | 8305. 1 | P | |||||||||||||||||
BDL 56 | 8305. 1 | Av. | |||||||||||||||||
BDL 56 | 8301. 1 | P | |||||||||||||||||
BDL 56 | 8301. 1 | Av. | |||||||||||||||||
BDL 56 | 8301. 2 | P | 0.39 | ||||||||||||||||
BDL 56 | 8301. 2 | Av. | 1.24 | ||||||||||||||||
BDL 56 | 8301. 3 | P | |||||||||||||||||
BDL 56 | 8301. 3 | Av. | |||||||||||||||||
BDL 56 | 8303. 1 | P | 0.43 | ||||||||||||||||
BDL 56 | 8303. 1 | Av. | 1.11 | ||||||||||||||||
BDL 56 | 8303. 2 | P | |||||||||||||||||
BDL 56 | 8303. 2 | Av. |
WO 2009/141824
PCT/IL2009/000508
2018200117 05 Jan 2018
138
Gene | Ev. | Par. | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 | 16 | 17 |
BDL 59 | 7792. 1 | P | 0.00 | 0.05 | 0.14 | 0.23 | 0.06 | 0.04 | 0.23 | 0.06 | 0.04 | 0.08 | 0.00 | 0.06 | 0.09 | ||||
BDL 59 | 7792. 1 | Av. | 1.21 | 1.15 | 1.10 | 1.25 | 1.24 | 1.24 | 1.25 | 1.24 | 1.24 | 1.16 | 1.17 | 1.13 | 1.16 | ||||
BDL 59 | 7792. 2 | P | 0.05 | 0.20 | |||||||||||||||
BDL 59 | 7792. 2 | Av. | 1.09 | 1.12 | |||||||||||||||
BDL 59 | 7792. 3 | P | 0.21 | 0.16 | 0.03 | 0.05 | 0.57 | 0.03 | 0.12 | 0.10 | 0.57 | 0.03 | 0.12 | 0.10 | 0.58 | 0.07 | 0.09 | 0.00 | 0.62 |
BDL 59 | 7792. 3 | Av. | 1.12 | 1.13 | 1.17 | 1.11 | 1.22 | 1.23 | 1.18 | 1.13 | 1.22 | 1.23 | 1.18 | 1.13 | 1.14 | 1.09 | 1.12 | 1.20 | 1.13 |
BDL 59 | 7793. 3 | P | 0.07 | 0.09 | |||||||||||||||
BDL 59 | 7793. 3 | Av. | 1.05 | 1.07 | |||||||||||||||
BDL 59 | 7794. 1 | P | |||||||||||||||||
BDL 59 | 7794. 1 | Av. | |||||||||||||||||
BDL 60 | 8011. 4 | P | 0.47 | 0.40 | 0.42 | 0.47 | 0.40 | 0.42 | 0.27 | 0.00 | |||||||||
BDL 60 | 8011. 4 | Av. | 1.18 | 1.21 | 1.19 | 1.18 | 1.21 | 1.19 | 1.11 | 1.11 | |||||||||
BDL 60 | 8011. 7 | P | |||||||||||||||||
BDL 60 | 8011. 7 | Av. | |||||||||||||||||
BDL 60 | 8013. 4 | P | |||||||||||||||||
BDL 60 | 8013. 4 | Av. | |||||||||||||||||
BDL 60 | 8013. 6 | P | |||||||||||||||||
BDL 60 | 8013. 6 | Av. | |||||||||||||||||
BDL 60 | 8014. 5 | P | |||||||||||||||||
BDL 60 | 8014. 5 | Av. | |||||||||||||||||
BDL 60 | 8013. 6 | P | |||||||||||||||||
BDL 60 | 8013. 6 | Av. | |||||||||||||||||
BDL 60 | 8014. 2 | P | 0.00 | ||||||||||||||||
BDL 60 | 8014. 2 | Av. | 1.20 | ||||||||||||||||
BDL 60 | 8014. 7 | P | 0.48 | ||||||||||||||||
BDL 60 | 8014. 7 | Av. | 1.27 | ||||||||||||||||
BDL 60 | 8014. 8 | P |
WO 2009/141824
PCT/IL2009/000508
2018200117 05 Jan 2018
139
Gene | Ev. | Par. | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 | 16 | 17 |
BDL 60 | 8014. 8 | Av. | |||||||||||||||||
BDL 65 | 7824. 1 | P | |||||||||||||||||
BDL 65 | 7824. 1 | Av. | |||||||||||||||||
BDL 65 | 7825. 2 | P | 0.36 | ||||||||||||||||
BDL 65 | 7825. 2 | Av. | 1.27 | ||||||||||||||||
BDL 65 | 8473. 2 | P | |||||||||||||||||
BDL 65 | 8473. 2 | Av. | |||||||||||||||||
BDL 65 | 8474. 1 | P | 0.03 | 0.50 | 0.50 | 0.30 | |||||||||||||
BDL 65 | 8474. 1 | Av. | 1.32 | 1.14 | 1.14 | 1.36 | |||||||||||||
BDL 67 | 7901. 5 | P | |||||||||||||||||
BDL 67 | 7901. 5 | Av. | |||||||||||||||||
BDL 67 | 7902. 3 | P | |||||||||||||||||
BDL 67 | 7902. 3 | Av. | |||||||||||||||||
BDL 67 | 7902. 7 | P | |||||||||||||||||
BDL 67 | 7902. 7 | Av. | |||||||||||||||||
BDL 67 | 7903. 3 | P | |||||||||||||||||
BDL 67 | 7903. 3 | Av. | |||||||||||||||||
BDL 67 | 7903. 5 | P | |||||||||||||||||
BDL 67 | 7903. 5 | Av. | |||||||||||||||||
BDL 68 | 7761. 3 | P | |||||||||||||||||
BDL 68 | 7761. 3 | Av. | |||||||||||||||||
BDL 68 | 7761. 8 | P | |||||||||||||||||
BDL 68 | 7761. 8 | Av. | |||||||||||||||||
BDL 68 | 7761. 9 | P | |||||||||||||||||
BDL 68 | 7761. 9 | Av. | |||||||||||||||||
BDL 68 | 7763. 2 | P | |||||||||||||||||
BDL 68 | 7763. 2 | Av. |
WO 2009/141824
PCT/IL2009/000508
2018200117 05 Jan 2018
140
Gene | Ev. | Par. | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 | 16 | 17 |
BDL 68 | ΊΊΜ. 1 | P | |||||||||||||||||
BDL 68 | 7764. 1 | Av. | |||||||||||||||||
BDL 78 | 7911. 11 | P | 0.03 | 0.55 | |||||||||||||||
BDL 78 | 7911. 11 | Av. | 1.34 | 1.12 | |||||||||||||||
BDL 78 | 7911. 8 | P | 0.31 | ||||||||||||||||
BDL 78 | 7911. 8 | Av. | 1.20 | ||||||||||||||||
BDL 78 | 7911. 9 | P | |||||||||||||||||
BDL 78 | 7911. 9 | Av. | |||||||||||||||||
BDL 78 | 7912. 6 | P | 0.11 | ||||||||||||||||
BDL 78 | 7912. 6 | Av. | 1.23 | ||||||||||||||||
BDL 78 | 7913. 11 | P | 0.48 | ||||||||||||||||
BDL 78 | 7913. 11 | Av. | 1.11 | ||||||||||||||||
BDL 78 | 7913. 3 | P | 0.00 | 0.47 | QAl | 0.19 | |||||||||||||
BDL 78 | 7913. 3 | Av. | 1.46 | 1.13 | 1.13 | 1.33 | |||||||||||||
BDL 78 | 7913. 6 | P | |||||||||||||||||
BDL 78 | 7913. 6 | Av. | |||||||||||||||||
BDL 78 | 7913. 8 | P | 0.39 | ||||||||||||||||
BDL 78 | 7913. 8 | Av. | 1.12 | ||||||||||||||||
BDL 78 | 7913. 9 | P | 0.01 | ||||||||||||||||
BDL 78 | 7913. 9 | Av. | 1.38 | ||||||||||||||||
BDL 82 | 7801. 1 | P | |||||||||||||||||
BDL 82 | 7801. 1 | Av. | |||||||||||||||||
BDL 82 | 7801. 3 | P | |||||||||||||||||
BDL 82 | 7801. 3 | Av. | |||||||||||||||||
BDL 82 | 7802. 2 | P | |||||||||||||||||
BDL 82 | 7802. 2 | Av. | |||||||||||||||||
BDL 82 | 7802. 3 | P |
WO 2009/141824
PCT/IL2009/000508
2018200117 05 Jan 2018
141
Gene | Ev. | Par. | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 | 16 | 17 |
BDL 82 | 7802. 3 | Av. | |||||||||||||||||
BDL 82 | 7803. 9 | P | 0.14 | 0.02 | 0.01 | 0.02 | 0.00 | 0.13 | 0.01 | 0.08 | 0.00 | 0.13 | 0.01 | 0.08 | 0.01 | 0.02 | 0.00 | 0.12 | 0.00 |
BDL 82 | 7803. 9 | Av. | 1.29 | 1.13 | 1.16 | 1.14 | 1.48 | 1.25 | 1.38 | 1.30 | 1.48 | 1.25 | 1.38 | 1.30 | 1.26 | 1.14 | 1.11 | 1.12 | 1.34 |
BDL 89 | 7812. 2 | P | 0.07 | ||||||||||||||||
BDL 89 | 7812. 2 | Av. | 1.05 | ||||||||||||||||
BDL 89 | 7812. 5 | P | |||||||||||||||||
BDL 89 | 7812. 5 | Av. | |||||||||||||||||
BDL 89 | 7814. 1 | P | 0.19 | ||||||||||||||||
BDL 89 | 7814. 1 | Av. | 1.20 | ||||||||||||||||
BDL 89 | 7814. 4 | P | |||||||||||||||||
BDL 89 | 7814. 4 | Av. | |||||||||||||||||
BDL 89 | 7814. 5 | P | |||||||||||||||||
BDL 89 | 7814. 5 | Av. |
Table 25. “P” = P-value; “Av” = ratio between the averages of event and control. Note that when the average ratio is higher than “1” the effect of exogenous expression of the gene is an increase of the desired trait; “Par” = Parameter according to the parameters listed in Table 24 above; “Ev” = event.
Table 26
Gene | Ev. | Par. | 18 | 19 | 20 | 21 | 22 | 23 | 24 | 25 | 26 | 27 | 28 | 29 | 30 | 31 | 32 | 33 | 34 |
BDL 95 | 7841.5 | P | 0.71 | 0.78 | 0.70 | 0.66 | |||||||||||||
BDL 95 | 7841.5 | Av. | 1.23 | 1.18 | 1.19 | 1.31 | |||||||||||||
BDL 95 | 7842.1 2 | P | 0.67 | 0.75 | 0.19 | 0.70 | 0.32 | ||||||||||||
BDL 95 | 7842.1 2 | Av. | 1.11 | 1.18 | 2.66 | 1.28 | 2.84 | ||||||||||||
BDL 95 | 7842.2 | P | 0.78 | 0.47 | 0.41 | ||||||||||||||
BDL 95 | 7842.2 | Av. | 1.11 | 55.8 3 | 28.9 9 | ||||||||||||||
BDL 95 | 7842.8 | P | 0.56 | 0.56 | 0.46 | 0.35 | 0.41 | 0.46 | |||||||||||
BDL 95 | 7842.8 | Av. | 1.36 | 1.29 | 3.76 | 1.56 | 1.57 | 4.32 | |||||||||||
BDL 95 | 7843.4 | P | 0.03 | 0.56 | 0.54 | 0.00 | 0.53 | 0.16 | 0.48 | 0.54 | |||||||||
BDL 95 | 7843.4 | Av. | 2.00 | 2.47 | 1.84 | 1.84 | 2.94 | 1.23 | 2.18 | 2.06 |
WO 2009/141824
PCT/IL2009/000508
2018200117 05 Jan 2018
142
Gene | Ev. | Par. | 18 | 19 | 20 | 21 | 22 | 23 | 24 | 25 | 26 | 27 | 28 | 29 | 30 | 31 | 32 | 33 | 34 |
BDL 100 | 7871.2 | P | 0.72 | GAI | |||||||||||||||
BDL 100 | 7871.2 | Av. | 1.17 | 1.28 | |||||||||||||||
BDL 100 | 7872.2 | P | 0.00 | 0.82 | 0.00 | 0.13 | 0.75 | 0.57 | 0.36 | ||||||||||
BDL 100 | 7872.2 | Av. | 1.63 | 1.13 | 1.53 | 1.18 | 1.18 | 1.35 | 1.11 | ||||||||||
BDL 100 | 7872.3 | P | 0.47 | 0.39 | 0.76 | 0.24 | 0.76 | ||||||||||||
BDL 100 | 7872.3 | Av. | 1.26 | 1.11 | 2.13 | 1.10 | 2.04 | ||||||||||||
BDL 100 | 7873.3 | P | 0.24 | 0.19 | 0.22 | 0.15 | 0.59 | ||||||||||||
BDL 100 | 7873.3 | Av. | 1.13 | 6.24 | 1.17 | 5.93 | 1.16 | ||||||||||||
BDL 100 | 7873.4 | P | 0.33 | 0.54 | 0.55 | 0.55 | 0.57 | 0.31 | |||||||||||
BDL 100 | 7873.4 | Av. | 1.17 | 1.87 | 2.80 | 2.06 | 2.78 | 2.02 | |||||||||||
BDL 106 | 7881.1 | P | 0.03 | 0.57 | 0.03 | 0.60 | 0.00 | ||||||||||||
BDL 106 | 7881.1 | Av. | 1.21 | 1.33 | 1.21 | 1.34 | 1.32 | ||||||||||||
BDL 106 | 7881.4 | P | 0.44 | 0.63 | 0.35 | 0.27 | 0.27 | 0.21 | 0.01 | 0.34 | |||||||||
BDL 106 | 7881.4 | Av. | 5.50 | 1.25 | 1.74 | 2.42 | 1.63 | 1.81 | 3.39 | 1.20 | |||||||||
BDL 106 | 7882.6 | P | 0.48 | 0.31 | 0.61 | 0.70 | 0.27 | 0.06 | |||||||||||
BDL 106 | 7882.6 | Av. | 1.37 | 1.61 | 1.35 | 1.14 | 1.98 | 1.49 | |||||||||||
BDL 106 | 7884.1 | P | 0.22 | 0.46 | 0.65 | 0.31 | 0.47 | 0.00 | 0.60 | ||||||||||
BDL 106 | 7884.1 | Av. | 1.87 | 2.65 | 1.11 | 1.67 | 3.05 | 1.34 | 1.56 | ||||||||||
BDL 106 | 7884.9 | P | 0.50 | 0.41 | 0.67 | 0.22 | 0.48 | 0.38 | 0.57 | 0.05 | 0.44 | ||||||||
BDL 106 | 7884.9 | Av. | 2.57 | 1.15 | 1.20 | 1.76 | 1.86 | 1.47 | 1.56 | 2.59 | 1.13 | ||||||||
BDL 106 | 7881.1 | P | 0.59 | 0.66 | 0.47 | 0.58 | 0.61 | 0.23 | 0.38 | ||||||||||
BDL 106 | 7881.1 | Av. | 4.09 | 1.25 | 1.56 | 4.38 | 1.29 | 1.32 | 1.69 | ||||||||||
BDL 106 | 7881.2 | P | 0.22 | 0.01 | 0.30 | 0.17 | 0.22 | 0.58 | |||||||||||
BDL 106 | 7881.2 | Av. | 1.16 | 5.82 | 1.38 | 6.35 | 1.42 | 2.85 | |||||||||||
BDL 106 | 7882.2 | P | 0.10 | 0.57 | 0.46 | 0.59 | 0.03 | 0.65 | 0.54 | 0.66 | 0.15 | ||||||||
BDL 106 | 7882.2 | Av. | 1.32 | 1.75 | 1.84 | 1.58 | 1.05 | 1.55 | 1.82 | 1.64 | 1.68 | ||||||||
BDL 106 | 7882.4 | P | 0.77 | 0.60 | 0.67 | 0.66 | 0.46 |
WO 2009/141824
PCT/IL2009/000508
2018200117 05 Jan 2018
143
Gene | Ev. | Par. | 18 | 19 | 20 | 21 | 22 | 23 | 24 | 25 | 26 | 27 | 28 | 29 | 30 | 31 | 32 | 33 | 34 |
BDL 106 | 7882A | Av. | 1.23 | 1.49 | 1.13 | 1.42 | 1.71 | ||||||||||||
BDL 106 | 7882.5 | P | 0.21 | 0.75 | 0.21 | 0.84 | |||||||||||||
BDL 106 | 7882.5 | Av. | 1.53 | 1.19 | 1.58 | 1.19 | |||||||||||||
BDL 108 | 8122.2 | P | 0.08 | 0.39 | 0.17 | 0.30 | 0.48 | 0.45 | |||||||||||
BDL 108 | 8122.2 | Av. | 2.85 | 1.94 | 2.11 | 3.00 | 1.38 | 2.73 | |||||||||||
BDL 108 | 8122.3 | P | 0.46 | 0.00 | 0.50 | 0.08 | 0.04 | 0.09 | |||||||||||
BDL 108 | 8122.3 | Av. | 2.61 | 1.46 | 1.58 | 1.20 | 1.50 | 1.18 | |||||||||||
BDL 108 | 8123.1 | P | 0.20 | 0.00 | 0.22 | 0.41 | |||||||||||||
BDL 108 | 8123.1 | Av. | 1.96 | 1.91 | 1.21 | 1.59 | |||||||||||||
BDL 108 | 8123.2 | P | 0.30 | 0.42 | 0.20 | 0.38 | 0.62 | 0.53 | |||||||||||
BDL 108 | 8123.2 | Av. | 3.17 | 3.64 | 2.36 | 4.07 | 1.26 | 2.81 | |||||||||||
BDL 108 | 8123.5 | P | 0.42 | 0.31 | 0.27 | 0.04 | 0.36 | 0.35 | 0.31 | 0.14 | |||||||||
BDL 108 | 8123.5 | Av. | 2.96 | 1.12 | 1.42 | 3.68 | 1.86 | 1.38 | 1.68 | 4.42 | |||||||||
BDL 108 | 8121.1 | P | 0.12 | 0.63 | 0.26 | 0.73 | 0.10 | 0.51 | 0.00 | 0.18 | 0.64 | ||||||||
BDL 108 | 8121.1 | Av. | 4.75 | 1.33 | 1.54 | 1.19 | 6.16 | 1.59 | 2.33 | 2.15 | 1.28 | ||||||||
BDL 108 | 8121.3 | P | 0.65 | 0.35 | 0.44 | 0.68 | 0.62 | 0.35 | 0.50 | ||||||||||
BDL 108 | 8121.3 | Av. | 2.11 | 1.24 | 1.36 | 1.88 | 1.12 | 1.61 | 1.34 | ||||||||||
BDL 108 | 8121.4 | P | 0.44 | 0.48 | 0.44 | 0.13 | 0.14 | 0.74 | |||||||||||
BDL 108 | 8121.4 | Av. | 2.83 | 1.17 | 3.66 | 1.46 | 1.32 | 1.14 | |||||||||||
BDL 108 | 8122.7 | P | 0.67 | 0.28 | 0.63 | 0.84 | 0.30 | 0.05 | 0.85 | ||||||||||
BDL 108 | 8122.7 | Av. | 4.00 | 1.52 | 5.66 | 1.22 | 1.64 | 2.58 | 1.56 | ||||||||||
BDL 108 | 8123.7 | P | 0.71 | 0.38 | 0.06 | 0.32 | 0.72 | 0.23 | 0.00 | 0.08 | |||||||||
BDL 108 | 8123.7 | Av. | 2.15 | 1.54 | 1.18 | 1.32 | 2.11 | 1.77 | 1.48 | 1.67 | |||||||||
BDL 110 | 8092.1 | P | 0.00 | ||||||||||||||||
BDL 110 | 8092.1 | Av. | 1.28 | ||||||||||||||||
BDL 110 | 8092.2 | P | 0.52 | 0.24 | 0.44 | 0.22 | 0.37 | 0.26 | 0.45 | 0.27 | |||||||||
BDL 110 | 8092.2 | Av. | 1.35 | 1.76 | 1.62 | 1.14 | 1.48 | 1.96 | 1.92 | 1.22 |
WO 2009/141824
PCT/IL2009/000508
2018200117 05 Jan 2018
144
Gene | Ev. | Par. | 18 | 19 | 20 | 21 | 22 | 23 | 24 | 25 | 26 | 27 | 28 | 29 | 30 | 31 | 32 | 33 | 34 |
BDL 110 | 8092.5 | P | 0.23 | 0.01 | 0.01 | 0.37 | 0.09 | ||||||||||||
BDL 110 | 8092.5 | Av. | 1.16 | 1.15 | 1.17 | 1.28 | 1.32 | ||||||||||||
BDL 110 | 8095.2 | P | 0.00 | ||||||||||||||||
BDL 110 | 8095.2 | Av. | 1.24 | ||||||||||||||||
BDL 111 | 8102.7 | P | 0.00 | 0.25 | 0.01 | 0.02 | 0.30 | 0.25 | |||||||||||
BDL 111 | 8102.7 | Av. | 1.62 | 1.11 | 1.57 | 1.42 | 1.12 | 1.26 | |||||||||||
BDL 111 | 8103.1 | P | 0.41 | 0.06 | 0.08 | 0.32 | 0.36 | 0.29 | 0.30 | 0.12 | 0.32 | ||||||||
BDL 111 | 8103.1 | Av. | 2.15 | 1.27 | 1.11 | 2.44 | 1.85 | 1.76 | 1.40 | 3.38 | 1.37 | ||||||||
BDL 111 | 8103.2 | P | 0.00 | 0.00 | 0.13 | ||||||||||||||
BDL 111 | 8103.2 | Av. | 1.79 | 1.66 | 1.20 | ||||||||||||||
BDL 111 | 8103.4 | P | 0.41 | 0.12 | 0.00 | 0.50 | 0.28 | 0.22 | 0.00 | 0.40 | |||||||||
BDL 111 | 8103.4 | Av. | 1.87 | 1.44 | 1.52 | 2.06 | 1.58 | 1.72 | 1.87 | 2.83 | |||||||||
BDL 111 | 8103.5 | P | 0.06 | 0.71 | 0.34 | 0.00 | 0.12 | 0.35 | 0.18 | 0.00 | 0.73 | ||||||||
BDL 111 | 8103.5 | Av. | 1.77 | 1.11 | 1.21 | 4.29 | 1.66 | 1.25 | 1.37 | 5.17 | 1.14 | ||||||||
BDL 111 | 8102.7 | P | 0.46 | 0.20 | 0.63 | 0.13 | 0.44 | 0.28 | 0.34 | 0.06 | |||||||||
BDL 111 | 8102.7 | Av. | 2.95 | 1.35 | 1.15 | 1.51 | 3.43 | 1.57 | 1.37 | 1.68 | |||||||||
BDL 111 | 8103.1 | P | 0.57 | 0.65 | 0.26 | 0.27 | 0.24 | 0.32 | |||||||||||
BDL 111 | 8103.1 | Av. | 1.12 | 1.11 | 1.13 | 2,19 | 2.28 | 1.58 | |||||||||||
BDL 111 | 8103.2 | P | 0.96 | 0.51 | 0.20 | 0.88 | 0.68 | 0.34 | 0.33 | ||||||||||
BDL 111 | 8103.2 | Av. | 1.35 | 1.16 | 1.53 | 2.21 | 1.21 | 1.47 | 2.07 | ||||||||||
BDL 111 | 8103.4 | P | 0.90 | 0.79 | 0.83 | ||||||||||||||
BDL 111 | 8103.4 | Av. | 1.51 | 2.47 | 1.42 | ||||||||||||||
BDL 111 | 8103.5 | P | 0.88 | 0.58 | 0.82 | 0.53 | 0.69 | ||||||||||||
BDL 111 | 8103.5 | Av. | 2.94 | 1.19 | 4.21 | 1.46 | 1.37 | ||||||||||||
BDL 112 | 7502.1 | P | 0.69 | 0.43 | 0.44 | 0.37 | 0.32 | ||||||||||||
BDL 112 | 7502.1 | Av. | 1.20 | 2.10 | 1.46 | 2.26 | 1.63 | ||||||||||||
BDL 112 | 7502.1 4 | P | 0.52 | 0.50 | 0.57 | 0.50 | 0.48 | 0.47 | 0.46 |
WO 2009/141824
PCT/IL2009/000508
2018200117 05 Jan 2018
145
Gene | Ev. | Par. | 18 | 19 | 20 | 21 | 22 | 23 | 24 | 25 | 26 | 27 | 28 | 29 | 30 | 31 | 32 | 33 | 34 |
BDL 112 | 7502.1 4 | Av. | 1.67 | 3.18 | 1.34 | 1.44 | 3.42 | 1.55 | 2.15 | ||||||||||
BDL 112 | 7502.4 | P | 0.19 | 0.75 | 0.11 | 0.29 | 0.02 | 0.44 | 0.65 | 0.51 | |||||||||
BDL 112 | 7502.4 | Av. | 2.17 | 1.18 | 2.04 | 1.46 | 1.24 | 1.48 | 1.24 | 1.36 | |||||||||
BDL 112 | 7502.7 | P | 0.19 | 0.19 | 0.07 | 0.18 | 0.00 | 0.84 | 0.25 | ||||||||||
BDL 112 | 7502.7 | Av. | 1.88 | 1.36 | 1.70 | 1.36 | 1.44 | 1.13 | 1.52 | ||||||||||
BDL 112 | 7502.9 | P | 0.30 | 0.62 | 0.62 | 0.26 | 0.16 | 0.50 | |||||||||||
BDL 112 | 7502.9 | Av. | 2.12 | 1.23 | 1.22 | 1.20 | 2.29 | 1.30 | |||||||||||
BDL 112 | 7502.1 | P | 0.42 | 0.41 | 0.41 | 0.61 | |||||||||||||
BDL 112 | 7502.1 | Av. | 1.29 | 1.15 | 1.27 | 1.40 | |||||||||||||
BDL 112 | 7502.4 | P | 0.58 | 0.55 | 0.48 | 0.18 | |||||||||||||
BDL 112 | 7502.4 | Av. | 1.19 | 1.84 | 2.27 | 2.78 | |||||||||||||
BDL 112 | 7502.7 | P | 0.64 | 0.82 | 0.61 | 0.71 | 0.72 | ||||||||||||
BDL 112 | 7502.7 | Av. | 3.88 | 1.14 | 4.86 | 1.19 | 1.36 | ||||||||||||
BDL 112 | 7502.8 | P | 0.54 | 0.67 | 0.57 | 0.51 | 0.54 | 0.60 | |||||||||||
BDL 112 | 7502.8 | Av. | 2.50 | 1.20 | 1.40 | 2.33 | 1.41 | 1.52 | |||||||||||
BDL 112 | 7502.9 | P | 0.07 | 0.79 | 0.07 | 0.48 | 0.62 | 0.56 | |||||||||||
BDL 112 | 7502.9 | Av. | 4.27 | 1.11 | 4.93 | 1.12 | 1.23 | 1.22 | |||||||||||
BDL 113 | 7683.4 | P | 0.13 | 0.00 | 0.69 | 0.18 | 0.35 | 0.10 | 0.58 | 0.24 | |||||||||
BDL 113 | 7683.4 | Av. | 1.51 | 1.24 | 1.63 | 1.76 | 1.13 | 1.53 | 2.03 | 1.60 | |||||||||
BDL 113 | 7683.6 | P | 0.06 | 0.10 | 0.09 | 0.20 | 0.01 | 0.04 | 0.00 | 0.02 | 0.00 | ||||||||
BDL 113 | 7683.6 | Av. | 2.09 | 1.38 | 1.25 | 1.80 | 1.93 | 2.10 | 1.67 | 2.80 | 1.59 | ||||||||
BDL 113 | 7684.3 | P | 0.24 | 0.56 | 0.38 | 0.62 | 0.05 | 0.53 | 0.35 | 0.52 | |||||||||
BDL 113 | 7684.3 | Av. | 1.45 | 1.34 | 1.50 | 1.69 | 1.42 | 1.61 | 1.90 | 2.95 | |||||||||
BDL 113 | 7684.6 | P | 0.12 | 0.04 | 0.54 | 0.17 | 0.00 | 0.51 | |||||||||||
BDL 113 | 7684.6 | Av. | 1.81 | 1.29 | 3.37 | 1.68 | 1.63 | 4.60 | |||||||||||
BDL 113 | 7684.7 | P | 0.57 | 0.90 | 0.31 | 0.70 | |||||||||||||
BDL 113 | 7684.7 | Av. | 1.15 | 1.19 | 1.59 | 1.88 |
WO 2009/141824
PCT/IL2009/000508
2018200117 05 Jan 2018
146
Gene | Ev. | Par. | 18 | 19 | 20 | 21 | 22 | 23 | 24 | 25 | 26 | 27 | 28 | 29 | 30 | 31 | 32 | 33 | 34 |
BDL 113 | 7683.1 | P | 0.18 | 0.41 | 0.63 | 0.16 | 0.23 | 0.33 | 0.06 | 0.11 | 0.61 | ||||||||
BDL 113 | 7683.1 | Av. | 4.92 | 1.37 | 1.11 | 1.68 | 6.15 | 1.83 | 1.32 | 2.01 | 2.09 | ||||||||
BDL 113 | 7683.1 1 | P | 0.00 | 0.00 | |||||||||||||||
BDL 113 | 7683.1 1 | Av. | 3.76 | 4.28 | |||||||||||||||
BDL 113 | 7683.4 | P | 0.29 | 0.47 | 0.94 | 0.36 | 0.47 | 0.78 | |||||||||||
BDL 113 | 7683.4 | Av. | 1.28 | 1.32 | 1.72 | 1.56 | 1.62 | 1.47 | |||||||||||
BDL 113 | 7684.1 | P | |||||||||||||||||
BDL 113 | 7684.1 | Av. | |||||||||||||||||
BDL 113 | 7684.5 | P | 0.00 | 0.00 | |||||||||||||||
BDL 113 | 7684.5 | Av. | 3.01 | 4.03 | |||||||||||||||
BDL 114 | 7741.3 | P | 0.41 | 0.12 | 0.30 | 0.40 | 0.00 | 0.23 | 0.53 | ||||||||||
BDL 114 | 7741.3 | Av. | 3.87 | 1.92 | 3.64 | 4.33 | 2.51 | 4.94 | 2.47 | ||||||||||
BDL 114 | 7741.6 | P | 0.36 | 0.50 | 0.01 | 0.58 | 0.49 | 0.06 | 0.43 | ||||||||||
BDL 114 | 7741.6 | Av. | 1.37 | 12.1 8 | 2.96 | 1.16 | 4.68 | 2.99 | 3.15 | ||||||||||
BDL 114 | 7742.1 | P | 0.36 | 0.30 | 0.30 | 0.50 | |||||||||||||
BDL 114 | 7742.1 | Av. | 1.56 | 1.35 | 1.21 | 1.29 | |||||||||||||
BDL 114 | 7742.3 | P | 0.39 | 0.23 | 0.59 | 0.29 | 0.00 | 0.02 | 0.10 | ||||||||||
BDL 114 | 7742.3 | Av. | 4.22 | 1.73 | 1.24 | 2.30 | 2.68 | 1.73 | 1.70 | ||||||||||
BDL 114 | 7742.5 | P | 0.16 | 0.25 | 0.18 | 0.63 | 0.00 | 0.25 | 0.13 | 0.27 | 0.53 | ||||||||
BDL 114 | 7742.5 | Av. | 3.66 | 1.85 | 1.38 | 1.33 | 2.39 | 2.81 | 2.01 | 2.23 | 1.62 | ||||||||
BDL 115 | 8152.3 | P | 0.05 | 0.34 | |||||||||||||||
BDL 115 | 8152.3 | Av. | 1.28 | 1.14 | |||||||||||||||
BDL 115 | 8152.4 | P | 0.13 | 0.71 | 0.08 | 0.79 | 0.08 | 0.39 | |||||||||||
BDL 115 | 8152.4 | Av. | 1.16 | 1.15 | 2.16 | 1.11 | 2.20 | 1.39 | |||||||||||
BDL 115 | 8154.1 | P | 0.40 | 0.36 | 0.60 | ||||||||||||||
BDL 115 | 8154.1 | Av. | 2.40 | 2.88 | 1.11 | ||||||||||||||
BDL 115 | 8155.2 | P | 0.51 | 0.26 | 0.52 | 0.26 | 0.54 |
WO 2009/141824
PCT/IL2009/000508
2018200117 05 Jan 2018
147
Gene | Ev. | Par. | 18 | 19 | 20 | 21 | 22 | 23 | 24 | 25 | 26 | 27 | 28 | 29 | 30 | 31 | 32 | 33 | 34 |
BDL 115 | 8155.2 | Av. | 2.70 | 2.22 | 3.09 | 2.28 | 2.66 | ||||||||||||
BDL 115 | 8155.4 | P | 0.36 | 0.48 | 0.25 | 0.47 | 0.53 | ||||||||||||
BDL 115 | 8155.4 | Av. | 2.31 | 1.84 | 1.88 | 2.66 | 2.33 | ||||||||||||
BDL 115 | 8152.3 | P | 0.43 | 0.35 | 0.01 | 0.36 | 0.37 | 0.20 | 0.24 | 0.09 | |||||||||
BDL 115 | 8152.3 | Av. | 1.84 | 1.26 | 1.22 | 1.88 | 1.96 | 1.41 | 1.51 | 2.04 | |||||||||
BDL 115 | 8152.4 | P | 0.25 | 0.59 | 0.25 | 0.05 | 0.15 | 0.41 | |||||||||||
BDL 115 | 8152.4 | Av. | 2.58 | 1.13 | 2.87 | 1.61 | 1.42 | 1.30 | |||||||||||
BDL 115 | 8154.1 | P | 0.02 | 0.27 | 0.16 | 0.12 | |||||||||||||
BDL 115 | 8154.1 | Av. | 5.48 | 1.16 | 5.83 | 1.36 | |||||||||||||
BDL 115 | 8155.2 | P | 0.05 | 0.24 | 0.20 | 0.13 | 0.80 | 0.85 | |||||||||||
BDL 115 | 8155.2 | Av. | 3.97 | 1.36 | 3.99 | 1.33 | 1.13 | 1.25 | |||||||||||
BDL 115 | 8155.4 | P | 0.52 | 0.01 | 0.43 | 0.09 | 0.28 | 0.02 | 0.27 | 0.23 | 0.02 | ||||||||
BDL 115 | 8155.4 | Av. | 1.11 | 4.85 | 1.20 | 1.64 | 1.42 | 5.32 | 1.71 | 1.86 | 2.24 | ||||||||
BDL 116 | 7481.2 | P | 0.10 | 0.07 | 0.54 | 0.52 | 0.49 | ||||||||||||
BDL 116 | 7481.2 | Av. | 1.59 | 1.64 | 1.46 | 1.16 | 1.14 | ||||||||||||
BDL 116 | 7481.7 | P | 0.06 | 0.51 | 0.14 | 0.23 | 0.41 | 0.64 | |||||||||||
BDL 116 | 7481.7 | Av. | 1.17 | 1.40 | 1.19 | 1.13 | 1.52 | 1.22 | |||||||||||
BDL 116 | 7481.8 | P | 0.75 | 0.51 | 0.32 | 0.68 | 0.50 | 0.18 | 0.54 | ||||||||||
BDL 116 | 7481.8 | Av. | 1.15 | 5.20 | 1.78 | 1.17 | 3.75 | 2.05 | 1.87 | ||||||||||
BDL 116 | 7482.2 | P | 0.19 | 0.22 | 0.03 | 0.16 | 0.35 | ||||||||||||
BDL 116 | 7482.2 | Av. | 1.14 | 2.69 | 1.25 | 2.82 | 1.46 | ||||||||||||
BDL 116 | 7485.1 | P | 0.00 | 0.52 | 0.40 | 0.02 | 0.29 | 0.07 | 0.37 | 0.59 | |||||||||
BDL 116 | 7485.1 | Av. | 2.16 | 1.17 | 2.56 | 1.92 | 1.62 | 1.27 | 3.36 | 1.26 | |||||||||
BDL 119 | 7732.2 | P | 0.05 | 0.61 | 0.00 | 0.74 | 0.00 | 0.39 | 0.00 | 0.62 | 0.34 | ||||||||
BDL 119 | 7732.2 | Av. | 2.07 | 1.16 | 1.63 | 1.36 | 1.83 | 1.47 | 2.00 | 1.76 | 1.30 | ||||||||
BDL 119 | 7733.2 | P | 0.42 | 0.46 | 0.11 | 0.15 | 0.07 | 0.01 | 0.73 | 0.32 | 0.10 | ||||||||
BDL 119 | 7733.2 | Av. | 1.27 | 1.15 | 1.19 | 1.37 | 1.38 | 1.39 | 1.19 | 1.10 | 1.13 |
WO 2009/141824
PCT/IL2009/000508
2018200117 05 Jan 2018
148
Gene | Ev. | Par. | 18 | 19 | 20 | 21 | 22 | 23 | 24 | 25 | 26 | 27 | 28 | 29 | 30 | 31 | 32 | 33 | 34 |
BDL 119 | 7734.1 | P | 0.23 | 0.07 | 0.01 | 0.01 | 0.00 | ||||||||||||
BDL 119 | 7734.1 | Av. | 1.50 | 1.66 | 1.42 | 1.56 | 1.30 | ||||||||||||
BDL 119 | 7734.5 | P | 0.37 | 0.26 | 0.62 | 0.69 | 0.00 | 0.15 | 0.42 | 0.41 | 0.15 | ||||||||
BDL 119 | 7734.5 | Av. | 1.12 | 1.37 | 1.16 | 1.16 | 1.30 | 1.58 | 1.39 | 1.34 | 1.21 | ||||||||
BDL 119 | 7734.7 | P | 0.62 | 0.60 | 0.25 | 0.58 | 0.54 | 0.75 | 0.62 | 0.56 | 0.52 | ||||||||
BDL 119 | 7734.7 | Av. | 1.11 | 1.12 | 1.15 | 1.41 | 2.92 | 1.16 | 1.18 | 2.29 | 1.90 | ||||||||
BDL 120 | 7891.3 | P | 0.09 | 0.01 | 0.00 | 0.01 | 0.01 | 0.43 | |||||||||||
BDL 120 | 7891.3 | Av. | 3.31 | 2.89 | 2.31 | 1.30 | 3.58 | 1.24 | |||||||||||
BDL 120 | 7892.4 | P | 0.23 | 0.62 | 0.12 | 0.31 | 0.53 | 0.48 | |||||||||||
BDL 120 | 7892.4 | Av. | 1.53 | 1.55 | 1.46 | 1.36 | 1.94 | 1.14 | |||||||||||
BDL 120 | 7892.6 | P | 0.39 | 0.60 | 0.59 | 0.58 | 0.69 | ||||||||||||
BDL 120 | 7892.6 | Av. | 1.20 | 2.56 | 1.13 | 2.70 | 1.10 | ||||||||||||
BDL 120 | 7893.2 | P | 0.38 | 0.30 | 0.91 | 0.43 | 0.14 | 0.77 | 0.13 | ||||||||||
BDL 120 | 7893.2 | Av. | 1.48 | 4.78 | 1.11 | 1.26 | 5.34 | 1.42 | 3.99 | ||||||||||
BDL 120 | 7893.5 | P | 0.02 | 0.46 | 0.60 | 0.08 | 0.61 | ||||||||||||
BDL 120 | 7893.5 | Av. | 1.18 | 1.10 | 2.19 | 1.04 | 2.28 | ||||||||||||
BDL 122 | 7513.1 | P | 0.74 | 0.47 | 0.69 | 0.46 | |||||||||||||
BDL 122 | 7513.1 | Av. | 1.20 | 2.77 | 1.22 | 2.94 | |||||||||||||
BDL 122 | 7513.1 | P | 0.49 | 0.80 | 0.35 | 0.83 | 0.35 | ||||||||||||
BDL 122 | 7513.1 | Av. | 1.56 | 1.40 | 1.57 | 1.31 | 1.70 | ||||||||||||
BDL 122 | 7513.1 4 | P | 0.17 | 0.19 | 0.17 | 0.53 | 0.06 | 0.59 | |||||||||||
BDL 122 | 7513.1 4 | Av. | 1.87 | 1.82 | 1.82 | 1.26 | 2.38 | 1.27 | |||||||||||
BDL 122 | 7513.9 | P | 0.01 | 0.46 | 0.52 | 0.00 | 0.44 | 0.52 | 0.45 | ||||||||||
BDL 122 | 7513.9 | Av. | 1.79 | 2.20 | 4.29 | 1.57 | 3.19 | 4.97 | 3.28 | ||||||||||
BDL 122 | 7514.3 | P | 0.22 | 0.15 | 0.58 | 0.57 | 0.01 | 0.04 | 0.61 | 0.65 | 0.55 | ||||||||
BDL 122 | 7514.3 | Av. | 1.29 | 1.23 | 1.68 | 2.10 | 1.12 | 1.03 | 2.11 | 1.63 | 2.58 | ||||||||
BDL 122 | 7513.1 | P | 0.17 | 0.09 | 0.01 | 0.02 | 0.12 |
WO 2009/141824
PCT/IL2009/000508
2018200117 05 Jan 2018
149
Gene | Ev. | Par. | 18 | 19 | 20 | 21 | 22 | 23 | 24 | 25 | 26 | 27 | 28 | 29 | 30 | 31 | 32 | 33 | 34 |
BDL 122 | 7513.1 | Av. | 1.18 | 1.11 | 4.25 | 4.24 | 1.89 | ||||||||||||
BDL 122 | 7513.1 4 | P | 0.50 | 0.88 | 0.74 | 0.54 | |||||||||||||
BDL 122 | 7513.1 4 | Av. | 1.13 | 1.32 | 1.97 | 3.21 | |||||||||||||
BDL 122 | 7513.9 | P | 0.31 | 0.35 | 0.86 | 0.31 | 0.37 | ||||||||||||
BDL 122 | 7513.9 | Av. | 1.19 | 4.01 | 1.34 | 3.97 | 2.13 | ||||||||||||
BDL 122 | 7514.3 | P | 0.32 | 0.28 | 0.81 | ||||||||||||||
BDL 122 | 7514.3 | Av. | 2.36 | 2.69 | 1.22 | ||||||||||||||
BDL 123 | 8082.1 | P | 0.31 | 0.09 | 0.06 | 0.11 | 0.17 | ||||||||||||
BDL 123 | 8082.1 | Av. | 1.16 | 1.12 | 2.47 | 2.20 | 1.37 | ||||||||||||
BDL 123 | 8082.3 | P | 0.14 | 0.48 | 0.26 | 0.05 | 0.04 | 0.40 | |||||||||||
BDL 123 | 8082.3 | Av. | 1.11 | 1.12 | 2.00 | 1.13 | 1.02 | 1.85 | |||||||||||
BDL 123 | 8082.6 | P | |||||||||||||||||
BDL 123 | 8082.6 | Av. | |||||||||||||||||
BDL 123 | 8083.2 | P | 0.64 | 0.53 | 0.81 | 0.56 | 0.55 | 0.86 | 0.62 | ||||||||||
BDL 123 | 8083.2 | Av. | 1.39 | 3.11 | 1.43 | 1.36 | 3.02 | 1.27 | 1.69 | ||||||||||
BDL 123 | 8083.3 | P | 0.07 | 0.00 | 0.39 | 0.01 | 0.28 | ||||||||||||
BDL 123 | 8083.3 | Av. | 1.37 | 1.32 | 1.77 | 1.15 | 1.75 | ||||||||||||
BDL 124 | 8482.1 | P | 0.38 | 0.31 | 0.22 | 0.00 | 0.29 | 0.35 | 0.00 | ||||||||||
BDL 124 | 8482.1 | Av. | 2.25 | 1.48 | 1.85 | 1.50 | 2.12 | 1.54 | 1.20 | ||||||||||
BDL 125 | 7491.1 | P | 0.21 | 0.06 | 0.20 | 0.15 | |||||||||||||
BDL 125 | 7491.1 | Av. | 1.23 | 1.18 | 5.44 | 4.43 | |||||||||||||
BDL 125 | 7491.5 | P | 0.51 | 0.55 | |||||||||||||||
BDL 125 | 7491.5 | Av. | 1.67 | 1.56 | |||||||||||||||
BDL 125 | 7492.5 | P | 0.72 | 0.66 | 0.65 | ||||||||||||||
BDL 125 | 7492.5 | Av. | 1.11 | 1.16 | 1.38 | ||||||||||||||
BDL 125 | 7494.1 | P | 0.46 | 0.78 | 0.44 | 0.43 | 0.77 | 0.41 | |||||||||||
BDL 125 | 7494.1 | Av. | 1.41 | 1.12 | 2.37 | 1.24 | 1.13 | 2.53 |
WO 2009/141824
PCT/IL2009/000508
2018200117 05 Jan 2018
150
Gene | Ev. | Par. | 18 | 19 | 20 | 21 | 22 | 23 | 24 | 25 | 26 | 27 | 28 | 29 | 30 | 31 | 32 | 33 | 34 |
BDL 125 | 7495.5 | P | 0.36 | 0.43 | 0.02 | 0.31 | 0.23 | ||||||||||||
BDL 125 | 7495.5 | Av. | 1.22 | 2.05 | 1.34 | 2.25 | 1.54 | ||||||||||||
BDL 128 | 7711.3 | P | 0.11 | 0.72 | 0.46 | 0.66 | 0.14 | 0.73 | 0.32 | 0.63 | |||||||||
BDL 128 | 7711.3 | Av. | 1.44 | 1.14 | 1.14 | 1.90 | 1.32 | 1.18 | 1.18 | 2.03 | |||||||||
BDL 128 | 8361.5 | P | 0.36 | 0.45 | 0.61 | 0.50 | 0.59 | ||||||||||||
BDL 128 | 8361.5 | Av. | 1.24 | 1.80 | 1.14 | 2.15 | 2.09 | ||||||||||||
BDL 128 | 8362.2 | P | 0.10 | 0.09 | 0.10 | ||||||||||||||
BDL 128 | 8362.2 | Av. | 1.12 | 2.14 | 2.13 | ||||||||||||||
BDL 128 | 8363.2 | P | 0.42 | 0.54 | 0.36 | 0.00 | 0.50 | 0.29 | |||||||||||
BDL 128 | 8363.2 | Av. | 1.88 | 3.77 | 1.84 | 1.54 | 5.39 | 1.30 | |||||||||||
BDL 128 | 8365.2 | P | 0.41 | 0.47 | 0.42 | 0.47 | 0.48 | ||||||||||||
BDL 128 | 8365.2 | Av. | 1.22 | 2.55 | 1.27 | 3.56 | 3.78 | ||||||||||||
BDL 129 | 7691.4 | P | 0.39 | 0.65 | 0.00 | 0.16 | |||||||||||||
BDL 129 | 7691.4 | Av. | 1.53 | 1.17 | 1.61 | 2.61 | |||||||||||||
BDL 129 | 7691.6 | P | 0.20 | 0.64 | 0.04 | 0.21 | 0.52 | 0.38 | 0.23 | ||||||||||
BDL 129 | 7691.6 | Av. | 1.91 | 1.48 | 1.92 | 1.75 | 1.37 | 2.87 | 1.38 | ||||||||||
BDL 129 | 7692.2 | P | 0.50 | 0.51 | 0.53 | ||||||||||||||
BDL 129 | 7692.2 | Av. | 3.65 | 3.67 | 3.01 | ||||||||||||||
BDL 129 | 7692.6 | P | 0.23 | 0.26 | 0.22 | 0.08 | |||||||||||||
BDL 129 | 7692.6 | Av. | 1.12 | 2.87 | 3.20 | 1.17 | |||||||||||||
BDL 129 | 7693.1 | P | 0.35 | 0.47 | 0.00 | 0.21 | 0.27 | 0.45 | 0.00 | 0.23 | 0.52 | ||||||||
BDL 129 | 7693.1 | Av. | 1.50 | 4.24 | 1.22 | 3.15 | 1.43 | 4.30 | 1.44 | 4.15 | 3.58 | ||||||||
BDL 130 | 7663.1 | P | 0.03 | 0.48 | |||||||||||||||
BDL 130 | 7663.1 | Av. | 1.02 | 1.14 | |||||||||||||||
BDL 130 | 7663.3 | P | 0.39 | 0.39 | 0.33 | 0.13 | 0.23 | 0.24 | 0.59 | 0.06 | |||||||||
BDL 130 | 7663.3 | Av. | 4.91 | 1.51 | 1.44 | 2.34 | 2.51 | 2.32 | 1.93 | 1.37 | |||||||||
BDL 130 | 7663.6 | P | 0.36 | 0.48 | 0.48 | 0.41 | 0.40 |
WO 2009/141824
PCT/IL2009/000508
2018200117 05 Jan 2018
151
Gene | Ev. | Par. | 18 | 19 | 20 | 21 | 22 | 23 | 24 | 25 | 26 | 27 | 28 | 29 | 30 | 31 | 32 | 33 | 34 |
BDL 130 | 7663.6 | Av. | 1.30 | 2.15 | 1.30 | 2.24 | 1.28 | ||||||||||||
BDL 130 | 7664.5 | P | 0.76 | 0.76 | 0.09 | ||||||||||||||
BDL 130 | 7664.5 | Av. | 1.17 | 1.20 | 1.06 | ||||||||||||||
BDL 131 | 7461.2 | P | 0.02 | 0.01 | 0.14 | 0.54 | 0.06 | 0.67 | 0.01 | ||||||||||
BDL 131 | 7461.2 | Av. | 1.18 | 1.33 | 1.22 | 1.74 | 1.10 | 1.48 | 1.28 | ||||||||||
BDL 131 | 7461.4 | P | 0.14 | 0.06 | 0.24 | 0.09 | 0.00 | 0.00 | 0.06 | ||||||||||
BDL 131 | 7461.4 | Av. | 1.12 | 1.14 | 1.11 | 1.08 | 1.05 | 1.04 | 1.02 | ||||||||||
BDL 131 | 7462.2 | P | 0.00 | 0.08 | 0.01 | 0.66 | 0.30 | 0.04 | 0.08 | 0.70 | |||||||||
BDL 131 | 7462.2 | Av. | 1.38 | 1.43 | 1.25 | 3.42 | 1.12 | 1.07 | 1.05 | 2.57 | |||||||||
BDL 131 | 7463.4 | P | 0.19 | 0.85 | 0.02 | 0.93 | |||||||||||||
BDL 131 | 7463.4 | Av. | 1.11 | 1.25 | 1.03 | 1.10 | |||||||||||||
BDL 131 | 7464.5 | P | 0.01 | 0.01 | 0.16 | 0.21 | 0.49 | 0.04 | 0.38 | ||||||||||
BDL 131 | 7464.5 | Av. | 1.26 | 1.19 | 2.44 | 1.29 | 1.17 | 2.63 | 1.15 | ||||||||||
BDL 132 | 7471.1 | P | 0.07 | 0.09 | 0.43 | 0.67 | 0.71 | 0.13 | |||||||||||
BDL 132 | 7471.1 | Av. | 1.31 | 1.21 | 1.17 | 1.76 | 1.57 | 1.41 | |||||||||||
BDL 132 | 7471.4 | P | 0.51 | 0.07 | 0.09 | 0.26 | 0.27 | 0.76 | 0.68 | ||||||||||
BDL 132 | 7471.4 | Av. | 1.11 | 1.20 | 1.13 | 3.00 | 2.64 | 1.19 | 1.20 | ||||||||||
BDL 132 | 7472.4 | P | 0.48 | 0.94 | 0.48 | 0.96 | |||||||||||||
BDL 132 | 7472.4 | Av. | 1.33 | 1.18 | 1.27 | 1.12 | |||||||||||||
BDL 132 | 7473.1 | P | 0.00 | 0.39 | 0.48 | 0.03 | 0.51 | 0.40 | |||||||||||
BDL 132 | 7473.1 | Av. | 1.27 | 1.15 | 1.70 | 1.02 | 2.06 | 2.66 | |||||||||||
BDL 132 | 7474.4 | P | 0.20 | 0.51 | 0.09 | 0.17 | 0.51 | 0.02 | 0.81 | 0.89 | 0.56 | ||||||||
BDL 132 | 7474.4 | Av. | 1.74 | 1.92 | 1.20 | 1.74 | 2.41 | 1.29 | 1.16 | 1.15 | 1.87 | ||||||||
BDL 132 | 7471.1 | P | 0.01 | 0.00 | 0.75 | 0.32 | |||||||||||||
BDL 132 | 7471.1 | Av. | 4.76 | 6.37 | 1.12 | 2.49 | |||||||||||||
BDL 132 | 7471.4 | P | 0.08 | 0.20 | 0.61 | 0.11 | 0.00 | 0.18 | 0.16 | ||||||||||
BDL 132 | 7471.4 | Av. | 5.36 | 1.12 | 1.16 | 6.92 | 1.49 | 1.50 | 3.72 |
WO 2009/141824
PCT/IL2009/000508
2018200117 05 Jan 2018
152
Gene | Ev. | Par. | 18 | 19 | 20 | 21 | 22 | 23 | 24 | 25 | 26 | 27 | 28 | 29 | 30 | 31 | 32 | 33 | 34 |
BDL 132 | 7472.4 | P | 0.05 | 0.04 | 0.54 | ||||||||||||||
BDL 132 | 7472.4 | Av. | 3.38 | 3.70 | 1.22 | ||||||||||||||
BDL 132 | 7473.1 | P | 0.83 | 0.36 | 0.62 | 0.38 | |||||||||||||
BDL 132 | 7473.1 | Av. | 1.13 | 1.27 | 1.16 | 1.35 | |||||||||||||
BDL 132 | 7475.4 | P | 0.13 | 0.72 | 0.76 | 0.11 | 0.51 | ||||||||||||
BDL 132 | 7475.4 | Av. | 1.64 | 1.22 | 1.11 | 1.73 | 1.40 | ||||||||||||
BDL 133 | 8161.1 | P | 0.34 | 0.26 | 0.47 | 0.39 | 0.27 | 0.02 | 0.30 | ||||||||||
BDL 133 | 8161.1 | Av. | 1.55 | 1.14 | 1.28 | 1.41 | 1.32 | 1.35 | 1.18 | ||||||||||
BDL 133 | 8161.2 | P | 0.04 | 0.05 | 0.02 | 0.31 | 0.46 | 0.01 | 0.16 | 0.46 | 0.01 | 0.35 | |||||||
BDL 133 | 8161.2 | Av. | 1.08 | 1.17 | 1.13 | 1.31 | 1.20 | 2.62 | 1.16 | 1.18 | 2.22 | 1.20 | |||||||
BDL 133 | 8161.3 | P | 0.17 | 0.00 | 0.48 | 0.09 | 0.71 | 0.39 | 0.82 | 0.36 | |||||||||
BDL 133 | 8161.3 | Av. | 1.11 | 1.20 | 7.63 | 1.19 | 1.59 | 2.03 | 1.29 | 2.21 | |||||||||
BDL 133 | 8161.4 | P | 0.02 | 0.53 | 0.00 | 0.00 | 0.04 | 0.01 | 0.20 | ||||||||||
BDL 133 | 8161.4 | Av. | 1.26 | 1.15 | 1.46 | 1.47 | 1.28 | 1.60 | 1.61 | ||||||||||
BDL 133 | 8162.1 | P | 0.27 | 0.01 | 0.54 | 0.06 | 0.10 | 0.00 | 0.39 | 0.13 | 0.34 | ||||||||
BDL 133 | 8162.1 | Av. | 1.15 | 1.41 | 1.27 | 1.17 | 1.37 | 1.59 | 1.50 | 1.16 | 1.11 | ||||||||
BDL 133 | 8162.3 | P | 0.05 | 0.11 | 0.48 | ||||||||||||||
BDL 133 | 8162.3 | Av. | 1.02 | 1.49 | 1.16 | ||||||||||||||
BDL 133 | 8162.5 | P | 0.08 | 0.19 | 0.00 | 0.00 | 0.25 | 0.02 | |||||||||||
BDL 133 | 8162.5 | Av. | 1.12 | 1.19 | 3.57 | 2.84 | 1.23 | 1.17 | |||||||||||
BDL 133 | 8163.2 | P | 0.59 | 0.74 | 0.57 | 0.78 | 0.65 | ||||||||||||
BDL 133 | 8163.2 | Av. | 1.53 | 1.26 | 1.69 | 1.33 | 1.53 | ||||||||||||
BDL 134 | 7671.2 | P | 0.00 | 0.23 | 0.14 | 0.00 | 0.08 | 0.07 | 0.49 | 0.17 | |||||||||
BDL 134 | 7671.2 | Av. | 1.93 | 1.18 | 1.20 | 1.94 | 1.73 | 1.76 | 1.38 | 1.39 | |||||||||
BDL 134 | 7672.1 | P | 0.01 | 0.00 | 0.00 | 0.07 | 0.45 | 0.14 | 0.46 | ||||||||||
BDL 134 | 7672.1 | Av. | 3.86 | 2.37 | 1.49 | 1.38 | 1.31 | 1.46 | 1.27 | ||||||||||
BDL 134 | 7673.1 | P | 0.46 | 0.46 | 0.40 | 0.77 | 0.18 | 0.09 | 0.06 | 0.06 | 0.17 |
WO 2009/141824
PCI7IL2009/000508
2018200117 05 Jan 2018
153
Gene | Ev. | Par. | 18 | 19 | 20 | 21 | 22 | 23 | 24 | 25 | 26 | 27 | 28 | 29 | 30 | 31 | 32 | 33 | 34 |
BDL 134 | 7673.1 | Av. | 11.8 4 | 1.30 | 1.26 | 1.10 | 2.40 | 2.03 | 2.04 | 1.95 | 1.14 | ||||||||
BDL 134 | 7673.2 | P | 0.19 | 0.39 | 0.26 | 0.01 | 0.18 | 0.11 | 0.16 | 0.00 | 0.62 | ||||||||
BDL 134 | 7673.2 | Av. | 1.67 | 1.26 | 1.42 | 2.03 | 1.66 | 1.62 | 1.78 | 2.56 | 1.20 | ||||||||
BDL 135 | 7722.1 | P | 0.51 | 0.34 | 0.66 | 0.07 | 0.45 | 0.43 | 0.64 | 0.24 | 0.10 | ||||||||
BDL 135 | 7722.1 | Av. | 1.13 | 1.11 | 1.85 | 1.14 | 1.17 | 1.11 | 1.86 | 1.25 | 1.11 | ||||||||
BDL 135 | 7723.1 | P | 0.02 | 0.24 | |||||||||||||||
BDL 135 | 7723.1 | Av. | 1.02 | 1.22 | |||||||||||||||
BDL 135 | 7723.3 | P | 0.43 | 0.27 | 0.51 | 0.06 | 0.29 | 0.02 | |||||||||||
BDL 135 | 7723.3 | Av. | 1.13 | 5.05 | 1.20 | 1.29 | 6.62 | 1.34 | |||||||||||
BDL 135 | 7723.8 | P | 0.72 | 0.61 | 0.35 | 0.26 | |||||||||||||
BDL 135 | 7723.8 | Av. | 1.12 | 1.13 | 1.10 | 1.13 | |||||||||||||
BDL 135 | 7723.9 | P | 0.03 | 0.12 | 0.05 | 0.17 | 0.04 | 0.29 | |||||||||||
BDL 135 | 7723.9 | Av. | 1.19 | 1.15 | 1.12 | 1.16 | 1.03 | 1.21 | |||||||||||
BDL 136 | 7751.4 | P | 0.19 | 0.57 | 0.19 | 0.48 | |||||||||||||
BDL 136 | 7751.4 | Av. | 1.26 | 1.18 | 1.21 | 1.19 | |||||||||||||
BDL 136 | 7751.5 | P | 0.53 | 0.75 | 0.53 | 0.39 | 0.44 | 0.44 | 0.36 | 0.01 | |||||||||
BDL 136 | 7751.5 | Av. | 1.57 | 1.12 | 1.40 | 1.49 | 1.35 | 1.41 | 1.77 | 1.12 | |||||||||
BDL 136 | 7751.8 | P | 0.03 | 0.02 | 0.05 | 0.05 | 0.10 | 0.39 | |||||||||||
BDL 136 | 7751.8 | Av. | 1.20 | 1.23 | 1.31 | 1.08 | 1.02 | 1.14 | |||||||||||
BDL 136 | 7752.6 | P | 0.12 | ||||||||||||||||
BDL 136 | 7752.6 | Av. | 1.35 | ||||||||||||||||
BDL 137 | 7701.2 | P | 0.21 | 0.05 | 0.50 | 0.06 | 0.47 | 0.40 | 0.05 | ||||||||||
BDL 137 | 7701.2 | Av. | 1.15 | 1.14 | 5.92 | 1.02 | 1.90 | 2.37 | 1.21 | ||||||||||
BDL 137 | 7701.5 | P | 0.61 | 0.73 | 0.47 | 0.68 | 0.68 | ||||||||||||
BDL 137 | 7701.5 | Av. | 1.28 | 1.41 | 1.23 | 1.57 | 1.12 | ||||||||||||
BDL 137 | 7701.6 | P | 0.84 | 0.75 | 0.73 | 0.76 | 0.01 | 0.14 | |||||||||||
BDL 137 | 7701.6 | Av. | 1.10 | 1.42 | 1.15 | 1.41 | 1.30 | 1.13 |
WO 2009/141824
PCT/IL2009/000508
2018200117 05 Jan 2018
154
Gene | Ev. | Par. | 18 | 19 | 20 | 21 | 22 | 23 | 24 | 25 | 26 | 27 | 28 | 29 | 30 | 31 | 32 | 33 | 34 |
BDL 137 | 7702.1 | P | 0.19 | 0.14 | 0.25 | 0.02 | 0.10 | 0.00 | 0.15 | 0.00 | |||||||||
BDL 137 | 7702.1 | Av. | 2.42 | 1.29 | 1.38 | 1.95 | 1.94 | 1.49 | 2.00 | 1.42 | |||||||||
BDL 137 | 7703.2 | P | 0.41 | 0.45 | 0.59 | 0.35 | 0.41 | 0.46 | 0.61 | 0.30 | |||||||||
BDL 137 | 7703.2 | Av. | 1.55 | 1.52 | 2.47 | 1.15 | 1.50 | 1.59 | 2.22 | 1.27 | |||||||||
BDL 137 | 7703.3 | P | 0.32 | 0.01 | 0.18 | 0.30 | 0.52 | 0.19 | |||||||||||
BDL 137 | 7703.3 | Av. | 1.19 | 1.25 | 1.23 | 1.42 | 1.20 | 1.27 | |||||||||||
BDL 137 | 7703.7 | P | 0.53 | 0.55 | 0.53 | 0.53 | 0.41 | 0.17 | |||||||||||
BDL 137 | 7703.7 | Av. | 1.12 | 1.45 | 1.16 | 1.18 | 1.42 | 1.32 | |||||||||||
BDL 139 | 8131.1 | P | |||||||||||||||||
BDL 139 | 8131.1 | Av. | |||||||||||||||||
BDL 139 | 8131.2 | P | 0.12 | 0.44 | 0.10 | 0.83 | 0.00 | 0.27 | 0.00 | 0.64 | 0.38 | 0.50 | |||||||
BDL 139 | 8131.2 | Av. | 1.70 | 1.21 | 1.21 | 1.19 | 1.79 | 1.78 | 1.71 | 1.64 | 1.20 | 1.18 | |||||||
BDL 139 | 8132.7 | P | |||||||||||||||||
BDL 139 | 8132.7 | Av. | |||||||||||||||||
BDL 139 | 8133.2 | P | |||||||||||||||||
BDL 139 | 8133.2 | Av. | |||||||||||||||||
BDL 141 | 8141.2 | P | 0.30 | 0.01 | |||||||||||||||
BDL 141 | 8141.2 | Av. | 1.12 | 1.13 | |||||||||||||||
BDL 141 | 8142.2 | P | |||||||||||||||||
BDL 141 | 8142.2 | Av. | |||||||||||||||||
BDL 142 | 8282.1 | P | 0.43 | 0.35 | 0.52 | 0.15 | 0.27 | 0.38 | 0.42 | 0.13 | 0.01 | ||||||||
BDL 142 | 8282.1 | Av. | 1.17 | 1.21 | 1.20 | 1.47 | 1.31 | 1.37 | 1.33 | 1.49 | 1.25 | ||||||||
BDL 142 | 8283.1 | P | 0.27 | 0.26 | 0.14 | 0.03 | 0.65 | 0.24 | 0.33 | ||||||||||
BDL 142 | 8283.1 | Av. | 4.32 | 1.94 | 2.12 | 1.30 | 1.17 | 2.04 | 1.10 | ||||||||||
BDL 142 | 8283.2 | P | 0.04 | 0.01 | 0.30 | ||||||||||||||
BDL 142 | 8283.2 | Av. | 1.07 | 1.14 | 1.42 | ||||||||||||||
BDL 142 | 8284.1 | P | 0.68 | 0.35 | 0.64 | 0.85 | 0.29 | 0.17 |
WO 2009/141824
PCT/IL2009/000508
2018200117 05 Jan 2018
155
Gene | Ev. | Par. | 18 | 19 | 20 | 21 | 22 | 23 | 24 | 25 | 26 | 27 | 28 | 29 | 30 | 31 | 32 | 33 | 34 |
BDL 142 | 8284.1 | Av. | 1.18 | 1.20 | 1.23 | 1.11 | 1.21 | 1.13 | |||||||||||
BDL 142 | 8285.3 | P | 0.21 | 0.60 | 0.14 | 0.45 | 0.61 | 0.56 | 0.22 | 0.03 | |||||||||
BDL 142 | 8285.3 | Av. | 2.01 | 1.50 | 1.82 | 1.21 | 1.28 | 1.66 | 1.40 | 1.16 | |||||||||
BDL 142 | 8285.5 | P | 0.52 | 0.65 | 0.36 | ||||||||||||||
BDL 142 | 8285.5 | Av. | 1.33 | 1.26 | 1.29 | ||||||||||||||
BDL 143 | 8411.1 | P | 0.00 | 0.00 | 0.11 | 0.15 | 0.00 | 0.02 | 0.02 | 0.06 | |||||||||
BDL 143 | 8411.1 | Av. | 1.28 | 1.24 | 1.41 | 1.17 | 1.05 | 1.02 | 1.03 | 1.17 | |||||||||
BDL 143 | 8411.5 | P | 0.91 | 0.17 | |||||||||||||||
BDL 143 | 8411.5 | Av. | 1.24 | 1.11 | |||||||||||||||
BDL 143 | 8412.2 | P | 0.31 | 0.43 | 0.09 | 0.77 | 0.00 | 0.24 | 0.13 | 0.69 | 0.02 | ||||||||
BDL 143 | 8412.2 | Av. | 1.22 | 1.24 | 1.49 | 1.35 | 1.31 | 1.51 | 1.63 | 1.52 | 1.34 | ||||||||
BDL 143 | 8412.4 | P | 0.23 | 0.63 | 0.59 | 0.03 | 0.42 | 0.28 | 0.78 | ||||||||||
BDL 143 | 8412.4 | Av. | 1.14 | 1.21 | 1.26 | 1.80 | 1.90 | 2.17 | 1.22 | ||||||||||
BDL 143 | 8413.3 | P | 0.09 | 0.42 | 0.03 | 0.43 | 0.00 | 0.27 | 0.00 | 0.31 | 0.44 | ||||||||
BDL 143 | 8413.3 | Av. | 1.69 | 1.28 | 1.29 | 1.40 | 1.61 | 1.50 | 1.55 | 1.64 | 1.20 | ||||||||
BDL 143 | 8414.4 | P | 0.34 | 0.68 | 0.73 | 0.66 | 0.07 | 0.67 | |||||||||||
BDL 143 | 8414.4 | Av. | 1.16 | 1.72 | 1.17 | 1.13 | 1.25 | 1.68 | |||||||||||
BDL 143 | 8414.5 | P | 0.35 | 0.60 | 0.20 | 0.26 | 0.40 | 0.30 | 0.29 | ||||||||||
BDL 143 | 8414.5 | Av. | 1.23 | 1.13 | 1.19 | 1.28 | 1.38 | 1.40 | 1.13 | ||||||||||
BDL 144 | 8384.1 | P | 0.09 | 0.35 | 0.10 | 0.37 | 0.36 | ||||||||||||
BDL 144 | 8384.1 | Av. | 1.24 | 1.18 | 1.23 | 1.17 | 1.35 | ||||||||||||
BDL 144 | 8384.5 | P | 0.36 | 0.13 | |||||||||||||||
BDL 144 | 8384.5 | Av. | 1.18 | 1.24 | |||||||||||||||
BDL 144 | 8385.1 | P | 0.00 | 0.07 | 0.39 | 0.73 | 0.00 | 0.05 | 0.00 | 0.06 | 0.13 | ||||||||
BDL 144 | 8385.1 | Av. | 2.50 | 1.35 | 1.25 | 1.14 | 2.06 | 2.23 | 1.86 | 1.71 | 1.50 | ||||||||
BDL 145 | 8233.2 | P | 0.25 | 0.00 | 0.73 | 0.08 | |||||||||||||
BDL 145 | 8233.2 | Av. | 1.47 | 1.47 | 1.24 | 1.15 |
WO 2009/141824
PCT/IL2009/000508
2018200117 05 Jan 2018
156
Gene | Ev. | Par. | 18 | 19 | 20 | 21 | 22 | 23 | 24 | 25 | 26 | 27 | 28 | 29 | 30 | 31 | 32 | 33 | 34 |
BDL 145 | 8233.3 | P | 0.37 | 0.45 | 0.58 | 0.08 | 0.06 | 0.30 | 0.48 | 0.39 | 0.23 | ||||||||
BDL 145 | 8233.3 | Av. | 9.00 | 1.13 | 1.21 | 2.55 | 1.79 | 1.75 | 1.51 | 1.35 | 1.36 | ||||||||
BDL 145 | 8235.1 | P | 0.36 | 0.41 | 0.22 | 0.32 | 0.79 | 0.32 | |||||||||||
BDL 145 | 8235.1 | Av. | 1.25 | 1.57 | 1.27 | 1.73 | 1.34 | 1.16 | |||||||||||
BDL 145 | 8235.3 | P | 0.21 | 0.16 | 0.65 | 0.02 | 0.14 | 0.00 | 0.43 | 0.41 | 0.38 | ||||||||
BDL 145 | 8235.3 | Av. | 3.39 | 1.17 | 1.35 | 2.32 | 1.87 | 1.92 | 2.33 | 1.31 | 1.21 | ||||||||
BDL 145 | 8235.4 | P | |||||||||||||||||
BDL 145 | 8235.4 | Av. | |||||||||||||||||
BDL 146 | 8241.1 | P | 0.29 | 0.42 | 0.12 | 0.32 | 0.30 | ||||||||||||
BDL 146 | 8241.1 | Av. | 1.18 | 1.14 | 1.11 | 1.10 | 1.37 | ||||||||||||
BDL 146 | 8241.3 | P | 0.10 | 0.11 | 0.31 | 0.01 | 0.45 | 0.01 | 0.42 | 0.04 | |||||||||
BDL 146 | 8241.3 | Av. | 1.19 | 1.29 | 1.88 | 1.26 | 1.24 | 1.41 | 1.96 | 1.08 | |||||||||
BDL 146 | 8243.2 | P | 0.62 | 0.72 | 0.59 | 0.15 | 0.05 | ||||||||||||
BDL 146 | 8243.2 | Av. | 1.52 | 1.12 | 1.42 | 1.18 | 1.16 | ||||||||||||
BDL 146 | 8243.5 | P | 0.50 | 0.59 | 0.68 | 0.32 | 0.56 | 0.59 | 0.62 | 0.70 | |||||||||
BDL 146 | 8243.5 | Av. | 1.42 | 1.20 | 1.13 | 1.46 | 1.47 | 1.34 | 1.31 | 1.11 | |||||||||
BDL 146 | 8244.4 | P | 0.29 | 0.21 | 0.33 | 0.77 | 0.01 | 0.89 | |||||||||||
BDL 146 | 8244.4 | Av. | 1.15 | 1.17 | 1.30 | 1.39 | 1.04 | 1.17 | |||||||||||
BDL 146 | 8244.7 | P | 0.07 | 0.00 | 0.01 | 0.29 | 0.01 | 0.00 | 0.00 | 0.18 | 0.47 | ||||||||
BDL 146 | 8244.7 | Av. | 1.74 | 1.58 | 1.42 | 1.41 | 1.66 | 2.03 | 1.77 | 1.97 | 1.26 | ||||||||
BDL 146 | 8245.2 | P | 0.69 | 0.50 | 0.43 | 0.35 | 0.59 | 0.47 | |||||||||||
BDL 146 | 8245.2 | Av. | 1.21 | 3.35 | 1.11 | 1.12 | 1.30 | 3.30 | |||||||||||
BDL 146 | 8245.5 | P | 0.02 | 0.67 | 0.08 | 0.71 | 0.00 | ||||||||||||
BDL 146 | 8245.5 | Av. | 1.13 | 2.48 | 1.07 | 2.05 | 1.25 | ||||||||||||
BDL 42 | 7771.1 | P | |||||||||||||||||
BDL 42 | 7771.1 | Av. | |||||||||||||||||
BDL 42 | 7772.1 | P |
WO 2009/141824
PCT/IL2009/000508
2018200117 05 Jan 2018
157
Gene | Ev. | Par. | 18 | 19 | 20 | 21 | 22 | 23 | 24 | 25 | 26 | 27 | 28 | 29 | 30 | 31 | 32 | 33 | 34 |
BDL 42 | 7772.1 | Av. | |||||||||||||||||
BDL 42 | 7772.7 | P | |||||||||||||||||
BDL 42 | 7772.7 | Av. | |||||||||||||||||
BDL 42 | 7774.1 | P | 0.01 | 0.15 | 0.35 | 0.73 | 0.00 | 0.00 | 0.15 | 0.01 | |||||||||
BDL 42 | 7774.1 | Av. | 4.17 | 1.16 | 1.25 | 1.11 | 2.40 | 2.04 | 2.29 | 2.15 | |||||||||
BDL 42 | 7774.2 | P | |||||||||||||||||
BDL 42 | 7774.2 | Av. | |||||||||||||||||
BDL 42 | 7774.4 | P | 0.43 | 0.31 | 0.73 | 0.24 | 0.06 | 0.00 | 0.12 | 0.46 | |||||||||
BDL 42 | 7774.4 | Av. | 3.46 | 1.18 | 1.10 | 2.06 | 1.55 | 1.85 | 2.09 | 1.15 | |||||||||
BDL 46 | 7833.3 | P | 0.02 | 0.70 | 0.33 | 0.47 | 0.00 | 0.34 | 0.09 | 0.43 | 0.31 | ||||||||
BDL 46 | 7833.3 | Av. | 1.53 | 1.11 | 1.19 | 4.71 | 1.55 | 1.52 | 1.51 | 6.07 | 1.24 | ||||||||
BDL 46 | 7833.4 | P | 0.02 | 0.02 | |||||||||||||||
BDL 46 | 7833.4 | Av. | 1.04 | 1.17 | |||||||||||||||
BDL 46 | 7833.5 | P | 0.49 | 0.43 | |||||||||||||||
BDL 46 | 7833.5 | Av. | 1.55 | 1.44 | |||||||||||||||
BDL 46 | 7833.6 | P | 0.12 | 0.54 | 0.52 | 0.33 | 0.53 | 0.50 | |||||||||||
BDL 46 | 7833.6 | Av. | 1.24 | 1.74 | 3.06 | 1.18 | 1.94 | 3.78 | |||||||||||
BDL 46 | 7834.1 | P | |||||||||||||||||
BDL 46 | 7834.1 | Av. | |||||||||||||||||
BDL 46 | 7833.1 | P | 0.81 | 0.15 | 0.06 | 0.37 | 0.80 | 0.25 | 0.00 | 0.04 | |||||||||
BDL 46 | 7833.1 | Av. | 2.17 | 1.81 | 1.26 | 1.29 | 2.21 | 2.29 | 1.66 | 1.76 | |||||||||
BDL 46 | 7833.3 | P | 0.75 | 0.30 | 0.00 | 0.79 | |||||||||||||
BDL 46 | 7833.3 | Av. | 1.13 | 1.50 | 1.41 | 1.44 | |||||||||||||
BDL 46 | 7833.4 | P | |||||||||||||||||
BDL 46 | 7833.4 | Av. | |||||||||||||||||
BDL 46 | 7833.5 | P | 0.54 | 0.25 | 0.09 | ||||||||||||||
BDL 46 | 7833.5 | Av. | 1.22 | 1.77 | 1.68 |
WO 2009/141824
PCT/IL2009/000508
2018200117 05 Jan 2018
158
Gene | Ev. | Par. | 18 | 19 | 20 | 21 | 22 | 23 | 24 | 25 | 26 | 27 | 28 | 29 | 30 | 31 | 32 | 33 | 34 |
BDL 46 | 7834.4 | P | 0.25 | 0.00 | 0.13 | 0.04 | 0.41 | 0.00 | 0.04 | 0.00 | |||||||||
BDL 46 | 7834.4 | Av. | 2.23 | 3.05 | 2.50 | 3.07 | 1.88 | 3.45 | 2.95 | 3.50 | |||||||||
BDL 51 | 7291.1 | P | 0.17 | 0.34 | 0.24 | 0.07 | 0.06 | 0.22 | 0.13 | 0.04 | 0.10 | ||||||||
BDL 51 | 7291.1 | Av. | 2.46 | 1.84 | 1.59 | 3.10 | 2.14 | 2.30 | 2.12 | 4.63 | 1.11 | ||||||||
BDL 51 | 8021.1 | P | 0.00 | 0.58 | 0.03 | 0.50 | |||||||||||||
BDL 51 | 8021.1 | Av. | 2.43 | 3.13 | 4.73 | 7.50 | |||||||||||||
BDL 51 | 8022.4 | P | 0.02 | 0.31 | 0.63 | 0.02 | 0.25 | 0.16 | 0.49 | ||||||||||
BDL 51 | 8022.4 | Av. | 2.50 | 1.54 | 1.30 | 4.06 | 3.15 | 3.24 | 1.29 | ||||||||||
BDL 51 | 8022.5 | P | 0.28 | 0.31 | 0.21 | 0.15 | 0.16 | 0.15 | 0.12 | 0.14 | |||||||||
BDL 51 | 8022.5 | Av. | 3.27 | 2.22 | 1.66 | 2.02 | 2.40 | 3.77 | 4.00 | 5.31 | |||||||||
BDL 51 | 8024.4 | P | 0.23 | 0.06 | 0.32 | 0.55 | 0.10 | 0.12 | 0.30 | 0.51 | 0.85 | ||||||||
BDL 51 | 8024.4 | Av. | 2.16 | 1.60 | 1.55 | 3.05 | 1.80 | 2.19 | 2.27 | 4.90 | 1.14 | ||||||||
BDL 51 | 8024.7 | P | 0.40 | 0.45 | 0.29 | 0.79 | |||||||||||||
BDL 51 | 8024.7 | Av. | 1.50 | 1.12 | 1.71 | 1.12 | |||||||||||||
BDL 52 | 7861.1 | P | 0.64 | 0.68 | |||||||||||||||
BDL 52 | 7861.1 | Av. | 1.20 | 1.15 | |||||||||||||||
BDL 52 | 7861.5 | P | 0.38 | 0.03 | 0.38 | 0.04 | 0.01 | ||||||||||||
BDL 52 | 7861.5 | Av. | 1.28 | 2.63 | 1.19 | 2.58 | 1.16 | ||||||||||||
BDL 52 | 7863.2 | P | |||||||||||||||||
BDL 52 | 7863.2 | Av. | |||||||||||||||||
BDL 52 | 7864.5 | P | 0.16 | 0.63 | 0.62 | ||||||||||||||
BDL 52 | 7864.5 | Av. | 1.12 | 1.30 | 1.14 | ||||||||||||||
BDL 54 | 7781.1 | P | 0.51 | 0.51 | 0.51 | ||||||||||||||
BDL 54 | 7781.1 | Av. | 4.05 | 3.55 | 2.68 | ||||||||||||||
BDL 54 | 7781.4 | P | 0.18 | 0.29 | 0.72 | ||||||||||||||
BDL 54 | 7781.4 | Av. | 1.67 | 1.57 | 1.15 | ||||||||||||||
BDL 54 | 7784.3 | P | 0.21 | 0.43 | 0.17 | 0.31 | 0.29 |
WO 2009/141824
PCT/IL2009/000508
2018200117 05 Jan 2018
159
Gene | Ev. | Par. | 18 | 19 | 20 | 21 | 22 | 23 | 24 | 25 | 26 | 27 | 28 | 29 | 30 | 31 | 32 | 33 | 34 |
BDL 54 | 7784.3 | Av. | 2.32 | 2.78 | 2.05 | 3.64 | 2.55 | ||||||||||||
BDL 54 | 7784.5 | P | 0.11 | 0.40 | 0.01 | 0.27 | 0.35 | 0.18 | |||||||||||
BDL 54 | 7784.5 | Av. | 1.38 | 3.91 | 1.29 | 1.23 | 4.08 | 1.29 | |||||||||||
BDL 54 | 7785.4 | P | 0.00 | 0.00 | 0.02 | ||||||||||||||
BDL 54 | 7785.4 | Av. | 1.70 | 1.56 | 1.23 | ||||||||||||||
BDL 54 | 7781.1 | P | 0.08 | 0.78 | 0.25 | 0.59 | 0.52 | 0.23 | |||||||||||
BDL 54 | 7781.1 | Av. | 3.23 | 1.30 | 3.98 | 1.88 | 1.41 | 1.72 | |||||||||||
BDL 54 | 7781.4 | P | 0.55 | 0.54 | 0.24 | 0.92 | |||||||||||||
BDL 54 | 7781.4 | Av. | 3.16 | 3.57 | 1.52 | 1.12 | |||||||||||||
BDL 54 | 7784.3 | P | 0.52 | 0.17 | |||||||||||||||
BDL 54 | 7784.3 | Av. | 1.21 | 1.51 | |||||||||||||||
BDL 54 | 7785.4 | P | 0.04 | 0.53 | 0.13 | 0.11 | 0.34 | ||||||||||||
BDL 54 | 7785.4 | Av. | 6.70 | 1.20 | 10.2 4 | 1.62 | 3.57 | ||||||||||||
BDL 54 | 7785.8 | P | 0.14 | 0.37 | 0.16 | 0.33 | 0.00 | ||||||||||||
BDL 54 | 7785.8 | Av. | 6.30 | 1.51 | 8.24 | 1.48 | 3.47 | ||||||||||||
BDL 56 | 7181.2 | P | 0.15 | 0.21 | 0.73 | 0.52 | 0.14 | 0.26 | 0.66 | 0.50 | 0.46 | ||||||||
BDL 56 | 7181.2 | Av. | 1.26 | 1.91 | 1.41 | 2.39 | 1.44 | 2.65 | 1.64 | 3.57 | 2.09 | ||||||||
BDL 56 | 8301.1 | P | 0.00 | 0.05 | 0.11 | 0.55 | 0.32 | 0.01 | 0.03 | 0.66 | |||||||||
BDL 56 | 8301.1 | Av. | 1.28 | 1.27 | 1.22 | 1.82 | 1.13 | 1.04 | 1.03 | 1.45 | |||||||||
BDL 56 | 8301.3 | P | 0.40 | 0.81 | 0.35 | 0.75 | |||||||||||||
BDL 56 | 8301.3 | Av. | 2.62 | 1.11 | 2.83 | 1.15 | |||||||||||||
BDL 56 | 8304.1 | P | 0.38 | ||||||||||||||||
BDL 56 | 8304.1 | Av. | 1.11 | ||||||||||||||||
BDL 56 | 8305.1 | P | 0.38 | 0.43 | 0.07 | 0.46 | 0.79 | ||||||||||||
BDL 56 | 8305.1 | Av. | 1.19 | 1.52 | 1.17 | 1.58 | 1.12 | ||||||||||||
BDL 56 | 8301.1 | P | 0.29 | 0.00 | |||||||||||||||
BDL 56 | 8301.1 | Av. | 1.27 | 1.63 |
WO 2009/141824
PCT/IL2009/000508
2018200117 05 Jan 2018
160
Gene | Ev. | Par. | 18 | 19 | 20 | 21 | 22 | 23 | 24 | 25 | 26 | 27 | 28 | 29 | 30 | 31 | 32 | 33 | 34 |
BDL 56 | 8301.2 | P | 0.77 | ||||||||||||||||
BDL 56 | 8301.2 | Av. | 1.68 | ||||||||||||||||
BDL 56 | 8301.3 | P | 0.54 | 0.95 | 0.91 | 0.84 | 0.36 | ||||||||||||
BDL 56 | 8301.3 | Av. | 1.25 | 1.36 | 1.62 | 1.11 | 1.80 | ||||||||||||
BDL 56 | 8303.1 | P | |||||||||||||||||
BDL 56 | 8303.1 | Av. | |||||||||||||||||
BDL 56 | 8303.2 | P | 0.53 | 0.01 | 0.33 | 0.00 | 0.08 | 0.51 | 0.12 | ||||||||||
BDL 56 | 8303.2 | Av. | 1.11 | 6.56 | 1.13 | 9.42 | 1.25 | 1.22 | 5.45 | ||||||||||
BDL 59 | 7792.1 | P | 0.39 | 0.07 | 0.50 | ||||||||||||||
BDL 59 | 7792.1 | Av. | 1.69 | 1.08 | 1.58 | ||||||||||||||
BDL 59 | 7792.2 | P | 0.69 | 0.68 | |||||||||||||||
BDL 59 | 7792.2 | Av. | 2.56 | 2.78 | |||||||||||||||
BDL 59 | 7792.3 | P | 0.16 | 0.05 | |||||||||||||||
BDL 59 | 7792.3 | Av. | 1.17 | 1.03 | |||||||||||||||
BDL 59 | 7793.3 | P | 0.64 | 0.83 | 0.57 | 0.73 | 0.36 | ||||||||||||
BDL 59 | 7793.3 | Av. | 1.21 | 1.15 | 1.26 | 1.24 | 1.35 | ||||||||||||
BDL 59 | 7794.1 | P | 0.27 | 0.86 | 0.Y1 | 0.81 | 0.00 | ||||||||||||
BDL 59 | 7794.1 | Av. | 2.60 | 1.13 | 3.67 | 1.18 | 3.34 | ||||||||||||
BDL 60 | 8011.4 | P | 0.45 | 0.45 | |||||||||||||||
BDL 60 | 8011.4 | Av. | 1.13 | 1.12 | |||||||||||||||
BDL 60 | 8011.7 | P | 0.00 | 0.48 | 0.01 | 0.44 | 0.41 | 0.45 | |||||||||||
BDL 60 | 8011.7 | Av. | 2.02 | 2.83 | 1.98 | 3.86 | 1.35 | 2.63 | |||||||||||
BDL 60 | 8013.4 | P | 0.08 | 0.40 | 0.01 | 0.05 | 0.27 | ||||||||||||
BDL 60 | 8013.4 | Av. | 2.96 | 2.37 | 2.30 | 1.57 | 3.52 | ||||||||||||
BDL 60 | 8013.6 | P | 0.21 | 0.49 | 0.00 | 0.70 | 0.04 | 0.47 | 0.26 | ||||||||||
BDL 60 | 8013.6 | Av. | 1.96 | 6.84 | 1.85 | 1.11 | 1.20 | 8.09 | 1.42 | ||||||||||
BDL 60 | 8014.5 | P | 0.36 | 0.90 | 0.23 | 0.62 | 0.76 | 0.70 |
WO 2009/141824
PCT/IL2009/000508
2018200117 05 Jan 2018
161
Gene | Ev. | Par. | 18 | 19 | 20 | 21 | 22 | 23 | 24 | 25 | 26 | 27 | 28 | 29 | 30 | 31 | 32 | 33 | 34 |
BDL 60 | 8014.5 | Av. | 2.07 | 1.16 | 1.84 | 1.19 | 1.29 | 1.76 | |||||||||||
BDL 60 | 8013.6 | P | 0.01 | 0.34 | 0.32 | 0.21 | 0.00 | 0.04 | 0.19 | 0.09 | 0.77 | 0.89 | |||||||
BDL 60 | 8013.6 | Av. | 6.90 | 1.59 | 1.30 | 2.17 | 8.76 | 1.88 | 1.59 | 2.45 | 1.23 | 1.17 | |||||||
BDL 60 | 8014.2 | P | 0.04 | 0.18 | 0.01 | 0.00 | 0.16 | 0.00 | |||||||||||
BDL 60 | 8014.2 | Av. | 1.58 | 1.50 | 2.12 | 2.04 | 2.11 | 3.09 | |||||||||||
BDL 60 | 8014.7 | P | 0.56 | 0.43 | 0.42 | 0.45 | 0.50 | ||||||||||||
BDL 60 | 8014.7 | Av. | 1.55 | 1.26 | 1.23 | 1.29 | 2.00 | ||||||||||||
BDL 60 | 8014.8 | P | 0.81 | 0.12 | 0.16 | 0.66 | 0.17 | 0.25 | 0.24 | 0.41 | |||||||||
BDL 60 | 8014.8 | Av. | 1.12 | 7.59 | 1.18 | 1.14 | 9.76 | 1.41 | 1.39 | 4.18 | |||||||||
BDL 65 | 7824.1 | P | 0.57 | 0.36 | 0.65 | 0.41 | 0.01 | 0.55 | 0.47 | 0.03 | |||||||||
BDL 65 | 7824.1 | Av. | 1.51 | 1.24 | 1.37 | 1.51 | 1.72 | 1.21 | 2.26 | 1.36 | |||||||||
BDL 65 | 7825.2 | P | 0.40 | 0.49 | 0.11 | 0.17 | 0.21 | 0.15 | |||||||||||
BDL 65 | 7825.2 | Av. | 1.29 | 1.18 | 1.76 | 1.49 | 1.45 | 2.51 | |||||||||||
BDL 65 | 8473.2 | P | 0.13 | 0.20 | 0.07 | 0.51 | 0.01 | 0.05 | 0.00 | 0.42 | 0.13 | ||||||||
BDL 65 | 8473.2 | Av. | 3.11 | 1.16 | 1.31 | 2.00 | 2.17 | 1.78 | 1.82 | 2.80 | 1.34 | ||||||||
BDL 65 | 8474.1 | P | 0.13 | 0.22 | 0.05 | 0.33 | 0.64 | ||||||||||||
BDL 65 | 8474.1 | Av. | 1.25 | 1.78 | 1.28 | 2.01 | 1.12 | ||||||||||||
BDL 67 | 7901.5 | P | 0.38 | 0.26 | 0.15 | 0.17 | 0.36 | 0.18 | 0.23 | 0.12 | |||||||||
BDL 67 | 7901.5 | Av. | 1.56 | 1.22 | 1.29 | 1.92 | 1.46 | 1.34 | 1.48 | 2.49 | |||||||||
BDL 67 | 7902.3 | P | 0.46 | 0.65 | 0.47 | 0.68 | 0.48 | 0.49 | |||||||||||
BDL 67 | 7902.3 | Av. | 1.12 | 1.11 | 2.65 | 1.11 | 3.06 | 2.43 | |||||||||||
BDL 67 | 7902.7 | P | 0.19 | 0.54 | 0.20 | 0.51 | 0.66 | 0.55 | |||||||||||
BDL 67 | 7902.7 | Av. | 1.49 | 1.94 | 1.46 | 2.91 | 1.15 | 2.69 | |||||||||||
BDL 67 | 7903.3 | P | 0.68 | 0.73 | 0.71 | 0.68 | |||||||||||||
BDL 67 | 7903.3 | Av. | 1.19 | 1.99 | 1.17 | 2.50 | |||||||||||||
BDL 67 | 7903.5 | P | 0.12 | 0.54 | 0.00 | 0.00 | 0.05 | 0.49 | 0.04 | ||||||||||
BDL 67 | 7903.5 | Av. | 2.41 | 2.43 | 2.03 | 1.41 | 1.33 | 2.85 | 1.26 |
WO 2009/141824
PCT/IL2009/000508
2018200117 05 Jan 2018
162
Gene | Ev. | Par. | 18 | 19 | 20 | 21 | 22 | 23 | 24 | 25 | 26 | 27 | 28 | 29 | 30 | 31 | 32 | 33 | 34 |
BDL 68 | 7761.3 | P | 0.59 | 0.74 | 0.59 | 0.66 | 0.72 | ||||||||||||
BDL 68 | 7761.3 | Av. | 1.42 | 1.55 | 1.32 | 1.17 | 1.60 | ||||||||||||
BDL 68 | 7761.8 | P | 0.45 | 0.21 | 0.23 | 0.00 | 0.29 | 0.04 | 0.09 | ||||||||||
BDL 68 | 7761.8 | Av. | 7.80 | 1.77 | 2.62 | 2.04 | 1.30 | 2.56 | 2.02 | ||||||||||
BDL 68 | 7761.9 | P | 0.39 | 0.64 | 0.96 | 0.63 | |||||||||||||
BDL 68 | 7761.9 | Av. | 1.60 | 1.67 | 1.12 | 1.41 | |||||||||||||
BDL 68 | 7763.2 | P | 0.24 | 0.30 | 0.19 | 0.14 | 0.46 | ||||||||||||
BDL 68 | 7763.2 | Av. | 2.08 | 1.62 | 1.91 | 1.99 | 1.28 | ||||||||||||
BDL 68 | 7764.1 | P | 0.42 | 0.54 | 0.83 | 0.13 | 0.46 | 0.53 | 0.45 | 0.40 | |||||||||
BDL 68 | 7764.1 | Av. | 9.83 | 2.45 | 1.14 | 2.76 | 3.43 | 1.26 | 1.50 | 2.71 | |||||||||
BDL 78 | 7911.1 1 | P | 0.40 | 0.08 | 0.56 | 0.14 | 0.00 | ||||||||||||
BDL 78 | 7911.1 1 | Av. | 1.11 | 1.16 | 1.14 | 1.21 | 1.24 | ||||||||||||
BDL 78 | 7911.8 | P | 0.63 | 0.15 | 0.57 | 0.60 | 0.36 | ||||||||||||
BDL 78 | 7911.8 | Av. | 1.79 | 1.21 | 1.22 | 2.17 | 1.30 | ||||||||||||
BDL 78 | 7911.9 | P | 0.20 | 0.00 | 0.14 | 0.00 | 0.69 | 0.00 | |||||||||||
BDL 78 | 7911.9 | Av. | 6.36 | 2.58 | 1.94 | 1.88 | 1.25 | 1.48 | |||||||||||
BDL 78 | 7912.6 | P | 0.70 | 0.61 | 0.63 | 0.37 | |||||||||||||
BDL 78 | 7912.6 | Av. | 1.21 | 1.14 | 1.28 | 1.16 | |||||||||||||
BDL 78 | 7913.1 1 | P | 0.24 | 0.66 | 0.05 | 0.32 | 0.24 | 0.13 | 0.67 | ||||||||||
BDL 78 | 7913.1 1 | Av. | 1.72 | 1.13 | 1.84 | 1.18 | 1.50 | 1.60 | 1.11 | ||||||||||
BDL 78 | 7913.3 | P | 0.53 | 0.44 | 0.00 | ||||||||||||||
BDL 78 | 7913.3 | Av. | 1.14 | 1.20 | 1.31 | ||||||||||||||
BDL 78 | 7913.6 | P | 0.45 | 0.25 | 0.49 | 0.68 | 0.18 | 0.12 | 0.06 | 0.24 | 0.49 | 0.42 | |||||||
BDL 78 | 7913.6 | Av. | 8.48 | 1.13 | 1.22 | 1.23 | 2.37 | 1.90 | 1.81 | 1.92 | 1.16 | 1.44 | |||||||
BDL 78 | 7913.8 | P | 0.31 | 0.21 | 0.68 | 0.04 | 0.23 | 0.10 | 0.53 | 0.07 | 0.48 | ||||||||
BDL 78 | 7913.8 | Av. | 1.36 | 1.28 | 1.29 | 1.30 | 1.69 | 1.58 | 1.69 | 1.14 | 1.11 | ||||||||
BDL 78 | 7913.9 | P | 0.51 | 0.52 | 0.20 | 0.34 | 0.49 | 0.46 | 0.15 | 0.07 |
WO 2009/141824
PCT/IL2009/000508
2018200117 05 Jan 2018
163
Gene | Ev. | Par. | 18 | 19 | 20 | 21 | 22 | 23 | 24 | 25 | 26 | 27 | 28 | 29 | 30 | 31 | 32 | 33 | 34 |
BDL 78 | 7913.9 | Av. | 1.37 | 1.14 | 1.41 | 1.48 | 1.25 | 1.28 | 1.50 | 1.53 | |||||||||
BDL 82 | 7801.1 | P | 0.20 | 0.00 | 0.24 | 0.34 | 0.00 | 0.00 | 0.12 | 0.25 | |||||||||
BDL 82 | 7801.1 | Av. | 2.67 | 1.39 | 1.66 | 2.12 | 2.04 | 1.80 | 2.22 | 3.05 | |||||||||
BDL 82 | 7801.3 | P | 0.33 | 0.83 | 0.03 | 0.03 | 0.14 | ||||||||||||
BDL 82 | 7801.3 | Av. | 8.14 | 1.12 | 2.90 | 1.28 | 2.08 | ||||||||||||
BDL 82 | 7802.2 | P | 0.18 | 0.44 | 0.14 | 0.77 | 0.01 | 0.41 | 0.09 | ||||||||||
BDL 82 | 7802.2 | Av. | 2.55 | 5.01 | 2.16 | 1.11 | 1.26 | 6.53 | 1.35 | ||||||||||
BDL 82 | 7802.3 | P | 0.16 | 0.67 | 0.00 | 0.43 | 0.08 | 0.48 | 0.21 | 0.06 | |||||||||
BDL 82 | 7802.3 | Av. | 2.36 | 1.21 | 1.20 | 1.58 | 2.03 | 1.70 | 1.72 | 2.45 | |||||||||
BDL 82 | 7803.9 | P | 0.24 | 0.01 | 0.37 | 0.00 | 0.00 | 0.46 | |||||||||||
BDL 82 | 7803.9 | Av. | 1.15 | 1.30 | 1.18 | 1.14 | 1.04 | 1.28 | |||||||||||
BDL 89 | 7812.2 | P | 0.49 | 0.67 | 0.34 | ||||||||||||||
BDL 89 | 7812.2 | Av. | 1.15 | 1.14 | 1.11 | ||||||||||||||
BDL 89 | 7812.5 | P | 0.44 | 0.55 | 0.26 | 0.45 | 0.46 | 0.29 | 0.49 | ||||||||||
BDL 89 | 7812.5 | Av. | 3.98 | 1.46 | 7.37 | 3.87 | 1.49 | 7.29 | 2.55 | ||||||||||
BDL 89 | 7814.1 | P | 0.03 | 0.20 | 0.29 | 0.44 | 0.42 | 0.49 | 0.45 | 0.43 | 0.77 | ||||||||
BDL 89 | 7814.1 | Av. | 1.22 | 1.11 | 1.17 | 2.98 | 1.12 | 1.12 | 1.14 | 2.97 | 1.11 | ||||||||
BDL 89 | 7814.4 | P | 0.51 | 0.42 | 0.00 | 0.44 | 0.51 | 0.39 | 0.15 | 0.10 | 0.33 | ||||||||
BDL 89 | 7814.4 | Av. | 3.96 | 2.15 | 1.23 | 1.63 | 1.94 | 3.04 | 1.58 | 2.16 | 1.96 | ||||||||
BDL 89 | 7814.5 | P | 0.42 | 0.55 | 0.43 | 0.31 | 0.20 | 0.42 | 0.19 | 0.32 | 0.13 | ||||||||
BDL 89 | 7814.5 | Av. | 3.45 | 1.14 | 1.67 | 2.25 | 1.16 | 1.45 | 2.21 | 1.39 | 1.12 |
Table 26.
Table 27
Gene | Ev. | Par. | 35 | 36 | 37 | 38 | 39 | 40 | 41 | 42 | 43 | 44 | 45 | 46 | 47 | 48 | 49 | 50 | 51 | 52 | 53 | 54 | 55 |
BDL 95 | 7841 .5 | P | 0.6 7 | 0.7 0 | 0.7 4 | 0.5 5 | 0.1 4 | 0.Ί 4 | 0.5 5 | 0.0 3 | 0.0 1 | ||||||||||||
BDL 95 | 7841 .5 | Av. | 1.6 4 | 1.3 6 | 1.2 2 | 1.1 1 | 1.1 8 | 1.2 2 | 1.1 1 | 1.1 4 | 1.0 9 | ||||||||||||
BDL 95 | 7842 .12 | p | 0.7 7 | 0.0 3 | 0.1 2 | 0.1 2 | 0.3 2 | 0.0 5 |
WO 2009/141824
PCT/IL2009/000508
2018200117 05 Jan 2018
164
Gene | Ev. | Par. | 35 | 36 | 37 | 38 | 39 | 40 | 41 | 42 | 43 | 44 | 45 | 46 | 47 | 48 | 49 | 50 | 51 | 52 | 53 | 54 | 55 |
BDL 95 | 7842 .12 | Av. | 1.1 2 | 1.1 9 | 1.2 4 | 1.1 1 | 1.2 8 | 1.0 4 | |||||||||||||||
BDL 95 | 7842 .2 | P | 0.7 1 | 0.5 8 | 0.0 7 | 0.1 2 | 0.1 9 | 0.2 0 | 0.0 0 | ||||||||||||||
BDL 95 | 7842 .2 | Av. | 1.1 4 | 1.1 1 | 1.0 7 | 1.1 1 | 1.3 3 | 1.1 4 | 1.1 2 | ||||||||||||||
BDL 95 | 7842 .8 | P | 0.2 8 | 0.5 8 | 0.7 8 | 0.0 1 | 0.0 0 | 0.0 1 | 0.2 0 | 0.0 1 | |||||||||||||
BDL 95 | 7842 .8 | Av. | 1.1 8 | 1.1 4 | 1.1 1 | 1.2 1 | 1.2 9 | 1.2 1 | 1.3 1 | 1.0 9 | |||||||||||||
BDL 95 | 7843 .4 | P | 0.4 9 | 0.4 9 | 0.4 9 | 0.4 9 | 0.0 1 | ||||||||||||||||
BDL 95 | 7843 .4 | Av. | 10. 16 | 5.8 9 | 9.5 1 | 5.8 9 | 1.2 4 | ||||||||||||||||
BDL 100 | 7871 .2 | P | 0.3 9 | 0.3 6 | 0.3 7 | 0.0 8 | 0.2 1 | 0.3 7 | 0.0 9 | 0.3 4 | 0.3 9 | ||||||||||||
BDL 100 | 7871 .2 | Av. | 1.1 3 | 1.2 5 | 1.1 4 | 1.2 5 | 1.1 5 | 1.1 4 | 1.1 2 | 1.1 0 | 1.1 6 | ||||||||||||
BDL 100 | 7872 .2 | P | 0.0 3 | 0.2 9 | 0.4 6 | 0.2 6 | 0.3 2 | 0.0 9 | 0.2 6 | 0.2 7 | 0.1 2 | 0.0 0 | |||||||||||
BDL 100 | 7872 .2 | Av. | 1.4 0 | 1.2 5 | 1.4 0 | 1.2 0 | 1.4 0 | 1.2 0 | 1.2 0 | 1.1 7 | 1.1 1 | 1.4 9 | |||||||||||
BDL 100 | 7872 .3 | P | 0.0 1 | 0.5 6 | 0.3 2 | ||||||||||||||||||
BDL 100 | 7872 .3 | Av. | 1.4 9 | 1.1 1 | 1.2 7 | ||||||||||||||||||
BDL 100 | 7873 .3 | P | 0.4 2 | 0.0 3 | 0.0 2 | 0.4 2 | 0.0 3 | 0.3 2 | 0.1 2 | ||||||||||||||
BDL 100 | 7873 .3 | Av. | 1.1 8 | 1.1 6 | 1.2 3 | 1.1 8 | 1.1 6 | 1.2 0 | 1.1 1 | ||||||||||||||
BDL 100 | 7873 .4 | P | 0.5 0 | 0.0 1 | 0.4 3 | 0.4 3 | 0.0 6 | ||||||||||||||||
BDL 100 | 7873 .4 | Av. | 2.9 3 | 1.3 7 | 2.5 8 | 2.5 8 | 1.4 1 | ||||||||||||||||
BDL 106 | 7881 .1 | P | 0.0 1 | 0.5 0 | 0.0 0 | 0.0 0 | 0.0 3 | ||||||||||||||||
BDL 106 | 7881 .1 | Av. | 1.4 1 | 1.3 9 | 1.4 0 | 1.4 0 | 1.1 4 | ||||||||||||||||
BDL 106 | 7881 .4 | P | 0.4 7 | 0.0 6 | 0.6 8 | 0.6 8 | 0.2 3 | 0.1 6 | |||||||||||||||
BDL 106 | 7881 .4 | Av. | 8.1 2 | 1.6 9 | 1.1 2 | 1.1 2 | 1.4 2 | 1.2 3 | |||||||||||||||
BDL 106 | 7882 .6 | P | 0.6 3 | 0.2 5 | 0.0 4 | 0.0 4 | 0.3 0 | ||||||||||||||||
BDL 106 | 7882 .6 | Av. | 1.4 2 | 1.1 9 | 1.1 5 | 1.1 5 | 1.1 0 | ||||||||||||||||
BDL 106 | 7884 .1 | P | 0.4 9 | 0.5 0 | 0.5 1 | 0.1 6 | 0.5 0 | 0.4 7 | 0.1 2 | ||||||||||||||
BDL 106 | 7884 .1 | Av. | 12. 26 | 5.7 9 | 4.0 4 | 1.3 6 | 5.7 9 | 1.2 2 | 1.1 1 | ||||||||||||||
BDL 106 | 7884 .9 | P | 0.5 4 | 0.3 1 | 0.6 9 | 0.4 7 | 0.6 2 | 0.2 4 | 0.6 9 | 0.4 7 | 0.0 3 | 0.0 0 | 0.0 0 | ||||||||||
BDL 106 | 7884 .9 | Av. | 3.9 0 | 2.5 9 | 1.3 2 | 1.1 3 | 1.1 2 | 1.1 9 | 1.3 2 | 1.1 3 | 1.2 6 | 1.0 9 | 1.0 9 |
WO 2009/141824
PCT/IL2009/000508
2018200117 05 Jan 2018
165
Gene | Ev. | Par. | 35 | 36 | 37 | 38 | 39 | 40 | 41 | 42 | 43 | 44 | 45 | 46 | 47 | 48 | 49 | 50 | 51 | 52 | 53 | 54 | 55 |
BDL 106 | 7881 .1 | P | 0.4 4 | 0.0 0 | 0.4 6 | 0.0 1 | 0.2 3 | 0.2 1 | 0.0 1 | 0.2 3 | |||||||||||||
BDL 106 | 7881 .1 | Av. | 1.1 9 | 1.3 7 | 1.4 9 | 1.1 5 | 1.1 6 | 1.2 1 | 1.1 5 | 1.1 6 | |||||||||||||
BDL 106 | 7881 .2 | P | 0.7 4 | 0.2 9 | 0.4 0 | 0.6 2 | 0.4 0 | 0.3 8 | 0.3 7 | ||||||||||||||
BDL 106 | 7881 .2 | Av. | 1.1 7 | 1.6 9 | 1.1 6 | 1.2 1 | 1.1 6 | 1.1 4 | 1.1 6 | ||||||||||||||
BDL 106 | 7882 .2 | P | 0.1 1 | 0.7 3 | |||||||||||||||||||
BDL 106 | 7882 .2 | Av. | 1.3 0 | 1.5 4 | |||||||||||||||||||
BDL 106 | 7882 .4 | p | 0.0 8 | 0.2 4 | 0.6 0 | 0.0 9 | 0.2 4 | ||||||||||||||||
BDL 106 | 7882 .4 | Av. | 2.0 0 | 1.1 2 | 1.2 2 | 1.2 5 | 1.1 2 | ||||||||||||||||
BDL 106 | 7882 .5 | p | 0.1 4 | 0.4 4 | 0.4 3 | 0.2 6 | 0.0 6 | 0.0 3 | 0.4 3 | 0.3 5 | 0.5 0 | ||||||||||||
BDL 106 | 7882 .5 | Av. | 1.3 0 | 1.7 2 | 1.2 1 | 1.1 2 | 1.3 9 | 1.1 6 | 1.2 1 | 1.1 4 | 1.1 3 | ||||||||||||
BDL 108 | 8122 .2 | p | 0.0 5 | 0.6 2 | 0.4 8 | 0.5 8 | 0.4 9 | 0.3 9 | 0.4 8 | 0.2 5 | 0.4 9 | 0.3 9 | 0.0 6 | 0.2 6 | 0.0 8 | ||||||||
BDL 108 | 8122 .2 | Av. | 1.1 5 | 3.4 7 | 4.9 2 | 1.2 6 | 4.6 3 | 1.1 6 | 2.5 8 | 1.4 0 | 4.6 3 | 1.1 6 | 1.2 7 | 1.1 5 | 1.0 9 | ||||||||
BDL 108 | 8122 .3 | p | 0.4 2 | 0.5 3 | 0.4 4 | 0.3 1 | 0.4 4 | 0.0 5 | 0.4 4 | 0.3 1 | 0.0 5 | 0.2 5 | 0.0 0 | ||||||||||
BDL 108 | 8122 .3 | Av. | 4.0 7 | 1.4 6 | 1.3 7 | 1.1 3 | 1.2 2 | 1.1 7 | 1.3 7 | 1.1 3 | 1.2 0 | 1.1 7 | 1.1 1 | ||||||||||
BDL 108 | 8123 .1 | P | 0.1 4 | 0.7 8 | 0.0 3 | 0.3 7 | 0.4 0 | 0.0 3 | 0.1 5 | ||||||||||||||
BDL 108 | 8123 .1 | Av. | 3.1 9 | 1.1 3 | 1.9 3 | 1.2 5 | 1.2 2 | 1.9 3 | 1.1 3 | ||||||||||||||
BDL 108 | 8123 .2 | P | 0.5 9 | 0.5 1 | 0.3 9 | 0.7 1 | 0.5 2 | 0.5 0 | 0.5 4 | 0.3 8 | 0.7 1 | 0.5 2 | 0.5 0 | 0.0 0 | 0.0 5 | 0.5 3 | |||||||
BDL 108 | 8123 .2 | Av. | 6.6 1 | 11. 57 | 2.1 3 | 2.1 7 | 6.4 8 | 1.3 0 | 3.2 4 | 1.5 6 | 2.1 7 | 6.4 8 | 1.3 0 | 1.3 5 | 1.1 5 | 1.2 1 | |||||||
BDL 108 | 8123 .5 | P | 1 | 0.4 5 | 0.2 2 | 0.4 7 | 0.1 3 | 0.4 3 | 0.4 7 | 0.1 3 | 0.0 9 | 0.0 5 | |||||||||||
BDL 108 | 8123 .5 | Av. | 4.4 0 | 1.3 0 | 1.3 4 | 1.1 1 | 1.3 0 | 1.3 4 | 1.1 1 | 1.3 0 | 1.1 5 | ||||||||||||
BDL 108 | 8121 .1 | P | 0.2 1 | ||||||||||||||||||||
BDL 108 | 8121 .1 | Av. | 3.0 8 | ||||||||||||||||||||
BDL 108 | 8121 .3 | P | 0.0 1 | ||||||||||||||||||||
BDL 108 | 8121 .3 | Av. | 1.6 5 | ||||||||||||||||||||
BDL 108 | 8121 .4 | P | 0.7 6 | 0.0 6 | |||||||||||||||||||
BDL 108 | 8121 .4 | Av. | 1.2 3 | 1.4 4 | |||||||||||||||||||
BDL 108 | 8122 .7 | p | 0.0 2 |
WO 2009/141824
PCT/IL2009/000508
2018200117 05 Jan 2018
166
Gene | Ev. | Par. | 35 | 36 | 37 | 38 | 39 | 40 | 41 | 42 | 43 | 44 | 45 | 46 | 47 | 48 | 49 | 50 | 51 | 52 | 53 | 54 | 55 |
BDL 108 | 8122 .7 | Av. | 1.9 0 | ||||||||||||||||||||
BDL 108 | 8123 .7 | P | 0.4 8 | 0.3 4 | 0.0 9 | 0.7 4 | 0.0 0 | ||||||||||||||||
BDL 108 | 8123 .7 | Av. | 1.2 1 | 1.1 5 | 1.5 8 | 1.1 1 | 1.2 1 | ||||||||||||||||
BDL 110 | 8092 .1 | P | 0.2 4 | 0.1 8 | 0.0 2 | ||||||||||||||||||
BDL 110 | 8092 .1 | Av. | 1.1 8 | 1.1 2 | 1.1 5 | ||||||||||||||||||
BDL 110 | 8092 .2 | P | 0.1 1 | 0.0 1 | 0.0 1 | 0.0 1 | 0.0 0 | 0.0 3 | |||||||||||||||
BDL 110 | 8092 .2 | Av. | 1.7 5 | 1.2 0 | 1.2 4 | 1.2 0 | 1.3 0 | 1.2 1 | |||||||||||||||
BDL 110 | 8092 .5 | P | 0.2 7 | 0.0 4 | 0.0 4 | 0.0 5 | 0.0 0 | ||||||||||||||||
BDL 110 | 8092 .5 | Av. | 1.1 7 | 1.0 9 | 1.0 9 | 1.1 4 | 1.1 2 | ||||||||||||||||
BDL 110 | 8095 .2 | P | 0.6 1 | 0.2 0 | 0.0 1 | ||||||||||||||||||
BDL 110 | 8095 .2 | Av. | 1.1 1 | 1.1 6 | 1.1 0 | ||||||||||||||||||
BDL 111 | 8102 .7 | P | 0.2 4 | 0.5 4 | 0.1 4 | 0.0 4 | 0.0 2 | 0.2 1 | 0.0 4 | 0.1 5 | 0.0 0 | 0.3 7 | |||||||||||
BDL 111 | 8102 .7 | Av. | 1.3 3 | 1.2 4 | 1.8 1 | 1.2 4 | 1.3 0 | 1.1 3 | 1.2 4 | 1.2 6 | 1.1 5 | 1.2 8 | |||||||||||
BDL 111 | 8103 .1 | P | 0.6 8 | 0.0 9 | 0.0 4 | 0.2 0 | 0.0 0 | 0.0 7 | 0.2 0 | 0.0 0 | 0.0 0 | ||||||||||||
BDL 111 | 8103 .1 | Av. | 1.3 7 | 1.7 0 | 1.7 7 | 1.5 4 | 1.3 7 | 1.1 5 | 1.5 4 | 1.2 0 | 1.1 6 | ||||||||||||
BDL 111 | 8103 .2 | P | 0.2 6 | 0.7 2 | 0.7 6 | 0.7 2 | 0.0 3 | 0.3 0 | 0.0 0 | ||||||||||||||
BDL 111 | 8103 .2 | Av. | 2.2 9 | 1.1 3 | 1.1 4 | 1.1 3 | 1.3 4 | 1.1 4 | 1.3 7 | ||||||||||||||
BDL 111 | 8103 .4 | P | 0.5 2 | 0.5 3 | 0.0 8 | 0.4 Ί | 0.0 0 | 0.1 2 | 0.1 2 | 0.0 0 | |||||||||||||
BDL 111 | 8103 .4 | Av. | 2.0 1 | 1.2 2 | 1.8 1 | 1.1 9 | 1.1 9 | 1.1 1 | 1.1 5 | 1.0 8 | |||||||||||||
BDL 111 | 8103 .5 | P | 0.2 5 | 0.4 0 | 0.1 Ί | 0.6 7 | 0.6 4 | 0.2 7 | 0.0 3 | 0.6 7 | 0.6 4 | 0.2 7 | 0.0 0 | 0.0 1 | |||||||||
BDL 111 | 8103 .5 | Av. | 1.8 7 | 1.1 9 | 1.7 1 | 1.2 0 | 1.1 2 | 1.1 3 | 1.2 0 | 1.2 0 | 1.1 2 | 1.1 3 | 1.1 6 | 1.0 9 | |||||||||
BDL 111 | 8102 .7 | P | 0.3 1 | 0.5 2 | 0.4 4 | 0.2 7 | 0.4 4 | ||||||||||||||||
BDL 111 | 8102 .7 | Av. | 1.3 2 | 1.2 9 | 1.1 2 | 1.2 3 | 1.1 2 | ||||||||||||||||
BDL 111 | 8103 .1 | P | 0.4 5 | 0.2 4 | 0.0 0 | 0.2 4 | 0.1 8 | ||||||||||||||||
BDL 111 | 8103 .1 | Av. | 1.2 4 | 1.1 2 | 1.3 1 | 1.1 2 | 1.1 7 | ||||||||||||||||
BDL 111 | 8103 .2 | P | 0.6 1 | 0.5 1 | 0.3 3 | 0.2 5 | |||||||||||||||||
BDL 111 | 8103 .2 | Av. | 1.9 3 | 1.8 0 | 1.2 5 | 1.2 2 |
WO 2009/141824
PCT/IL2009/000508
2018200117 05 Jan 2018
Gene | Ev. | Par. | 35 | 36 | 37 | 38 | 39 | 40 | 41 | 42 | 43 | 44 | 45 | 46 | 47 | 48 | 49 | 50 | 51 | 52 | 53 | 54 | 55 |
BDL 111 | 8103 .4 | P | 0.1 5 | 0.2 5 | 0.4 0 | ||||||||||||||||||
BDL 111 | 8103 .4 | Av. | 1.6 6 | 1.1 8 | 1.1 7 | ||||||||||||||||||
BDL 111 | 8103 .5 | P | 0.1 5 | 0.3 4 | 0.1 0 | 0.1 0 | |||||||||||||||||
BDL 111 | 8103 .5 | Av. | 1.8 0 | 1.7 2 | 1.1 1 | 1.1 1 | |||||||||||||||||
BDL 112 | 7502 .1 | P | 0.0 7 | 0.3 8 | 0.0 9 | 0.0 7 | 0.3 1 | 0.0 7 | |||||||||||||||
BDL 112 | 7502 .1 | Av. | 1.3 0 | 1.2 2 | 1.1 4 | 1.3 0 | 1.1 3 | 1.2 2 | |||||||||||||||
BDL 112 | 7502 .14 | P | 0.5 0 | 0.4 9 | 0.4 9 | 0.4 9 | 0.5 6 | 0.1 2 | |||||||||||||||
BDL 112 | 7502 .14 | Av. | 9.5 3 | 4.9 8 | 9.3 3 | 4.9 8 | 1.1 1 | 1.1 6 | |||||||||||||||
BDL 112 | 7502 .4 | P | 0.4 0 | 0.3 3 | 0.0 2 | 0.6 5 | 0.4 8 | 0.0 0 | 0.0 3 | 0.6 5 | 0.4 8 | 0.0 0 | 0.0 0 | 0.0 3 | |||||||||
BDL 112 | 7502 .4 | Av. | 2.8 1 | 1.2 0 | 1.3 5 | 1.3 7 | 1.3 1 | 1.2 3 | 1.1 9 | 1.3 7 | 1.3 1 | 1.1 6 | 1.0 9 | 1.0 7 | |||||||||
BDL 112 | 7502 .7 | p | 0.2 6 | 0.3 1 | 0.4 5 | 0.0 0 | 0.2 0 | 0.4 5 | 0.0 3 | ||||||||||||||
BDL 112 | 7502 .7 | Av. | 2.0 0 | 1.7 6 | 1.2 1 | 1.2 2 | 1.1 5 | 1.2 1 | 1.0 8 | ||||||||||||||
BDL 112 | 7502 .9 | p | 0.5 9 | 0.4 8 | 0.2 8 | 0.1 5 | 0.4 8 | 0.0 0 | 0.0 8 | ||||||||||||||
BDL 112 | 7502 .9 | Av. | 1.1 4 | 1.2 9 | 1.1 5 | 1.1 1 | 1.2 9 | 1.2 1 | 1.1 0 | ||||||||||||||
BDL 112 | 7502 .1 | p | 0.3 1 | 0.3 9 | 0.0 3 | 0.0 4 | 0.0 2 | 0.0 3 | |||||||||||||||
BDL 112 | 7502 .1 | Av. | 2.0 0 | 1.3 8 | 1.1 1 | 1.3 8 | 1.2 6 | 1.1 1 | |||||||||||||||
BDL 112 | 7502 .4 | P | 0.0 1 | 0.2 2 | 0.0 1 | 0.0 2 | 0.2 6 | 0.4 3 | 0.0 1 | 0.0 2 | 0.0 8 | ||||||||||||
BDL 112 | 7502 .4 | Av. | 1.2 6 | 1.8 5 | 1.1 5 | 1.1 3 | 1.2 9 | 1.1 9 | 1.1 5 | 1.1 3 | 1.1 0 | ||||||||||||
BDL 112 | 7502 .7 | p | 0.2 5 | 0.1 1 | 0.2 0 | 0.4 1 | 0.0 0 | 0.2 5 | 0.5 7 | 0.4 1 | 0.0 0 | 0.3 4 | 0.0 5 | ||||||||||
BDL 112 | 7502 .7 | Av. | 1.2 8 | 1.5 0 | 1.2 0 | 1.1 1 | 1.2 3 | 1.3 0 | 1.1 0 | 1.1 1 | 1.2 3 | 1.1 2 | 1.2 3 | ||||||||||
BDL 112 | 7502 .8 | p | 0.3 8 | 0.4 9 | 0.5 8 | 0.0 1 | 0.0 1 | 0.0 7 | 0.1 5 | 0.0 1 | 0.0 1 | 0.0 1 | |||||||||||
BDL 112 | 7502 .8 | Av. | 1.2 1 | 1.6 4 | 1.1 7 | 1.1 4 | 1.1 5 | 1.1 6 | 1.2 1 | 1.2 5 | 1.1 4 | 1.1 5 | |||||||||||
BDL 112 | 7502 .9 | p | 0.0 6 | 0.0 7 | 0.1 1 | 0.0 0 | 0.1 1 | 0.2 8 | 0.0 9 | ||||||||||||||
BDL 112 | 7502 .9 | Av. | 1.2 2 | 1.6 3 | 1.1 2 | 1.3 4 | 1.1 2 | 1.2 5 | 1.4 1 | ||||||||||||||
BDL 113 | 7683 .4 | P | 0.2 9 | 0.0 6 | 0.2 8 | 0.0 1 | 0.0 2 | 0.0 7 | 0.2 8 | 0.0 1 | 0.3 9 | 0.2 3 | |||||||||||
BDL 113 | 7683 .4 | Av. | 2.6 4 | 2.4 9 | 1.8 8 | 1.2 3 | 1.1 1 | 1.1 5 | 1.8 8 | 1.2 3 | 1.2 8 | 1.1 4 | |||||||||||
BDL 113 | 7683 .6 | P | 0.3 0 | 0.2 4 | 0.0 0 | 0.0 3 | 0.3 3 | 0.0 3 | 0.3 9 | 0.2 6 |
WO 2009/141824
PCT/IL2009/000508
2018200117 05 Jan 2018
168
Gene | Ev. | Par. | 35 | 36 | 37 | 38 | 39 | 40 | 41 | 42 | 43 | 44 | 45 | 46 | 47 | 48 | 49 | 50 | 51 | 52 | 53 | 54 | 55 |
BDL 113 | 7683 .6 | Av. | 2.3 3 | 1.4 0 | 1.6 7 | 1.4 7 | 1.2 1 | 1.4 7 | 1.2 9 | 1.1 2 | |||||||||||||
BDL 113 | 7684 .3 | P | 0.6 8 | 0.1 4 | 0.0 0 | 0.3 4 | 0.1 7 | ||||||||||||||||
BDL 113 | 7684 .3 | Av. | 1.4 2 | 1.2 1 | 1.9 2 | 1.3 0 | 1.1 4 | ||||||||||||||||
BDL 113 | 7684 .6 | P | 0.2 5 | 0.2 1 | 0.7 0 | 0.5 1 | 0.3 7 | 0.7 0 | 0.5 1 | 0.0 0 | 0.0 1 | ||||||||||||
BDL 113 | 7684 .6 | Av. | 2.2 1 | 1.5 5 | 1.2 0 | 1.1 2 | 1.1 0 | 1.2 0 | 1.1 2 | 1.1 7 | 1.0 9 | ||||||||||||
BDL 113 | 7684 .7 | P | 0.0 2 | 0.3 2 | 0.2 2 | 0.0 0 | |||||||||||||||||
BDL 113 | 7684 .7 | Av. | 1.6 Ί | 1.1 5 | 1.1 9 | 1.1 5 | |||||||||||||||||
BDL 113 | 7683 .1 | P | 0.0 5 | 0.4 3 | 0.5 4 | 0.4 1 | 0.0 1 | 0.5 4 | |||||||||||||||
BDL 113 | 7683 .1 | Av. | 1.3 9 | 1.6 2 | 1.1 5 | 1.2 0 | 1.2 0 | 1.1 5 | |||||||||||||||
BDL 113 | 7683 .11 | P | |||||||||||||||||||||
BDL 113 | 7683 .11 | Av. | |||||||||||||||||||||
BDL 113 | 7683 .4 | P | 0.7 2 | 0.7 7 | 0.6 9 | 0.3 9 | 0.0 0 | 0.6 9 | |||||||||||||||
BDL 113 | 7683 .4 | Av. | 1.3 3 | 1.2 1 | 1.1 2 | 1.1 4 | 1.2 4 | 1.1 2 | |||||||||||||||
BDL 113 | 7684 .1 | p | |||||||||||||||||||||
BDL 113 | 7684 .1 | Av. | |||||||||||||||||||||
BDL 113 | 7684 .5 | p | |||||||||||||||||||||
BDL 113 | 7684 .5 | Av. | |||||||||||||||||||||
BDL 114 | 7741 .3 | P | 0.5 0 | 0.0 0 | 0.5 0 | 0.1 0 | 0.4 9 | 0.3 3 | 0.5 0 | 0.1 0 | 0.2 6 | 0.1 0 | |||||||||||
BDL 114 | 7741 .3 | Av. | 24. 74 | 1.7 3 | 10. 33 | 1.1 4 | 6.5 6 | 1.1 4 | 10. 33 | 1.1 4 | 1.2 7 | 1.1 5 | |||||||||||
BDL 114 | 7741 .6 | P | 0.5 0 | 0.4 9 | 0.5 0 | 0.4 9 | 0.4 0 | 0.7 2 | |||||||||||||||
BDL 114 | 7741 .6 | Av. | 65. 41 | 11. 28 | 9.2 4 | 11. 28 | 1.2 3 | 1.1 2 | |||||||||||||||
BDL 114 | 7742 .1 | P | 0.5 0 | 0.3 9 | 0.0 1 | 0.2 0 | 0.3 9 | 0.1 6 | |||||||||||||||
BDL 114 | 7742 .1 | Av. | 1.5 1 | 1.2 2 | 1.1 6 | 1.1 1 | 1.2 2 | 1.1 3 | |||||||||||||||
BDL 114 | 7742 .3 | P | 0.4 8 | 0.0 0 | 0.0 3 | 0.1 5 | 0.0 3 | 0.2 0 | 0.1 5 | ||||||||||||||
BDL 114 | 7742 .3 | Av. | 6.6 1 | 1.9 4 | 1.6 9 | 1.3 0 | 1.6 9 | 1.4 1 | 1.1 6 | ||||||||||||||
BDL 114 | 7742 .5 | P | 0.2 2 | 0.2 9 | 0.0 2 | 0.4 5 | 0.1 7 | 0.0 2 | 0.3 4 | 0.4 5 | 0.1 7 | 0.0 6 | 0.0 7 | ||||||||||
BDL 114 | 7742 .5 | Av. | 3.3 Ί | 1.9 3 | 2.2 2 | 1.5 8 | 1.1 4 | 1.5 7 | 1.3 2 | 1.5 8 | 1.1 4 | 1.4 4 | 1.2 1 |
WO 2009/141824
PCT/IL2009/000508
2018200117 05 Jan 2018
169
Gene | Ev. | Par. | 35 | 36 | 37 | 38 | 39 | 40 | 41 | 42 | 43 | 44 | 45 | 46 | 47 | 48 | 49 | 50 | 51 | 52 | 53 | 54 | 55 |
BDL 115 | 8152 .3 | P | 0.2 7 | 0.1 1 | 0.2 4 | 0.0 3 | 0.0 8 | ||||||||||||||||
BDL 115 | 8152 .3 | Av. | 1.2 8 | 1.2 6 | 1.1 4 | 1.2 5 | 1.1 3 | ||||||||||||||||
BDL 115 | 8152 .4 | P | 0.0 5 | 0.0 0 | 0.0 2 | 0.0 7 | 0.0 2 | 0.0 7 | 0.1 5 | ||||||||||||||
BDL 115 | 8152 .4 | Av. | 1.4 2 | 1.6 7 | 1.5 8 | 1.1 2 | 1.5 8 | 1.1 2 | 1.1 3 | ||||||||||||||
BDL 115 | 8154 .1 | P | 0.1 5 | 0.1 1 | 0.4 0 | 0.2 2 | 0.4 0 | 0.0 5 | 0.0 0 | 0.3 1 | |||||||||||||
BDL 115 | 8154 .1 | Av. | 1.4 1 | 1.3 1 | 1.3 2 | 1.2 3 | 1.3 2 | 1.3 1 | 1.1 4 | 1.3 6 | |||||||||||||
BDL 115 | 8155 .2 | P | 0.4 9 | 0.0 3 | 0.5 0 | 0.5 0 | 0.5 0 | 0.0 0 | 0.1 2 | 0.5 0 | |||||||||||||
BDL 115 | 8155 .2 | Av. | 9.9 5 | 1.3 2 | 6.8 0 | 12. 32 | 6.8 0 | 1.2 4 | 1.1 1 | 1.1 3 | |||||||||||||
BDL 115 | 8155 .4 | P | 0.7 2 | 0.4 9 | 0.0 0 | 0.5 1 | 0.4 5 | 0.5 1 | 0.1 2 | 0.1 2 | |||||||||||||
BDL 115 | 8155 .4 | Av. | 2.2 6 | 4.2 2 | 1.6 0 | 3.5 9 | 1.8 3 | 3.5 9 | 1.2 7 | 1.1 1 | |||||||||||||
BDL 115 | 8152 .3 | P | 0.5 1 | 0.2 4 | 0.0 1 | 0.1 2 | 0.3 3 | 0.0 1 | |||||||||||||||
BDL 115 | 8152 .3 | Av. | 1.5 6 | 1.8 4 | 1.2 7 | 1.2 2 | 1.1 3 | 1.2 7 | |||||||||||||||
BDL 115 | 8152 .4 | P | 0.0 1 | 0.5 7 | 0.0 1 | 0.2 5 | 0.0 8 | 0.0 8 | 0.0 2 | 0.2 5 | 0.0 8 | ||||||||||||
BDL 115 | 8152 .4 | Av. | 2.4 0 | 1.2 9 | 2.0 1 | 1.2 0 | 1.1 9 | 1.6 3 | 1.2 5 | 1.2 0 | 1.1 9 | ||||||||||||
BDL 115 | 8154 .1 | p | 0.3 5 | 0.8 5 | 0.0 0 | 0.2 9 | 0.0 1 | 0.4 0 | 0.4 2 | 0.2 9 | 0.0 1 | 0.1 7 | |||||||||||
BDL 115 | 8154 .1 | Av. | 1.7 8 | 1.1 5 | 2.5 1 | 1.1 9 | 1.1 6 | 1.4 7 | 1.1 4 | 1.1 9 | 1.1 6 | 1.4 3 | |||||||||||
BDL 115 | 8155 .2 | P | 0.1 1 | ||||||||||||||||||||
BDL 115 | 8155 .2 | Av. | 1.6 0 | ||||||||||||||||||||
BDL 115 | 8155 .4 | P | 0.0 5 | ||||||||||||||||||||
BDL 115 | 8155 .4 | Av. | 2.3 0 | ||||||||||||||||||||
BDL 116 | 7481 .2 | P | 0.2 4 | 0.1 6 | 0.1 8 | 0.1 2 | 0.2 2 | 0.1 2 | 0.0 2 | 0.0 0 | |||||||||||||
BDL 116 | 7481 .2 | Av. | 1.6 1 | 1.1 9 | 1.1 6 | 1.2 1 | 1.1 7 | 1.2 1 | 1.3 2 | 1.1 7 | |||||||||||||
BDL 116 | 7481 .7 | P | 0.4 8 | 0.6 9 | 0.2 6 | 0.7 4 | 0.4 4 | 0.6 3 | 0.7 4 | 0.4 4 | 0.0 0 | 0.0 0 | 0.2 7 | ||||||||||
BDL 116 | 7481 .7 | Av. | 1.1 1 | 1.1 1 | 1.4 4 | 1.1 4 | 1.1 3 | 1.1 1 | 1.1 4 | 1.1 3 | 1.2 4 | 1.1 3 | 1.1 0 | ||||||||||
BDL 116 | 7481 .8 | P | 0.4 9 | 0.5 0 | 0.4 9 | 0.3 3 | 0.5 0 | 0.5 6 | 0.3 6 | 0.0 4 | 0.6 0 | ||||||||||||
BDL 116 | 7481 .8 | Av. | 15. 78 | 5.3 3 | 13. 31 | 1.1 0 | 5.3 3 | 1.1 2 | 1.1 1 | 1.2 2 | 1.3 3 | ||||||||||||
BDL 116 | 7482 .2 | P | 0.4 5 | 0.1 0 | 0.4 6 | 0.0 2 | 0.1 3 | 0.4 6 | 0.0 2 | 0.0 0 | 0.0 0 |
WO 2009/141824
PCT/IL2009/000508
2018200117 05 Jan 2018
170
Gene | Ev. | Par. | 35 | 36 | 37 | 38 | 39 | 40 | 41 | 42 | 43 | 44 | 45 | 46 | 47 | 48 | 49 | 50 | 51 | 52 | 53 | 54 | 55 |
BDL 116 | 7482 .2 | Av. | 1.2 3 | 1.5 3 | 1.3 4 | 1.1 8 | 1.2 2 | 1.3 4 | 1.1 8 | 1.2 0 | 1.0 4 | ||||||||||||
BDL 116 | 7485 .1 | P | 0.0 0 | 0.1 3 | 0.3 6 | 0.4 6 | 0.0 8 | 0.5 5 | 0.2 0 | 0.4 6 | 0.0 8 | 0.1 2 | 0.2 4 | ||||||||||
BDL 116 | 7485 .1 | Av. | 2.0 3 | 1.3 5 | 1.4 7 | 1.2 7 | 1.2 0 | 1.1 0 | 1.3 1 | 1.2 7 | 1.2 0 | 1.2 7 | 1.2 4 | ||||||||||
BDL 119 | 7732 .2 | p | 0.0 9 | 0.0 3 | 0.0 9 | 0.1 0 | 0.0 9 | 0.0 2 | 0.0 0 | 0.1 2 | |||||||||||||
BDL 119 | 7732 .2 | Av. | 2.3 0 | 1.6 1 | 1.1 6 | 1.4 4 | 1.1 6 | 1.1 0 | 1.1 1 | 1.1 3 | |||||||||||||
BDL 119 | 7733 .2 | P | 0.7 0 | 0.0 1 | 0.2 3 | 0.0 6 | 0.2 7 | 0.0 6 | |||||||||||||||
BDL 119 | 7733 .2 | Av. | 1.1 2 | 1.4 7 | 1.2 8 | 1.2 1 | 1.3 9 | 1.2 1 | |||||||||||||||
BDL 119 | 7734 .1 | P | 0.3 0 | 0.0 2 | 0.5 2 | 0.2 1 | 0.1 5 | 0.5 2 | 0.2 1 | 0.0 2 | 0.0 1 | ||||||||||||
BDL 119 | 7734 .1 | Av. | 1.2 1 | 1.5 0 | 1.1 2 | 1.1 3 | 1.3 6 | 1.1 2 | 1.1 3 | 1.1 1 | 1.1 0 | ||||||||||||
BDL 119 | 7734 .5 | P | 0.3 9 | 0.1 4 | |||||||||||||||||||
BDL 119 | 7734 .5 | Av. | 1.1 6 | 1.1 3 | |||||||||||||||||||
BDL 119 | 7734 .7 | P | |||||||||||||||||||||
BDL 119 | 7734 .7 | Av. | |||||||||||||||||||||
BDL 120 | 7891 .3 | P | 0.0 0 | 0.0 6 | 0.1 5 | 0.0 2 | 0.3 5 | 0.1 0 | 0.1 5 | 0.0 2 | 0.0 0 | 0.1 2 | 0.5 1 | ||||||||||
BDL 120 | 7891 .3 | Av. | 5.3 0 | 1.4 2 | 1.8 4 | 1.1 9 | 1.3 0 | 1.1 3 | 1.8 4 | 1.1 9 | 1.3 4 | 1.1 1 | 1.2 2 | ||||||||||
BDL 120 | 7892 .4 | p | 0.3 6 | 0.0 1 | 0.0 3 | 0.0 0 | 0.2 6 | 0.0 3 | 0.2 3 | 0.3 7 | |||||||||||||
BDL 120 | 7892 .4 | Av. | 1.3 7 | 1.4 8 | 1.2 8 | 1.3 7 | 1.1 5 | 1.2 8 | 1.1 5 | 1.1 1 | |||||||||||||
BDL 120 | 7892 .6 | P | 0.1 5 | 0.0 0 | 0.0 7 | ||||||||||||||||||
BDL 120 | 7892 .6 | Av. | 1.1 3 | 1.3 4 | 1.1 1 | ||||||||||||||||||
BDL 120 | 7893 .2 | P | 0.6 5 | 0.3 6 | 0.8 6 | 0.1 9 | 0.1 4 | 0.1 9 | 0.1 4 | 0.0 7 | 0.2 1 | 0.0 6 | |||||||||||
BDL 120 | 7893 .2 | Av. | 1.1 1 | 22. 46 | 1.2 0 | 11. 26 | 1.1 3 | 11. 26 | 1.1 3 | 1.2 9 | 1.1 1 | 1.2 0 | |||||||||||
BDL 120 | 7893 .5 | P | 0.3 9 | 0.2 2 | 0.2 2 | 0.0 3 | 0.2 5 | ||||||||||||||||
BDL 120 | 7893 .5 | Av. | 1.1 3 | 1.1 9 | 1.1 9 | 1.0 8 | 1.1 7 | ||||||||||||||||
BDL 122 | 7513 .1 | P | 0.1 6 | 0.2 9 | 0.1 3 | ||||||||||||||||||
BDL 122 | 7513 .1 | Av. | 1.2 0 | 1.1 5 | 1.1 3 | ||||||||||||||||||
BDL 122 | 7513 .1 | P | 0.1 7 | 0.4 8 | 0.0 6 | 0.7 6 | 0.3 0 | 0.0 6 | 0.1 8 | ||||||||||||||
BDL 122 | 7513 .1 | Av. | 1.1 2 | 1.9 0 | 1.5 1 | 1.1 3 | 1.2 6 | 1.5 1 | 1.2 2 |
WO 2009/141824
PCT/IL2009/000508
2018200117 05 Jan 2018
171
Gene | Ev. | Par. | 35 | 36 | 37 | 38 | 39 | 40 | 41 | 42 | 43 | 44 | 45 | 46 | 47 | 48 | 49 | 50 | 51 | 52 | 53 | 54 | 55 |
BDL 122 | 7513 .14 | P | 0.2 3 | 0.3 1 | 0.0 0 | 0.0 2 | 0.3 1 | 0.1 4 | 0.0 1 | 0.1 0 | 0.0 0 | ||||||||||||
BDL 122 | 7513 .14 | Av. | 2.1 7 | 1.1 8 | 1.2 7 | 1.3 0 | 1.1 8 | 1.2 5 | 1.3 7 | 1.1 3 | 1.0 8 | ||||||||||||
BDL 122 | 7513 .9 | P | 0.4 9 | 0.4 8 | 0.4 5 | 0.4 8 | 0.2 1 | 0.0 1 | |||||||||||||||
BDL 122 | 7513 .9 | Av. | 5.9 6 | 5.2 5 | 3.9 3 | 5.2 5 | 1.1 4 | 1.1 0 | |||||||||||||||
BDL 122 | 7514 .3 | P | 0.5 3 | 0.5 3 | 0.4 2 | 0.5 3 | 0.5 1 | ||||||||||||||||
BDL 122 | 7514 .3 | Av. | 4.1 0 | 4.1 9 | 1.3 4 | 4.1 9 | 1.2 0 | ||||||||||||||||
BDL 122 | 7513 .1 | P | 0.4 4 | 0.3 3 | 0.4 7 | ||||||||||||||||||
BDL 122 | 7513 .1 | Av. | 1.1 7 | 1.1 6 | 1.1 4 | ||||||||||||||||||
BDL 122 | 7513 .14 | P | 0.3 6 | 0.4 2 | 0.0 4 | 0.0 4 | |||||||||||||||||
BDL 122 | 7513 .14 | Av. | 1.2 8 | 1.1 7 | 1.2 6 | 1.2 6 | |||||||||||||||||
BDL 122 | 7513 .9 | P | |||||||||||||||||||||
BDL 122 | 7513 .9 | Av. | |||||||||||||||||||||
BDL 122 | 7514 .3 | P | 0.3 4 | ||||||||||||||||||||
BDL 122 | 7514 .3 | Av. | 1.7 3 | ||||||||||||||||||||
BDL 123 | 8082 .1 | p | 0.0 0 | 0.0 0 | 0.4 9 | ||||||||||||||||||
BDL 123 | 8082 .1 | Av. | 1.3 0 | 1.3 0 | 1.2 1 | ||||||||||||||||||
BDL 123 | 8082 .3 | P | 0.0 3 | ||||||||||||||||||||
BDL 123 | 8082 .3 | Av. | 1.2 4 | ||||||||||||||||||||
BDL 123 | 8082 .6 | P | 0.7 2 | 0.3 8 | 0.6 8 | 0.0 8 | 0.6 8 | 0.1 3 | |||||||||||||||
BDL 123 | 8082 .6 | Av. | 1.2 1 | 1.4 5 | 1.1 7 | 1.1 5 | 1.1 7 | 1.2 1 | |||||||||||||||
BDL 123 | 8083 .2 | P | 0.5 0 | 0.5 0 | 0.5 0 | 0.5 0 | 0.2 8 | 0.2 6 | 0.0 7 | ||||||||||||||
BDL 123 | 8083 .2 | Av. | 20. 40 | 9.0 6 | 17. 24 | 9.0 6 | 1.3 8 | 1.1 5 | 1.3 2 | ||||||||||||||
BDL 123 | 8083 .3 | P | 0.0 7 | ||||||||||||||||||||
BDL 123 | 8083 .3 | Av. | 1.0 3 | ||||||||||||||||||||
BDL 124 | 8482 .1 | p | 0.1 7 | 0.3 9 | 0.0 4 | 0.0 1 | 0.0 9 | 0.0 1 | 0.1 3 | 0.2 2 | |||||||||||||
BDL 124 | 8482 .1 | Av. | 1.1 2 | 2.2 1 | 1.3 5 | 1.1 2 | 1.1 8 | 1.1 2 | 1.3 0 | 1.2 9 | |||||||||||||
BDL 125 | 7491 .1 | P | 0.0 4 |
WO 2009/141824
PCT/IL2009/000508
2018200117 05 Jan 2018
172
Gene | Ev. | Par. | 35 | 36 | 37 | 38 | 39 | 40 | 41 | 42 | 43 | 44 | 45 | 46 | 47 | 48 | 49 | 50 | 51 | 52 | 53 | 54 | 55 |
BDL 125 | 7491 .1 | Av. | 1.2 3 | ||||||||||||||||||||
BDL 125 | 7491 .5 | P | 0.3 7 | 0.0 5 | 0.0 5 | ||||||||||||||||||
BDL 125 | 7491 .5 | Av. | 1.2 7 | 1.1 6 | 1.1 6 | ||||||||||||||||||
BDL 125 | 7492 .5 | p | 0.4 3 | 0.5 4 | 0.5 6 | 0.4 0 | 0.1 3 | 0.5 6 | 0.0 2 | 0.0 0 | 0.4 0 | 0.0 6 | |||||||||||
BDL 125 | 7492 .5 | Av. | 1.7 2 | 1.6 2 | 1.5 3 | 1.1 2 | 1.1 6 | 1.5 3 | 1.2 1 | 1.1 3 | 1.2 3 | 1.0 4 | |||||||||||
BDL 125 | 7494 .1 | P | 0.5 4 | 0.0 3 | 0.5 9 | 0.2 0 | 0.5 9 | 0.2 0 | 0.0 0 | 0.0 0 | |||||||||||||
BDL 125 | 7494 .1 | Av. | 1.6 5 | 1.6 5 | 1.2 1 | 1.1 0 | 1.2 1 | 1.1 0 | 1.1 7 | 1.0 9 | |||||||||||||
BDL 125 | 7495 .5 | P | 0.4 8 | 0.3 3 | 0.1 7 | 0.4 3 | 0.3 7 | 0.4 7 | 0.4 3 | 0.0 6 | 0.0 0 | 0.2 8 | |||||||||||
BDL 125 | 7495 .5 | Av. | 1.4 1 | 1.2 8 | 1.7 5 | 1.5 0 | 1.1 4 | 1.2 4 | 1.5 0 | 1.1 4 | 1.0 9 | 1.2 0 | |||||||||||
BDL 128 | 7711 .3 | P | 0.5 5 | 0.7 9 | 0.5 9 | 0.8 2 | 0.8 5 | 0.5 3 | 0.8 2 | 0.8 5 | 0.5 3 | 0.1 8 | 0.0 0 | 0.2 4 | |||||||||
BDL 128 | 7711 .3 | Av. | 1.4 1 | 1.2 6 | 1.7 3 | 1.1 2 | 1.1 2 | 1.1 3 | 1.1 2 | 1.1 2 | 1.1 3 | 1.2 9 | 1.1 5 | 1.2 0 | |||||||||
BDL 128 | 8361 .5 | P | 0.5 0 | 0.6 4 | 0.5 3 | 0.4 3 | 0.3 6 | 0.5 3 | 0.4 3 | 0.2 6 | 0.3 0 | 0.0 5 | |||||||||||
BDL 128 | 8361 .5 | Av. | 4.0 9 | 1.6 1 | 3.7 6 | 1.1 4 | 1.3 0 | 3.7 6 | 1.1 4 | 1.1 6 | 1.1 2 | 1.0 4 | |||||||||||
BDL 128 | 8362 .2 | P | 0.7 2 | 0.2 6 | 0.0 2 | 0.0 1 | 0.3 1 | 0.0 4 | |||||||||||||||
BDL 128 | 8362 .2 | Av. | 1.1 5 | 1.1 2 | 1.0 8 | 1.3 6 | 1.2 3 | 1.1 1 | |||||||||||||||
BDL 128 | 8363 .2 | P | 0.4 8 | 0.6 0 | 0.1 6 | 0.4 1 | 0.0 6 | ||||||||||||||||
BDL 128 | 8363 .2 | Av. | 2.2 8 | 1.4 6 | 1.1 4 | 1.2 4 | 1.1 1 | ||||||||||||||||
BDL 128 | 8365 .2 | P | 0.4 8 | 0.4 9 | 0.4 8 | 0.4 6 | 0.4 8 | 0.0 6 | 0.0 0 | 0.0 1 | |||||||||||||
BDL 128 | 8365 .2 | Av. | 7.0 1 | 1.5 0 | 5.5 6 | 3.1 8 | 5.5 6 | 1.4 3 | 1.1 7 | 1.4 2 | |||||||||||||
BDL 129 | 7691 .4 | P | 0.2 6 | 0.7 0 | 0.0 5 | 0.0 0 | 0.0 4 | ||||||||||||||||
BDL 129 | 7691 .4 | Av. | 1.4 1 | 1.2 5 | 1.1 7 | 1.1 5 | 1.0 8 | ||||||||||||||||
BDL 129 | 7691 .6 | P | 0.2 5 | 0.0 4 | 0.3 4 | 0.1 6 | 0.0 2 | 0.1 6 | 0.3 3 | 0.1 2 | |||||||||||||
BDL 129 | 7691 .6 | Av. | 1.8 8 | 1.3 4 | 1.3 8 | 1.3 4 | 1.2 8 | 1.3 4 | 1.2 6 | 1.1 6 | |||||||||||||
BDL 129 | 7692 .2 | p | 0.5 0 | 0.0 9 | 0.5 1 | 0.5 1 | 0.5 1 | 0.4 2 | |||||||||||||||
BDL 129 | 7692 .2 | Av. | 11. 03 | 1.7 7 | 6.0 6 | 7.4 7 | 6.0 6 | 1.1 5 | |||||||||||||||
BDL 129 | 7692 .6 | p | 0.0 6 | 0.6 8 | |||||||||||||||||||
BDL 129 | 7692 .6 | Av. | 1.3 1 | 1.1 9 |
WO 2009/141824
PCT/IL2009/000508
2018200117 05 Jan 2018
173
Gene | Ev. | Par. | 35 | 36 | 37 | 38 | 39 | 40 | 41 | 42 | 43 | 44 | 45 | 46 | 47 | 48 | 49 | 50 | 51 | 52 | 53 | 54 | 55 |
BDL 129 | 7693 .1 | P | 0.5 0 | 0.5 0 | 0.4 9 | 0.5 0 | 0.0 0 | 0.1 7 | |||||||||||||||
BDL 129 | 7693 .1 | Av. | 12. 70 | 6.1 6 | 3.5 8 | 6.1 6 | 1.2 1 | 1.1 4 | |||||||||||||||
BDL 130 | 7663 .1 | P | 0.3 5 | 0.0 8 | 0.6 6 | 0.0 8 | 0.3 3 | 0.0 3 | |||||||||||||||
BDL 130 | 7663 .1 | Av. | 1.2 6 | 1.1 4 | 1.1 5 | 1.1 4 | 1.1 6 | 1.1 3 | |||||||||||||||
BDL 130 | 7663 .3 | P | 0.4 3 | 0.3 3 | 0.2 7 | 0.0 1 | 0.1 9 | 0.0 3 | 0.0 5 | 0.0 1 | 0.1 9 | 0.0 3 | 0.1 3 | ||||||||||
BDL 130 | 7663 .3 | Av. | 6.1 2 | 1.6 7 | 1.8 2 | 1.4 1 | 1.1 3 | 1.2 1 | 1.4 3 | 1.4 1 | 1.1 3 | 1.3 5 | 1.2 8 | ||||||||||
BDL 130 | 7663 .6 | P | 0.1 1 | ||||||||||||||||||||
BDL 130 | 7663 .6 | Av. | 1.2 4 | ||||||||||||||||||||
BDL 130 | 7664 .5 | P | |||||||||||||||||||||
BDL 130 | 7664 .5 | Av. | |||||||||||||||||||||
BDL 131 | 7461 .2 | P | 0.3 8 | 0.0 0 | 0.0 0 | 0.0 0 | 0.1 7 | ||||||||||||||||
BDL 131 | 7461 .2 | Av. | 1.1 6 | 1.3 0 | 1.1 6 | 1.3 0 | 1.2 5 | ||||||||||||||||
BDL 131 | 7461 .4 | P | 0.1 6 | ||||||||||||||||||||
BDL 131 | 7461 .4 | Av. | 1.1 7 | ||||||||||||||||||||
BDL 131 | 7462 .2 | p | |||||||||||||||||||||
BDL 131 | 7462 .2 | Av. | |||||||||||||||||||||
BDL 131 | 7463 .4 | P | 0.4 1 | 0.1 6 | 0.0 1 | 0.1 6 | 0.0 0 | ||||||||||||||||
BDL 131 | 7463 .4 | Av. | 1.2 6 | 1.2 1 | 1.2 4 | 1.2 1 | 1.0 9 | ||||||||||||||||
BDL 131 | 7464 .5 | P | 0.5 7 | 0.3 4 | 0.0 6 | 0.2 6 | 0.0 6 | 0.0 0 | 0.0 3 | 0.1 1 | |||||||||||||
BDL 131 | 7464 .5 | Av. | 1.1 3 | 1.5 7 | 1.1 4 | 1.2 5 | 1.1 4 | 1.2 7 | 1.1 5 | 1.1 6 | |||||||||||||
BDL 132 | 7471 .1 | P | 0.0 0 | 0.4 3 | 0.0 5 | 0.0 5 | |||||||||||||||||
BDL 132 | 7471 .1 | Av. | 1.7 9 | 1.1 0 | 1.7 4 | 1.7 4 | |||||||||||||||||
BDL 132 | 7471 .4 | P | 0.7 2 | 0.7 2 | 0.6 0 | ||||||||||||||||||
BDL 132 | 7471 .4 | Av. | 1.2 1 | 1.2 1 | 1.2 7 | ||||||||||||||||||
BDL 132 | 7472 .4 | p | 0.4 5 | 0.2 7 | 0.0 3 | 0.4 5 | 0.4 5 | 0.0 2 | |||||||||||||||
BDL 132 | 7472 .4 | Av. | 1.8 9 | 1.1 5 | 1.3 1 | 1.3 0 | 1.3 0 | 1.1 7 | |||||||||||||||
BDL 132 | 7473 .1 | P | 0.4 7 | 0.4 6 | 0.5 0 | 0.4 6 |
WO 2009/141824
PCT/IL2009/000508
2018200117 05 Jan 2018
174
Gene | Ev. | Par. | 35 | 36 | 37 | 38 | 39 | 40 | 41 | 42 | 43 | 44 | 45 | 46 | 47 | 48 | 49 | 50 | 51 | 52 | 53 | 54 | 55 |
BDL 132 | 7473 .1 | Av. | 4.6 5 | 4.7 9 | 69. 02 | 4.7 9 | |||||||||||||||||
BDL 132 | 7474 .4 | P | 0.9 3 | 0.5 0 | 0.6 8 | 0.5 1 | 0.4 9 | 0.5 1 | 0.0 6 | 0.0 4 | |||||||||||||
BDL 132 | 7474 .4 | Av. | 1.2 4 | 8.0 5 | 1.2 4 | 5.7 0 | 10. 13 | 5.7 0 | 1.2 8 | 1.1 5 | |||||||||||||
BDL 132 | 7471 .1 | P | 0.5 0 | 0.2 3 | |||||||||||||||||||
BDL 132 | 7471 .1 | Av. | 1.2 8 | 1.2 4 | |||||||||||||||||||
BDL 132 | 7471 .4 | P | 0.4 5 | 0.1 0 | 0.1 0 | 0.4 1 | |||||||||||||||||
BDL 132 | 7471 .4 | Av. | 1.8 4 | 1.1 6 | 1.1 6 | 1.2 5 | |||||||||||||||||
BDL 132 | 7472 .4 | P | 0.4 9 | 0.1 0 | 0.1 0 | 0.5 7 | 0.8 1 | ||||||||||||||||
BDL 132 | 7472 .4 | Av. | 1.8 7 | 1.0 9 | 1.0 9 | 1.3 4 | 1.1 4 | ||||||||||||||||
BDL 132 | 7473 .1 | P | 0.6 3 | 0.2 9 | 0.6 1 | 0.2 8 | 0.0 3 | 0.2 8 | 0.2 1 | ||||||||||||||
BDL 132 | 7473 .1 | Av. | 1.2 0 | 1.3 8 | 1.3 6 | 1.2 3 | 1.2 1 | 1.2 3 | 1.1 1 | ||||||||||||||
BDL 132 | 7475 .4 | P | 0.3 7 | 0.7 0 | 0.5 1 | ||||||||||||||||||
BDL 132 | 7475 .4 | Av. | 1.7 5 | 1.1 1 | 1.1 6 | ||||||||||||||||||
BDL 133 | 8161 .1 | P | 0.0 2 | 0.5 6 | 0.7 4 | ||||||||||||||||||
BDL 133 | 8161 .1 | Av. | 2.1 2 | 1.1 7 | 1.4 3 | ||||||||||||||||||
BDL 133 | 8161 .2 | P | 0.3 4 | ||||||||||||||||||||
BDL 133 | 8161 .2 | Av. | 1.1 6 | ||||||||||||||||||||
BDL 133 | 8161 .3 | P | 0.3 2 | 0.4 8 | 0.6 6 | 0.7 3 | 0.6 3 | 0.6 0 | 0.3 0 | 0.7 3 | 0.6 3 | 0.3 2 | 0.0 2 | 0.1 5 | |||||||||
BDL 133 | 8161 .3 | Av. | 1.1 2 | 15. 21 | 1.2 4 | 1.3 1 | 1.1 3 | 1.7 6 | 1.2 2 | 1.3 1 | 1.1 3 | 1.1 1 | 1.2 1 | 1.1 6 | |||||||||
BDL 133 | 8161 .4 | P | 0.1 6 | 0.3 6 | 0.1 2 | 0.2 4 | 0.0 0 | 0.2 4 | 0.0 5 | 0.0 4 | 0.4 3 | ||||||||||||
BDL 133 | 8161 .4 | Av. | 1.1 3 | 1.4 8 | 1.2 4 | 1.1 3 | 1.4 3 | 1.1 3 | 1.0 8 | 1.1 2 | 1.1 7 | ||||||||||||
BDL 133 | 8162 .1 | P | 0.0 7 | 0.4 2 | 0.0 1 | ||||||||||||||||||
BDL 133 | 8162 .1 | Av. | 1.3 9 | 1.1 0 | 1.1 3 | ||||||||||||||||||
BDL 133 | 816^ .3 | P | 0.1 9 | 0.0 3 | 0.0 4 | 0.5 8 | |||||||||||||||||
BDL 133 | 8162 .3 | Av. | 1.1 3 | 1.0 9 | 1.0 7 | 1.3 4 | |||||||||||||||||
BDL 133 | 8162 .5 | P | 0.0 2 | 0.0 2 | 0.1 0 | 0.0 6 | |||||||||||||||||
BDL 133 | 8162 .5 | Av. | 1.2 0 | 1.2 0 | 1.1 6 | 1.2 5 |
WO 2009/141824
PCT/IL2009/000508
2018200117 05 Jan 2018
175
Gene | Ev. | Par. | 35 | 36 | 37 | 38 | 39 | 40 | 41 | 42 | 43 | 44 | 45 | 46 | 47 | 48 | 49 | 50 | 51 | 52 | 53 | 54 | 55 |
BDL 133 | 8163 .2 | P | 0.5 1 | 0.5 1 | 0.2 7 | ||||||||||||||||||
BDL 133 | 8163 .2 | Av. | 1.3 8 | 1.1 3 | 1.2 7 | ||||||||||||||||||
BDL 134 | 7671 .2 | P | 0.4 0 | 0.0 2 | 0.2 6 | 0.5 7 | 0.1 1 | 0.2 6 | 0.1 1 | 0.0 1 | |||||||||||||
BDL 134 | 7671 .2 | Av. | 3.7 2 | 1.7 9 | 1.1 5 | 3.4 6 | 1.2 2 | 1.1 5 | 1.2 1 | 1.1 7 | |||||||||||||
BDL 134 | 7672 .1 | p | 0.2 6 | 0.4 4 | 0.0 8 | 0.4 9 | 0.0 0 | 0.0 8 | 0.0 5 | 0.0 5 | 0.5 0 | 0.0 0 | |||||||||||
BDL 134 | 7672 .1 | Av. | 4.4 0 | 1.2 4 | 1.2 6 | 1.1 4 | 1.2 9 | 1.2 6 | 1.0 8 | 1.1 0 | 1.1 2 | 1.2 5 | |||||||||||
BDL 134 | 7673 .1 | P | 0.4 6 | 0.1 6 | 0.0 7 | 0.0 7 | 0.0 1 | 0.0 7 | 0.0 2 | 0.0 2 | |||||||||||||
BDL 134 | 7673 .1 | Av. | 13. 42 | 1.4 4 | 1.3 0 | 1.1 4 | 1.3 7 | 1.1 4 | 1.2 3 | 1.1 3 | |||||||||||||
BDL 134 | 7673 .2 | P | 0.0 2 | 0.1 6 | 0.1 5 | 0.3 2 | 0.1 5 | 0.0 0 | 0.0 0 | ||||||||||||||
BDL 134 | 7673 .2 | Av. | 1.6 3 | 1.2 8 | 1.1 8 | 1.1 2 | 1.1 8 | 1.1 6 | 1.1 0 | ||||||||||||||
BDL 135 | 7722 .1 | p | 0.4 7 | 0.2 9 | 0.2 9 | ||||||||||||||||||
BDL 135 | 7722 .1 | Av. | 1.1 8 | 1.1 6 | 1.1 6 | ||||||||||||||||||
BDL 135 | 7723 .1 | P | 0.5 6 | 0.6 2 | 0.0 3 | 0.5 7 | 0.5 4 | 0.6 2 | 0.0 3 | ||||||||||||||
BDL 135 | 7723 .1 | Av. | 1.1 4 | 2.2 9 | 1.1 8 | 3.8 3 | 1.2 2 | 2.2 9 | 1.1 8 | ||||||||||||||
BDL 135 | 7723 .3 | P | 0.2 1 | 0.4 0 | |||||||||||||||||||
BDL 135 | 7723 .3 | Av. | 1.2 2 | 1.1 5 | |||||||||||||||||||
BDL 135 | 7723 .8 | P | 0.7 4 | 0.2 5 | 0.5 6 | 0.2 5 | 0.0 1 | ||||||||||||||||
BDL 135 | 7723 .8 | Av. | 1.1 5 | 1.1 2 | 1.1 3 | 1.1 2 | 1.1 0 | ||||||||||||||||
BDL 135 | 7723 .9 | P | 0.7 1 | 0.5 5 | 0.4 Ί | 0.0 9 | |||||||||||||||||
BDL 135 | 7723 .9 | Av. | 1.1 4 | 1.2 0 | 1.1 5 | 1.0 3 | |||||||||||||||||
BDL 136 | 7751 .4 | P | 0.0 5 | 0.1 3 | 0.1 3 | 0.0 1 | |||||||||||||||||
BDL 136 | 7751 .4 | Av. | 1.5 1 | 1.1 2 | 1.1 2 | 1.1 8 | |||||||||||||||||
BDL 136 | 7751 .5 | P | 0.3 8 | 0.3 9 | 0.4 2 | 0.2 4 | 0.4 0 | 0.4 2 | 0.2 4 | 0.0 2 | 0.0 1 | 0.3 3 | |||||||||||
BDL 136 | 7751 .5 | Av. | 1.5 1 | 1.3 4 | 1.1 1 | 1.1 1 | 1.1 1 | 1.1 2 | 1.1 1 | 1.1 0 | 1.0 8 | 1.1 0 | |||||||||||
BDL 136 | 7751 .8 | P | 0.1 2 | 0.0 0 | |||||||||||||||||||
BDL 136 | 7751 .8 | Av. | 1.1 0 | 1.2 4 | |||||||||||||||||||
BDL 136 | 7752 .6 | p | 0.4 0 | 0.1 6 | 0.0 6 | 0.2 1 |
WO 2009/141824
PCT/IL2009/000508
2018200117 05 Jan 2018
176
Gene | Ev. | Par. | 35 | 36 | 37 | 38 | 39 | 40 | 41 | 42 | 43 | 44 | 45 | 46 | 47 | 48 | 49 | 50 | 51 | 52 | 53 | 54 | 55 |
BDL 136 | 7752 .6 | Av. | 1.1 6 | 1.1 6 | 1.2 0 | 1.1 1 | |||||||||||||||||
BDL 137 | 7701 .2 | P | 0.5 0 | 0.5 2 | 0.7 5 | 0.1 3 | 0.7 3 | 0.4 1 | 0.4 1 | 0.7 5 | 0.1 3 | 0.2 7 | |||||||||||
BDL 137 | 7701 .2 | Av. | 14. 76 | 1.2 4 | 1.4 1 | 1.2 5 | 1.4 2 | 1.1 1 | 1.1 4 | 1.4 1 | 1.2 5 | 1.1 0 | |||||||||||
BDL 137 | 7701 .5 | P | 0.5 3 | 0.6 4 | 0.0 5 | 0.0 1 | 0.1 0 | 0.6 2 | |||||||||||||||
BDL 137 | 7701 .5 | Av. | 1.5 0 | 1.2 5 | 1.1 4 | 1.2 2 | 1.1 5 | 1.1 3 | |||||||||||||||
BDL 137 | 7701 .6 | P | 0.7 6 | 0.5 5 | 0.5 5 | 0.7 7 | |||||||||||||||||
BDL 137 | 7701 .6 | Av. | 1.1 3 | 1.1 1 | 1.1 1 | 1.1 1 | |||||||||||||||||
BDL 137 | 7702 .1 | P | 0.0 5 | 0.3 7 | 0.0 3 | 0.1 7 | 0.2 5 | 0.1 6 | 0.1 Ί | 0.2 5 | 0.0 7 | 0.1 5 | |||||||||||
BDL 137 | 7702 .1 | Av. | 2.5 2 | 1.2 0 | 1.5 1 | 1.2 5 | 1.1 3 | 1.4 3 | 1.2 5 | 1.1 3 | 1.2 4 | 1.1 9 | |||||||||||
BDL 137 | 7703 .2 | P | 0.1 8 | 0.1 0 | 0.0 7 | 0.3 7 | |||||||||||||||||
BDL 137 | 7703 .2 | Av. | 1.2 4 | 1.4 3 | 1.1 9 | 1.1 5 | |||||||||||||||||
BDL 137 | 7703 .3 | P | 0.3 4 | 0.2 1 | 0.6 7 | 0.2 2 | 0.0 0 | 0.6 7 | 0.2 2 | 0.0 0 | 0.1 4 | 0.4 8 | |||||||||||
BDL 137 | 7703 .3 | Av. | 1.2 7 | 1.3 5 | 1.1 1 | 1.1 5 | 1.2 9 | 1.1 1 | 1.1 5 | 1.2 7 | 1.1 6 | 1.1 7 | |||||||||||
BDL 137 | 7703 .7 | P | 0.1 5 | 0.0 2 | 0.1 0 | 0.0 2 | 0.0 6 | 0.1 8 | |||||||||||||||
BDL 137 | 7703 .7 | Av. | 1.3 2 | 1.2 1 | 1.1 2 | 1.2 1 | 1.2 3 | 1.1 3 | |||||||||||||||
BDL 139 | 8131 .1 | P | |||||||||||||||||||||
BDL 139 | 8131 .1 | Av. | |||||||||||||||||||||
BDL 139 | 8131 .2 | P | 0.2 5 | 0.0 1 | 0.6 3 | 0.5 6 | 0.0 5 | 0.2 6 | 0.5 6 | 0.0 8 | 0.0 2 | 0.1 0 | |||||||||||
BDL 139 | 8131 .2 | Av. | 1.1 9 | 1.8 3 | 1.1 6 | 1.1 3 | 1.2 3 | 1.1 6 | 1.1 3 | 1.1 5 | 1.1 5 | 1.1 9 | |||||||||||
BDL 139 | 8132 .7 | p | |||||||||||||||||||||
BDL 139 | 8132 .7 | Av. | |||||||||||||||||||||
BDL 139 | 8133 .2 | P | |||||||||||||||||||||
BDL 139 | 8133 .2 | Av. | |||||||||||||||||||||
BDL 141 | 8141 .2 | P | 0.1 5 | 0.1 5 | 0.0 5 | ||||||||||||||||||
BDL 141 | 8141 .2 | Av. | 1.1 6 | 1.1 1 | 1.1 2 | ||||||||||||||||||
BDL 141 | 8142 .2 | P | |||||||||||||||||||||
BDL 141 | 8142 .2 | Av. |
WO 2009/141824
PCT/IL2009/000508
2018200117 05 Jan 2018
177
Gene | Ev. | Par. | 35 | 36 | 37 | 38 | 39 | 40 | 41 | 42 | 43 | 44 | 45 | 46 | 47 | 48 | 49 | 50 | 57 | 52 | 53 | 54 | 55 |
BDL 142 | 8282 .1 | P | 0.0 3 | 0.4 3 | 0.6 2 | 0.2 0 | 0.0 3 | 0.1 0 | 0.2 0 | 0.0 1 | 0.0 0 | 0.6 8 | |||||||||||
BDL 142 | 8282 .1 | Av, | 1.1 6 | 1.2 5 | 1.2 5 | 1.1 4 | 1.2 0 | 1.1 2 | 1.1 4 | 1.2 4 | 1.1 9 | 1.1 1 | |||||||||||
BDL 142 | 8283 .1 | P | 0.4 1 | 0.3 3 | 0.5 2 | 0.1 1 | 0.5 9 | 0.1 6 | 0.1 1 | ||||||||||||||
BDL 142 | 8283 .1 | Av. | 1.2 3 | 8.5 6 | 1.2 7 | 1.1 6 | 2.4 7 | 1.2 8 | 1.1 6 | ||||||||||||||
BDL 142 | 8283 .2 | P | 0.2 7 | 0.0 5 | 0.3 0 | 0.4 8 | 0.3 0 | 0.3 2 | 0.4 3 | ||||||||||||||
BDL 142 | 8283 .2 | Av. | 1.1 4 | 1.4 2 | 1.1 8 | 1.1 5 | 1.1 8 | 1.1 2 | 1.2 0 | ||||||||||||||
BDL 142 | 8284 .1 | P | 0.8 3 | 0.5 7 | 0.4 1 | 0.3 8 | 0.4 1 | ||||||||||||||||
BDL 142 | 8284 .1 | Av. | 1.1 1 | 1.1 4 | 1.1 6 | 1.3 2 | 1.1 6 | ||||||||||||||||
BDL 142 | 8285 .3 | P | 0.0 3 | 0.3 4 | 0.6 5 | 0.4 1 | 0.4 4 | 0.5 7 | 0.0 1 | 0.1 8 | 0.4 1 | 0.4 4 | 0.0 0 | 0.0 0 | 0.6 3 | ||||||||
BDL 142 | 8285 .3 | Av. | 1.1 7 | 2.6 7 | 1.2 0 | 1.2 2 | 1.1 6 | 2.9 0 | 1.3 1 | 1.2 1 | 1.2 2 | 1.1 6 | 1.2 7 | 1.1 6 | 1.1 2 | ||||||||
BDL 142 | 8285 .5 | P | 0.4 9 | ||||||||||||||||||||
BDL 142 | 8285 .5 | Av. | 1.1 3 | ||||||||||||||||||||
BDL 143 | 8411 .1 | P | 0.4 0 | 0.3 7 | |||||||||||||||||||
BDL 143 | 8411 .1 | Av. | 1.2 1 | 1.2 4 | |||||||||||||||||||
BDL 143 | 8411 .5 | P | 0.5 4 | 0.5 4 | 0.5 4 | 0.0 3 | 0.3 8 | 0.2 4 | |||||||||||||||
BDL 143 | 8411 .5 | Av. | 1.1 3 | 1.1 0 | 1.1 3 | 1.0 8 | 1.1 0 | 1.2 1 | |||||||||||||||
BDL 143 | 8412 .2 | p | 0.4 3 | 0.0 1 | 0.0 3 | 0.1 4 | 0.0 3 | 0.0 3 | 0.0 0 | 0.0 5 | |||||||||||||
BDL 143 | 8412 .2 | Av. | 1.3 2 | 1.5 4 | 1.2 2 | 1.2 8 | 1.2 2 | 1.3 2 | 1.2 4 | 1.0 3 | |||||||||||||
BDL 143 | 8412 .4 | p | 0.0 1 | 0.4 7 | 0.5 6 | 0.0 3 | 0.4 7 | 0.0 0 | 0.0 0 | ||||||||||||||
BDL 143 | 8412 .4 | Av. | 2.0 8 | 1.1 8 | 1.1 7 | 1.3 0 | 1.1 8 | 1.3 7 | 1.2 9 | ||||||||||||||
BDL 143 | 8413 .3 | P | 0.0 2 | 0.1 5 | 0.1 8 | 0.0 0 | 0.1 8 | 0.2 4 | 0.0 5 | ||||||||||||||
BDL 143 | 8413 .3 | Av. | 1.7 2 | 1.3 5 | 1.1 1 | 1.2 4 | 1.1 1 | 1.1 8 | 1.1 6 | ||||||||||||||
BDL 143 | 8414 .4 | P | 0.3 6 | 0.7 9 | 0.1 6 | 0.0 0 | |||||||||||||||||
BDL 143 | 8414 .4 | Av. | 1.1 8 | 1.1 5 | 1.1 1 | 1.1 8 | |||||||||||||||||
BDL 143 | 8414 .5 | P | 0.1 6 | 0.1 1 | 0.0 1 | ||||||||||||||||||
BDL 143 | 8414 .5 | Av. | 1.1 7 | 1.2 3 | 1.1 9 | ||||||||||||||||||
BDL 144 | 8384 .1 | p | 0.5 8 | 0.2 8 | 0.1 8 | 0.4 1 | 0.1 8 | 0.0 3 | 0.0 0 | 0.0 3 |
WO 2009/141824
PCT/IL2009/000508
2018200117 05 Jan 2018
178
Gene | Ev. | Par. | 35 | 36 | 37 | 38 | 39 | 40 | 41 | 42 | 43 | 44 | 45 | 46 | 47 | 48 | 49 | 50 | 51 | 52 | 53 | 54 | 55 |
BDL 144 | 8384 .1 | Av. | 1.3 3 | 1.4 7 | 1.1 3 | 1.1 8 | 1.1 3 | 1.2 9 | 1.2 1 | 1.0 3 | |||||||||||||
BDL 144 | 8384 .5 | P | 0.0 8 | 0.1 4 | 0.1 4 | 0.0 0 | 0.0 1 | ||||||||||||||||
BDL 144 | 8384 .5 | Av. | 1.4 5 | 1.2 0 | 1.2 0 | 1.3 3 | 1.3 2 | ||||||||||||||||
BDL 144 | 8385 .1 | P | 0.0 0 | 0.7 6 | 0.0 6 | 0.4 0 | 0.0 5 | 0.2 3 | 0.4 0 | 0.0 5 | 0.1 2 | 0.0 4 | |||||||||||
BDL 144 | 8385 .1 | Av. | 3.3 3 | 1.1 1 | 1.6 9 | 1.2 4 | 1.2 0 | 1.4 0 | 1.2 4 | 1.2 0 | 1.4 4 | 1.3 3 | |||||||||||
BDL 145 | 8233 .2 | P | 0.1 5 | 0.0 5 | 0.1 3 | 0.1 5 | 0.1 3 | ||||||||||||||||
BDL 145 | 8233 .2 | Av. | 1.4 8 | 1.5 1 | 1.2 3 | 1.1 4 | 1.2 3 | ||||||||||||||||
BDL 145 | 8233 .3 | P | 0.3 9 | 0.0 2 | 0.5 8 | 0.5 6 | 0.0 5 | 0.0 0 | 0.5 8 | 0.5 6 | 0.1 1 | 0.1 0 | |||||||||||
BDL 145 | 8233 .3 | Av. | 14. 58 | 1.6 2 | 1.1 5 | 1.1 2 | 1.2 8 | 1.2 8 | 1.1 5 | 1.1 2 | 1.2 7 | 1.2 1 | |||||||||||
BDL 145 | 8235 .1 | P | 0.3 0 | 0.1 5 | 0.2 1 | 0.0 5 | 0.1 7 | 0.1 9 | |||||||||||||||
BDL 145 | 8235 .1 | Av. | 1.1 9 | 1.5 3 | 1.2 0 | 1.0 8 | 1.1 2 | 1.1 0 | |||||||||||||||
BDL 145 | 8235 .3 | P | 0.1 9 | 0.0 2 | 0.2 9 | 0.3 9 | 0.1 1 | 0.2 9 | 0.0 2 | 0.0 3 | |||||||||||||
BDL 145 | 8235 .3 | Av. | 5.4 8 | 1.6 5 | 1.2 0 | 1.3 1 | 1.2 7 | 1.2 0 | 1.2 1 | 1.1 5 | |||||||||||||
BDL 145 | 8235 .4 | P | |||||||||||||||||||||
BDL 145 | 8235 .4 | Av. | |||||||||||||||||||||
BDL 146 | 8241 .1 | P | 0.1 7 | ||||||||||||||||||||
BDL 146 | 8241 .1 | Av. | 1.3 2 | ||||||||||||||||||||
BDL 146 | 8241 .3 | P | 0.3 1 | 0.6 0 | 0.0 0 | 0.0 0 | 0.0 0 | 0.0 0 | 0.0 0 | 0.4 7 | 0.0 2 | ||||||||||||
BDL 146 | 8241 .3 | Av. | 1.1 8 | 1.2 4 | 1.1 7 | 1.3 5 | 1.1 7 | 1.1 6 | 1.1 5 | 1.1 1 | 1.1 5 | ||||||||||||
BDL 146 | 8243 .2 | P | 0.2 0 | 0.2 0 | 0.0 0 | 0.0 2 | |||||||||||||||||
BDL 146 | 8243 .2 | Av. | 1.1 4 | 1.1 4 | 1.2 0 | 1.1 5 | |||||||||||||||||
BDL 146 | 8243 .5 | P | 0.7 3 | 0.3 3 | 0.4 4 | 0.0 3 | 0.0 0 | 0.0 3 | 0.1 0 | 0.0 1 | |||||||||||||
BDL 146 | 8243 .5 | Av. | 1.2 2 | 1.4 3 | 1.4 2 | 1.2 3 | 1.3 9 | 1.2 3 | 1.1 9 | 1.1 0 | |||||||||||||
BDL 146 | 8244 .4 | P | 0.4 3 | 0.1 9 | 0.5 8 | 0.0 8 | 0.6 7 | 0.4 3 | 0.5 8 | 0.0 8 | 0.1 7 | ||||||||||||
BDL 146 | 8244 .4 | Av. | 1.1 5 | 1.2 6 | 2.8 3 | 1.1 6 | 1.6 8 | 1.2 1 | 2.8 3 | 1.1 6 | 1.1 7 | ||||||||||||
BDL 146 | 8244 .7 | P | 0.0 0 | 0.6 1 | 0.2 3 | 0.1 5 | 0.0 7 | 0.1 5 | 0.0 4 | 0.1 5 | |||||||||||||
BDL 146 | 8244 .7 | Av. | 1.9 6 | 1.1 8 | 1.3 9 | 1.1 4 | 1.3 3 | 1.1 4 | 1.1 8 | 1.1 9 |
WO 2009/141824
PCT/IL2009/000508
2018200117 05 Jan 2018
179
Gene | Ev. | Par. | 35 | 36 | 37 | 38 | 39 | 40 | 41 | 42 | 43 | 44 | 45 | 46 | 47 | 48 | 49 | 50 | 51 | 52 | 53 | 54 | 55 |
BDL 146 | 8245 .2 | P | 0.1 0 | 0.0 3 | 0.0 2 | 0.0 3 | 0.3 8 | ||||||||||||||||
BDL 146 | 8245 .2 | Av. | 1.3 4 | 1.1 8 | 1.5 0 | 1.1 8 | 1.3 5 | ||||||||||||||||
BDL 146 | 8245 .5 | P | 0.2 0 | 0.2 2 | 0.0 6 | ||||||||||||||||||
BDL 146 | 8245 .5 | Av. | 1.2 4 | 1.2 1 | 1.4 4 | ||||||||||||||||||
BDL 42 | 7771 .1 | P | |||||||||||||||||||||
BDL 42 | 7771 .1 | Av. | |||||||||||||||||||||
BDL 42 | 7772 .1 | P | |||||||||||||||||||||
BDL 42 | 7772 .1 | Av. | |||||||||||||||||||||
BDL 42 | 7772 .7 | P | |||||||||||||||||||||
BDL 42 | 7772 .7 | Av. | |||||||||||||||||||||
BDL 42 | 7774 .1 | P | 0.0 7 | 0.5 8 | 0.0 0 | 0.0 6 | 0.2 4 | 0.1 2 | 0.0 6 | 0.0 0 | 0.0 1 | ||||||||||||
BDL 42 | 7774 .1 | Av. | 5.7 5 | 1.1 4 | 1.5 9 | 1.1 1 | 1.2 1 | 1.1 9 | 1.1 1 | 1.3 1 | 1.2 7 | ||||||||||||
BDL 42 | 7774 .2 | P | |||||||||||||||||||||
BDL 42 | 7774 .2 | Av. | |||||||||||||||||||||
BDL 42 | 7774 .4 | P | 0.4 7 | 0.0 1 | 0.0 6 | 0.2 1 | |||||||||||||||||
BDL 42 | 7774 .4 | Av. | 4.1 8 | 1.8 1 | 1.3 6 | 1.2 1 | |||||||||||||||||
BDL 46 | 7833 .3 | P | 0.0 2 | 0.3 2 | 0.4 5 | 0.1 9 | 0.1 9 | 0.1 6 | 0.0 0 | 0.5 4 | |||||||||||||
BDL 46 | 7833 .3 | Av. | 1.3 7 | 1.4 4 | 1.6 8 | 1.3 6 | 1.3 6 | 1.3 0 | 1.1 5 | 1.1 5 | |||||||||||||
BDL 46 | 7833 .4 | P | 0.5 6 | 0.0 0 | |||||||||||||||||||
BDL 46 | 7833 .4 | Av. | 1.1 9 | 1.4 0 | |||||||||||||||||||
BDL 46 | 7833 .5 | P | 0.4 Ί | 0.4 5 | 0.5 1 | 0.5 4 | 0.5 4 | 0.0 4 | 0.0 7 | 0.1 9 | |||||||||||||
BDL 46 | 7833 .5 | Av. | 2.2 5 | 1.1 4 | 1.3 2 | 1.3 1 | 1.3 1 | 1.1 4 | 1.0 3 | 1.1 5 | |||||||||||||
BDL 46 | 7833 .6 | P | 0.1 4 | 0.3 0 | 0.6 1 | 0.6 1 | 0.6 3 | 0.2 2 | |||||||||||||||
BDL 46 | 7833 .6 | Av. | 1.2 1 | 1.2 4 | 1.1 9 | 1.1 9 | 1.1 6 | 1.5 2 | |||||||||||||||
BDL 46 | 7834 .1 | P | 0.7 5 | 0.4 6 | 0.3 3 | 0.0 0 | 0.0 1 | ||||||||||||||||
BDL 46 | 7834 .1 | Av. | 1.1 3 | 1.1 5 | 1.1 5 | 1.0 9 | 1.0 7 | ||||||||||||||||
BDL 46 | 7833 .1 | P | 0.2 0 | 0.4 3 | 0.0 9 | 0.0 2 | 0.2 1 | 0.3 9 | 0.0 2 | 0.1 2 | 0.0 2 |
WO 2009/141824
PCT/IL2009/000508
2018200117 05 Jan 2018
180
Gene | Ev. | Far. | 35 | 36 | 37 | 38 | 39 | 40 | 41 | 42 | 43 | 44 | 45 | 46 | 47 | 48 | 49 | 50 | 51 | 52 | 53 | 54 | 55 |
BDL 46 | 7833 .1 | Av. | 2.1 6 | 1.4 7 | 1.7 0 | 1.1 8 | 1.3 2 | 1.2 0 | 1.1 8 | 1.1 2 | 1.1 4 | ||||||||||||
BDL 46 | 7833 .3 | P | 0.8 1 | ||||||||||||||||||||
BDL 46 | 7833 .3 | Av. | 1.2 0 | ||||||||||||||||||||
BDL 46 | 7833 .4 | P | 0.3 3 | 0.7 3 | 0.7 5 | ||||||||||||||||||
BDL 46 | 7833 .4 | Av. | 1.7 3 | 1.2 5 | 1.2 5 | ||||||||||||||||||
BDL 46 | 7833 .5 | P | 0.6 5 | 0.1 7 | 0.3 2 | ||||||||||||||||||
BDL 46 | 7833 .5 | Av. | 1.1 4 | 1.7 7 | 1.2 4 | ||||||||||||||||||
BDL 46 | 7834 .4 | P | 0.0 2 | 0.2 7 | 0.0 2 | 0.0 2 | 0.2 9 | 0.0 0 | 0.0 2 | ||||||||||||||
BDL 46 | 7834 .4 | Av. | 1.2 2 | 1.9 6 | 2.2 6 | 1.2 9 | 1.1 3 | 1.3 3 | 1.2 9 | ||||||||||||||
BDL 51 | 7291 .1 | P | 0.1 9 | 0.7 8 | 0.0 0 | 0.3 1 | 0.8 1 | 0.4 9 | 0.0 4 | 0.3 1 | 0.0 4 | 0.0 1 | 0.0 0 | ||||||||||
BDL 51 | 7291 .1 | Av. | 3.9 7 | 1.1 9 | 1.7 7 | 1.8 2 | 1.2 1 | 1.3 2 | 1.2 3 | 1.8 2 | 1.2 2 | 1.0 9 | 1.1 3 | ||||||||||
BDL 51 | 8021 .1 | P | 0.0 2 | 0.9 3 | 0.5 0 | 0.1 3 | 0.9 3 | 0.5 0 | 0.1 3 | 0.1 0 | 0.1 1 | ||||||||||||
BDL 51 | 8021 .1 | Av. | 3.2 8 | 1.1 8 | 26. 01 | 1.1 5 | 1.1 8 | 26. 01 | 1.1 5 | 1.6 9 | 1.2 4 | ||||||||||||
BDL 51 | 8022 .4 | p | 0.0 4 | 0.0 3 | 0.3 4 | 0.7 7 | 0.4 0 | 0.3 4 | 0.1 8 | 0.0 0 | |||||||||||||
BDL 51 | 8022 .4 | Av. | 2.9 8 | 2.4 3 | 1.5 4 | 1.1 7 | 1.1 5 | 1.5 4 | 1.4 1 | 1.1 9 | |||||||||||||
BDL 51 | 8022 .5 | P | 0.3 5 | 0.4 4 | 0.4 4 | 0.1 3 | 0.0 3 | 0.5 0 | 0.0 3 | 0.1 1 | 0.0 1 | 0.0 7 | |||||||||||
BDL 51 | 8022 .5 | Av. | 1.1 9 | 4.2 4 | 2.3 9 | 3.0 3 | 1.4 3 | 1.2 5 | 1.4 3 | 1.2 6 | 1.1 4 | 1.0 5 | |||||||||||
BDL 51 | 8024 .4 | P | 0.3 9 | 0.0 0 | 0.2 8 | 0.6 6 | 0.5 3 | 0.3 0 | 0.5 5 | 0.2 8 | 0.6 6 | 0.5 3 | 0.3 0 | 0.4 9 | |||||||||
BDL 51 | 8024 .4 | Av. | 3.3 8 | 1.6 9 | 1.6 3 | 1.3 2 | 1.3 0 | 1.1 5 | 1.3 0 | 1.2 6 | 1.3 2 | 1.3 0 | 1.1 5 | 1.1 4 | |||||||||
BDL 51 | 8024 .7 | P | 0.3 3 | 0.3 7 | 0.4 1 | 0.4 1 | 0.3 5 | ||||||||||||||||
BDL 51 | 8024 .7 | Av. | 1.2 9 | 1.3 9 | 1.2 1 | 1.2 1 | 1.2 4 | ||||||||||||||||
BDL 52 | 7861 .1 | P | 0.7 2 | 0.5 7 | 0.6 1 | 0.6 1 | 0.3 0 | ||||||||||||||||
BDL 52 | 7861 .1 | Av. | 1.2 5 | 1.2 4 | 1.1 8 | 1.1 8 | 1.3 8 | ||||||||||||||||
BDL 52 | 7861 .5 | P | 0.1 1 | 0.6 8 | 0.0 1 | 0.0 1 | 0.3 6 | 0.1 0 | |||||||||||||||
BDL 52 | 7861 .5 | Av. | 1.3 1 | 1.1 4 | 1.2 7 | 1.2 7 | 1.1 7 | 1.1 2 | |||||||||||||||
BDL 52 | 7863 .2 | P | 0.8 2 | 0.0 7 | 0.1 4 | 0.0 2 | |||||||||||||||||
BDL 52 | 7863 .2 | Av. | 1.2 1 | 1.0 3 | 1.1 1 | 1.0 9 |
WO 2009/141824
PCT/IL2009/000508
2018200117 05 Jan 2018
181
Gene | Ev. | Par. | 35 | 36 | 37 | 38 | 39 | 40 | 41 | 42 | 43 | 44 | 45 | 46 | 47 | 48 | 49 | 50 | 51 | 52 | 53 | 54 | 55 |
BDL 52 | 7864 .5 | P | 0.6 1 | 0.7 6 | 0.7 1 | 0.4 0 | 0.7 6 | 0.7 1 | 0.3 9 | ||||||||||||||
BDL 52 | 7864 .5 | Av. | 1.2 5 | 1.1 7 | 1.1 0 | 1.2 6 | 1.1 7 | 1.1 0 | 1.3 5 | ||||||||||||||
BDL 54 | 7781 .1 | P | 0.5 0 | 0.7 3 | 0.5 0 | 0.4 7 | 0.5 0 | 0.0 1 | 0.0 0 | ||||||||||||||
BDL 54 | 7781 .1 | Av. | 13. 03 | 1.1 6 | 6.5 9 | 3.9 0 | 6.5 9 | 1.1 2 | 1.0 9 | ||||||||||||||
BDL 54 | 7781 .4 | P | 0.0 6 | 0.0 9 | 0.7 8 | 0.2 7 | 0.5 5 | 0.2 7 | 0.0 0 | 0.5 0 | |||||||||||||
BDL 54 | 7781 .4 | Av. | 1.2 8 | 1.2 5 | 1.1 3 | 1.1 9 | 1.2 2 | 1.1 9 | 1.0 9 | 1.3 1 | |||||||||||||
BDL 54 | 7784 .3 | P | 0.8 7 | 0.4 9 | 0.1 6 | 0.4 8 | 0.0 5 | 0.4 9 | 0.0 6 | 0.4 8 | 0.0 5 | 0.0 0 | 0.0 5 | 0.2 2 | |||||||||
BDL 54 | 7784 .3 | Av. | 1.4 9 | 9.5 6 | 1.6 8 | 5.7 7 | 1.1 5 | 14. 83 | 1.2 6 | 5.7 7 | 1.1 5 | 1.3 5 | 1.1 5 | 1.1 2 | |||||||||
BDL 54 | 7784 .5 | P | 0.4 4 | 0.4 7 | 0.0 7 | 0.4 7 | 0.2 3 | 0.7 5 | |||||||||||||||
BDL 54 | 7784 .5 | Av. | 1.4 9 | 1.1 9 | 1.2 7 | 1.1 9 | 1.1 5 | 1.1 2 | |||||||||||||||
BDL 54 | 7785 .4 | P | 0.1 6 | 0.0 6 | 0.3 6 | 0.0 0 | 0.3 6 | 0.2 5 | 0.1 5 | 0.1 6 | |||||||||||||
BDL 54 | 7785 .4 | Av. | 1.5 2 | 1.4 0 | 1.2 2 | 1.3 0 | 1.2 2 | 1.1 6 | 1.1 2 | 1.2 0 | |||||||||||||
BDL 54 | 7781 .1 | P | 0.5 5 | 0.1 9 | 0.0 8 | 0.2 3 | 0.1 0 | 0.2 3 | |||||||||||||||
BDL 54 | 7781 .1 | Av. | 1.5 0 | 1.3 3 | 3.0 5 | 1.1 3 | 1.2 7 | 1.1 3 | |||||||||||||||
BDL 54 | 7781 .4 | P | 0.0 4 | 0.2 5 | 0.0 1 | 0.5 2 | 0.0 0 | 0.5 2 | 0.1 5 | ||||||||||||||
BDL 54 | 7781 .4 | Av. | 1.8 7 | 1.3 6 | 1.8 5 | 1.1 8 | 1.3 7 | 1.1 8 | 1.1 9 | ||||||||||||||
BDL 54 | 7784 .3 | P | 0.4 9 | 0.4 7 | 0.4 3 | 0.0 2 | 0.0 3 | 0.0 2 | |||||||||||||||
BDL 54 | 7784 .3 | Av. | 1.5 4 | 1.3 7 | 1.8 1 | 1.1 4 | 1.3 0 | 1.1 4 | |||||||||||||||
BDL 54 | 7785 .4 | P | 0.4 0 | 0.6 7 | 0.3 4 | 0.2 6 | |||||||||||||||||
BDL 54 | 7785 .4 | Av. | 1.5 7 | 1.1 3 | 1.1 8 | 1.2 0 | |||||||||||||||||
BDL 54 | 7785 .8 | P | 0.4 1 | 0.0 7 | 0.1 0 | 0.3 2 | |||||||||||||||||
BDL 54 | 7785 .8 | Av. | 1.3 9 | 1.2 1 | 1.2 8 | 1.2 1 | |||||||||||||||||
BDL 56 | 7181 .2 | P | 0.5 1 | 0.5 1 | 0.5 0 | 0.4 3 | 0.5 0 | 0.0 0 | 0.0 0 | 0.7 0 | |||||||||||||
BDL 56 | 7181 .2 | Av. | 3.8 1 | 1.7 9 | 3.2 8 | 3.7 5 | 3.2 8 | 1.4 2 | 1.1 9 | 1.1 3 | |||||||||||||
BDL 56 | 8301 .1 | P | 0.0 1 | 0.0 5 | |||||||||||||||||||
BDL 56 | 8301 .1 | Av. | 1.0 5 | 1.2 4 | |||||||||||||||||||
BDL 56 | 8301 .3 | P | 0.4 2 | 0.6 4 | 0.3 4 | 0.6 4 |
WO 2009/141824
PCT/IL2009/000508
2018200117 05 Jan 2018
182
Gene | Ev. | Par. | 35 | 36 | 37 | 38 | 39 | 40 | 41 | 42 | 43 | 44 | 45 | 46 | 47 | 48 | 49 | 50 | 51 | 52 | 53 | 54 | 55 |
BDL 56 | 8301 .3 | Av. | 1.1 0 | 1.1 5 | 1.1 1 | 1.1 5 | |||||||||||||||||
BDL 56 | 8304 .1 | P | 0.4 0 | ||||||||||||||||||||
BDL 56 | 8304 .1 | Av. | 1.1 2 | ||||||||||||||||||||
BDL 56 | 8305 .1 | P | 0.1 9 | 0.5 2 | 0.7 6 | 0.7 1 | 0.7 6 | 0.7 1 | 0.2 3 | ||||||||||||||
BDL 56 | 8305 .1 | Av. | 1.1 7 | 1.2 6 | 1.1 1 | 1.1 3 | 1.1 1 | 1.1 3 | 1.2 0 | ||||||||||||||
BDL 56 | 8301 .1 | P | 0.6 4 | 0.7 0 | 0.7 0 | 0.6 5 | 0.4 1 | 0.4 0 | 0.4 1 | ||||||||||||||
BDL 56 | 8301 .1 | Av. | 1.2 1 | 1.2 9 | 1.1 1 | 1.3 3 | 1.1 5 | 1.1 9 | 1.1 5 | ||||||||||||||
BDL 56 | 8301 .2 | P | 0.4 4 | 0.1 3 | 0.0 1 | 0.0 1 | 0.1 2 | 0.0 1 | 0.0 7 | ||||||||||||||
BDL 56 | 8301 .2 | Av. | 2.0 0 | 1.6 7 | 1.1 7 | 1.3 0 | 1.3 2 | 1.1 Ί | 1.1 0 | ||||||||||||||
BDL 56 | 8301 .3 | P | 0.2 3 | 0.2 3 | 0.6 3 | 0.6 1 | 0.3 8 | 0.6 1 | 0.2 5 | ||||||||||||||
BDL 56 | 8301 .3 | Av. | 1.1 1 | 1.7 0 | 1.4 6 | 1.1 8 | 1.3 6 | 1.1 8 | 1.1 1 | ||||||||||||||
BDL 56 | 8303 .1 | P | 0.5 3 | ||||||||||||||||||||
BDL 56 | 8303 .1 | Av. | 1.3 9 | ||||||||||||||||||||
BDL 56 | 8303 .2 | P | 0.2 9 | 0.3 9 | 0.1 6 | 0.1 6 | 0.5 7 | ||||||||||||||||
BDL 56 | 8303 .2 | Av. | 1.3 2 | 1.7 8 | 1.1 2 | 1.1 2 | 1.1 1 | ||||||||||||||||
BDL 59 | 7792 .1 | p | 0.0 2 | ||||||||||||||||||||
BDL 59 | 7792 .1 | Av. | 1.1 0 | ||||||||||||||||||||
BDL 59 | 7792 .2 | P | 0.7 0 | 0.2 0 | |||||||||||||||||||
BDL 59 | 7792 .2 | Av. | 1.1 9 | 1.1 6 | |||||||||||||||||||
BDL 59 | 7792 .3 | p | 0.3 1 | 0.0 4 | |||||||||||||||||||
BDL 59 | 7792 .3 | Av. | 1.4 3 | 1.0 6 | |||||||||||||||||||
BDL 59 | 7793 .3 | P | 0.6 6 | 0.0 4 | 0.5 7 | 0.5 6 | 0.5 7 | 0.5 6 | 0.3 6 | 0.2 0 | |||||||||||||
BDL 59 | 7793 .3 | Av. | 1.4 8 | 1.4 3 | 1.4 0 | 1.1 1 | 1.4 0 | 1.1 1 | 1.2 4 | 1.1 4 | |||||||||||||
BDL 59 | 7794 .1 | P | 0.1 3 | 0.0 1 | 0.3 6 | 0.0 1 | 0.0 2 | 0.0 0 | |||||||||||||||
BDL 59 | 7794 .1 | Av. | 7.9 0 | 6.4 6 | 4.8 0 | 6.4 6 | 1.1 3 | 1.0 9 | |||||||||||||||
BDL 60 | 8011 .4 | P | 0.2 9 | 0.0 3 | 0.1 2 | ||||||||||||||||||
BDL 60 | 8011 .4 | Av. | 1.1 3 | 1.2 4 | 1.1 5 |
WO 2009/141824
PCT/IL2009/000508
2018200117 05 Jan 2018
183
Gene | Ev. | Par. | 35 | 36 | 37 | 38 | 39 | 40 | 41 | 42 | 43 | 44 | 45 | 46 | 47 | 48 | 49 | 50 | 51 | 52 | 53 | 54 | 55 |
BDL 60 | 8011 .7 | P | 0.4 9 | 0.0 0 | 0.4 8 | 0.4 7 | 0.0 6 | 0.4 8 | 0.1 5 | 0.0 4 | 0.3 8 | 0.0 4 | |||||||||||
BDL 60 | 8011 .7 | Av. | 10. 85 | 1.5 1 | 5.5 9 | 2.4 4 | 1.2 8 | 5.5 9 | 1.3 7 | 1.1 8 | 1.1 1 | 1.1 8 | |||||||||||
BDL 60 | 8013 .4 | P | 0.9 7 | 0.3 9 | 0.5 0 | 0.3 8 | 0.4 9 | 0.3 5 | 0.5 0 | 0.3 8 | 0.0 6 | 0.0 0 | 0.6 0 | ||||||||||
BDL 60 | 8013 .4 | Av. | 1.1 0 | 1.6 6 | 27. 18 | 1.1 3 | 16. 70 | 1.2 0 | 27. 18 | 1.1 3 | 1.5 6 | 1.1 9 | 1.1 5 | ||||||||||
BDL 60 | 8013 .6 | P | 0.3 5 | 0.7 4 | 0.6 2 | 0.1 4 | 0.2 5 | 0.6 2 | 0.1 4 | 0.0 0 | 0.0 8 | ||||||||||||
BDL 60 | 8013 .6 | Av. | 2.4 3 | 1.3 4 | 1.1 8 | 1.1 0 | 1.1 2 | 1.1 8 | 1.1 0 | 1.5 3 | 1.1 9 | ||||||||||||
BDL 60 | 8014 .5 | p | 0.4 8 | 0.1 0 | 0.6 1 | 0.7 2 | 0.3 7 | 0.6 1 | 0.0 7 | 0.0 8 | |||||||||||||
BDL 60 | 8014 .5 | Av. | 3.2 1 | 1.7 3 | 1.4 3 | 1.2 0 | 1.1 2 | 1.4 3 | 1.3 8 | 1.1 7 | |||||||||||||
BDL 60 | 8013 .6 | P | 0.7 8 | 0.5 9 | 0.0 2 | 0.2 4 | 0.3 5 | 0.0 2 | |||||||||||||||
BDL 60 | 8013 .6 | Av. | 1.1 5 | 1.3 7 | 1.1 2 | 1.2 2 | 1.1 5 | 1.1 2 | |||||||||||||||
BDL 60 | 8014 .2 | P | 0.0 2 | 0.0 1 | 0.0 2 | 0.0 1 | |||||||||||||||||
BDL 60 | 8014 .2 | Av. | 2.0 3 | 2.0 5 | 1.3 5 | 1.1 9 | |||||||||||||||||
BDL 60 | 8014 .7 | p | 0.4 0 | 0.1 7 | 0.7 2 | 0.0 7 | 0.0 1 | 0.0 4 | 0.0 7 | ||||||||||||||
BDL 60 | 8014 .7 | Av. | 1.2 3 | 1.3 2 | 1.2 0 | 1.2 2 | 1.3 3 | 1.1 7 | 1.2 2 | ||||||||||||||
BDL 60 | 8014 .8 | p | 0.7 2 | 0.0 1 | 0.4 6 | 0.1 4 | 0.6 1 | 0.2 9 | 0.4 6 | 0.1 4 | 0.2 5 | 0.1 0 | |||||||||||
BDL 60 | 8014 .8 | Av. | 1.5 3 | 1.9 5 | 1.3 0 | 1.1 0 | 1.1 9 | 1.1 8 | 1.3 0 | 1.1 0 | 1.1 6 | 1.2 4 | |||||||||||
BDL 65 | 7824 .1 | P | 0.7 3 | 0.6 9 | 0.2 7 | 0.1 3 | 0.1 8 | ||||||||||||||||
BDL 65 | 7824 .1 | Av. | 1.4 0 | 1.1 1 | 1.1 3 | 1.4 4 | 1.2 2 | ||||||||||||||||
BDL 65 | 7825 .2 | P | 0.2 0 | 0.5 6 | 0.0 3 | 0.0 0 | 0.0 5 | ||||||||||||||||
BDL 65 | 7825 .2 | Av. | 1.2 5 | 1.3 3 | 1.3 3 | 1.2 7 | 1.1 4 | ||||||||||||||||
BDL 65 | 8473 .2 | P | 0.1 0 | 0.3 7 | 0.0 0 | 0.0 1 | 0.0 1 | 0.4 5 | 0.5 0 | 0.0 5 | 0.0 1 | 0.0 1 | 0.0 0 | 0.0 0 | |||||||||
BDL 65 | 8473 .2 | Av. | 4.5 5 | 1.1 7 | 1.6 9 | 1.2 7 | 1.2 2 | 3.4 2 | 1.4 2 | 1.3 3 | 1.2 7 | 1.2 2 | 1.2 5 | 1.1 8 | |||||||||
BDL 65 | 8474 .1 | p | 0.5 8 | 0.0 1 | |||||||||||||||||||
BDL 65 | 8474 .1 | Av. | 1.1 1 | 1.0 8 | |||||||||||||||||||
BDL 67 | 7901 .5 | P | 0.4 2 | 0.4 6 | 0.0 0 | 0.5 2 | 0.3 8 | 0.5 2 | 0.0 0 | 0.0 0 | 0.3 1 | 0.0 2 | |||||||||||
BDL 67 | 7901 .5 | Av. | 1.9 2 | 1.1 0 | 1.7 0 | 1.2 7 | 1.1 3 | 1.2 7 | 1.2 9 | 1.1 5 | 1.1 3 | 1.1 4 | |||||||||||
BDL 67 | 7902 .3 | p | 0.3 0 | 0.4 8 | 0.4 8 | 0.5 0 | 0.5 0 | 0.4 8 | 0.1 2 | 0.2 1 | 0.0 4 | 0.0 0 |
WO 2009/141824
PCT/IL2009/000508
2018200117 05 Jan 2018
184
Gene | Ev. | Par. | 35 | 36 | 37 | 38 | 39 | 40 | 41 | 42 | 43 | 44 | 45 | 46 | 47 | 48 | 49 | 50 | 51 | 52 | 53 | 54 | 55 |
BDL 67 | 7902 .3 | Av. | 1.2 2 | 8.1 0 | 5A 4 | 20. 18 | 1.1 9 | 5.4 4 | 1.3 6 | 1.1 3 | 1.4 0 | 1.1 1 | |||||||||||
BDL 67 | 7902 .7 | P | 0.4 9 | 0.1 2 | 0.5 0 | 0.0 8 | 0.5 0 | 0.5 0 | 0.0 8 | 0.0 4 | 0.0 4 | 0.4 4 | 0.0 0 | ||||||||||
BDL 67 | 7902 .7 | Av. | 8.0 1 | 1.4 3 | 6.3 1 | 1.1 3 | 6.9 5 | 6.3 1 | 1.1 3 | 1.4 2 | 1.1 6 | 1.1 6 | 1.1 1 | ||||||||||
BDL 67 | 7903 .3 | P | 0.5 2 | 0.3 3 | 0.1 9 | 0.1 9 | |||||||||||||||||
BDL 67 | 7903 .3 | Av. | 1.2 3 | 1.2 1 | 1.1 8 | 1.4 6 | |||||||||||||||||
BDL 67 | 7903 .5 | P | 0.2 6 | 0.0 0 | 0.3 5 | 0.4 7 | 0.0 0 | 0.1 5 | 0.4 7 | 0.0 0 | 0.0 0 | 0.1 3 | |||||||||||
BDL 67 | 7903 .5 | Av. | 1.1 0 | 3.1 9 | 1.6 1 | 1.2 9 | 1.2 6 | 1.3 9 | 1.2 9 | 1.2 6 | 1.3 4 | 1.1 3 | |||||||||||
BDL 68 | 7761 .3 | P | 0.2 6 | 0.4 9 | 0.5 0 | 0.4 9 | 0.3 4 | 0.0 0 | |||||||||||||||
BDL 68 | 7761 .3 | Av. | 1.2 5 | 12. 65 | 24. 18 | 12. 65 | 1.2 1 | 1.1 4 | |||||||||||||||
BDL 68 | 7761 .8 | P | 0.4 8 | 0.5 0 | 0.0 1 | 0.1 9 | 0.0 8 | 0.3 6 | 0.0 8 | 0.1 9 | 0.0 8 | 0.0 0 | 0.0 8 | 0.2 7 | |||||||||
BDL 68 | 7761 .8 | Av. | 10. 41 | 1.2 3 | 1.4 9 | 1.6 7 | 1.1 8 | 1.4 2 | 1.4 1 | 1.6 7 | 1.1 8 | 1.3 6 | 1.1 6 | 1.1 8 | |||||||||
BDL 68 | 7761 .9 | P | 0.2 5 | 0.4 9 | 0.4 4 | 0.5 9 | 0.1 3 | 0.0 0 | 0.4 9 | 0.4 4 | 0.0 0 | 0.0 0 | |||||||||||
BDL 68 | 7761 .9 | Av. | 1.7 3 | 2.0 9 | 1.2 2 | 1.2 3 | 1.6 9 | 1.4 5 | 2.0 9 | 1.2 2 | 1.5 2 | 1.1 8 | |||||||||||
BDL 68 | 7763 .2 | P | 0.4 0 | 0.0 3 | 0.5 1 | 0.0 2 | 0.7 5 | 0.0 5 | 0.2 0 | 0.5 1 | 0.0 2 | 0.0 0 | 0.0 4 | 0.2 9 | 0.2 2 | ||||||||
BDL 68 | 7763 .2 | Av. | 3.1 4 | 1.5 5 | 1.5 4 | 1.1 8 | 1.2 0 | 1.4 6 | 1.2 1 | 1.5 4 | 1.1 8 | 1.3 2 | 1.1 3 | 1.3 1 | 1.1 3 | ||||||||
BDL 68 | 7764 .1 | P | 0.5 5 | 0.5 0 | 0.3 3 | 0.4 9 | 0.0 3 | 0.4 7 | 0.0 1 | 0.4 9 | 0.0 3 | 0.0 9 | 0.2 4 | 0.3 3 | |||||||||
BDL 68 | 7764 .1 | Av. | 10. 21 | 13. 08 | 1.5 0 | 7.9 3 | 1.1 6 | 5.3 0 | 1.2 7 | 7.9 3 | 1.1 6 | 1.4 7 | 1.1 7 | 1.1 3 | |||||||||
BDL 78 | 7911 .11 | P | 0.1 3 | 0.5 2 | 0.3 5 | 0.0 0 | 0.1 2 | ||||||||||||||||
BDL 78 | 7911 .11 | Av. | 1.1 2 | 1.1 7 | 1.2 3 | 1.2 0 | 1.1 4 | ||||||||||||||||
BDL 78 | 7911 .8 | P | 0.5 1 | 0.6 4 | 0.0 7 | 0.2 2 | 0.0 7 | 0.0 5 | 0.0 8 | ||||||||||||||
BDL 78 | 7911 .8 | Av. | 1.1 5 | 1.2 6 | 1.0 7 | 1.1 1 | 1.0 7 | 1.1 2 | 1.1 3 | ||||||||||||||
BDL 78 | 7911 .9 | P | 0.2 2 | 0.0 0 | 0.0 6 | 0.3 8 | 0.3 9 | 0.0 6 | 0.0 7 | 0.0 0 | 0.1 9 | 0.3 7 | |||||||||||
BDL 78 | 7911 .9 | Av. | 7.5 2 | 1.8 2 | 1.1 9 | 1.1 7 | 1.1 6 | 1.1 9 | 1.3 7 | 1.2 Ί | 1.2 2 | 1.1 2 | |||||||||||
BDL 78 | 791^ .6 | P | 0.5 8 | 0.1 4 | 0.2 0 | 0.2 4 | 0.2 0 | 0.0 2 | 0.3 7 | ||||||||||||||
BDL 78 | 7912 .6 | Av. | 1.1 0 | 1.3 1 | 1.1 9 | 1.2 2 | 1.1 9 | 1.0 9 | 1.1 1 | ||||||||||||||
BDL 78 | 7913 .11 | P | 0.2 0 | 0.2 1 | 0.1 4 | 0.2 9 | 0.5 3 | 0.3 6 | 0.1 4 | 0.2 9 | 0.0 0 | 0.0 0 | |||||||||||
BDL 78 | 7913 .11 | Av. | 1.1 8 | 1.9 9 | 1.1 3 | 1.1 1 | 1.2 3 | 1.4 3 | 1.1 3 | 1.1 1 | 1.1 9 | 1.1 5 |
WO 2009/141824
PCT/IL2009/000508
2018200117 05 Jan 2018
185
Gene | Ev. | Par. | 35 | 36 | 37 | 38 | 39 | 40 | 41 | 42 | 43 | 44 | 45 | 46 | 47 | 48 | 49 | 50 | 51 | 52 | 53 | 54 | 55 |
BDL 78 | 7913 .3 | P | 0.0 3 | 0.0 4 | |||||||||||||||||||
BDL 78 | 7913 .3 | Av. | 1.1 4 | 1.0 3 | |||||||||||||||||||
BDL 78 | 7913 .6 | P | 0.4 2 | 0.0 4 | 0.0 9 | 0.6 1 | 0.0 1 | 0.0 9 | 0.0 0 | 0.0 1 | |||||||||||||
BDL 78 | 7913 .6 | Av. | 11. 13 | 1.4 5 | 1.2 1 | 1.2 3 | 1.2 2 | 1.2 1 | 1.2 7 | 1.2 2 | |||||||||||||
BDL 78 | 7913 .8 | P | 0.1 1 | 0.0 7 | 0.0 4 | 0.0 7 | 0.2 1 | 0.0 0 | 0.3 7 | 0.0 2 | |||||||||||||
BDL 78 | 7913 .8 | Av. | 1.3 3 | 1.1 6 | 1.1 5 | 1.1 6 | 1.2 5 | 1.1 6 | 1.1 1 | 1.1 9 | |||||||||||||
BDL 78 | 7913 .9 | P | 0.4 8 | 0.6 3 | 0.2 4 | 0.5 4 | 0.0 1 | 0.2 4 | 0.1 6 | 0.0 7 | |||||||||||||
BDL 78 | 7913 .9 | Av. | 1.8 5 | 1.2 6 | 1.1 6 | 5.7 2 | 1.2 2 | 1.1 6 | 1.1 5 | 1.1 0 | |||||||||||||
BDL 82 | 7801 .1 | P | 0.3 1 | 0.0 1 | 0.2 3 | 0.0 5 | 0.3 7 | 0.2 7 | 0.2 3 | 0.0 5 | 0.0 7 | 0.0 2 | 0.6 3 | 0.0 3 | |||||||||
BDL 82 | 7801 .1 | Av. | 3.9 4 | 1.8 8 | 1.4 4 | 1.1 4 | 1.4 5 | 1.4 1 | 1.4 4 | 1.1 4 | 1.4 1 | 1.1 5 | 1.1 3 | 1.0 7 | |||||||||
BDL 82 | 7801 .3 | P | 0.3 9 | 0.4 7 | 0.5 1 | 0.4 7 | 0.1 3 | 0.0 0 | |||||||||||||||
BDL 82 | 7801 .3 | Av. | 13. 27 | 1.3 6 | 1.2 1 | 1.3 6 | 1.4 4 | 1.2 1 | |||||||||||||||
BDL 82 | 7802 .2 | p | 0.4 1 | 0.4 6 | 0.5 2 | 0.0 Ί | 0.4 5 | 0.5 2 | 0.0 0 | 0.1 6 | |||||||||||||
BDL 82 | 7802 .2 | Av. | 3.7 8 | 1.2 0 | 1.5 4 | 1.3 4 | 1.1 7 | 1.5 4 | 1.1 7 | 1.1 2 | |||||||||||||
BDL 82 | 7802 .3 | P | 0.1 8 | 0.0 2 | 0.4 5 | 0.3 2 | 0.1 2 | 0.0 6 | 0.3 2 | 0.1 3 | 0.0 0 | ||||||||||||
BDL 82 | 7802 .3 | Av. | 2.1 4 | 1.4 1 | 1.4 0 | 1.1 4 | 1.1 6 | 1.2 4 | 1.1 4 | 1.3 0 | 1.1 6 | ||||||||||||
BDL 82 | 7803 .9 | P | 0.5 4 | 0.5 4 | 0.2 8 | ||||||||||||||||||
BDL 82 | 7803 .9 | Av. | 1.1 8 | 1.1 8 | 1.3 5 | ||||||||||||||||||
BDL 89 | 7812 .2 | p | 0.6 7 | 0.2 6 | 0.4 2 | ||||||||||||||||||
BDL 89 | 7812 .2 | Av. | 1.1 2 | 1.1 7 | 1.1 3 | ||||||||||||||||||
BDL 89 | 7812 .5 | p | 0.5 1 | 0.5 1 | 0.1 8 | 0.5 0 | 0.5 1 | 0.1 8 | 0.1 1 | 0.1 8 | 0.0 3 | ||||||||||||
BDL 89 | 7812 .5 | Av. | 12. 24 | 5.8 4 | 1.1 8 | 16. 66 | 5.8 4 | 1.1 8 | 1.2 6 | 1.1 2 | 1.0 4 | ||||||||||||
BDL 89 | 7814 .1 | p | 0.2 3 | 0.3 9 | 0.5 8 | 0.0 6 | 0.5 8 | 0.0 0 | 0.0 0 | ||||||||||||||
BDL 89 | 781ή .1 | Av. | 1.1 6 | 1.1 4 | 1.1 6 | 1.1 6 | 1.1 6 | 1.1 7 | 1.0 4 | ||||||||||||||
BDL 89 | 7814 .4 | p | 0.4 7 | 0.4 2 | 0.4 6 | 0.0 5 | 0.4 8 | 0.4 3 | 0.4 6 | 0.0 5 | 0.3 6 | 0.2 1 | |||||||||||
BDL 89 | 7814 .4 | Av. | 9.4 0 | 2.0 2 | 5.5 9 | 1.1 7 | 6.7 6 | 1.2 1 | 5.5 9 | 1.1 7 | 1.2 4 | 1.1 3 | |||||||||||
BDL 89 | 7814 .5 | p | 0.4 7 | 0.2 6 | 0.4 6 | 0.5 2 | 0.2 0 | 0.1 5 | 0.4 6 | 0.0 2 | 0.0 5 | 0.0 0 | 0.1 0 |
WO 2009/141824
PCT/IL2009/000508
2018200117 05 Jan 2018
186
Gene | Ev. | Par. | 35 | 36 | 37 | 38 | 39 | 40 | 41 | 42 | 43 | 44 | 45 | 46 | 47 | 48 | 49 | 50 | 51 | 52 | 53 | 54 | 55 |
BDL 89 | 7814 .5 | Av. | 7.6 2 | 1.5 7 | 1.9 8 | 1.6 5 | 1.2 6 | 1.1 4 | 1.9 8 | 1.3 8 | 1.2 1 | 1.5 9 | 1.1 5 |
Table 27.
EXAMPLE 8
EVALUATING TRANSGENIC ARABIDOPSIS PLANT GROWTH UNDER
ABIOTIC STRESS AND NITROGEN DEFICIENCY CONDITIONS IN TISSUE
CULTURE ASSAY
Assay 1: plant growth under osmotic stress [poly (ethylene glycol) (PEG)] in tissue culture conditions - One of the consequences of drought is the induction of osmotic stress in the area surrounding the roots; therefore, in many scientific studies, 10 PEG (e.g., 1.5% PEG8000) is used to simulate the osmotic stress conditions resembling the high osmolarity found during drought stress.
Surface sterilized seeds were sown in basal media [50 % Murashige-Skoog medium (MS) supplemented with 0.8 % plant agar as solidifying agent] in the presence of Kanamycin (for selecting only transgenic plants). After sowing, plates were 15 transferred for 2-3 days for stratification at 4 °C and then grown at 25 °C under 12-hour light 12-hour dark daily cycles for 7 to 10 days. At this time point, seedlings randomly chosen were carefully transferred to plates containing 1.5% PEG: 0.5 MS media or Normal growth conditions (0.5 MS media). Each plate contained 5 seedlings of the same transgenic event, and 3-4 different plates (replicates) for each event. For each 20 polynucleotide of the invention at least four independent transformation events were analyzed from each construct. Plants expressing the polynucleotides of the invention were compared to the average measurement of the control plants (empty vector or GUS reporter gene under the same promoter) used in the same experiment.
Assay 2: plant growth at nitrogen deficiency under tissue culture conditions 25 The present inventors have found the nitrogen use efficiency (NUE) assay to be relevant for the evaluation of the ABST candidate genes, since nitrogen deficiency encourages root elongation, increase of root coverage and allows detecting the potential of the plant to generate a better root system under drought conditions. In addition, there are indications in the literature that biological mechanisms of NUE and drought tolerance
WO 2009/141824
PCT/IL2009/000508
2018200117 05 Jan 2018
187 are linked (Wesley et al., 2002 Journal of Experiment Botany Vol 53, No.366, pp. 1325).
Surface sterilized seeds were sown in basal media [50 % Murashige-Skoog medium (MS) supplemented with 0.8 % plant agar as solidifying agent] in the presence 5 of Kanamycin (for selecting only transgenic plants). After sowing, plates were transferred for 2-3 days for stratification at 4 °C and then grown at 25 °C under 12-hour light 12-hour dark daily cycles for 7 to 10 days. At this time point, seedlings randomly chosen were carefully transferred to plates with nitrogen-limiting conditions: 0.5 MS media in which the combined nitrogen concentration (NH4NO3 and KNO3) is 0.75 mM 10 (nitrogen deficient conditions). Each plate contains 5 seedlings of same event, and 3-4 different plates (replicates) for each event. For each polynucleotide of the invention at least four independent transformation events were analyzed from each construct. Plants expressing the polynucleotides of the invention were compared to the average measurement of the control plants (empty vector or GUS reporter under the same 15 promoter) used in the same experiment.
Digital imaging - A laboratory image acquisition system, which consists of a digital reflex camera (Canon EOS 300D) attached with a 55 mm focal length lens (Canon EF-S series), mounted on a reproduction device (Kaiser RS), which included 4 light units (4x150 Watts light bulb) and located in a darkroom, was used for capturing 20 images of plantlets sawn in agar plates.
The image capturing process was repeated every 2-5 days starting at day 1 till day 10-15 (see for example the images in Figures 2A-B)
An image analysis system was used, which consists of a personal desktop computer (Intel P4 3.0 GHz processor) and a public domain program - ImageJ 1.39 25 (Java based image processing program which was developed at the U.S. National Institutes of Health and freely available on the internet at Hypertext Transfer Protocol://rsbweb (dot) nih (dot) gov/). Images were captured in resolution of 10 Mega Pixels (3888 x 2592 pixels) and stored in a low compression JPEG (Joint Photographic Experts Group standard) format. Next, analyzed data was saved to text files and 30 processed using the JMP statistical analysis software (SAS institute).
Seedling analysis - Using the digital analysis seedling data was calculated, including leaf area, root coverage and root length.
WO 2009/141824
PCT/IL2009/000508
2018200117 05 Jan 2018
188
The relative growth rate for the various seedling parameters was calculated according to the following Formulas.
Formula VI:
Relative growth rate of leaf area = (Δ rosette area / At) * (1/ rosette area ti)
Δ rosette area is the interval between the current rosette area (measured at t2) and the rosette area measured at the previous day (Area tx)
Δί is the time interval 02-tj, in days) between the current analyzed image day 02) and the previous day (ti).
Thus, the relative growth rate of leaf area is in units of 1/day.
Formula VII:
Relative growth rate of root coverage = (Δ root coverage area / At) * (1/ root coverage area ti)
Δ root coverage area is the interval between the current root coverage area (measured at t2) and the root coverage area measured at the previous day (Area ti)
Δί is the time interval (t2-ti, in days) between the current analyzed image day
02) and the previous day 0i).
Thus, the relative growth rate of root coverage area is in units of 1/day.
Formula VIII:
Relative growth rate of root length = (Δ root length / Δί) * (1/ root length ti)
Δ root length is the interval between the current root length (measured at t2) and the root length measured at the previous day (Area ti)
Δί is the time interval 02-ti, in days) between the current analyzed image day 02) and the previous day 0i).
Thus, the relative growth rate of root length is in units of 1/day.
At the end of the experiment, plantlets were removed from the media and weighed for the determination of plant fresh weight. Plantlets were then dried for 24 hours at 60 °C, and weighed again to measure plant dry weight for later statistical analysis. Growth rate was determined by comparing the leaf area coverage, root coverage and root length, between each couple of sequential photographs, and results 30 were used to resolve the effect of the gene introduced on plant vigor, under osmotic stress, as well as under optimal conditions. Similarly, the effect of the gene introduced on biomass accumulation, under osmotic stress as well as under optimal conditions, was
WO 2009/141824
PCT/IL2009/000508
2018200117 05 Jan 2018
189 determined by comparing the plants' fresh and dry weight to that of control plants (containing an empty vector or the GUS reporter gene under the same promoter). From every construct created, 3-5 independent transformation events were examined in replicates.
Statistical analyses - To identify genes conferring significantly improved tolerance to abiotic stresses or enlarged root architecture, the results obtained from the transgenic plants were compared to those obtained from control plants. To identify outperforming genes and constructs, results from the independent transformation events tested were analyzed separately. To evaluate the effect of a gene event over a control the 10 data was analyzed by Student’s t-test and the p value was calculated. Results were considered significant if p < 0.1. The JMP statistics software package was used (Version 5.2.1, SAS Institute Inc., Cary, NC, USA).
Experimental Results - The polynucleotide sequences of the invention were assayed for a number of commercially desired traits. Table 28 provides the parameters 15 measured in a tissue culture assay (results are presented in Tables 29 and 30). In cases where a certain event appears more than once, the event was tested in several independent experiments.
Table 28
Parameter symbol used in result Table 29 | Parameter name |
1 | Leaf Area time point 1 |
2 | Leaf Area time point 2 |
3 | Leaf Area time point 3 |
4 | Roots Length time point 1 |
5 | Roots Length time point 2 |
6 | Roots Length time point 3 |
7 | Roots Coverage time point 1 |
8 | Roots Coverage time point 2 |
9 | Roots Coverage time point 3 |
10 | RGR of Leaf Area time point 2 |
11 | RGR of Leaf Area time point 3 |
12 | RGR of Roots Coverage time point 2 |
13 | RGR of Roots Coverage time point 3 |
14 | RGR of Roots Length time point 2 |
15 | RGR of Roots Length time point 3 |
WO 2009/141824
PCT/IL2009/000508
117 05 Jan 2018
190
Parameter symbol used in result Table 29 | Parameter name |
16 | Fresh Weight |
17 | Dry Weight |
Table 28.
Table 29
Gene | p.n. SEQ ID NO: | Ev. | Par | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 | 16 | 17 |
BDL 100 | 657 | 7872. 2 | P | 0.29 | 0.10 | 0.53 | 0.08 | 0.54 | 0.03 | |||||||||||
BDL 100 | 657 | 7872. 2 | Av | 1.55 | 1.21 | 1.66 | 1.95 | 1.49 | 1.63 | |||||||||||
BDL 100 | 657 | 7872. 3 | P | 0.60 | 0.08 | 0.12 | 0.18 | |||||||||||||
BDL 100 | 657 | 7872. 3 | Av | 1.10 | 1.13 | 1.71 | 1.51 | |||||||||||||
BDL 100 | 657 | 7873. 2 | P | 0.41 | 0.12 | 0.01 | 0.00 | |||||||||||||
BDL 100 | 657 | 7873. 2 | Av | 1.23 | 1.12 | 1.61 | 1.50 | |||||||||||||
BDL 100 | 657 | 7873. 4 | P | 0.28 | 0.32 | 0.13 | 0.33 | 0.21 | 0.36 | 0.47 | 0.01 | 0.45 | 0.48 | |||||||
BDL 100 | 657 | 7873. 4 | Av | 1.16 | 1.18 | 1.39 | 1.17 | 1.41 | 1.19 | 1.12 | 1.28 | 1.22 | 1.19 | |||||||
BDL 51 | 694 | 8021. 1 | P | 0.13 | 0.02 | 0.08 | ||||||||||||||
BDL 51 | 694 | 8021. 1 | Av | 1.23 | 2.20 | 1.47 | ||||||||||||||
BDL 51 | 694 | 8022. 4 | P | 0.00 | 0.09 | 0.05 | ||||||||||||||
BDL 51 | 694 | 8022. 4 | Av | 1.32 | 1.97 | 1.49 | ||||||||||||||
BDL 51 | 694 | 8022. 5 | P | 0.08 | 0.04 | |||||||||||||||
BDL 51 | 694 | 8022. 5 | Av | 1.14 | 1.49 | |||||||||||||||
BDL 51 | 694 | 8024. 4 | P | 0.36 | 0.00 | 0.16 | ||||||||||||||
BDL 51 | 694 | 8024. 4 | Av | 1.41 | 2.12 | 1.55 | ||||||||||||||
BDL 51 | 694 | 8024. 7 | P | 0.34 | 0.23 | |||||||||||||||
BDL 51 | 694 | 8024. 7 | Av | 1.29 | 1.28 | |||||||||||||||
BDL 82 | 704 | 7801. 3 | P | 0.23 | 0.00 | 0.04 | 0.00 |
WO 2009/141824
PCT/IL2009/000508
2018200117 05 Jan 2018
191
Gene | p.n. SEQ ID NO: | Ev. | Par | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 | 16 | 17 |
BDL 82 | 704 | 7801. 3 | Av | 1.18 | 1.51 | 2.15 | 1.67 | |||||||||||||
BDL 82 | 704 | 7802. 2 | P | 0.01 | 0.00 | 0.01 | ||||||||||||||
BDL 82 | 704 | 7802. 2 | Av | 1.24 | 2.69 | 1.98 | ||||||||||||||
BDL 82 | 704 | 7802. 3 | P | 0.02 | 0.11 | 0.03 | ||||||||||||||
BDL 82 | 704 | 7802. 3 | Av | 1.24 | 1.57 | 1.42 | ||||||||||||||
BDL 82 | 704 | 7803. 8 | P | 0.15 | 0.16 | 0.12 | 0.04 | 0.02 | ||||||||||||
BDL 82 | 704 | 7803. 8 | Av | 1.29 | 2.22 | 1.63 | 1.41 | 1.33 | ||||||||||||
BDL 82 | 704 | 7803. 9 | P | |||||||||||||||||
BDL 82 | 704 | 7803. 9 | Av | |||||||||||||||||
BDL 89 | 705 | 7812. 2 | P | 0.30 | 0.05 | 0.58 | 0.05 | 0.38 | 0.01 | |||||||||||
BDL 89 | 705 | 7812. 2 | Av | 1.19 | 1.50 | 1.52 | 2.31 | 1.41 | 1.65 | |||||||||||
BDL 89 | 705 | 7812. 5 | P | 0.05 | 0.01 | 0.00 | ||||||||||||||
BDL 89 | 705 | 7812. 5 | Av | 1.32 | 3.25 | 2.10 | ||||||||||||||
BDL 89 | 705 | 7814. 1 | P | 0.60 | 0.00 | 0.24 | 0.01 | |||||||||||||
BDL 89 | 705 | 7814. 1 | Av | 1.13 | 1.40 | 2.18 | 1.70 | |||||||||||||
BDL 89 | 705 | 7814. 4 | P | 0.07 | 0.33 | 0.07 | 0.07 | |||||||||||||
BDL 89 | 705 | 7814. 4 | Av | 1.35 | 1.19 | 1.74 | 1.52 | |||||||||||||
BDL 89 | 705 | 7814. 5 | P | 0.08 | 0.19 | 0.33 | 0.30 | 0.20 | 0.36 | |||||||||||
BDL 89 | 705 | 7814. 5 | Av | 1.29 | 1.26 | 1.79 | 1.56 | 1.56 | 1.30 | |||||||||||
BDL 95_S hort | 706 | 7841. 2 | P | 0.14 | 0.66 | 0.14 | 0.65 | 0.04 | ||||||||||||
BDL 95_S hort | 706 | 7841. 2 | Av | 1.22 | 1.29 | 1.42 | 1.17 | 1.27 | ||||||||||||
BDL 95_S hort | 706 | 7842. 12 | P | 0.30 | 0.05 | 0.04 | 0.07 | 0.20 | ||||||||||||
BDL 95_S hort | 706 | 7842. 12 | Av | 1.14 | 1.17 | 1.36 | 1.19 | 1.19 |
WO 2009/141824
PCT/IL2009/000508
2018200117 05 Jan 2018
192
Gene | p.n. SEQ ID NO: | Ev. | Par | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 | 16 | 17 |
BDL 95_S hort | 706 | 7842. 2 | Ρ | 0.15 | 0.29 | 0.08 | ||||||||||||||
BDL 95_S hort | 706 | 7842. 2 | Av | 1.45 | 1.27 | 1.28 | ||||||||||||||
BDL 95_S hort | 706 | 7842. 8 | Ρ | 0.35 | 0.00 | 0.07 | 0.07 | |||||||||||||
BDL 95_S hort | 706 | 7842. 8 | Av | 1.10 | 1.37 | 2.82 | 2.07 | |||||||||||||
BDL 95_S hort | 706 | 7843. 4 | P | 0.43 | 0.00 | 0.01 | 0.01 | 0.41 | ||||||||||||
BDL 95_S hort | 706 | 7843. 4 | Av | 1.14 | 1.42 | 3.00 | 2.12 | 1.26 | ||||||||||||
BDL 108 | 659 | 8122. 1 | P | 0.11 | 0.18 | 0.45 | 0.61 | 0.73 | 0.51 | |||||||||||
BDL 108 | 659 | 8122. 1 | Av | 1.28 | 1.24 | 1.44 | 1.13 | 1.16 | 1.20 | |||||||||||
BDL 108 | 659 | 8122. 2 | P | 0.09 | 0.02 | 0.00 | 0.00 | 0.12 | 0.01 | 0.77 | 0.38 | |||||||||
BDL 108 | 659 | 8122. 2 | Av | 1.59 | 1.37 | 1.82 | 2.09 | 1.29 | 1.71 | 1.11 | 1.17 | |||||||||
BDL 108 | 659 | 8123. 6 | P | 0.59 | 0.57 | 0.40 | 0.08 | |||||||||||||
BDL 108 | 659 | 8123. 6 | Av | 1.10 | 1.33 | 1.27 | 1.53 | |||||||||||||
BDL 108 | 659 | 8123. 5 | P | 0.04 | 0.29 | 0.25 | ||||||||||||||
BDL 108 | 659 | 8123. 5 | Av | 1.14 | 1.75 | 1.36 | ||||||||||||||
BDL 59 | 698 | 7792. 1 | P | 0.26 | 0.70 | |||||||||||||||
BDL 59 | 698 | 7792. 1 | Av | 1.38 | 1.11 | |||||||||||||||
BDL 59 | 698 | 7792. 2 | P | 0.33 | 0.31 | 0.02 | 0.25 | 0.14 | 0.01 | |||||||||||
BDL 59 | 698 | 7792. 2 | Av | 1.33 | 1.23 | 1.63 | 1.26 | 1.28 | 1.40 | |||||||||||
BDL 59 | 698 | 7792. 3 | P | 0.02 | 0.11 | 0.29 | ||||||||||||||
BDL 59 | 698 | 7792. 3 | Av | 1.36 | 1.43 | 1.28 | ||||||||||||||
BDL 59 | 698 | 7793. 3 | P | 0.06 | 0.32 | 0.30 | 0.16 | 0.11 | 0.05 | |||||||||||
BDL 59 | 698 | 7793. 3 | Av | 1.76 | 1.19 | 1.99 | 1.56 | 1.65 | 1.27 |
WO 2009/141824
PCT/IL2009/000508
2018200117 05 Jan 2018
193
Gene | p.n. SEQ ID NO: | Ev. | Par | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 | 16 | 17 |
BDL 59 | 698 | 7794. 1 | P | 0.18 | 0.11 | 0.13 | ||||||||||||||
BDL 59 | 698 | 7794. 1 | Av | 1.15 | 1.83 | 1.35 | ||||||||||||||
BDL 68 | 702 | 7761. 3 | P | 0.32 | 0.46 | |||||||||||||||
BDL 68 | 702 | 7761. 3 | Av | 1.15 | 1.17 | |||||||||||||||
BDL 68 | 702 | 7761. 5 | P | 0.40 | 0.15 | 0.21 | 0.14 | 0.20 | ||||||||||||
BDL 68 | 702 | 7761. 5 | Av | 2.43 | 1.86 | 1.58 | 1.60 | 1.42 | ||||||||||||
BDL 68 | 702 | 7761. 9 | P | |||||||||||||||||
BDL 68 | 702 | 7761. 9 | Av | |||||||||||||||||
BDL 68 | 702 | 7764. 1 | P | 0.00 | 0.53 | 0.22 | ||||||||||||||
BDL 68 | 702 | 7764. 1 | Av | 1.44 | 1.45 | 1.61 |
Table 29. Provided are the growth and biomass parameters of transgenic vs. control plants as measured in Tissue Culture assay under 1.5% PEG. “P” = P-value; “Av” = ratio between the averages of event and control. Note that when the average ratio is higher than “1” the effect of exogenous expression of the gene is an increase of the desired trait; “Par” = Parameter according to 5 the parameters listed in Table 28 above; “Ev” = event, “p.n.” = polynucleotide.
Table 30
Gen e | p.n. SEQ ID NO: | Ev. | Par | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 | 16 | 17 |
BDL 100 | 657 | 7872 .2 | P | 0.1 6 | 0.1 1 | 0.0 8 | 0.0 1 | |||||||||||||
BDL 100 | 657 | 7872 .2 | Av | 1.3 6 | 1.5 8 | 2.1 8 | 1.6 5 | |||||||||||||
BDL 100 | 657 | 7872 .3 | P | 0.4 0 | 0.1 9 | 0.0 2 | 0.0 3 | |||||||||||||
BDL 100 | 657 | 7872 .3 | Av | 1.1 3 | 1.1 3 | 1.9 6 | 1.6 0 | |||||||||||||
BDL 100 | 657 | 7873 .2 | P | 0.0 3 | 0.0 0 | 0.0 0 | ||||||||||||||
BDL 100 | 657 | 7873 .2 | Av | 1.5 2 | 2.0 8 | 1.7 2 | ||||||||||||||
BDL 100 | 657 | 7873 .3 | P | 0.6 0 | 0.3 6 | 0.5 6 | 0.5 2 | 0.1 5 | 0.0 2 | 0.0 1 | ||||||||||
BDL 100 | 657 | 7873 .3 | Av | 1.1 5 | 1.1 2 | 1.2 7 | 1.1 2 | 1.2 3 | 1.3 2 | 1.2 3 |
WO 2009/141824
PCT/IL2009/000508
2018200117 05 Jan 2018
194
Gen e | p.n. SEQ ID NO: | Ev. | Par | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 75 | 16 | 17 |
BDL 100 | 657 | 7873 .4 | P | 0.2 4 | 0.0 3 | 0.0 3 | 0.0 0 | 0.0 1 | 0.3 3 | 0.2 1 | 0.2 3 | 0.1 6 | 0.0 2 | |||||||
BDL 100 | 657 | 7873 .4 | Av | 1.2 5 | 1.3 6 | 1.3 9 | 1.5 5 | 1.9 6 | 1.1 2 | 1.1 8 | 1.2 2 | 1.1 3 | 1.4 2 | |||||||
BDL 51 | 694 | 8021 .1 | P | 0.0 6 | 0.0 0 | 0.0 0 | ||||||||||||||
BDL 51 | 694 | 8021 .1 | Av | 1.3 3 | 2.6 1 | 1.6 0 | ||||||||||||||
BDL 51 | 694 | 8022 .4 | P | 0.5 1 | 0.0 3 | 0.0 2 | 0.1 4 | |||||||||||||
BDL 51 | 694 | 8022 .4 | Av | 1.3 1 | 1.1 7 | 2.1 3 | 1.4 6 | |||||||||||||
BDL 51 | 694 | 8022 .5 | P | 0.0 2 | 0.0 9 | 0.0 8 | 0.0 0 | 0.0 2 | 0.0 6 | |||||||||||
BDL 51 | 694 | 8022 .5 | Av | 1.2 4 | 1.3 0 | 1.2 2 | 1.3 6 | 2.4 2 | 1.7 5 | |||||||||||
BDL 51 | 694 | 8024 .4 | P | 0.0 0 | 0.3 5 | 0.0 7 | ||||||||||||||
BDL 51 | 694 | 8024 .4 | Av | 1.3 2 | 3.1 0 | 1.8 6 | ||||||||||||||
BDL 51 | 694 | 8024 .7 | P | 0.5 5 | 0.0 4 | 0.0 9 | 0.0 5 | 0.2 4 | 0.1 8 | 0.3 8 | 0.2 3 | |||||||||
BDL 51 | 694 | 8024 .7 | Av | 1.1 1 | 1.4 8 | 1.0 9 | 2.3 0 | 1.1 2 | 1.2 4 | 1.1 9 | 1.1 5 | |||||||||
BDL 82 | 704 | 7801 .1 | P | 0.1 1 | 0.0 2 | 0.1 4 | ||||||||||||||
BDL 82 | 704 | 7801 .1 | Av | 1.2 6 | 3.2 3 | 1.7 6 | ||||||||||||||
BDL 82 | 704 | 7801 .3 | P | 0.1 3 | 0.0 0 | 0.0 0 | ||||||||||||||
BDL 82 | 704 | 7801 .3 | Av | 1.2 7 | 3.0 7 | 1.7 6 | ||||||||||||||
BDL 82 | 704 | 7802 .2 | P | 0.1 4 | 0.0 1 | 0.0 0 | ||||||||||||||
BDL 82 | 704 | 7802 .2 | Av | 1.3 7 | 5.5 5 | 2.6 9 | ||||||||||||||
BDL 82 | 704 | 7802 .3 | P | 0.5 2 | 0.4 3 | 0.4 1 | 0.5 0 | |||||||||||||
BDL 82 | 704 | 7802 .3 | Av | 1.1 4 | 1.1 1 | 1.1 7 | 1.1 7 | |||||||||||||
BDL 82 | 704 | 7803 .8 | P | 0.0 1 | 0.0 0 | |||||||||||||||
BDL 82 | 704 | 7803 .8 | Av | 2.1 6 | 1.7 7 | |||||||||||||||
BDL 82 | 704 | 7803 .9 | P | 0.6 1 | 0.1 2 | 0.0 1 | 0.5 3 | |||||||||||||
BDL 82 | 704 | 7803 .9 | Av | 1.1 1 | 1.8 1 | 1.4 9 | 1.1 4 | |||||||||||||
BDL 89 | 705 | 7812 .2 | P | 0.2 9 | 0.0 0 | 0.0 0 | 0.3 0 | 0.1 8 |
WO 2009/141824
PCT/IL2009/000508
2018200117 05 Jan 2018
195
Gen e | p.n. SEQ ID NO: | Ev. | Par | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 | 16 | 17 |
BDL 89 | 705 | 7812 .2 | Av | 1.1 3 | 1.3 0 | 1.3 8 | 1.1 1 | 1.1 6 | ||||||||||||
BDL 89 | 705 | 7812 .5 | P | 0.0 3 | 0.0 2 | 0.0 1 | ||||||||||||||
BDL 89 | 705 | 7812 .5 | Av | 1.3 9 | 5.2 8 | 2.8 3 | ||||||||||||||
BDL 89 | 705 | 7814 .1 | P | 0.0 0 | 0.0 1 | 0.0 0 | ||||||||||||||
BDL 89 | 705 | 7814 .1 | Av | 1.4 5 | 1.8 4 | 1.3 8 | ||||||||||||||
BDL 89 | 705 | 7814 .4 | P | 0.1 9 | 0.3 0 | 0.0 3 | 0.3 9 | 0.0 1 | 0.1 7 | |||||||||||
BDL 89 | 705 | 7814 .4 | Av | 1.1 9 | 1.2 1 | 1.6 1 | 1.1 6 | 1.4 9 | 1.1 4 | |||||||||||
BDL 89 | 705 | 7814 .5 | P | 0.4 2 | 0.2 2 | 0.0 9 | 0.0 4 | 0.0 3 | ||||||||||||
BDL 89 | 705 | 7814 .5 | Av | 1.1 1 | 1.2 0 | 1.3 6 | 1.7 4 | 1.5 9 | ||||||||||||
BDL 95_S hort | 706 | 7841 .2 | P | 0.0 7 | 0.0 0 | 0.0 0 | ||||||||||||||
BDL 95_S hort | 706 | 7841 .2 | Av | 1.3 1 | 2.7 5 | 1.8 1 | ||||||||||||||
BDL 95_S hort | 706 | 7842 .12 | P | 0.2 8 | 0.1 7 | 0.1 9 | 0.2 2 | 0.4 4 | 0.0 2 | 0.1 1 | 0.4 3 | 0.6 4 | ||||||||
BDL 95_S hort | 706 | 7842 .12 | Av | 1.1 5 | 1.1 3 | 1.1 7 | 1.2 6 | 1.1 4 | 1.2 4 | 1.1 6 | 1.2 5 | 1.1 1 | ||||||||
BDL 95_S hort | 706 | 7842 .2 | P | 0.1 7 | 0.1 9 | 0.0 2 | 0.0 0 | |||||||||||||
BDL 95_S hort | 706 | 7842 .2 | Av | 1.3 2 | 1.1 7 | 2.0 6 | 1.6 1 | |||||||||||||
BDL 95_S hort | 706 | 7842 .8 | P | 0.1 7 | 0.0 3 | 0.0 0 | 0.0 0 | |||||||||||||
BDL 95_S hort | 706 | 7842 .8 | Av | 1.1 4 | 1.1 8 | 2.1 7 | 1.4 4 | |||||||||||||
BDL 95_S hort | 706 | 7843 .4 | P | 0.0 1 | 0.0 1 | 0.0 0 | ||||||||||||||
BDL 95_S hort | 706 | 7843 .4 | Av | 1.6 7 | 4.5 8 | 2.5 9 | ||||||||||||||
BDL 108 | 659 | 8122 .1 | P | 0.3 2 | 0.3 1 | |||||||||||||||
BDL 108 | 659 | 8122 .1 | Av | 1.2 5 | 1.9 1 |
WO 2009/141824
PCT/IL2009/000508
2018200117 05 Jan 2018
196
Gen e | p.n. SEQ ID NO: | Ev. | Par | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 | 16 | 17 |
BDL 108 | 659 | 8122 .2 | P | 0.0 8 | 0.0 0 | 0.0 8 | 0.0 1 | 0.2 7 | 0.0 0 | 0.0 5 | 0.0 0 | 0.0 2 | ||||||||
BDL 108 | 659 | 8122 .2 | Av | 1.1 0 | 1.2 2 | 1.2 4 | 2.0 1 | 1.1 6 | 1.8 1 | 1.5 0 | 1.5 5 | 1.3 9 | ||||||||
BDL 108 | 659 | 8123 .6 | P | 0.1 5 | 0.0 2 | 0.0 9 | 0.0 7 | 0.0 7 | ||||||||||||
BDL 108 | 659 | 8123 .6 | Av | 1.2 5 | 1.5 6 | 1.5 7 | 1.2 1 | 1.3 6 | ||||||||||||
BDL 108 | 659 | 8123 .5 | P | 0.1 8 | 0.1 9 | |||||||||||||||
BDL 108 | 659 | 8123 .5 | Av | 1.6 2 | 1.4 0 | |||||||||||||||
BDL 59 | 698 | 7792 .1 | P | 0.1 1 | ||||||||||||||||
BDL 59 | 698 | 7792 .1 | Av | 1.5 0 | ||||||||||||||||
BDL 59 | 698 | 7792 .2 | P | 0.1 7 | 0.2 1 | 0.1 6 | 0.3 3 | 0.5 0 | ||||||||||||
BDL 59 | 698 | 7792 .2 | Av | 1.3 1 | 1.3 1 | 1.6 2 | 1.1 1 | 1.1 7 | ||||||||||||
BDL 59 | 698 | 7792 .3 | P | 0.0 1 | 0.2 7 | |||||||||||||||
BDL 59 | 698 | 7792 .3 | Av | 1.7 3 | 1.1 8 | |||||||||||||||
BDL 59 | 698 | 7793 .3 | P | 0.3 3 | 0.0 3 | 0.0 1 | 0.0 3 | 0.0 2 | 0.0 4 | |||||||||||
BDL 59 | 698 | 7793 .3 | Av | 1.1 2 | 1.8 9 | 1.7 5 | 1.8 7 | 1.3 9 | 1.4 0 | |||||||||||
BDL 59 | 698 | 7794 .1 | P | 0.1 4 | 0.0 8 | 0.2 9 | ||||||||||||||
BDL 59 | 698 | 7794 .1 | Av | 1.2 2 | 1.5 9 | 1.1 8 | ||||||||||||||
BDL 68 | 702 | 7761 .3 | P | 0.2 2 | 0.2 6 | 0.1 4 | 0.1 7 | 0.3 4 | ||||||||||||
BDL 68 | 702 | 7761 .3 | Av | 1.2 0 | 1.1 5 | 1.3 2 | 1.3 8 | 1.1 3 | ||||||||||||
BDL 68 | 702 | 7761 .5 | P | 0.3 0 | 0.0 2 | 0.4 6 | 0.0 2 | |||||||||||||
BDL 68 | 702 | 7761 .5 | Av | 1.5 6 | 1.7 1 | 1.2 2 | 1.5 9 | |||||||||||||
BDL 68 | 702 | 7761 .9 | P | 0.3 3 | ||||||||||||||||
BDL 68 | 702 | 7761 .9 | Av | 1.3 0 | ||||||||||||||||
BDL 68 | 702 | 7764 .1 | P | 0.0 8 | 0.1 5 | 0.3 8 | ||||||||||||||
BDL 68 | 702 | 7764 .1 | Av | 1.2 Ί | 1.7 7 | 1.2 1 |
Table 30. Provided are the growth and biomass parameters of transgenic vs. control plants as measured in Tissue Calture assay under 0.75 mM Nitrogen concentration. “P” = P-value; “Av” = ratio between the averages of event and control. Note that when the average ratio is higher than “1”
WO 2009/141824
PCT/IL2009/000508
2018200117 05 Jan 2018
197 the effect of exogenous expression of the gene is an increase of the desired trait; “Par” = Parameter according to the parameters listed in Table 28 above; “Ev” = event.
EXAMPLE 9
IMPROVING DESIRED TRAITS OF INTEREST IN TRANSGENIC PLANTS GROWN UNDER NORMAL CONDITIONS BY REDUCING GENE EXPRESSION
Transgenic plants exogenously expressing the BDL127 gene (SEQ ID NO:673) were assayed for a number of commercially desired traits under normal 10 conditions.
To analyze the effect of expression of the BDL127 exogenous polynucleotide in transgenic plants, plants were grown in pots with an adequate amount of nutrients and water. The plants were evaluated using various parameters for their overall size (biomass), structure (plant architecture), relative growth rate, time to inflorescence 15 emergence (bolting) and flowering, seed yield, weight of 1,000 seeds, dry matter, oil content and harvest index [(HI) seed yield/ dry matter]. Transgenic plants performance was compared to control plants grown in parallel under the same conditions. Mocktransgenic plants with an empty vector or expressing the uidA reporter gene (GUSIntron) under the same promoter were used as control.
Parameters were measured as described in Example 3 above.
Statistical analyses - All parameters including plant growth rate, plant area, biomass, plant architecture, time to bolting, time to flowering, weight of 1,000 seeds, seed yield, oil yield, dry matter, and harvest index area data were analyzed using t-test. To identify outperforming genes and constructs, results from mix of transformation 25 events or independent events were analyzed. For gene versus control analysis t- test was applied, using significance threshold of p < 0.1.
Experimental Results
The polynucleotide sequences of the invention were assayed for a number of commercially desired traits. Table 22 provides the parameters measured in a tissue 30 culture and green house assays (results are presented in Tables 31 and 32). In cases where a certain event appears more than once, the event was tested in several independent experiments.
WO 2009/141824
PCT/IL2009/000508
2018200117 05 Jan 2018
198
Analysis of plants in tissue culture assay - Table 31, hereinbelow, depicts analyses of transgenic plants overexpressing the BDL127 polynucleotide of the invention under the regulation of the constitutive 35S (SEQ ID NO:777) promoter.
Table 31
Gene | Ev. | Par. | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 | 16 | 17 |
BDL1 27 | 8172. 1 | P | 8.5E -03 | 1.5E -03 | 2.0E -03 | 2.4E -04 | 1.4E -03 | 1.6E -01 | 1.3E -03 | 4.7E -03 | 1.2E -01 | 2.6E -02 | 3.8E -01 | 2.3E -02 | |||||
BDL1 27 | 8172. 1 | Av | 7.4E -01 | 6.1E -01 | 6.3E -01 | 2.8E -01 | 5.1E -01 | 6.5E -01 | 1.7E -01 | 3.6E -01 | 5.3E -01 | 7.5E -01 | 8.7E -01 | 7.6E -01 | |||||
BDL1 27 | 8172. 4 | P | 4.5E -03 | 1.9E -05 | 3.3E -03 | 7.4E -04 | 2.2E -05 | 2.3E -04 | 2.4E -03 | 9.2E -04 | 4.1E -03 | 1.6E -02 | 4.9E -01 | 2.0E -02 | |||||
BDL1 27 | 8172. 4 | Av | 7.7E -01 | 6.2E -01 | 7.0E -01 | 4.1E -01 | 3.9E -01 | 5.2E -01 | 2.7E -01 | 2.1E -01 | 3.1E -01 | 7.3E -01 | 8.1E -01 | 7.6E -01 | |||||
BDL1 27 | 8172. 7 | P | 1.8E -01 | 3.8E -04 | 2.0E -03 | 3.4E -02 | 1.8E -03 | 1.7E -02 | 7.9E -02 | 2.9E -01 | 2.8E -01 | ||||||||
BDL1 27 | 8172. 7 | Av | 8.4E -01 | 3.5E -01 | 6.0E -01 | 6.7E -01 | 2.3E -01 | 5.3E -01 | 6.0E -01 | 8.9E -01 | 7.5E -01 | ||||||||
BDL1 27 | 8172. 8 | P | 4.8E -01 | 3.5E -01 | 3.1E -03 | 2.7E -01 | 2.2E -01 | 5.4E -01 | 3.8E -01 | 3.1E -01 | |||||||||
BDL1 27 | 8172. 8 | Av | 8.9E -01 | 8.5E -01 | 5.4E -01 | 8.0E -01 | 6.0E -01 | 9.0E -01 | 8.3E -01 | 8.7E -01 | |||||||||
BDL1 27 | 8172. 9 | P | 3.3E -03 | 1.8E -05 | 3.0E -03 | 3.1E -04 | 2.3E -05 | 4.5E -05 | 1.5E -03 | 6.5E -04 | 1.2E -03 | 1.3E -03 | 2.0E -01 | 7.4E -01 | 6.1E -02 | 4.9E -02 | |||
BDL1 27 | 8172. 9 | Av | 7.9E -01 | 5.2E -01 | 5.4E -01 | 3.4E -01 | 3.4E -01 | 3.7E -01 | 2.1E -01 | 1.6E -01 | 1.4E -01 | 5.1E -01 | 6.9E -01 | 9.0E -01 | 7.3E -01 | 6.4E -01 |
Table 31. “P” = P-value; “Av” = ratio between the averages of event and control. Note that when the average ratio is less than “1” the effect of exogenous expression of the gene is a decrease of the desired trait; “Par” = Parameter according to the parameters listed in Table 22 above; “Ev” = event.
Greenhouse assays - Tables 33-36 represent experiments that were done using greenhouse assays. Table 32 specifies the parameters that were measured in the green house assays and which are presented in Tables 33-36. In cases where a certain event appears more than once, the event was tested in several independent experiments.
Table 32
Parameter symbol used in result Tables 33-36 | Parameter name |
1 | Rosette Diameter time point 1 |
2 | Rosette Diameter time point 2 |
3 | Rosette Diameter time point 3 |
4 | Rosette Diameter time point 4 |
5 | Rosette Area time point 1 |
6 | Rosette Area time point 2 |
7 | Rosette Area time point 3 |
8 | Rosette Area time point 4 |
9 | Plot Coverage time point 1 |
WO 2009/141824
PCT/IL2009/000508
2018200117 05 Jan 2018
199
Parameter symbol used in result Tables 33-36 | Parameter name |
10 | Plot Coverage time point 2 |
11 | Plot Coverage time point 3 |
12 | Plot Coverage time point 4 |
13 | Leaf Number time point 1 |
14 | Leaf Number time point 2 |
15 | Leaf Number time point 3 |
16 | Leaf Number time point 4 |
17 | Leaf Blade Area time point 1 |
18 | Leaf Blade Area time point 2 |
19 | Leaf Blade Area time point 3 |
20 | Leaf Blade Area time point 4 |
21 | Leaf Petiole Area time point 1 |
22 | Leaf Petiole Area time point 2 |
23 | Leaf Petiole Area time point 3 |
24 | Leaf Petiole Area time point 4 |
25 | Blade Relative Area time point 1 |
26 | Blade Relative Area time point 2 |
27 | Blade Relative Area time point 3 |
28 | Blade Relative Area time point 4 |
29 | Petiole Relative Area time point 1 |
30 | Petiole Relative Area time point 2 |
31 | Petiole Relative Area time point 3 |
32 | Petiole Relative Area time point 4 |
33 | RGR of Leaf Blade Area time point 2 |
34 | RGR of Leaf Blade Area time point 3 |
35 | RGR of Leaf Blade Area time point 4 |
36 | RGR of Leaf Number time point 2 |
37 | RGR of Leaf Number time point 3 |
38 | RGR of Leaf Number time point 4 |
39 | RGR of Rosette Area time point 2 |
40 | RGR of Rosette Area time point 3 |
41 | RGR of Rosette Area time point 4 |
42 | RGR of Rosette Diameter time point 2 |
43 | RGR of Rosette Diameter time point 3 |
44 | RGR of Rosette Diameter time point 4 |
45 | RGR of Plot Coverage time point 2 |
46 | RGR of Plot Coverage time point 3 |
47 | RGR of Plot Coverage time point 4 |
48 | Bolting |
49 | Flowering |
50 | Dry Weight |
51 | Seed Yield |
52 | Harvest Index |
53 | 1000 Seeds Weight |
54 | oil content |
55 | Fresh Weight |
Table 32.
WO 2009/141824
PCT/IL2009/000508
2018200117 05 Jan 2018
200
Table 33
Gene | Ev | Par | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 | 16 |
BDL1 27 | 8172. 10 | P | ||||||||||||||||
BDL1 27 | 8172. 10 | Av | ||||||||||||||||
BDL1 27 | 8172. 4 | P | 1.2E -03 | 1.7E -03 | 7.1E -03 | 1.7E -03 | 5.9E -03 | 1.6E -03 | 7.1E -03 | 1.7E -03 | 5.9E -03 | 1.6E -03 | ||||||
BDL1 27 | 8172. 4 | Av | 7.6E -01 | 7.7E -01 | 7. IE -01 | 2.0E -01 | 6.7E -01 | 6.5E -01 | 7.1E -01 | 2.0E -01 | 6.7E -01 | 6.5E -01 | ||||||
BDL1 27 | 8172. 7 | P | ||||||||||||||||
BDL1 27 | 8172. 7 | Av | ||||||||||||||||
BDL1 27 | 8172. 8 | P | 8.0E -04 | 2.2E -04 | 1.8E -02 | 1.2E -02 | 1.7E -02 | 3.3E -02 | 1.8E -02 | 1.2E -02 | 1.7E -02 | 3.3E -02 | 3.6E -04 | |||||
BDL1 27 | 8172. 8 | Av | 7.4E -01 | 7.0E -01 | 6.2E -01 | 5.7E -01 | 5.2E -01 | 5.2E -01 | 6.2E -01 | 5.7E -01 | 5.2E -01 | 5.2E -01 | 7.8E -01 | |||||
BDL1 27 | 8172. 9 | P | 2.1E -02 | 6.4E -03 | 8.8E -04 | 7.1E -04 | 1.1E -02 | 4.4E -04 | 1.1E -02 | 4.4E -04 | 4.5E -02 | |||||||
BDL1 27 | 8172. 9 | Av | 8.0E -01 | 7.1E -01 | 7.3E -01 | 7.3E -01 | 6. IE -01 | 5.6E -01 | 6.1E -01 | 5.6E -01 | 8.5E -01 |
Table 33. “P” = P-value; “Av” = ratio between the averages of event and control. Note that when the average ratio is less than “1” the effect of exogenous expression of the gene is a decrease of the desired trait; “Par” = Parameter according to the parameters listed in Table 22 above; “Ev” = event.
Table 34
Gene | Ev | Par | 17 | 18 | 19 | 20 | 21 | 22 | 23 | 24 | 25 | 26 | 27 | 28 | 29 | 30 | 31 | 32 |
BDL1 27 | 8172. 10 | P | ||||||||||||||||
BDL1 27 | 8172. 10 | Av | ||||||||||||||||
BDL1 27 | 8172. 4 | P | 5.4E -04 | 2.0E -03 | 7.7E -03 | |||||||||||||
BDL1 27 | 8172. 4 | Av | 3.3E -01 | 6.9E -01 | 6.3E -01 | |||||||||||||
BDL1 27 | 8172. 7 | P | 1.8E -02 | 3.1E -02 | ||||||||||||||
BDL1 27 | 8172. 7 | Av | 6.8E -01 | 8.0E -01 | ||||||||||||||
BDL1 27 | 8172. 8 | P | 3.3E -03 | 1.4E -03 | 2.1E -02 | |||||||||||||
BDL1 27 | 8172. 8 | Av | 6.9E -01 | 6.2E -01 | 5.6E -01 | |||||||||||||
BDL1 27 | 8172. 9 | P | 3.8E -04 | |||||||||||||||
BDL1 27 | 8172. 9 | Av | 5.7E -01 |
Table 34. “P” = P-value; “Av” = ratio between the averages of event and control. Note that when the average ratio is less than “1” the effect of exogenous expression of the gene is a decrease of the desired trait; “Par” = Parameter according to the parameters listed in Table 22 above; “Ev” = event.
WO 2009/141824
PCT/IL2009/000508
2018200117 05 Jan 2018
201
Table 35
Gene | Ev | Par | 33 | 34 | 35 | 36 | 37 | 38 | 39 | 40 | 41 | 42 | 43 | 44 | 45 | 46 | 47 | 48 |
BDL1 27 | 8172. 10 | P | ||||||||||||||||
BDL1 27 | 8172. 10 | Av | ||||||||||||||||
BDL1 27 | 8172. 4 | P | 3.0E -07 | 4. IE -02 | 4.1E -02 | |||||||||||||
BDL1 27 | 8172. 4 | Av | 1.1E -02 | 5.2E -02 | 5.2E -02 | |||||||||||||
BDL1 27 | 8172. 7 | P | ||||||||||||||||
BDL1 27 | 8172. 7 | Av | ||||||||||||||||
BDL1 27 | 8172. 8 | P | ||||||||||||||||
BDL1 27 | 8172. 8 | Av | ||||||||||||||||
BDL1 27 | 8172. 9 | P | 3.4E -02 | 2.1E -02 | 3.4E -02 | |||||||||||||
BDL1 27 | 8172. 9 | Av | 8.0E -01 | 7.4E -01 | 8.0E -01 |
Table 35. “P” = P-value; “Av” = ratio between the averages of event and control. Note that when the average ratio is less than “1” the effect of exogenous expression of the gene is a decrease of the desired trait; “Par” = Parameter according to the parameters listed in Table 22 above; “Ev” = event.
Table 36
Gene | Ev | Par | 49 | 50 | 51 | 52 | 53 | 54 | 55 |
BDL127 | 8172.10 | P | |||||||
BDL127 | 8172.10 | Av | |||||||
BDL127 | 8172.4 | P | 2.0E-02 | ||||||
BDL127 | 8172.4 | Av | 6.9E-01 | ||||||
BDL127 | 8172.7 | P | 2.0E-02 | ||||||
BDL127 | 8172.7 | Av | 7.3E-01 | ||||||
BDL127 | 8172.8 | P | |||||||
BDL127 | 8172.8 | Av | |||||||
BDL127 | 8172.9 | P | 3.1E-02 | ||||||
BDL127 | 8172.9 | Av | 8.1E-01 |
Table 36. “P” = P-value; “Av” = ratio between the averages of event and control. Note that when the average ratio is less than “1” the effect of exogenous expression of the gene is 15 a decrease of the desired trait; “Par” = Parameter according to the parameters listed in Table above; “Ev” = event.
These results demonstrate that transformation of plants with the BDL127 gene results in decreased yield, seed yield, biomass and growth rate and thus agents which
WO 2009/141824
PCT/IL2009/000508
2018200117 05 Jan 2018
202 downregulate the expression level of the BDL127 gene in plants such as co-suppression agents, antisense suppression, RNA interference, remodeling of the promoter structure and/or Ribozyme can increase yield, seed yield, biomass and growth rate of a plant.
The genes identified herein improve plant yield in general, and more specifically oil yield, seed yield, oil content, plant growth rate, plant biomass, root measurements, ABST, NUE and plant vigor. The output of the bioinformatics method described herein is a set of genes highly predicted to improve yield (seed yield, oil yield and content, biomass) and/or other agronomic important yields by modifying their 10 expression. Although each gene is predicted to have its own impact, modifying the mode of expression of more than one gene is expected to provide an additive or synergistic effect on the plant yield, plant growth rate, root measurements, ABST, NUE, plant vigor and/or other agronomic important yields performance. Altering the expression of each gene described here alone or set of genes together increases the 15 overall yield plant growth rate, root measurements, ABST, NUE, plant vigor and/or
Although the invention has been described in conjunction with specific embodiments thereof, it is evident that many alternatives, modifications and variations will be apparent to those skilled in the art. Accordingly, it is intended to embrace all 20 such alternatives, modifications and variations that fall within the spirit and broad scope of the appended claims.
All publications, patents and patent applications mentioned in this specification are herein incorporated in their entirety by reference into the specification, to the same extent as if each individual publication, patent or patent application was 25 specifically and individually indicated to be incorporated herein by reference. In addition, citation or identification of any reference in this application shall not be construed as an admission that such reference is available as prior art to the present invention. To the extent that section headings are used, they should not be construed as necessarily limiting.
WO 2009/141824
PCT/IL2009/000508
2018200117 05 Jan 2018
203
CD-ROM Content
The following lists the file content of the CD-ROM which is enclosed herewith and filed with the application. File information is provided as: File name/byte size/date of creation/operating system/machine format.
CD-ROM1 (1 file of SEQUENCE LISTING):
1. 45731 ST25 .txt”/ 1,886,208 bytes/21 May 2009/ Microsoft Windows XP
Professional/ PC
204
2018200117 05 Jan 2018
Other embodiments of the invention as described herein are defined in the following paragraphs:
1. A method of increasing oil content, yield, growth rate, biomass, vigor, abiotic stress tolerance and/or nitrogen use efficiency of a plant, comprising expressing within the plant an exogenous polynucleotide comprising a nucleic acid sequence at least 80 % identical to SEQ ID NOs:18, 1-16, 19-50, 101-378, 657-672, 674-706, 716-719, 724-741 and 755-763 with the proviso that the nucleic acid sequence is not as set forth by SEQ ID NO:756 or 762, thereby increasing the oil content, yield, growth rate, biomass, vigor, abiotic stress tolerance and/or nitrogen use efficiency of the plant,
2. A method of increasing oil content, yield, growth rate, biomass, vigor, abiotic stress tolerance and/or nitrogen use efficiency of a plant, comprising expressing within the plant an exogenous polynucleotide comprising the nucleic acid sequence selected from the group consisting of SEQ ID NOs:18, 1-16, 19-50, 101-378, 657-672, 674-706, 716-719, 724-741, 755, 757-761 and 763, thereby increasing the oil content, yield, growth rate, biomass, vigor, abiotic stress tolerance and/or nitrogen use efficiency of the plant.
3. A method of increasing oil content, yield, growth rate, biomass, vigor, abiotic stress tolerance and/or nitrogen use efficiency of a plant, comprising transforming the plant with an exogenous polynucleotide capable of downregulating the expression level of a nucleic acid sequence at least 80 % identical to SEQ ID NO: 17 or 673, thereby increasing the oil content, yield, growth rate, biomass, vigor, abiotic stress tolerance and/or nitrogen use efficiency of the plant.
4. A method of increasing oil content, yield, growth rate, biomass, vigor, abiotic stress tolerance and/or nitrogen use efficiency of a plant, comprising transforming the plant with an exogenous polynucleotide capable of downregulating the expression level of the nucleic acid sequence set forth in SEQ ID NO: 17 or 673, thereby increasing the oil content, yield, growth rate, biomass, vigor, abiotic stress tolerance and/or nitrogen use efficiency of the plant.
5. A method of producing oil, comprising:
(a) providing the plant according to paragraph 1, 2, 3 or 4; and (b) extracting the oil from the plant;
thereby producing the oil.
6. An isolated polynucleotide comprising a nucleic acid sequence at least 80 % identical to SEQ ID NOs:18, 1-16, 19-50, 101-378, 657-672, 674-706, 716-719, 724-741 and 755-763 with the proviso that the nucleic acid sequence is not as set forth by SEQ ID NO:756 or 762.
7. An isolated polynucleotide comprising the nucleic acid sequence selected from the
205
2018200117 05 Jan 2018 group consisting of SEQ ID NOs:18, 1-16, 19-50, 101-378, 657-672, 674-706, 716-719, 724741,755,757-761 and 763.
8. An isolated polynucleotide comprising a nucleic acid sequence capable of downregulating the expression level of a nucleic acid sequence at least 80 % identical to SEQ ID NO: 17 or 673.
9. An isolated polynucleotide comprising a nucleic acid sequence capable of downregulating the expression level of the nucleic acid sequence set forth in SEQ ID NO: 17 or 673.
10. An isolated polynucleotide comprising a nucleic acid sequence encoding a polypeptide which comprises an amino acid sequence at least 80 % homologous to the amino acid sequence set forth in SEQ ID NOs:68, 51-66, 69-100, 379-656, 707-715, 720-723, 742-754 and 764-772 with the proviso that the amino acid sequence is not as set forth by SEQ ID NO: 765 or 771.
11. An isolated polynucleotide comprising a nucleic acid sequence encoding a polypeptide which comprises the amino acid sequence selected from the group consisting of SEQ ID NOs: 68, 51-66, 69-100, 379-656, 707-715, 720-723, 742-754, 764, 766-770 and 772.
12. An isolated polynucleotide comprising a nucleic acid sequence capable of downregulating the expression level or activity of a polypeptide at least 80 % homologous to the polypeptide set forth by SEQ ID NO:67.
13. An isolated polynucleotide comprising a nucleic acid sequence capable of downregulating the expression level or activity of the polypeptide set forth by SEQ ID NO:67.
14. A nucleic acid construct comprising the isolated polynucleotide of paragraph 6, 7, 8, 9, 10, 11, 12 or 13, and a promoter for directing transcription of said nucleic acid sequence in a host cell.
15. An isolated polypeptide comprising an amino acid sequence at least 80 % homologous to SEQ ID NO:68, 51-66, 69-100, 379-656, 707-715, 720-723, 742-754, 764-771 or 772 with the proviso that the amino acid sequence is not as set forth by SEQ ID NO:765 or 771.
16. An isolated polypeptide comprising the amino acid sequence selected from the group consisting of SEQ ID NOs: 68, 51-66, 69-100, 379-656, 707-715, 720-723, 742-754, 764, 766770 and 772.
17. A nucleic acid construct comprising a nucleic acid sequence selected from the group consisting of SEQ ID NOs:779-792 and a heterologous polynucleotide sequence, wherein said nucleic acid sequence is capable of regulating expression of said heterologous polynucleotide in a host cell.
18. The nucleic acid construct of paragraph 17, wherein said heterologous polynucleotide is
206
2018200117 05 Jan 2018 a reporter gene.
19. The nucleic acid construct of paragraph 17, wherein said regulating said expression of said heterologous polynucleotide is in a tissue specific manner.
20. The nucleic acid construct of paragraph 17, wherein said regulating said expression of said heterologous polynucleotide is in a developmental stage - specific manner.
21. The nucleic acid construct of paragraph 17, wherein said heterologous polynucleotide comprises a nucleic acid sequence at least 80 % identical to the nucleic acid sequence selected from the group consisting of SEQ ID NOs:18, 1-16, 19-50, 101-378, 657-672, 674-706, 716719, 724-741 and 755-763 with the proviso that the nucleic acid sequence is not as set forth by SEQ ID NO:756 or 762.
22. The nucleic acid construct of paragraph 17, wherein said heterologous polynucleotide encodes an amino acid sequence at least at least 80 % homologous to SEQ ID NOs:68, 51-66, 69-100, 379-656, 707-715, 720-723, 742-754 and 764-772 with the proviso that the amino acid sequence is not as set forth by SEQ ID NO: 765 or 771.
23. A method of increasing oil content, yield, growth rate, biomass, vigor, abiotic stress tolerance and/or nitrogen use efficiency of a plant comprising expressing within the plant the nucleic acid construct of paragraph 17, wherein said heterologous polynucleotide comprises a nucleic acid sequence at least 80 % identical to SEQ ID NOs:18, 1-16, 19-50, 101-378, 657672, 674-706, 716-719, 724-741 and 755-763 with the proviso that the nucleic acid sequence is not as set forth by SEQ ID NO:756 or 762, thereby increasing the oil content, yield, growth rate, biomass, vigor, abiotic stress tolerance and/or nitrogen use efficiency of the plant.
24. A method of increasing oil content, yield, growth rate, biomass, vigor, abiotic stress tolerance and/or nitrogen use efficiency of a plant comprising expressing within the plant the nucleic acid construct of paragraph 17, wherein said heterologous polynucleotide encodes an amino acid sequence at least at least 80 % homologous to SEQ ID NOs:68, 51-66, 69-100, 379656, 707-715, 720-723, 742-754 and 764-772 with the proviso that the amino acid sequence is not as set forth by SEQ ID NO: 765 or 771, thereby increasing the oil content, yield, growth rate, biomass, vigor, abiotic stress tolerance and/or nitrogen use efficiency of the plant.
25. A plant cell exogenously expressing the polynucleotide of paragraph 6, 7, 8, 9, 10, 11, 12 or 13 or the nucleic acid construct of paragraph 14, 17, 18, 19, 20, 21 or 22.
26. A plant cell exogenously expressing the polypeptide of paragraph 15 or 16.
27. The method of paragraph 1 or 23, the isolated polynucleotide of paragraph 6, the nucleic acid construct of paragraph 14 or 21 or the plant cell of paragraph 25, wherein said nucleic acid sequence is as set forth in SEQ ID NO:18, 1-16, 19-50, 101-378, 657-672, 674-706, 716-719,
207
2018200117 05 Jan 2018
724-741, 755, 757-761 or 763.
28. The method of paragraph 1, 2, 5 or 23, the isolated polynucleotide of paragraph 6 or 7, the nucleic acid construct of paragraph 14 or 21 or the plant cell of paragraph 25, wherein said polynucleotide consists of the nucleic acid sequence selected from the group consisting of SEQ ID NOs:18, 1-16, 19-50, 101-378, 657-672, 674-706, 716-719, 724-741, 755, 757-761 and 763.
29. The method of paragraph 1, 2 or 5, or the isolated polynucleotide of paragraph 6, 7, 10 or 11, wherein said nucleic acid sequence encodes an amino acid sequence at least 80 % homologous to SEQ ID NO:68, 51-66, 69-100, 379-656, 707-715, 720-723, 742-754, 764-771 or 772 with the proviso that the amino acid sequence is not as set forth by SEQ ID NO: 765 or 771.
30. The method of paragraph 1, 2 or 5, or the isolated polynucleotide of paragraph 6 or 7, wherein said nucleic acid sequence encodes the amino acid sequence selected from the group consisting of SEQ ID NOs: 68, 51-66, 69-100, 379-656, 707-715, 720-723, 742-754, 764, 766770 and 772.
31. The plant cell of paragraph 25 or 26, wherein said plant cell forms part of a plant.
32. The method of paragraph 1, 2, 3, 4, 23 or 24, further comprising growing the plant expressing said exogenous polynucleotide under the abiotic stress.
33. The method of paragraph 1, 2, 3, 4, 23, 24 or 32, wherein said abiotic stress is selected from the group consisting of salinity, drought, water deprivation, low temperature, high temperature, heavy metal toxicity, anaerobiosis, nutrient deficiency, nutrient excess, atmospheric pollution and UV irradiation.
34. The method of paragraph 3, 4 or 5, the isolated polynucleotide of paragraph 8, 9, 12 or 13, the nucleic acid construct of paragraph 14 or the plant cell of paragraph 25, wherein said polynucleotide is a co-suppression polynucleotide, an antisense polynucleotide, an RNAinterference polynucleotide or a Ribozyme polynucleotide.
Still further embodiments are within the scope of the following claims.
Claims (17)
1. A method of increasing yield, growth rate, biomass, vigor, abiotic stress tolerance and/or nitrogen use efficiency of a plant, comprising over-expressing within the plant a polypeptide comprising an amino acid sequence at least 80 % identical to the amino acid sequence set forth in SEQ ID NO: 96, wherein said abiotic stress is drought and/or osmotic stress, thereby increasing the yield, growth rate, biomass, vigor, abiotic stress tolerance and/or nitrogen use efficiency of the plant.
2. A method of producing a crop, comprising:
(a) transforming parent plants with an exogenous polynucleotide comprising a nucleic acid sequence encoding a polypeptide at least 80 % identical to the amino acid sequence set forth in SEQ ID NO: 96;
(b) obtaining a population of transformed crop plants from step (a); and (c) selecting a transformed crop plant from step (b) which expresses said exogenous polynucleotide, and which exhibits an increased yield, increased growth rate, increased biomass, increased vigor, increased abiotic stress tolerance and/or increased nitrogen use efficiency as compared to a wild type plant of the same species which is grown under the same growth conditions, wherein said abiotic stress is drought and/or osmotic stress, thereby producing the crop.
3. A method of selecting plants having increased yield, growth rate, biomass, vigor, abiotic stress tolerance and/or nitrogen use efficiency, comprising:
(a) obtaining a population of transgenic plants over-expressing a polypeptide comprising an amino acid sequence at least 80 % identical to the amino acid sequence set forth in SEQ ID NO: 96, as compared to a wild type plant of the same species, and (b) selecting from said population of step (a) a plant which exhibits an increased yield, increased growth rate, increased biomass, increased vigor, increased abiotic stress tolerance and/or increased nitrogen use efficiency as compared to a wild type plant of the same species which is grown under the same growth conditions, wherein said abiotic stress is drought and/or osmotic stress, thereby selecting the plants having the increased yield, growth rate, biomass, vigor, abiotic stress tolerance and/or nitrogen use efficiency.
209
2018200117 14 Feb 2019
4. The method of any one of claims 1 to 3, wherein said polypeptide is expressed from a polynucleotide comprising a nucleic acid sequence at least 80 % identical to SEQ ID NO: 702 or 46.
5. A nucleic acid construct comprising an isolated polynucleotide comprising a nucleic acid sequence encoding a polypeptide which comprises an amino acid sequence at least 80 % identical to the amino acid sequence set forth in SEQ ID NO: 96, and a promoter for directing transcription of said nucleic acid sequence in a host cell, wherein said promoter is heterologous to said isolated polynucleotide and wherein said promoter comprises a nucleic acid sequence selected from the group consisting of SEQ ID NOs:779-792.
6. A nucleic acid construct comprising an isolated polynucleotide comprising a nucleic acid sequence at least 80 % identical to SEQ ID NO: 702 or 46, and a promoter for directing transcription of said nucleic acid sequence in a host cell, wherein said promoter is heterologous to said isolated polynucleotide and wherein said promoter comprises a nucleic acid sequence selected from the group consisting of SEQ ID NOs:779-792.
7. A plant cell transformed with the nucleic acid construct of claim 5 or claim 6.
8. A transgenic plant transformed with the nucleic acid construct of claim 5 or claim 6.
9. The method of any one of claims 1 to 3, the nucleic acid construct of claim 5, the plant cell of claim 7, or the transgenic plant of claim 8, wherein said amino acid sequence is at least 85 % identical to the amino acid sequence set forth in SEQ ID NO: 96.
10. The method of any one of claims 1 to 3 the nucleic acid construct of claim 5, the plant cell of claim 7, or the transgenic plant of claim 8, wherein said amino acid sequence is at least 90 % identical to the amino acid sequence set forth in SEQ ID NO: 96.
11. The method of any one of claims 1 to 3 the nucleic acid construct of claim 5, the plant cell of claim 7, or the transgenic plant of claim 8, wherein said amino acid sequence is at least 95 % identical to the amino acid sequence set forth in SEQ ID NO: 96.
210
2018200117 14 Feb 2019
12. The method of any one of claims 1 to 3, the nucleic acid construct of claim 5, the plant cell of claim 7, or the transgenic plant of claim 8, wherein said amino acid sequence is selected from the group consisting of SEQ ID NOs: 96, and 589-592.
13. The method of claim 2 or claim 4, the nucleic acid construct of claim 5 or claim 6, the plant cell of claim 7, or the transgenic plant of claim 8, wherein said nucleic acid sequence is as set forth in SEQ ID NO: 702, 46, 311, 312, 313 or 314.
14. The method of any one of claims 1 to 3 and 9 to 13, further comprising growing the plant expressing said exogenous polynucleotide under the abiotic stress.
15. The method of any one of claims 1, 4, and 9 to 13, further comprising selecting a plant over-expressing said polypeptide for an increased nitrogen use efficiency as compared to a wild type plant of the same species which is grown under the same growth conditions.
16. The method of any one of claims 1, 4, and 9 to 13, further comprising selecting a plant over-expressing said polypeptide for an increased yield and/or growth rate as compared to a wild type plant of the same species which is grown under the same growth conditions.
17. The method of any one of claims 1, 4, and 9 to 13, further comprising selecting a plant over-expressing said polypeptide for a reduced time to inflorescence emergence as compared to a wild type plant of the same species which is grown under the same growth conditions.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU2018200117A AU2018200117B2 (en) | 2008-05-22 | 2018-01-05 | Isolated Polynucleotides and Polypeptides and Methods of Using Same for Increasing Plant Utility |
Applications Claiming Priority (8)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US7188508P | 2008-05-22 | 2008-05-22 | |
US61/071,885 | 2008-05-22 | ||
US12929608P | 2008-06-17 | 2008-06-17 | |
US61/129,296 | 2008-06-17 | ||
PCT/IL2009/000508 WO2009141824A2 (en) | 2008-05-22 | 2009-05-21 | Isolated polynucleotides and polypeptides and methods of using same for increasing plant yield, biomass, growth rate, vigor, oil content, abiotic stress tolerance of plants and nitrogen use efficieny |
AU2009250806A AU2009250806B2 (en) | 2008-05-22 | 2009-05-21 | Isolated polynucleotides and polypeptides and methods of using same for increasing plant utility |
AU2015202781A AU2015202781B2 (en) | 2008-05-22 | 2015-05-22 | Isolated Polynucleotides and Polypeptides and Methods of Using Same for Increasing Plant Utility |
AU2018200117A AU2018200117B2 (en) | 2008-05-22 | 2018-01-05 | Isolated Polynucleotides and Polypeptides and Methods of Using Same for Increasing Plant Utility |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2015202781A Division AU2015202781B2 (en) | 2008-05-22 | 2015-05-22 | Isolated Polynucleotides and Polypeptides and Methods of Using Same for Increasing Plant Utility |
Publications (2)
Publication Number | Publication Date |
---|---|
AU2018200117A1 AU2018200117A1 (en) | 2018-01-25 |
AU2018200117B2 true AU2018200117B2 (en) | 2019-03-28 |
Family
ID=53276503
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2015202781A Ceased AU2015202781B2 (en) | 2008-05-22 | 2015-05-22 | Isolated Polynucleotides and Polypeptides and Methods of Using Same for Increasing Plant Utility |
AU2018200117A Ceased AU2018200117B2 (en) | 2008-05-22 | 2018-01-05 | Isolated Polynucleotides and Polypeptides and Methods of Using Same for Increasing Plant Utility |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2015202781A Ceased AU2015202781B2 (en) | 2008-05-22 | 2015-05-22 | Isolated Polynucleotides and Polypeptides and Methods of Using Same for Increasing Plant Utility |
Country Status (1)
Country | Link |
---|---|
AU (2) | AU2015202781B2 (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TR201808744T4 (en) | 2008-05-22 | 2018-07-23 | Evogene Ltd | Isolated polynucleotides and polypeptides and methods for their use to enhance plant benefit. |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1586645A2 (en) * | 1999-02-25 | 2005-10-19 | Ceres Incorporated | Sequence-determined DNA fragments and corresponding polypeptides encoded thereby |
US20060150283A1 (en) * | 2004-02-13 | 2006-07-06 | Nickolai Alexandrov | Sequence-determined DNA fragments and corresponding polypeptides encoded thereby |
US20060183137A1 (en) * | 2000-08-24 | 2006-08-17 | The Scripps Research Institute | Stress-regulated genes of plants, transgenic plants containing same, and methods of use |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1033405A3 (en) * | 1999-02-25 | 2001-08-01 | Ceres Incorporated | Sequence-determined DNA fragments and corresponding polypeptides encoded thereby |
US7569389B2 (en) * | 2004-09-30 | 2009-08-04 | Ceres, Inc. | Nucleotide sequences and polypeptides encoded thereby useful for modifying plant characteristics |
US20060107345A1 (en) * | 2003-09-30 | 2006-05-18 | Nickolai Alexandrov | Sequence-determined DNA fragments and corresponding polypeptides encoded thereby |
-
2015
- 2015-05-22 AU AU2015202781A patent/AU2015202781B2/en not_active Ceased
-
2018
- 2018-01-05 AU AU2018200117A patent/AU2018200117B2/en not_active Ceased
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1586645A2 (en) * | 1999-02-25 | 2005-10-19 | Ceres Incorporated | Sequence-determined DNA fragments and corresponding polypeptides encoded thereby |
US20060183137A1 (en) * | 2000-08-24 | 2006-08-17 | The Scripps Research Institute | Stress-regulated genes of plants, transgenic plants containing same, and methods of use |
US20060150283A1 (en) * | 2004-02-13 | 2006-07-06 | Nickolai Alexandrov | Sequence-determined DNA fragments and corresponding polypeptides encoded thereby |
Also Published As
Publication number | Publication date |
---|---|
AU2015202781A1 (en) | 2015-06-11 |
AU2015202781B2 (en) | 2017-10-12 |
AU2018200117A1 (en) | 2018-01-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US20210115460A1 (en) | Isolated polynucleotides and polypeptides and methods of using same for increasing plant utility | |
AU2017279805B9 (en) | Isolated Polynucleotides and Polypeptides and Methods of Using Same for Increasing Plant Yield | |
US20210024946A1 (en) | Isolated polypeptides and polynucleotides useful for increasing nitrogen use efficiency, abiotic stress tolerance, yield and biomass in plants | |
AU2017251769B2 (en) | Polynucleotides, Polypeptides Encoded Thereby, and Methods of Using Same for Increasing Abiotic Stress Tolerance, Biomass and/or Yield in Plants Expressing Same | |
EP2519097B1 (en) | Isolated polynucleotides and polypeptides and methods of using same for increasing plant yield, biomass, growth rate, vigor, oil content, abiotic stress tolerance of plants and nitrogen use efficiency | |
AU2018200117B2 (en) | Isolated Polynucleotides and Polypeptides and Methods of Using Same for Increasing Plant Utility | |
AU2009309242B9 (en) | Isolated polynucleotides and polypeptides and methods of using same for increasing plant yield |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FGA | Letters patent sealed or granted (standard patent) | ||
MK14 | Patent ceased section 143(a) (annual fees not paid) or expired |